Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23428.Concentration of VLDL Particles,AGRP,Agouti-related protein,42754,0.212043995908548,0.00478488186052706,0.202665627461915,0.221422364355181,0
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN1,CCN family member 1,42569,0.303858468103055,0.00678582238419649,0.29055825623003,0.317158679976081,0
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFBP1,Fibroblast growth factor-binding protein 1,42679,0.124647721227784,0.00308788997858359,0.11859545686976,0.130699985585808,0
NMR metabolomics,X23428.Concentration of VLDL Particles,LDLR,Low-density lipoprotein receptor,42644,0.346594046816281,0.00408276460861667,0.338591828183392,0.354596265449169,0
NMR metabolomics,X23428.Concentration of VLDL Particles,NPY,Pro-neuropeptide Y,42721,0.258158305211833,0.00597384313703753,0.24644957266324,0.269867037760427,0
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G7,Platelet-activating factor acetylhydrolase,42611,0.207683477579883,0.00275029369423328,0.202292901939186,0.21307405322058,0
NMR metabolomics,X23428.Concentration of VLDL Particles,TFPI,Tissue factor pathway inhibitor,42618,0.116358597743799,0.00289293753520414,0.110688440174798,0.122028755312799,0
NMR metabolomics,X23428.Concentration of VLDL Particles,MFGE8,Lactadherin,42611,0.154248226156179,0.00410673984227312,0.146199016065323,0.162297436247034,1.17288054244702e-293
NMR metabolomics,X23428.Concentration of VLDL Particles,HHEX,Hematopoietically-expressed homeobox protein HHEX,40483,0.239515371639476,0.00711182768339313,0.225576189380025,0.253454553898926,5.01618614869201e-237
NMR metabolomics,X23428.Concentration of VLDL Particles,LCAT,Phosphatidylcholine-sterol acyltransferase,40532,0.0696469772916619,0.0021008922252659,0.0655292285301407,0.073764726053183,4.22371474533769e-230
NMR metabolomics,X23428.Concentration of VLDL Particles,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42689,0.13248949914659,0.00401942669932821,0.124611422815907,0.140367575477273,3.04821494769451e-229
NMR metabolomics,X23428.Concentration of VLDL Particles,PROC,Vitamin K-dependent protein C,42663,0.0769577119915634,0.00239530661739757,0.0722629110214642,0.0816525129616627,2.72904451474117e-218
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G10,Group 10 secretory phospholipase A2,42495,-0.179828573545546,0.00563048409556634,-0.190864322372856,-0.168792824718236,9.83568088750257e-216
NMR metabolomics,X23428.Concentration of VLDL Particles,F7,Coagulation factor VII,42671,0.0933300467304014,0.00295998610242663,0.0875284739696452,0.0991316194911576,1.33967702519325e-210
NMR metabolomics,X23428.Concentration of VLDL Particles,APCS,Serum amyloid P-component,40419,0.100188244495357,0.00326193539602187,0.0937948511191541,0.10658163787156,5.43658723285216e-199
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL23,C-C motif chemokine 23,42676,0.122559126959058,0.00401370858821103,0.114692258126164,0.130425995791952,4.5556150320188e-198
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL27,C-C motif chemokine 27,42636,0.171483609752665,0.00564290939087063,0.160423507346559,0.182543712158772,3.0570651981359e-196
NMR metabolomics,X23428.Concentration of VLDL Particles,SMOC1,SPARC-related modular calcium-binding protein 1,42721,0.0940075367029454,0.0031414229761155,0.087850347669759,0.100164725736132,1.4026783473757e-190
NMR metabolomics,X23428.Concentration of VLDL Particles,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42721,0.0980195494016376,0.00330369320855831,0.0915443107128633,0.104494788090412,1.78909794797383e-187
NMR metabolomics,X23428.Concentration of VLDL Particles,CES1,Liver carboxylesterase 1,42661,0.228443489533123,0.00776256699413769,0.213228858224613,0.243658120841633,1.52714275330778e-184
NMR metabolomics,X23428.Concentration of VLDL Particles,NRP1,Neuropilin-1,42705,-0.0782534405370201,0.00266475323419848,-0.0834763568760491,-0.0730305241979911,8.30867311034154e-184
NMR metabolomics,X23428.Concentration of VLDL Particles,GHR,Growth hormone receptor,40283,0.0798986908294274,0.00271235949728961,0.0745824662147398,0.085214915444115,1.07710397072483e-183
NMR metabolomics,X23428.Concentration of VLDL Particles,FURIN,Furin,42679,0.0894334361438425,0.00313078964797727,0.083297088433807,0.0955697838538779,2.62798065428022e-174
NMR metabolomics,X23428.Concentration of VLDL Particles,CFP,Properdin,40539,0.0595516227649316,0.00214484885841296,0.0553477190024422,0.063755526527421,3.28932736582507e-164
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42754,0.0678838530854014,0.00246147536218501,0.0630593613755188,0.072708344795284,6.04599002612012e-163
NMR metabolomics,X23428.Concentration of VLDL Particles,SMAD1,Mothers against decapentaplegic homolog 1,42346,0.214507251888085,0.00781850916895631,0.199182973916931,0.229831529859239,3.3832454996841e-161
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA5,Plasma serine protease inhibitor,40387,0.082736101825546,0.00303258567724209,0.0767922338981515,0.0886799697529405,9.95314825263007e-159
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB1,DnaJ homolog subfamily B member 1,42587,0.224666886889391,0.00832585755816615,0.208348206075386,0.240985567703397,3.27118733817552e-156
NMR metabolomics,X23428.Concentration of VLDL Particles,PTH,Parathyroid hormone,40182,0.212694227121043,0.00787207265596724,0.197264964715348,0.228123489526739,1.0140667089725e-155
NMR metabolomics,X23428.Concentration of VLDL Particles,ERBB3,Receptor tyrosine-protein kinase erbB-3,42586,0.0489026222947219,0.0018275137496401,0.0453206953454273,0.0524845492440165,1.02658177702749e-153
NMR metabolomics,X23428.Concentration of VLDL Particles,APOM,Apolipoprotein M,42663,0.0717155488451189,0.00272692235962574,0.0663707810202524,0.0770603166699853,1.07937974371164e-148
NMR metabolomics,X23428.Concentration of VLDL Particles,SNCA,Alpha-synuclein,40283,0.292029537185924,0.0110855036371056,0.270301950057197,0.313757124314651,2.12274914155073e-148
NMR metabolomics,X23428.Concentration of VLDL Particles,P4HB,Protein disulfide-isomerase,42563,0.0960279155115757,0.00368967345671762,0.0887961555364092,0.103259675486742,1.03469616686754e-145
NMR metabolomics,X23428.Concentration of VLDL Particles,CDKN1A,Cyclin-dependent kinase inhibitor 1,42587,0.261950961797142,0.0100762898549879,0.242201433681365,0.281700489912918,2.11223131815643e-145
NMR metabolomics,X23428.Concentration of VLDL Particles,LPL,Lipoprotein lipase,42636,-0.116179354463182,0.0045030803718891,-0.125005391992085,-0.10735331693428,2.65118353791188e-143
NMR metabolomics,X23428.Concentration of VLDL Particles,APOC1,Apolipoprotein C-I,40516,0.0916707855516519,0.00356656285377909,0.0846803223582449,0.098661248745059,1.19576330164715e-141
NMR metabolomics,X23428.Concentration of VLDL Particles,PAMR1,Inactive serine protease PAMR1,42611,0.0659215362481743,0.00258682334819126,0.0608513624857194,0.0709917100106292,6.21607352266379e-140
NMR metabolomics,X23428.Concentration of VLDL Particles,VPS37A,Vacuolar protein sorting-associated protein 37A,42587,0.194648814192472,0.00766678677794496,0.1796219121077,0.209675716277244,6.33849843486774e-139
NMR metabolomics,X23428.Concentration of VLDL Particles,RARRES2,Retinoic acid receptor responder protein 2,42705,0.115242710645766,0.00454390249488563,0.106336661755791,0.124148759535742,1.131569317691e-138
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB4A_DEFB4B,Beta-defensin 4A,42477,0.367002925672142,0.0144997594071073,0.338583397234211,0.395422454110072,4.41100358358754e-138
NMR metabolomics,X23428.Concentration of VLDL Particles,VMO1,Vitelline membrane outer layer protein 1 homolog,42587,0.168758728141261,0.00673607812543063,0.155556015015417,0.181961441267105,2.07423135770267e-135
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFBP3,Fibroblast growth factor-binding protein 3,40483,0.0896141203052271,0.00357029306632022,0.0826163458952395,0.0966118947152147,2.45551891251306e-135
NMR metabolomics,X23428.Concentration of VLDL Particles,SYAP1,Synapse-associated protein 1,40283,0.138703738560566,0.00552747224269605,0.127869892964881,0.14953758415625,3.31579960510222e-135
NMR metabolomics,X23428.Concentration of VLDL Particles,CHMP6,Charged multivesicular body protein 6,40511,0.133709713966035,0.00540674533875043,0.123112493102084,0.144306934829985,1.51499552406521e-131
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL3,Angiopoietin-related protein 3,42652,0.0850839496237255,0.00346166072230823,0.0782990946080014,0.0918688046394497,1.56825120873414e-130
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMP2,Lysosome-associated membrane glycoprotein 2,42238,0.046647947544729,0.00191566856336327,0.042893237160537,0.050402657928921,4.03504765071587e-128
NMR metabolomics,X23428.Concentration of VLDL Particles,KLKB1,Plasma kallikrein,40293,0.0580193614576551,0.00238671696370265,0.0533413962087979,0.0626973267065123,3.19873956370183e-127
NMR metabolomics,X23428.Concentration of VLDL Particles,CD4,T-cell surface glycoprotein CD4,42570,0.0728023559355434,0.00300530121190932,0.0669119655602011,0.0786927463108856,6.50334148133636e-127
NMR metabolomics,X23428.Concentration of VLDL Particles,TTR,Transthyretin,40424,0.0591391637765358,0.00244712940135179,0.0543427901498863,0.0639355374031853,7.86652836099635e-126
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL6,C-X-C motif chemokine 6,42754,0.175657155837103,0.0074195860968161,0.161114767087344,0.190199544586863,1.8781848654816e-121
NMR metabolomics,X23428.Concentration of VLDL Particles,GUSB,Beta-glucuronidase,42711,0.139127296108669,0.00588085528617398,0.127600819747768,0.15065377246957,2.82284559458086e-121
NMR metabolomics,X23428.Concentration of VLDL Particles,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42711,0.117099373601999,0.00502613934549132,0.107248140484836,0.126950606719162,9.54689036145272e-118
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL2,Angiopoietin-related protein 2,42640,0.0903735127369494,0.00389172671155621,0.0827457283822992,0.0980012970915995,5.39881825309726e-117
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN3,Contactin-3,42611,0.0702945130696111,0.00302872076254452,0.0643582203750239,0.0762308057641984,7.24389310742737e-117
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA4,Kallistatin,40342,0.054326664414235,0.00233950773308809,0.0497412292573824,0.0589120995710877,1.57093090496481e-116
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP3,Insulin-like growth factor-binding protein 3,42689,0.0712655420928975,0.00307972321594466,0.065229284589646,0.0773017995961491,3.287012444317e-116
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC39A5,Zinc transporter ZIP5,42594,0.120732478873653,0.00522827899747274,0.110485052038606,0.130979905708699,9.93198793490501e-116
NMR metabolomics,X23428.Concentration of VLDL Particles,CREG1,Protein CREG1,42445,0.0861382895741828,0.00374082761536435,0.0788062674480687,0.0934703117002969,4.52045941819035e-115
NMR metabolomics,X23428.Concentration of VLDL Particles,KDR,Vascular endothelial growth factor receptor 2,42679,0.0547372377724716,0.00239679139511665,0.0500395266380429,0.0594349489069002,2.69420138157729e-113
NMR metabolomics,X23428.Concentration of VLDL Particles,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42495,0.160648969509572,0.00707615290426883,0.146779709817206,0.174518229201939,5.56238430059998e-112
NMR metabolomics,X23428.Concentration of VLDL Particles,BCHE,Cholinesterase,40346,0.0611265650242493,0.0027067394248732,0.0558213557514978,0.0664317742970007,1.86338392166586e-110
NMR metabolomics,X23428.Concentration of VLDL Particles,FLI1,Friend leukemia integration 1 transcription factor,42346,0.238877032978191,0.0106591270145864,0.217985144029601,0.25976892192678,3.39579384309516e-109
NMR metabolomics,X23428.Concentration of VLDL Particles,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,40449,0.300452843566259,0.0134011683075228,0.274186553683515,0.326719133449004,5.99182685891232e-109
NMR metabolomics,X23428.Concentration of VLDL Particles,LATS1,Serine/threonine-protein kinase LATS1,40199,0.181590465905102,0.00819655779778055,0.165525212621452,0.197655719188752,1.96336159195655e-106
NMR metabolomics,X23428.Concentration of VLDL Particles,SNAPIN,SNARE-associated protein Snapin,40482,0.123405638346252,0.00557997519198614,0.112468886969959,0.134342389722545,3.9224608340887e-106
NMR metabolomics,X23428.Concentration of VLDL Particles,NUMB,Protein numb homolog,40199,0.176557731976812,0.0079840455839714,0.160909002632228,0.192206461321396,4.65545872727633e-106
NMR metabolomics,X23428.Concentration of VLDL Particles,ERP44,Endoplasmic reticulum resident protein 44,42569,0.0546501440304362,0.00247883192399282,0.0497916334594103,0.0595086546014621,7.79459215330904e-106
NMR metabolomics,X23428.Concentration of VLDL Particles,GCG,Pro-glucagon,42346,0.269712529180059,0.0122833424782897,0.245637177922611,0.293787880437507,5.57453488968128e-105
NMR metabolomics,X23428.Concentration of VLDL Particles,IGSF9,Protein turtle homolog A,40511,0.176811008848424,0.00806045574978904,0.161012515578838,0.192609502118011,1.75461094189299e-104
NMR metabolomics,X23428.Concentration of VLDL Particles,ATRN,"Attractin, Isoform 2",40539,0.0357208014755719,0.00163083974870756,0.0325243555681051,0.0389172473830387,3.42368387292952e-104
NMR metabolomics,X23428.Concentration of VLDL Particles,CFH,Complement factor H,39956,0.0486290300806154,0.00222479825808913,0.0442684254947607,0.0529896346664701,1.15707787776257e-103
NMR metabolomics,X23428.Concentration of VLDL Particles,CRIP2,Cysteine-rich protein 2,42495,0.0776785713832509,0.00356589730960399,0.0706894126564271,0.0846677301100747,2.10318048086555e-103
NMR metabolomics,X23428.Concentration of VLDL Particles,DSG2,Desmoglein-2,42611,-0.0577048675463642,0.00264960688380165,-0.0628980970386154,-0.0525116380541129,2.26048267511749e-103
NMR metabolomics,X23428.Concentration of VLDL Particles,SMAD2,Mothers against decapentaplegic homolog 2,40451,0.146273576106196,0.00671573848233719,0.133110728680815,0.159436423531577,4.66556353807401e-103
NMR metabolomics,X23428.Concentration of VLDL Particles,SORT1,Sortilin,42613,0.0776819160358834,0.00359398729240793,0.0706377009427638,0.0847261311290029,7.11630674035228e-102
NMR metabolomics,X23428.Concentration of VLDL Particles,AGR3,Anterior gradient protein 3,42326,0.125335115814129,0.00582361001142005,0.113920840191746,0.136749391436512,5.3457231397355e-101
NMR metabolomics,X23428.Concentration of VLDL Particles,MEGF9,Multiple epidermal growth factor-like domains protein 9,42760,0.040306704796066,0.00187877596879224,0.0366243038972332,0.0439891056948988,1.95106979057207e-100
NMR metabolomics,X23428.Concentration of VLDL Particles,LAT2,Linker for activation of T-cells family member 2,42587,0.257034605413595,0.0119802258739586,0.233553362700637,0.280515848126554,1.99742777532008e-100
NMR metabolomics,X23428.Concentration of VLDL Particles,PROS1,Vitamin K-dependent protein S,40539,0.0544153673209029,0.00254664358309806,0.0494239458980307,0.0594067887437751,2.39890269569771e-99
NMR metabolomics,X23428.Concentration of VLDL Particles,GPR37,Prosaposin receptor GPR37,42357,0.140503074036531,0.00665060465920438,0.12746788890449,0.153538259168571,1.87257244969203e-97
NMR metabolomics,X23428.Concentration of VLDL Particles,ENO3,Beta-enolase,40223,0.121103869728573,0.00574115687479346,0.109851202253977,0.132356537203168,7.28706372137467e-97
NMR metabolomics,X23428.Concentration of VLDL Particles,INHBC,Inhibin beta C chain,42611,0.0840346137680281,0.00399403307158732,0.0762063089477169,0.0918629185883392,1.02162842083197e-96
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINF2,Alpha-2-antiplasmin,40317,0.0276544320982247,0.00131917837563815,0.0250688424819739,0.0302400217144754,9.92254836649234e-96
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42582,0.0549130723977515,0.00263830059619039,0.0497420032292183,0.0600841415662847,1.01887164631248e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,IL13RA1,Interleukin-13 receptor subunit alpha-1,42448,0.0442742829951851,0.0021300389449284,0.0400994066631254,0.0484491593272447,1.86047244277432e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,EEF1D,Elongation factor 1-delta,40511,0.184811093203233,0.00889050406568155,0.167385705234498,0.202236481171969,3.19834821524318e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,MASP1,Mannan-binding lectin serine protease 1,42476,0.0474752828947658,0.00228833778677533,0.0429901408326862,0.0519604249568455,4.05847695757369e-94
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL13,C-X-C motif chemokine 13,42711,0.126352447011142,0.00610541051291477,0.114385842405829,0.138319051616455,1.07871603993312e-93
NMR metabolomics,X23428.Concentration of VLDL Particles,PSRC1,Proline/serine-rich coiled-coil protein 1,42346,0.119034728519448,0.00575301193911064,0.107758825118792,0.130310631920105,1.28782864696957e-93
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPK9,Mitogen-activated protein kinase 9,42594,0.0849203315782954,0.00410791152459512,0.076868824990089,0.0929718381665019,1.75392902831135e-93
NMR metabolomics,X23428.Concentration of VLDL Particles,NAA80,N-alpha-acetyltransferase 80,40182,0.241437281329188,0.0117174541627523,0.218471071170193,0.264403491488182,1.37723592328461e-92
NMR metabolomics,X23428.Concentration of VLDL Particles,CFI,Complement factor I,40539,0.0392007765267302,0.00190838342499447,0.0354603450137411,0.0429412080397194,4.30835669400793e-92
NMR metabolomics,X23428.Concentration of VLDL Particles,ERBB2,Receptor tyrosine-protein kinase erbB-2,42679,0.0470973723315882,0.00229708735711389,0.0425950811116449,0.0515996635515314,5.08276975307707e-92
NMR metabolomics,X23428.Concentration of VLDL Particles,FCN2,Ficolin-2,42597,0.0815118270811963,0.00400388641215748,0.0736642097133676,0.089359444449025,9.21241438888625e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42613,0.225501197782468,0.0110773787339499,0.203789535463926,0.24721286010101,9.41164599885311e-91
NMR metabolomics,X23428.Concentration of VLDL Particles,PLAT,Tissue-type plasminogen activator,42760,0.100131279643343,0.00492015293578205,0.0904877798892107,0.109774779397476,1.01804753125889e-90
NMR metabolomics,X23428.Concentration of VLDL Particles,LEFTY2,Left-right determination factor 2,42689,0.098964708588049,0.00487267595396499,0.0894142637182776,0.10851515345782,2.33265653265297e-90
NMR metabolomics,X23428.Concentration of VLDL Particles,SNAP29,Synaptosomal-associated protein 29,42679,0.179712755136225,0.0088714081917458,0.162324795080403,0.197100715192046,6.60188401040645e-90
NMR metabolomics,X23428.Concentration of VLDL Particles,DTYMK,Thymidylate kinase,40511,0.134061879215037,0.00661633429392256,0.121093863998949,0.147029894431125,1.06953843157965e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,40283,0.0426865496324787,0.00210977265281719,0.038551395232957,0.0468217040320004,2.04971131978504e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,ADIPOQ,Adiponectin,40539,-0.136063858817178,0.00675033041295701,-0.149294506426574,-0.122833211207783,8.36553047142078e-89
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,42346,0.132582718439851,0.00661523356642703,0.119616860649654,0.145548576230048,4.85914768200713e-88
NMR metabolomics,X23428.Concentration of VLDL Particles,NOMO1,Nodal modulator 1,42611,0.0451487675809535,0.002256261546532,0.0407264949497508,0.0495710402121563,8.48529827504322e-88
NMR metabolomics,X23428.Concentration of VLDL Particles,AP1G2,AP-1 complex subunit gamma-like 2,40451,0.153582577475419,0.00768943087132124,0.13851129296763,0.168653861983209,3.02878853681254e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,TJAP1,Tight junction-associated protein 1,42679,0.159665281009533,0.00801072436320423,0.143964261257653,0.175366300761414,3.88534308900139e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,CPB2,Carboxypeptidase B2,40516,0.0432434035273623,0.00216841323930822,0.0389933135783182,0.0474934934764064,5.38559705890863e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,IL16,Pro-interleukin-16,42754,0.080237555411846,0.00402951087187739,0.0723397141029664,0.0881353967207257,5.52609106291717e-87
NMR metabolomics,X23428.Concentration of VLDL Particles,CDHR5,Cadherin-related family member 5,42636,0.0749381001713602,0.0037810677687074,0.0675272073446937,0.0823489929980267,3.43640538627594e-86
NMR metabolomics,X23428.Concentration of VLDL Particles,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,40483,0.0767139943035993,0.00388941347732783,0.0690907438880368,0.0843372447191619,3.62889704355019e-85
NMR metabolomics,X23428.Concentration of VLDL Particles,GHRL,Appetite-regulating hormone,42636,0.162872733623642,0.00829737096346409,0.146609886535252,0.179135580712031,1.32053138297683e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,GRP,Gastrin-releasing peptide,40223,0.107186173863332,0.00547814132611888,0.0964490168641386,0.117923330862525,7.86181028900845e-84
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42587,0.0828469747560915,0.00425207947863086,0.074512898977975,0.091181050534208,2.13864121377211e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,YES1,Tyrosine-protein kinase Yes,42587,0.214509127305531,0.0110386847169337,0.192873305260341,0.236144949350721,5.6692344514651e-83
NMR metabolomics,X23428.Concentration of VLDL Particles,FYB1,FYN-binding protein 1,42590,0.1736647725709,0.00895711571265554,0.156108825774095,0.191220719367705,1.30362430541866e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,F10,Coagulation factor X,40532,0.0536699772076557,0.00277138128567636,0.04823806988773,0.0591018845275813,3.17088020166873e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,SARG,Specifically androgen-regulated gene protein,40456,0.204910825129555,0.010590182052873,0.184154068305924,0.225667581953186,4.42376392772995e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,42357,0.153244396202632,0.00793308269759588,0.137695554115344,0.16879323828992,5.24015712720604e-82
NMR metabolomics,X23428.Concentration of VLDL Particles,FN1,Fibronectin,40539,0.0502450886463413,0.00260539328893957,0.0451385178000198,0.0553516594926629,1.43980165948596e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,ABL1,Tyrosine-protein kinase ABL1,42587,0.125403871059484,0.0065125965384631,0.112639181844097,0.138168560274872,1.59636316802256e-81
NMR metabolomics,X23428.Concentration of VLDL Particles,STAB2,Stabilin-2,40527,0.0525083733740032,0.00273832684730103,0.0471412527532931,0.0578754939947132,1.11970157117645e-80
NMR metabolomics,X23428.Concentration of VLDL Particles,MYH9,Myosin-9,40527,0.21343063493741,0.0111679864938048,0.191541381409553,0.235319888465268,3.70920307985826e-80
NMR metabolomics,X23428.Concentration of VLDL Particles,IPCEF1,Interactor protein for cytohesin exchange factors 1,42475,0.16491517885562,0.00868574286327709,0.147891122843597,0.181939234867643,2.45331345732819e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,PLTP,Phospholipid transfer protein,42752,-0.0663189270467232,0.00350058881978311,-0.0731800811334981,-0.0594577729599483,5.0704956569774e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42594,0.178191513386322,0.00941167162405167,0.159744637003181,0.196638389769464,6.51019459602357e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,40302,0.206786621362581,0.0109100074860737,0.185403006689877,0.228170236035286,7.1626652864112e-79
NMR metabolomics,X23428.Concentration of VLDL Particles,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,40449,0.0558977032352674,0.00296328989280878,0.0500896550453622,0.0617057514251726,3.64020527795832e-78
NMR metabolomics,X23428.Concentration of VLDL Particles,TMPRSS15,Enteropeptidase,42587,0.167359292476442,0.00891384853027961,0.149888149357093,0.18483043559579,1.19294196555745e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,AFM,Afamin,40539,0.0366568382857289,0.00195047593541798,0.0328339054523097,0.0404797711191481,1.27415847107036e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL22,C-C motif chemokine 22,42509,0.0967982474474315,0.00517574323101374,0.0866537907146446,0.106942704180218,4.59306125368518e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTA3,Glutathione S-transferase A3,42346,0.139213191220931,0.00745486341888523,0.124601658919916,0.153824723521946,7.89352492866566e-77
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP2,Insulin-like growth factor-binding protein 2,42771,-0.112589832268824,0.00605796924235208,-0.124463451983834,-0.100716212553814,3.70496069956947e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,SOST,Sclerostin,42613,0.0707131785937559,0.00380938801940975,0.0632467780757128,0.078179579111799,5.72088316952054e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,YTHDF3,YTH domain-containing family protein 3,42370,0.153706772660869,0.008283850483199,0.137470425713799,0.169943119607939,6.86686944682641e-76
NMR metabolomics,X23428.Concentration of VLDL Particles,KYNU,Kynureninase,42754,0.0804936352385057,0.00434487783531529,0.0719776746812877,0.0890095957957237,1.08996946835702e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJA2,DnaJ homolog subfamily A member 2,42721,0.146123993294856,0.00791439290541321,0.130611783200246,0.161636203389466,3.42650206730105e-75
NMR metabolomics,X23428.Concentration of VLDL Particles,LDLRAP1,Low density lipoprotein receptor adapter protein 1,40482,0.174703638143901,0.00948500814630766,0.156113022177138,0.193294254110664,1.14422300619172e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,COL4A1,Collagen alpha-1(IV) chain,42636,-0.0718289350814181,0.00390732303191942,-0.0794872882239802,-0.0641705819388561,1.46573515343186e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,SMAD5,Mothers against decapentaplegic homolog 5,42587,0.0360013143386059,0.00196067231046923,0.0321583966100862,0.0398442320671256,2.1711211363753e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,EHBP1,EH domain-binding protein 1,40511,0.133144819310478,0.00724830045267001,0.118938150423244,0.147351488197711,2.77517836359871e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,MTSS1,Protein MTSS 1,40449,0.199952539712925,0.0109001479007884,0.17858824982738,0.22131682959847,4.40427740035047e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42689,-0.0671710649218145,0.00366727696317521,-0.0743589277696379,-0.0599832020739911,4.82658704516528e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,PDLIM7,PDZ and LIM domain protein 7,42676,0.220671767519164,0.0120494829172416,0.19705478100137,0.244288754036958,5.06102870393881e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,DAB2,Disabled homolog 2,42721,0.194932715974866,0.0106462339661598,0.174066097401193,0.215799334548539,5.37925007441014e-74
NMR metabolomics,X23428.Concentration of VLDL Particles,C1S,Complement C1s subcomponent,40539,0.037229391757518,0.00203839148688279,0.0332341444432277,0.0412246390718082,1.796368084288e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,AXIN1,Axin-1,42594,0.168538892473389,0.00924157856873067,0.150425398478677,0.186652386468101,2.02261819782142e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42495,0.0951787470965558,0.00522181350069063,0.0849439926352022,0.105413501557909,2.44884431837954e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,KAZN,Kazrin,40449,0.185351185427781,0.0101689771580658,0.165419990197972,0.205282380657589,3.53267539333496e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,40465,0.143073058557488,0.00785767896905362,0.127672007778143,0.158474109336833,4.93867154762453e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,BTD,Biotinidase,40539,0.0367080041421285,0.00201669627576124,0.0327552794416364,0.0406607288426205,5.41015313292126e-73
NMR metabolomics,X23428.Concentration of VLDL Particles,DPY30,Protein dpy-30 homolog,42651,0.106531600108465,0.00588879927834652,0.0949895535229056,0.118073646694024,2.71293610426586e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,40116,0.120141708518236,0.00663388471467238,0.107139294477478,0.133144122558994,2.99824621387376e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,GCC1,GRIP and coiled-coil domain-containing protein 1,40483,0.189273095579081,0.0104624236284895,0.168766745267241,0.20977944589092,3.91827899785753e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42587,0.170842908895173,0.00946291815688728,0.152295589307674,0.189390228482672,5.23397630979042e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,TPD52L2,Tumor protein D54,40283,0.188991158125553,0.0104728869774382,0.168464299649774,0.209518016601332,9.01785400904538e-72
NMR metabolomics,X23428.Concentration of VLDL Particles,MTSS2,Protein MTSS 2,40451,0.173220032121004,0.00962122571243318,0.154362429724635,0.192077634517373,1.8162501469306e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL10,C-X-C motif chemokine 10,42676,0.118487712136788,0.00661155848999049,0.105529057496406,0.131446366777169,5.34887092803281e-71
NMR metabolomics,X23428.Concentration of VLDL Particles,C9,Complement component C9,40532,-0.092984878455129,0.00519584845085505,-0.103168741418805,-0.0828010154914531,1.1829672167116e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPIND1,Heparin cofactor 2,40516,0.0492453790202283,0.00275206591287958,0.0438513298309844,0.0546394282094723,1.22938451154546e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,STC1,Stanniocalcin-1,42711,0.078993933965135,0.00442149918247834,0.0703277955674775,0.0876600723627926,1.40680614727962e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,F13B,Coagulation factor XIII B chain,40479,0.0454148485714381,0.00253913463957639,0.0404381446778684,0.0503915524650078,1.42409157057768e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRB,Receptor-type tyrosine-protein phosphatase beta,40511,0.0516509189737911,0.0028894491688342,0.0459875986028761,0.0573142393447061,1.69257841057433e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,DAAM1,Disheveled-associated activator of morphogenesis 1,40283,0.145561592620537,0.00814326059935441,0.129600801845802,0.161522383395272,1.78894355606362e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJC6,Putative tyrosine-protein phosphatase auxilin,40223,0.146929215065095,0.00822514023503667,0.130807940204423,0.163050489925767,2.21897698495097e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB11FIP3,Rab11 family-interacting protein 3,40511,0.186156587627136,0.0104264589317771,0.165720728120853,0.206592447133419,2.45982223307421e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,BPIFB1,BPI fold-containing family B member 1,42573,-0.109016184984466,0.00611451209703224,-0.121000628694649,-0.0970317412742825,2.72771642706893e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL17,C-X-C motif chemokine 17,42754,0.0708045500027186,0.00397374252048728,0.0630160146625635,0.0785930853428737,3.22468230061849e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,MINK1,Misshapen-like kinase 1,40483,0.161093626881003,0.00904638434654376,0.143362713561777,0.178824540200228,5.57609469376716e-70
NMR metabolomics,X23428.Concentration of VLDL Particles,MLN,Promotilin,42594,0.153718513081884,0.00869095704990805,0.136684237264064,0.170752788899703,3.21516218260715e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,CES3,Carboxylesterase 3,42587,0.121640021318523,0.00689073122265792,0.108134188122113,0.135145854514932,5.84765259244581e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,TARBP2,RISC-loading complex subunit TARBP2,42311,0.134580193987978,0.00763253277668936,0.119620429745666,0.149539958230289,8.61502368919384e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,BANK1,B-cell scaffold protein with ankyrin repeats,42594,0.182162655732537,0.0103342206668837,0.161907583225445,0.202417728239629,9.09166409775257e-69
NMR metabolomics,X23428.Concentration of VLDL Particles,TXLNA,Alpha-taxilin,42495,0.1504389296755,0.00857726804089583,0.133627484315344,0.167250375035656,4.18985068899275e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,40482,0.143376989461214,0.00816665892214844,0.127370337973804,0.159383640948625,4.25489484708547e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK10,Kallikrein-10,42636,0.0696398438961088,0.00397811074845358,0.0618427468291397,0.0774369409630778,7.31718022896016e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,ARF6,ADP-ribosylation factor 6,40449,0.183402732096806,0.0104676300728884,0.162886177153945,0.203919287039667,7.85438723142636e-68
NMR metabolomics,X23428.Concentration of VLDL Particles,ZBTB16,Zinc finger and BTB domain-containing protein 16,42346,0.123081552564733,0.00703921993716203,0.109284681487896,0.136878423641571,1.08261142064689e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42636,-0.197499953839222,0.0113124867281173,-0.219672427826332,-0.175327479852112,1.64328879813383e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,NFX1,Transcriptional repressor NF-X1,40116,0.116397887999492,0.00665939166290611,0.103345480340196,0.129450295658788,1.71745366455969e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42587,0.0647342363820471,0.00371006159229669,0.0574625156611456,0.0720059571029487,1.97194754438443e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,ATG16L1,Autophagy-related protein 16-1,40449,0.143955623974597,0.00824807341116117,0.127789400088721,0.160121847860473,2.49621285963241e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,ISM1,Isthmin-1,42594,0.0656397023262855,0.00376888308857891,0.0582526914726708,0.0730267131799001,3.40956227133871e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,SKAP1,Src kinase-associated phosphoprotein 1,42476,0.125661443560676,0.00721679946985072,0.111516516599768,0.139806370521583,3.69728021781434e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,TCTN3,Tectonic-3,40511,0.0511852612234213,0.00293764065668527,0.0454274855363181,0.0569430369105244,4.06790250124454e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,CANT1,Soluble calcium-activated nucleotidase 1,42580,0.0349230447602434,0.00200713713570036,0.0309890559742707,0.0388570335462161,4.54980051946453e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,HJV,Hemojuvelin,40482,0.0751073140954029,0.00431376285596685,0.0666523388977079,0.083562289293098,5.08757281947427e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,BECN1,Beclin-1,40223,0.102098331012001,0.00586448658960185,0.0906039372963815,0.113592724727621,5.46660111668713e-67
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R9B,Neurabin-2,42754,0.158470794878468,0.00915148435000861,0.140533885552451,0.176407704204484,1.83225421994245e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF41,E3 ubiquitin-protein ligase NRDP1,42346,0.111693999803665,0.00645078266479437,0.0990504657806683,0.124337533826662,1.97995135274951e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,CPM,Carboxypeptidase M,42655,0.056952853788699,0.00330162553078723,0.0504816677483561,0.063424039829042,5.72536189731466e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,GLA,Alpha-galactosidase A,40267,0.0630693221948247,0.00365193065089226,0.0559115381190759,0.0702271062705735,5.7554652275884e-66
NMR metabolomics,X23428.Concentration of VLDL Particles,CD63,CD63 antigen,42475,0.0860193976907973,0.00500026005931008,0.0762188879745495,0.095819907407045,1.29435153163997e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,OTUD7B,OTU domain-containing protein 7B,40482,0.104129309573087,0.00604977094040839,0.0922717585298864,0.115986860616287,1.4745643963096e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6V1G1,V-type proton ATPase subunit G 1,40223,0.121877663020566,0.00708509350847071,0.107990879743964,0.135764446297169,1.82752342948677e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,RLN2,Prorelaxin H2,40257,0.0841145009177028,0.00489482877800321,0.0745206365128165,0.0937083653225891,2.44279453133694e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,RBPMS2,RNA-binding protein with multiple splicing 2,40223,0.172196458251274,0.0100231668058148,0.152551051311877,0.191841865190671,2.65076885491634e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,TNIP1,TNFAIP3-interacting protein 1,40483,0.148835877363976,0.00866568294275751,0.131851138796171,0.16582061593178,2.73640257647352e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF21,Fibroblast growth factor 21,42689,0.196617466029507,0.0114678649482062,0.174140450731023,0.219094481327991,3.34981475763352e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,HEG1,Protein HEG homolog 1,40283,0.0453191446595869,0.00264410722440072,0.0401366944997614,0.0505015948194123,5.14578191595347e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,AP3S2,AP-3 complex subunit sigma-2,40483,0.0796851182417362,0.00465152748887961,0.0705681243635322,0.0888021121199402,5.75908786849277e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",40408,0.182197163993855,0.0106439666599244,0.161334989340403,0.203059338647306,7.31547140240051e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGEF12,Rho guanine nucleotide exchange factor 12,42594,0.173175898911576,0.0101295296775245,0.153322020743628,0.193029777079524,7.71116047796808e-65
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL5,C-X-C motif chemokine 5,42605,0.189237228156881,0.0110791765317629,0.167522042154626,0.210952414159137,1.00231050294252e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,VEGFC,Vascular endothelial growth factor C,42679,0.0927027386759688,0.00542870686431015,0.082062473221921,0.103343004130017,1.06362040523241e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFC,Platelet-derived growth factor C,42346,0.0477223130313192,0.00279504359005644,0.0422440275948086,0.0532005984678299,1.1530620480374e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",40223,0.0957059227524471,0.00560232752864784,0.0847253607962973,0.106686484708597,1.33612358772613e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,NCK2,Cytoplasmic protein NCK2,42676,0.174134803463254,0.0102126613977702,0.154117987123624,0.194151619802883,1.63188655841215e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFR2,Fibroblast growth factor receptor 2,42679,0.0372946552638428,0.00218975697139478,0.033002731599909,0.0415865789277765,2.25952361664768e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,ERBIN,Erbin,42587,0.16941615123533,0.00995907741375581,0.149896359504369,0.188935942966291,3.19973535832281e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,SUGP1,SURP and G-patch domain-containing protein 1,40449,0.066509074111192,0.00390837020308844,0.0588486685131386,0.0741694797092453,3.87830026023682e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTN1,Dynactin subunit 1,42721,0.107225399157752,0.00632113597072687,0.0948359726551273,0.119614825660377,7.04924125500941e-64
NMR metabolomics,X23428.Concentration of VLDL Particles,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",40223,0.0427692980705807,0.00252145379441553,0.0378272486335263,0.0477113475076352,1.00249564541775e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,NOS3,"Nitric oxide synthase, endothelial",42311,0.0908610444483889,0.00536852849879302,0.0803387285907546,0.101383360306023,1.39563686622861e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,DKK1,Dickkopf-related protein 1,42711,0.097127591424375,0.00574197764757263,0.0858733152351326,0.108381867613617,1.55953245414816e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,F9,Coagulation factor IX,42663,0.0298738207456967,0.00176749483360088,0.026409530871839,0.0333381106195545,1.96423903091286e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4B,Eukaryotic translation initiation factor 4B,42495,0.0949177980102619,0.00563053358084,0.0838819521918155,0.105953643828708,4.15819944180457e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,42443,0.079989964509149,0.00474645719555254,0.070686908405866,0.089293020612432,4.55330094972698e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,IRAK1,Interleukin-1 receptor-associated kinase 1,42370,0.112262348683586,0.00666359281999242,0.0992017067564009,0.125322990610771,5.0237807951827e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A4,Protein S100-A4,42679,0.0937581465485414,0.00556744884258721,0.0828459468170704,0.104670346280012,5.42433524068265e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42679,0.157026530347389,0.0093381851270591,0.138723687498353,0.175329373196425,8.18645056207881e-63
NMR metabolomics,X23428.Concentration of VLDL Particles,CLIP2,CAP-Gly domain-containing linker protein 2,42594,0.181927555856336,0.0108682691866402,0.160625748250522,0.203229363462151,2.90269308625369e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42587,0.0652338177799729,0.00389856973532722,0.0575926210987316,0.0728750144612143,3.23668703450657e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,CD6,T-cell differentiation antigen CD6,42746,0.0865116552162477,0.00517154669371386,0.0763754236965685,0.0966478867359269,3.41965153580962e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,PHACTR2,Phosphatase and actin regulator 2,40482,0.18498463701995,0.0110801534446019,0.16326753626853,0.20670173777137,7.82286812956773e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,PON2,Serum paraoxonase/arylesterase 2,42357,0.0572073822816896,0.00343129999218469,0.0504820342970076,0.0639327302663716,8.96449830854573e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP20,Centrosomal protein 20,42346,0.121969419655181,0.0073185547218546,0.107625052400346,0.136313786910016,9.97373988644393e-62
NMR metabolomics,X23428.Concentration of VLDL Particles,CSNK2A1,Casein kinase II subunit alpha,40482,-0.0732676814771766,0.00439334812963697,-0.0818786438112651,-0.0646567191430881,1.05284428199561e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL17,C-C motif chemokine 17,42604,0.149247001811426,0.00896382641287827,0.131677902042185,0.166816101580668,1.25793019231654e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXNA4,Plexin-A4,42594,0.13350123558845,0.00802029808089197,0.117781451349902,0.149221019826998,1.35551365041403e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP85,Centrosomal protein of 85 kDa,42346,0.104177779591793,0.00625939439495933,0.0919093665776729,0.116446192605914,1.43798643838974e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,PRAP1,Proline-rich acidic protein 1,40527,0.0677231936524238,0.00406778855233185,0.0597503280898534,0.0756960592149942,1.66012614477281e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,CD99L2,CD99 antigen-like protein 2,42611,0.0394956527511415,0.0023784648755031,0.0348338615951555,0.0441574439071276,2.59780713562099e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,EFCAB14,EF-hand calcium-binding domain-containing protein 14,40449,0.047766853882137,0.0028752932945209,0.042131279024876,0.053402428739398,3.0082056596562e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,CDHR2,Cadherin-related family member 2,42587,0.114656663540754,0.00691404473917793,0.101105135851965,0.128208191229543,3.75165489438149e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,SELPLG,P-selectin glycoprotein ligand 1,42594,0.0447078614177506,0.00269674139237422,0.0394222482886971,0.0499934745468041,4.04607936917827e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,RGCC,Regulator of cell cycle RGCC,40482,0.122264582909512,0.00737203331267274,0.107815397616673,0.13671376820235,4.71582442764253e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,SLA2,Src-like-adapter 2,40482,0.168188464255283,0.0101462580799836,0.148301798418516,0.188075130092051,5.41557823584404e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINF1,Pigment epithelium-derived factor,40351,0.0433401969799568,0.00261814839924042,0.0382086261174456,0.048471767842468,7.971362139314e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,PCBP2,Poly(rC)-binding protein 2,40482,0.116529725214943,0.00704172053994347,0.102727952956653,0.130331497473232,8.5209111764959e-61
NMR metabolomics,X23428.Concentration of VLDL Particles,GP1BA,Platelet glycoprotein Ib alpha chain,42583,0.05338942193145,0.00323329491231755,0.0470521639033076,0.0597266799595924,1.18733853327722e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,PAXX,Protein PAXX,40283,0.073600025539843,0.00445626844599231,0.0648657393856981,0.082334311693988,1.48257958541746e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,STAT5B,Signal transducer and activator of transcription 5B,42587,0.220725035887175,0.0133854108684137,0.194489630585084,0.246960441189266,1.70774917557506e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,IKBKG,NF-kappa-B essential modulator,42594,0.146566888726025,0.00890125823518337,0.129120422585065,0.164013354866984,2.52254733268521e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,CIRBP,Cold-inducible RNA-binding protein,40449,0.153030736911184,0.00929316209687555,0.134816139201308,0.17124533462106,3.19698848393007e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL3,C-X-C motif chemokine 3,42620,0.149868876217693,0.00911082026600808,0.132011668496317,0.167726083939069,3.27660164891565e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,SDCCAG8,Serologically defined colon cancer antigen 8,40451,0.182807034087708,0.0111090762869473,0.161033244565291,0.204580823610125,3.84011967739071e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,DOK2,Docking protein 2,42636,0.193359122928221,0.0117646233063224,0.170300461247829,0.216417784608613,4.09677975264513e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,40302,0.169484952769916,0.0103066239029876,0.14928396992006,0.189685935619772,4.71198992724068e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB6,DnaJ homolog subfamily B member 6,40183,0.134531406971451,0.00819508369010349,0.118469042938848,0.150593771004054,7.54424888050723e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,42357,0.0890485802126248,0.0054311316373926,0.0784035622033353,0.0996935982219143,7.99805499971278e-60
NMR metabolomics,X23428.Concentration of VLDL Particles,NFKBIE,NF-kappa-B inhibitor epsilon,42346,0.0793287829950812,0.00485290470631044,0.0698170897707128,0.0888404762194497,1.77100273672668e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,NFKB1,Nuclear factor NF-kappa-B p105 subunit,40116,0.117929481600538,0.00722131701267923,0.103775700255687,0.13208326294539,2.99636995589559e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,USO1,General vesicular transport factor p115,42587,0.143336923233582,0.00879674761088711,0.126095297916243,0.16057854855092,4.00858966979653e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42754,0.156228325201237,0.00959318780496942,0.137425677103497,0.175030973298977,4.55563493172129e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,PAK4,Serine/threonine-protein kinase PAK 4,42311,0.0969191665396931,0.00595036260999862,0.0852564558240958,0.10858187725529,4.561450319066e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42794,0.0467240366319733,0.00286951242810715,0.0410997922728833,0.0523482809910633,4.71828201546577e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,CMIP,C-Maf-inducing protein,40451,0.131966397329249,0.00810231824747278,0.116085853564203,0.147846941094296,5.70816519213964e-59
NMR metabolomics,X23428.Concentration of VLDL Particles,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42657,0.163591110899854,0.0100761701373045,0.143841817430737,0.183340404368971,1.02185304887155e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,HBEGF,Proheparin-binding EGF-like growth factor,42674,0.115531291635201,0.00711736624942194,0.101581253786334,0.129481329484068,1.07265973965186e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC1B,C-type lectin domain family 1 member B,42711,0.150905451736848,0.00932145867033433,0.132635392742993,0.169175510730704,2.13263064033423e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,GPC5,Glypican-5,42495,0.0894641603861561,0.00552904171272135,0.0786272386292223,0.10030108214309,2.48264949950341e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,ADH1B,All-trans-retinol dehydrogenase,40283,0.117994026867638,0.00729920660937291,0.103687581913267,0.132300471822009,4.07976748065216e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,40449,0.171978509382171,0.0106456656179416,0.151113004771006,0.192844013993337,4.71525440839937e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,FOXO1,Forkhead box protein O1,42594,0.134033994866866,0.00830573630862249,0.117754751701966,0.150313238031766,4.89451745243718e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,ELN,Elastin,40511,0.0581507265025521,0.00360056647542492,0.0510936162107192,0.0652078367943849,5.01130560506456e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,NUCB2,Nucleobindin-2,42683,0.0582934671865133,0.00362106750018752,0.0511961748861458,0.0653907594868809,9.03035552806849e-58
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL16,C-C motif chemokine 16,42794,0.0823641663968329,0.00511891215441843,0.0723310985741727,0.092397234219493,1.01900649787422e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,BCR,Breakpoint cluster region protein,42594,0.142795261749528,0.00891984369133458,0.125312368114513,0.160278155384544,3.76008224336948e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,CRELD2,Protein disulfide isomerase CRELD2,42654,0.0810009994053112,0.00507407308308383,0.0710558161624669,0.0909461826481555,7.59897269536218e-57
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP45,Rho GTPase-activating protein 45,40283,0.128843721740259,0.00807301278480203,0.113020616682047,0.144666826798471,1.04010697257157e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,AAMDC,Mth938 domain-containing protein,40223,0.0832388526419129,0.00521581648871949,0.0730158523240227,0.0934618529598031,1.06270983122451e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,PLIN1,Perilipin-1,42311,0.0545864782679216,0.00342659334125668,0.0478703553190585,0.0613026012167847,1.32558159522094e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINH1,Serpin H1,40302,0.201438904029006,0.0126413217805525,0.176661913339123,0.226215894718889,1.53084695684839e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,ZFYVE19,Abscission/NoCut checkpoint regulator,40449,0.140524529452419,0.00884510070670346,0.123188132067281,0.157860926837558,3.16510635560422e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,NFE2,Transcription factor NF-E2 45 kDa subunit,40223,0.116001372317473,0.00730146901391013,0.101690493050209,0.130312251584737,3.24964256944064e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,IST1,IST1 homolog,40375,0.153112858758211,0.0096667334511482,0.13416606119396,0.172059656322461,6.75881743507428e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42754,0.0437417291847664,0.00276714470097787,0.0383181255708498,0.049165332798683,8.68685786492093e-56
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGEF1,Rho guanine nucleotide exchange factor 1,40483,0.138933102195419,0.00880099714069758,0.121683147799651,0.156183056591186,1.52137427421788e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,GIT1,ARF GTPase-activating protein GIT1,40199,0.149919967808806,0.00950182943411908,0.131296382117933,0.16854355349968,1.78447494694868e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMP4,Metalloproteinase inhibitor 4,42611,-0.0638536023276588,0.00405423946421754,-0.0717999116775251,-0.0559072929777924,2.15687140924209e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,FST,Follistatin,42654,0.0758752626561657,0.00482074380078235,0.0664266048066323,0.0853239205056992,2.5298444014753e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,HCLS1,Hematopoietic lineage cell-specific protein,42754,0.0848130356123546,0.00539115735042995,0.0742463672055119,0.0953797040191973,2.81635140122557e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,SRPK2,SRSF protein kinase 2,42594,0.128370749725366,0.00816478692982843,0.112367767342902,0.14437373210783,3.30137107844255e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,RILPL2,RILP-like protein 2,40511,0.149355462615649,0.00949601392407998,0.130743275324453,0.167967649906846,3.71219220606344e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,F11R,Junctional adhesion molecule A,42611,0.0853793432131849,0.00543981713797786,0.0747173016227483,0.0960413848036215,5.02575929131618e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,SELP,P-selectin,42689,0.085939850667334,0.00548140650189073,0.0751962939236282,0.0966834074110398,6.47832384631744e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC42BPB,Serine/threonine-protein kinase MRCK beta,40449,0.157851520519922,0.0100593673609404,0.138135160492478,0.177567880547365,6.54160384444251e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,IGSF8,Immunoglobulin superfamily member 8,42636,0.0470823935703137,0.00300789865258201,0.041186912211253,0.0529778749293745,9.64926903730945e-55
NMR metabolomics,X23428.Concentration of VLDL Particles,NCS1,Neuronal calcium sensor 1,42721,0.0443926782775027,0.00283726796212683,0.0388316330717342,0.0499537234832713,1.06174224019605e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,APPL2,DCC-interacting protein 13-beta,40283,0.17029343566187,0.0108822744191754,0.148964177800286,0.191622693523454,1.29920734625474e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF19,Fibroblast growth factor 19,42676,0.118574606404284,0.00760536094477964,0.103668098952516,0.133481113856052,2.49966965507032e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,OPHN1,Oligophrenin-1,40483,0.16308674103503,0.0104626882125136,0.142579872138503,0.183593609931557,3.24883070434837e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,CMC1,COX assembly mitochondrial protein homolog,40511,0.138160426484104,0.00887155952163065,0.120772169821708,0.1555486831465,4.01618210691952e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,BID,BH3-interacting domain death agonist,42594,0.102317323246248,0.00658596184366374,0.0894088380326673,0.115225808459829,5.87615720644475e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,THPO,Thrombopoietin,42357,0.0593907169829154,0.00382641547217925,0.0518909426574441,0.0668904913083868,7.47140640313009e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,YOD1,Ubiquitin thioesterase OTU1,40116,0.0967981051975205,0.00623275855387069,0.0845818984319339,0.109014311963107,8.09545132767262e-54
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,42476,0.16893286257062,0.0109011943786618,0.147566521588443,0.190299203552798,1.07648535520711e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,PLEKHO1,Pleckstrin homology domain-containing family O member 1,40483,0.104879466223629,0.00677183821401878,0.0916066633241519,0.118152269123105,1.49358118512362e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,NAGK,N-acetyl-D-glucosamine kinase,40209,0.0846896608738562,0.00546831295815972,0.0739717674758631,0.0954075542718492,1.54645734487069e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTA1,Glutathione S-transferase A1,42611,0.124830130638937,0.00807596915554594,0.109001231094067,0.140659030183807,1.95382488567112e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,ASAH2,Neutral ceramidase,42495,0.0812976217455127,0.00526073755632489,0.0709865761351159,0.0916086673559095,2.07443766803958e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42495,0.143490835652296,0.00929225879875573,0.125278008406735,0.161703662897858,2.47851677584591e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,GAS6,Growth arrest-specific protein 6,42718,-0.0383835420873506,0.00248804417378864,-0.0432601086679763,-0.0335069755067248,3.05086677320649e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,PRCP,Lysosomal Pro-X carboxypeptidase,42733,0.0476295037947107,0.00308817954907451,0.0415766718785247,0.0536823357108968,3.24014686751693e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,AP3B1,AP-3 complex subunit beta-1,40449,0.115458995234245,0.00749243098538528,0.10077383050289,0.1301441599656,4.86640238289978e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,GH1,Somatotropin,42613,-0.259340499691478,0.0168485859112585,-0.292363728077545,-0.226317271305411,5.21876459813849e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,NT5E,5'-nucleotidase,42679,0.0854549028834406,0.0055526713487468,0.0745716670398969,0.0963381387269843,5.39733014090826e-53
NMR metabolomics,X23428.Concentration of VLDL Particles,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,40449,0.133752963285364,0.00870859202753792,0.11668412291139,0.150821803659339,1.05835238980436e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX15,Sorting nexin-15,40283,0.0816205360758727,0.005327145764651,0.0711793303771567,0.0920617417745887,1.88635470967188e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,CNPY4,Protein canopy homolog 4,42587,0.110607752023388,0.00724652035419961,0.0964045721291565,0.124810931917619,3.67244601685071e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,EZR,Ezrin,42711,0.0356847585618728,0.00234198258754623,0.0310944726902822,0.0402750444334634,5.42975834690362e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,RBP5,Retinol-binding protein 5,42587,0.0832798685294735,0.00547329002539203,0.0725522200797051,0.0940075169792419,7.54707567517967e-52
NMR metabolomics,X23428.Concentration of VLDL Particles,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42587,0.114100667363521,0.00750836914906092,0.0993842638313618,0.128817070895681,1.00716812019506e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,LECT2,Leukocyte cell-derived chemotaxin-2,40511,0.0999729970133888,0.0065801444103997,0.0870759139690054,0.112870080057772,1.26702225194339e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,WASF1,Wiskott-Aldrich syndrome protein family member 1,42357,0.137652006982666,0.00907164271938038,0.11987158725268,0.155432426712651,1.43735641263815e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,CTBS,Di-N-acetylchitobiase,40383,0.0399735595989908,0.00263371458341004,0.0348114790155071,0.0451356401824745,1.61839983259794e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,NOTCH3,Neurogenic locus notch homolog protein 3,42794,-0.0506980273293612,0.00335004952434053,-0.0572641243970686,-0.0441319302616537,2.54719951659816e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,TACC3,Transforming acidic coiled-coil-containing protein 3,42587,0.171071541204076,0.0113057283413482,0.148912313655034,0.193230768753119,2.66779226547777e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,LZTFL1,Leucine zipper transcription factor-like protein 1,40283,0.105263854404824,0.00696675080682058,0.0916090228234555,0.118918685986192,4.51668568748636e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,CD2AP,CD2-associated protein,42636,0.0941654107092678,0.00623877520671071,0.0819374113041148,0.106393410114421,4.67549832471778e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,BIRC2,Baculoviral IAP repeat-containing protein 2,42346,0.0927035446933253,0.00614195033339562,0.0806653220398699,0.104741767346781,4.77968976531864e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA3F,Semaphorin-3F,42636,0.0402032826870379,0.00266456408678453,0.0349807370769402,0.0454258282971356,5.07080528422259e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,DNMBP,Dynamin-binding protein,42495,0.0887736622138807,0.0058863592776362,0.0772363980297137,0.100310926398048,5.67463422135398e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42587,0.0496345195012632,0.0032923195812174,0.0431815731220771,0.0560874658804493,6.10942908892765e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,IGF2R,Cation-independent mannose-6-phosphate receptor,42611,0.0344778940855685,0.00228878251959618,0.02999188034716,0.038963907823977,7.29097624021027e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,DBNL,Drebrin-like protein,42676,0.135004302318166,0.00896975609429479,0.117423580373348,0.152585024262984,8.77997176994178e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,40482,0.158721474779294,0.0105418705566853,0.13805940848819,0.179383541070397,9.74720473090586e-51
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM20A,Pseudokinase FAM20A,40511,0.0417806606199498,0.00277695136825655,0.036337835938167,0.0472234853017327,1.14025547860016e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,MITD1,MIT domain-containing protein 1,42495,0.141189945364461,0.00939173217719564,0.122782150297158,0.159597740431765,1.15547444424449e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,HYOU1,Hypoxia up-regulated protein 1,42794,0.0341243077401549,0.0022701618661495,0.0296747904825019,0.0385738249978079,1.16174837977256e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42594,0.0890392547360635,0.00592393600796454,0.077428340160453,0.100650169311674,1.1998287719453e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,AZI2,5-azacytidine-induced protein 2,40482,0.0811728167945307,0.00539648240809997,0.0705957112746548,0.0917499223144067,1.20816423328144e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,RTBDN,Retbindin,42587,0.0441166968238352,0.00293557365105664,0.0383629724677642,0.0498704211799063,1.23872783775998e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,TBCC,Tubulin-specific chaperone C,42495,0.118055878711378,0.00786628451343855,0.102637961065038,0.133473796357717,1.68918804770712e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,F2,Prothrombin,40539,0.0219822317793989,0.00146462215705314,0.0191115723515747,0.0248528912072231,1.9575870712618e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,SEC31A,Protein transport protein Sec31A,40223,0.113021408182423,0.0075301434972626,0.0982623269277883,0.127780489437058,2.00858298221602e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,RABEP1,Rab GTPase-binding effector protein 1,40283,0.11492319650424,0.00766955179680646,0.0998908749824989,0.12995551802598,2.88131090879413e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,TBC1D23,TBC1 domain family member 23,42587,0.131217233026049,0.00876520256382898,0.114037436000945,0.148397030051154,2.92802099171151e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,METAP2,Methionine aminopeptidase 2,42689,0.0834656152726889,0.00558543665673197,0.0725181594254942,0.0944130711198836,4.32116586509988e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,NPPC,C-type natriuretic peptide,42594,0.0736266351141776,0.00492908932255348,0.0639656200419728,0.0832876501863824,4.77078474888494e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,STAMBP,STAM-binding protein,42476,0.0925387833622035,0.00620496423377117,0.080377053464012,0.104700513260395,6.80143538436231e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,GFER,FAD-linked sulfhydryl oxidase ALR,42346,0.0918691077334928,0.0061609721189923,0.0797936023802679,0.103944613086718,7.09018835675551e-50
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH9,Protocadherin-9,40449,0.0504461443834027,0.00338912602924176,0.0438034573660888,0.0570888314007165,1.22727130431092e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,PLSCR3,Phospholipid scramblase 3,40457,0.0846087720945882,0.00568471403639538,0.0734667325832532,0.0957508116059231,1.2471498906561e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,CRKL,Crk-like protein,42636,0.152002390541372,0.0102422348790725,0.13192761017839,0.172077170904355,1.96546399320374e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,ASGR1,Asialoglycoprotein receptor 1,42495,0.0445006853544754,0.00299906669685329,0.038622514628643,0.0503788560803079,2.06020416884057e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN2,CCN family member 2,42624,0.080163433049357,0.00540430876884481,0.0695709878624212,0.0907558782362928,2.19569856214929e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,SH2B3,SH2B adapter protein 3,42346,0.141516078357046,0.00954213149558858,0.122813500625693,0.1602186560884,2.32384449280703e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",40223,0.099969792879992,0.00673916035275167,0.0867610385885987,0.113178547171385,2.62840981738485e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,PDLIM5,PDZ and LIM domain protein 5,40482,0.169702168702293,0.0114414283594123,0.147276969117845,0.192127368286741,2.63662531852598e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCD5,Programmed cell death protein 5,42711,0.0836307578682801,0.0056448036228716,0.0725669427674518,0.0946945729691084,2.83018174999793e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,MPRIP,Myosin phosphatase Rho-interacting protein,40417,0.0632616198478931,0.0042700078220625,0.0548924045166506,0.0716308351791356,3.39606508679133e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",40482,0.112386810327664,0.00758918694735865,0.0975120039108408,0.127261616744487,3.71317593287363e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,USP25,Ubiquitin carboxyl-terminal hydrolase 25,40451,0.10367499885914,0.00700336687813833,0.0899483997779884,0.117401597940291,4.01821519088889e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMP3,Metalloproteinase inhibitor 3,42676,0.188405528311468,0.0127621460601328,0.163391722033608,0.213419334589329,6.12815666595541e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,40451,0.118869079066411,0.0080478662971586,0.10309526112398,0.134642897008841,6.53086895050707e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42594,0.145312398721942,0.00984718352158126,0.126011919019643,0.164612878424242,6.73365515103708e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,OGFR,Opioid growth factor receptor,42587,0.0470767645384483,0.00319148052138538,0.040821462716533,0.0533320663603637,7.35137015500205e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,CES2,Cocaine esterase,42587,0.0794521858978512,0.00538685585664914,0.0688939484188189,0.0900104233768835,7.51298287847569e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,STK11,Serine/threonine-protein kinase STK11,42357,0.104687003612216,0.00710044860243751,0.0907701243514384,0.118603882872993,8.27126055909202e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,DUSP13,Dual specificity protein phosphatase 13 isoform A,40451,0.0609211637842203,0.00413202797936536,0.0528223889446642,0.0690199386237764,9.61729132926386e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM13A,Protein FAM13A,40449,0.0973455530819645,0.00660282612868862,0.0844040138697348,0.110287092294194,9.70810444321001e-49
NMR metabolomics,X23428.Concentration of VLDL Particles,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,40511,0.112616140772666,0.00764038645058776,0.0976409833295136,0.127591298215818,1.0146070074951e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,NIT2,Omega-amidase NIT2,40462,0.105641375514222,0.00717176788928167,0.0915847104512303,0.119698040577215,1.16846160262078e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,SNAP23,Synaptosomal-associated protein 23,42636,0.124948821193683,0.00849236113494803,0.108303793369184,0.141593849018181,1.26850970626745e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,MYDGF,Myeloid-derived growth factor,40511,0.141856611150192,0.00963811569639377,0.12296590438526,0.160747317915124,1.38215667680188e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",40482,0.114738211036422,0.00779748386470922,0.0994551426615922,0.130021279411252,1.4583632697052e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,BACH1,Transcription regulator protein BACH1,42594,0.10530429992249,0.00716223411911574,0.0912663210490228,0.119342278795957,1.47887768934738e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,40482,0.0950778258293405,0.00646237489727544,0.0824115710306807,0.107744080628,1.50679902591917e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP43,Centrosomal protein 43,42255,0.0995883973559121,0.00677515646845925,0.086309090677732,0.112867704034092,1.59493301351655e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,SKAP2,Src kinase-associated phosphoprotein 2,42676,0.149939361176795,0.010203176426525,0.129941135380806,0.169937586972784,1.63713845769527e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL13,C-C motif chemokine 13,42734,0.0995613161247965,0.00678466962948955,0.0862633636509969,0.112859268598596,2.20978632697366e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",42459,0.0601050685437883,0.00409599215494159,0.0520769239201028,0.0681332131674738,2.25987100557348e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,SYTL4,Synaptotagmin-like protein 4,40511,0.106321503286655,0.00724229266103,0.0921266096710365,0.120516396902274,2.38505351764613e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,GIGYF2,GRB10-interacting GYF protein 2,40482,0.10810081344463,0.00737563799509574,0.0936445629742425,0.122557063915018,3.39178452915017e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,TANK,TRAF family member-associated NF-kappa-B activator,42370,0.0996426723402756,0.00680556446262423,0.0863037659935321,0.112981578687019,3.65413062633617e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP10,Stromelysin-2,42608,-0.084499990452425,0.00577310335534086,-0.0958152730288931,-0.0731847078759569,3.84164790402016e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,SORD,Sorbitol dehydrogenase,42658,0.095837481218431,0.00655724976009691,0.082985271688641,0.108689690748221,5.21444353397981e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH2,Cadherin-2,42636,0.0510049038988346,0.0034900236956638,0.0441644574553336,0.0578453503423357,5.29862075470312e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,TOP2B,DNA topoisomerase 2-beta,40199,0.114279372424354,0.00782349677210726,0.0989453187510242,0.129613426097685,7.08267704630987e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,RBM17,Splicing factor 45,40482,0.109313903097416,0.00748925295640553,0.0946349673028613,0.123992838891971,8.1002373786541e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,EVI5,Ecotropic viral integration site 5 protein homolog,40199,0.127620603088101,0.00874707742510658,0.110476331334892,0.14476487484131,9.06012302343533e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,AKT1S1,Proline-rich AKT1 substrate 1,42311,0.0952734484788954,0.00653698298731298,0.082460961823762,0.108085935134029,9.62849573203049e-48
NMR metabolomics,X23428.Concentration of VLDL Particles,ACY1,Aminoacylase-1,42636,0.0864545250744131,0.00593597121382914,0.074820021495308,0.0980890286535182,1.08973624963285e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,VAMP8,Vesicle-associated membrane protein 8,40199,0.125866772004357,0.00865252472655813,0.108907823540303,0.142825720468411,1.68619639790286e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,NPL,N-acetylneuraminate lyase,40511,0.0650786536052407,0.00447882940983375,0.0563001479619666,0.0738571592485149,2.079424282959e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42570,0.148727826949832,0.0103014626025191,0.128536960248894,0.168918693650769,6.76132376669385e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,BRAP,BRCA1-associated protein,40342,0.154418523795819,0.0106890276671548,0.133468029568196,0.175369018023442,6.99033247974653e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,CKB,Creatine kinase B-type,40527,-0.0856780341733669,0.00593312372198337,-0.0973069566684543,-0.0740491116782795,7.47680593705529e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,TWF2,Twinfilin-2,40527,0.117537634277973,0.00814213193439773,0.101579055686553,0.133496212869392,8.01690427325812e-47
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA11,Annexin A11,42570,0.0942914654227205,0.00654344578249083,0.0814663116890384,0.107116619156402,1.00081328470389e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,TBL1X,F-box-like/WD repeat-containing protein TBL1X,42346,0.119261709994809,0.00828346147802451,0.103026125497881,0.135497294491737,1.21214912685358e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42587,0.0626860871380522,0.00435613793276371,0.0541480567898353,0.071224117486269,1.32516341088785e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,42346,0.0616213047738823,0.00428244094636489,0.0532277205190071,0.0700148890287575,1.36370785618912e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL5,C-C motif chemokine 5,42689,0.140260473863786,0.00976692203890551,0.121117306667531,0.159403641060041,2.00487943860472e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBPL,FK506-binding protein-like,40449,0.0826055437094297,0.00574845035043832,0.0713385810225706,0.0938725063962888,2.05191203125855e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,GMPR,GMP reductase 1,42754,0.0696141129084498,0.00484841106897677,0.0601112272132553,0.0791169986036442,2.0736466725964e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,ST13,Hsc70-interacting protein,40283,0.0796686510372312,0.00554444699083695,0.0688015349351908,0.0905357671392716,2.10945391502791e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,STAT2,Signal transducer and activator of transcription 2,40199,0.107338336311032,0.00747474021356159,0.0926878454924511,0.121988827129613,2.41187015029598e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,SUSD1,Sushi domain-containing protein 1,42357,0.0693916531036064,0.00484068018178243,0.0599039199473128,0.0788793862599,2.94322086399504e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFB1,Transforming growth factor beta-1 proprotein,42746,0.0535601504932278,0.00373808225945155,0.0462335092647028,0.0608867917217528,3.17102645407227e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA4D,Semaphorin-4D,42711,0.0419952547197081,0.00293540960526832,0.0362418518933822,0.047748657546034,4.32780969047377e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP5IF1,"ATPase inhibitor, mitochondrial",42676,0.15355401106405,0.010741577922665,0.132500518335627,0.174607503792474,5.07740585858507e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42679,0.100568654581269,0.00703995092768537,0.0867703507630061,0.114366958399533,5.83748473086519e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,SPART,Spartin,40283,0.107497343446427,0.00752666423276273,0.0927450815502125,0.122249605342642,7.20236646016321e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,IL18R1,Interleukin-18 receptor 1,42754,0.0462284542230667,0.00324260776948993,0.0398729429948664,0.0525839654512669,8.73828791424468e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKG1,cGMP-dependent protein kinase 1,40283,0.17429567496565,0.0122230913577609,0.150338415904438,0.198252934026861,9.90974982492238e-46
NMR metabolomics,X23428.Concentration of VLDL Particles,AHNAK,Neuroblast differentiation-associated protein AHNAK,40223,0.0447567675886009,0.00314198457412668,0.0385984778233126,0.0509150573538892,1.22631304276212e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM5,Tripartite motif-containing protein 5,42594,0.119057102716547,0.0083693528130562,0.102653171202957,0.135461034230137,1.36886295248086e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,TIA1,Nucleolysin TIA-1 isoform p40,42190,0.168358614196777,0.0118479576534915,0.145136617195934,0.19158061119762,1.74138098552895e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,40511,0.08825253362412,0.00621045078394541,0.076080050087587,0.100425017160653,1.94259934424657e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,EREG,Proepiregulin,42476,0.112299622004715,0.00791274596167058,0.0967906399198405,0.127808604089589,2.19578984751988e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,ARSB,Arylsulfatase B,42587,0.0765533409548364,0.00539497217786453,0.0659791954862219,0.0871274864234509,2.25968913022168e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,FTCD,Formimidoyltransferase-cyclodeaminase,40462,0.119172858657948,0.00839973444467581,0.102709379146383,0.135636338169513,2.67823375424178e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,HDGFL2,Hepatoma-derived growth factor-related protein 2,40483,0.088474533686826,0.00623947477089839,0.0762451631358652,0.100703904237787,2.98614766947634e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,COMMD1,COMM domain-containing protein 1,40223,0.0841877290014462,0.00593900082389427,0.0725472873866134,0.0958281706162789,3.24265271796266e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFB,Platelet-derived growth factor subunit B,42676,0.118650326906516,0.00837810773572354,0.102229235744498,0.135071418068534,3.32214782094338e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42679,0.0512992300832127,0.00362384998708897,0.0441964841085183,0.0584019760579071,3.61035058822905e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,TRAF2,TNF receptor-associated factor 2,42594,0.0964641666210179,0.00681711181448739,0.0831026274646226,0.109825705777413,3.92913117085929e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,DAG1,Dystroglycan,42676,0.0635714309815554,0.00449732756211465,0.0547566689598107,0.0723861930033001,4.82039733839876e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM21,E3 ubiquitin-protein ligase TRIM21,42594,0.109083093753232,0.0077328570748439,0.0939266938865375,0.124239493619926,7.2571183041807e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,SCAMP3,Secretory carrier-associated membrane protein 3,42587,0.116872890818381,0.00828775881197846,0.100628883546903,0.133116898089859,7.73860905557525e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,MARS1,"Methionine--tRNA ligase, cytoplasmic",40267,0.117625938835483,0.00834498226749729,0.101269773591188,0.133982104079777,9.86517334667371e-45
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,40283,0.0863170394262487,0.00614358993484535,0.0742756031539518,0.0983584756985456,1.85338392106221e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42594,0.098152895735525,0.00699579479534791,0.0844411379366431,0.111864653534407,2.09734989432568e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,HEXIM1,Protein HEXIM1,42594,0.110963114230662,0.0079134383032673,0.0954527751562583,0.126473453305066,2.34909632712426e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,HS1BP3,HCLS1-binding protein 3,40223,0.122095116818182,0.00870311663209466,0.105037008219277,0.139153225417088,2.49272707887893e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,AGRN,Agrin,42676,0.0499998551109827,0.00357275466400917,0.0429972559695247,0.0570024542524407,3.41849777372008e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,ASPSCR1,Tether containing UBX domain for GLUT4,40482,0.0921284452615764,0.00658521050040296,0.0792214326807866,0.105035457842366,4.17435468021171e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,TAX1BP1,Tax1-binding protein 1,40483,0.0867098583674146,0.00620396667959427,0.0745500836754098,0.0988696330594193,5.04277342405706e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,PBLD,Phenazine biosynthesis-like domain-containing protein,42311,0.0702738667248175,0.00503153168627096,0.0604120646197264,0.0801356688299085,5.14190643071831e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,CASC3,Protein CASC3,40182,0.0575458923315774,0.00411975362131369,0.0494711752338025,0.0656206094293522,5.78010358393811e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,KHK,Ketohexokinase,40223,0.0862061689572095,0.00617283488864024,0.0741074125754747,0.0983049253389444,5.99485868447507e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,USP8,Ubiquitin carboxyl-terminal hydrolase 8,42357,0.129225628142097,0.00926010064113668,0.11107583088547,0.147375425398725,6.02089997258909e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXNB3,Plexin-B3,42597,0.0641270854718949,0.00459687887019079,0.055117202886321,0.0731369680574689,6.36662285105212e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,FETUB,Fetuin-B,42663,0.043980241648646,0.00315920050371546,0.0377882086613637,0.0501722746359283,9.4453093666176e-44
NMR metabolomics,X23428.Concentration of VLDL Particles,DOK1,Docking protein 1,40483,0.185387089991525,0.0133275289048274,0.159265133338063,0.211509046644986,1.25935963323435e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,RAPGEF2,Rap guanine nucleotide exchange factor 2,40302,0.072091656120553,0.00518775779134439,0.061923650849518,0.082259661391588,1.53821843248009e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,BAG4,BAG family molecular chaperone regulator 4,40199,0.0669878032330573,0.00482142926150984,0.057537801880498,0.0764378045856166,1.60941778794394e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42587,0.119580785559193,0.00861378626565987,0.1026977644785,0.136463806639887,1.61888853083141e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,LYN,Tyrosine-protein kinase Lyn,42587,0.114211564846591,0.00823014482698205,0.0980804809857063,0.130342648707476,1.74043753040533e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,TP53,Cellular tumor antigen p53,42346,0.0586278090066056,0.00422969568475269,0.0503376054644903,0.0669180125487209,2.20258529365648e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,GTPBP2,GTP-binding protein 2,40182,0.109854768781881,0.00792657018201362,0.0943186912251339,0.125390846338627,2.59335860275427e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,PTS,6-pyruvoyl tetrahydrobiopterin synthase,42250,0.0750686192722577,0.00542678752304866,0.0644321157270823,0.085705122817433,3.25159835439219e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,UPB1,Beta-ureidopropionase,40511,0.122354896103848,0.00884307726075145,0.105022464672775,0.139687327534921,3.45971840006797e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,GDF2,Growth/differentiation factor 2,42636,0.0487963025855472,0.00352997977887127,0.0418775422189595,0.0557150629521349,3.63459096008862e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,VWA1,von Willebrand factor A domain-containing protein 1,42689,0.0559902849483395,0.00405118439092511,0.0480499635421263,0.0639306063545527,3.76026845628781e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,GYS1,"Glycogen [starch] synthase, muscle",42357,0.125235994941003,0.00906857590269667,0.107461586171718,0.143010403710289,4.43576485687743e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,GOLM2,Protein GOLM2,42711,0.0313131523352901,0.00226800870174095,0.0268678552798779,0.0357584493907024,4.56656390354501e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,MED18,Mediator of RNA polymerase II transcription subunit 18,42346,0.102385428187792,0.00741842383268253,0.0878453174757339,0.116925538899849,4.97728265614444e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,DRG2,Developmentally-regulated GTP-binding protein 2,42587,0.0760984219088124,0.0055146127823909,0.0652897808553263,0.0869070629622986,5.05922436264593e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,KIFBP,KIF-binding protein,42587,0.110444218765685,0.00800856166073569,0.0947474379106429,0.126140999620727,5.69400503376982e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,LAT,Linker for activation of T-cells family member 1,42754,0.101925989574071,0.00739250777238168,0.087436674340203,0.116415304807939,5.88575871084147e-43
NMR metabolomics,X23428.Concentration of VLDL Particles,DDHD2,Phospholipase DDHD2,40482,0.0884141038846299,0.00643572294440595,0.0758000869135943,0.101028120855666,1.32212586589678e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,SFRP4,Secreted frizzled-related protein 4,40283,0.0545358390421603,0.00396992807785114,0.0467547800095721,0.0623168980747485,1.35514197030228e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,SH3GLB2,Endophilin-B2,40483,0.0899294468972615,0.00654891096907184,0.0770935813978807,0.102765312396642,1.43528573471869e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,VASP,Vasodilator-stimulated phosphoprotein,40532,0.0972825332573136,0.0070909768213774,0.0833842186874139,0.111180847827213,1.70114939780364e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,AHSG,Alpha-2-HS-glycoprotein,40532,0.03667337489627,0.0026739875378401,0.0314323593221035,0.0419143904704366,1.80421994470259e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,ATXN2L,Ataxin-2-like protein,40482,0.0649749252792915,0.00474026339084658,0.0556840090332322,0.0742658415253508,2.01329142390688e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,40482,0.108421767746923,0.00791035495480591,0.0929174720355029,0.123926063458342,2.03302501371504e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",40449,0.195868256467069,0.0143044704357825,0.167831494412935,0.223905018521202,2.44678757210023e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,UBXN1,UBX domain-containing protein 1,40283,0.0920953883121959,0.00672555095616346,0.0789133084381155,0.105277468186276,2.45655009823849e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,GASK1A,Golgi-associated kinase 1A,40116,0.0583924274603708,0.00426687216173232,0.0500293580233754,0.0667554968973661,2.78136496776305e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,MGLL,Monoglyceride lipase,42654,0.114978492628847,0.00841270157857067,0.0984895975348485,0.131467387722845,3.04848783039851e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,NSFL1C,NSFL1 cofactor p47,42711,0.0869764240500724,0.00636597347098579,0.0744991160469402,0.0994537320532045,3.23329166683098e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,IL7,Interleukin-7,42594,0.0852056614617215,0.00623847201432772,0.0729782563136392,0.0974330666098038,3.46079439949248e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,NEXN,Nexilin,40532,0.0926605977482007,0.00678242176179532,0.0793670510950819,0.10595414440132,3.69668222455186e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,GLB1,Beta-galactosidase,42495,0.0555497190778521,0.00407163826885971,0.047569308070887,0.0635301300848171,4.26068165032832e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,GOLGA3,Golgin subfamily A member 3,40482,0.105001145126177,0.0076918907427799,0.0899250392703283,0.120077250982025,4.30241184431393e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK13,Kallikrein-13,42381,0.0617420898417753,0.00453475901634758,0.052853962169734,0.0706302175138165,6.2370899106781e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,MPHOSPH8,M-phase phosphoprotein 8,42357,0.100669055252053,0.00740068133578046,0.0861637198339229,0.115174390670182,7.4038307088413e-42
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNLR1,Interferon lambda receptor 1,42594,0.0485920706240341,0.00358282283717765,0.0415697378631659,0.0556144033849022,1.25735091996811e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,MXRA8,Matrix remodeling-associated protein 8,40283,-0.0416113337169516,0.00307239028168885,-0.0476332186690617,-0.0355894487648414,1.84475840949285e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGA5,Integrin alpha-5,42611,0.0333023102929634,0.00246257687194899,0.0284756596239434,0.0381289609619835,2.12571455614785e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42569,0.101553680970273,0.00751194441023276,0.086830269926217,0.116277092014329,2.2592494440406e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,GORASP2,Golgi reassembly-stacking protein 2,40449,0.0624132386107468,0.0046188026725045,0.053360385372638,0.0714660918488556,2.75428288745726e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDC,Nuclear migration protein nudC,42754,0.0820547905581993,0.00608841132270175,0.0701215043657039,0.0939880767506947,3.91843501857428e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,SHBG,Sex hormone-binding globulin,40532,-0.0670380430280703,0.00497419292382663,-0.0767874611587705,-0.0572886248973701,4.41233970578469e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,WASHC3,WASH complex subunit 3,40483,0.0990162283059247,0.00734925731641852,0.0846116839657444,0.113420772646105,4.68189928962121e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42636,0.109563103070649,0.00814808658915715,0.093592853355901,0.125533352785397,5.93789194550542e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,MAVS,Mitochondrial antiviral-signaling protein,42346,0.119765943901914,0.0089063081985588,0.102309579832738,0.137222307971089,5.95091469677375e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1R2,Interleukin-1 receptor type 2,42600,0.0262899328483666,0.00195596090508109,0.0224562494744077,0.0301236162223255,6.40472625025457e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,DLG4,Disks large homolog 4,40483,0.0924810749473449,0.00687863149853005,0.078998957210226,0.105963192684464,6.82210863696028e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,HTRA2,"Serine protease HTRA2, mitochondrial",42679,0.0798880808367548,0.00594792215008268,0.0682301534225928,0.0915460082509169,7.26029547197705e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,APOL1,Apolipoprotein L1,40532,0.0769935214478496,0.00573623653788963,0.0657504978335859,0.0882365450621132,9.15860893838418e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,RWDD1,RWD domain-containing protein 1,42711,0.0827861892413033,0.00617309562768575,0.0706869218110392,0.0948854566715674,9.51978360469354e-41
NMR metabolomics,X23428.Concentration of VLDL Particles,MAX,Protein max,42311,0.138032065064476,0.010298084724849,0.117847819003772,0.15821631112518,1.06597742429057e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,40030,0.0440995417847313,0.00328852204877487,0.0376540385691326,0.0505450450003301,1.11221338008794e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,NACC1,Nucleus accumbens-associated protein 1,40451,0.0727571519470911,0.00542780450610076,0.0621186551151336,0.0833956487790486,1.16558363046411e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,FLT4,Vascular endothelial growth factor receptor 3,42679,0.0433998922407222,0.0032434257524097,0.0370427777659992,0.0497570067154453,1.4190591813228e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,KITLG,Kit ligand,42636,-0.0494044339760723,0.00369667092785094,-0.0566499089946601,-0.0421589589574844,1.76520242126618e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,REN,Renin,42636,-0.112532958618325,0.00843175779521623,-0.129059203896949,-0.0960067133397012,2.24829171987126e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,CETN3,Centrin-3,40449,0.0993962418151191,0.00744269826153701,0.0848085532225065,0.113983930407732,2.25015776188798e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,GGT1,Glutathione hydrolase 1 proenzyme,42590,0.0659737978029974,0.00494635841914517,0.0562789353014729,0.0756686603045219,2.52018442702772e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",40483,0.127298568643835,0.00954059869695719,0.108598995197799,0.145998142089871,2.63260133300963e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,42346,0.101187109085906,0.00759216885251966,0.0863064581349674,0.116067760036844,2.90909166265148e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC27,Cell division cycle protein 27 homolog,42346,0.0787456111497446,0.00591497556364144,0.0671522590450074,0.0903389632544818,3.54244384784262e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,PACS2,Phosphofurin acidic cluster sorting protein 2,40116,0.0812342390061375,0.00609790658075663,0.0692823421078545,0.0931861359044205,3.56286440809038e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,MFAP5,Microfibrillar-associated protein 5,42794,0.0538768482890188,0.00404789861487714,0.0459429670038596,0.061810729574178,3.61870157299953e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,NIT1,Deaminated glutathione amidase,40223,0.0622664694545617,0.0046752518034318,0.0531029759198353,0.071429962989288,3.6978696640945e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,IRAK4,Interleukin-1 receptor-associated kinase 4,42594,0.135679830600733,0.0101960907277324,0.115695492774377,0.155664168427088,3.78666775302464e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,APOA2,Apolipoprotein A-II,40532,-0.0645685922541977,0.0048501892222532,-0.074074963129814,-0.0550622213785815,3.91155054578493e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,CNST,Consortin,42636,0.141597001728096,0.0106507182359736,0.120721593985588,0.162472409470604,4.45486873369506e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42636,0.0361672251816947,0.00272088165340619,0.0308342971410186,0.0415001532223708,4.58191477043094e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,IGBP1,Immunoglobulin-binding protein 1,40482,0.0796704410185066,0.00599165431577209,0.0679267985595933,0.0914140834774199,4.82423836302138e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1RL2,Interleukin-1 receptor-like 2,42370,0.050492919995926,0.00380071454818071,0.0430435194814918,0.0579423205103601,5.10757496682051e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,CRADD,Death domain-containing protein CRADD,42476,0.0977591772184616,0.00736090443419132,0.0833318045274466,0.112186549909477,5.37645931090428e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM58,E3 ubiquitin-protein ligase TRIM58,40451,0.114331495124433,0.0086077039256248,0.0974603954302089,0.131202594818658,5.84477175742672e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,SMNDC1,Survival of motor neuron-related-splicing factor 30,40449,0.077518306435254,0.00584694490566411,0.0660582944201524,0.0889783184503557,8.07013085688399e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,SPON2,Spondin-2,42562,-0.0468069070284335,0.00353474028902343,-0.0537349979949194,-0.0398788160619475,8.93806181976192e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,ICA1,Islet cell autoantigen 1,42370,0.102340465216219,0.00772896010026814,0.0871917034196938,0.117489227012745,9.1076006161441e-40
NMR metabolomics,X23428.Concentration of VLDL Particles,APOE,Apolipoprotein E,40539,0.0950442788943217,0.00717847920918798,0.0809744596443132,0.10911409814433,1.01313105879306e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,EHD3,EH domain-containing protein 3,40223,0.152892209117029,0.0115493116623308,0.130255558258861,0.175528859975197,1.0596592348994e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC3B,Tetranectin,40269,0.02747801133609,0.00207581910006012,0.0234094058999722,0.0315466167722078,1.07084619752725e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300LG,CMRF35-like molecule 9,42611,-0.0500695323540493,0.00378537635315818,-0.0574888700062393,-0.0426501947018592,1.0843759439699e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1RN,Interleukin-1 receptor antagonist protein,42585,0.0707122990460941,0.00534641784175314,0.0602333200762579,0.0811912780159302,1.09973089207965e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,HPGDS,Hematopoietic prostaglandin D synthase,42346,0.0499266619054415,0.00377912559513928,0.0425195757389685,0.0573337480719145,1.35173160357833e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,OGA,Protein O-GlcNAcase,40449,0.0909707922520013,0.00688284420821704,0.077480417603896,0.104461166900107,1.37914232305248e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,BTN3A2,Butyrophilin subfamily 3 member A2,42594,0.0507232678160577,0.00384073420445258,0.0431954287753306,0.0582511068567847,1.41885959016445e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS8,Galectin-8,42711,0.077520619443315,0.00587677175734847,0.066002146798912,0.089039092087718,1.7330903414339e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,HARS1,"Histidine--tRNA ligase, cytoplasmic",42611,0.0987059847906034,0.00750404705640371,0.0839980525600521,0.113413917021155,2.83530222579904e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,40511,0.096101986536759,0.0073062633412576,0.0817817103878941,0.110422262685624,3.15571555503177e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,STIP1,Stress-induced-phosphoprotein 1,42586,0.0834618784988907,0.006351727027882,0.0710124935242419,0.0959112634735394,3.39274403585902e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,F11,Coagulation factor XI,40383,0.0391044506242646,0.00297414739410326,0.0332751217318222,0.0449337795167069,3.40443290300238e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,GMPR2,GMP reductase 2,40283,0.0871233678612286,0.00662648486608564,0.0741354575237008,0.100111278198756,3.44139556528569e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39940,0.13772292765364,0.01047701498073,0.117187978291409,0.158257877015871,3.63198248756493e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPA1A,Heat shock 70 kDa protein 1A,42658,0.090161127738305,0.00686879489421731,0.0766982897456391,0.103623965730971,4.05163668509461e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB27B,Ras-related protein Rab-27B,40511,0.106238064859981,0.00810138349200665,0.0903593532156478,0.122116776504314,5.29638716900096e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,PSIP1,PC4 and SFRS1-interacting protein,42594,0.082883260834813,0.00632618457085696,0.0704839390759333,0.0952825825936926,5.59428008385215e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,42311,0.142608626698781,0.0108911559545909,0.121261961027782,0.163955292369779,6.25145600476126e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,SIAE,Sialate O-acetylesterase,42646,0.058977299201871,0.00450480599939998,0.050147879443047,0.0678067189606949,6.31954828728575e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,CD1C,T-cell surface glycoprotein CD1c,42679,0.0324702027548658,0.00248089139166959,0.0276076556271934,0.0373327498825382,6.64498179657309e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4G,C-type lectin domain family 4 member G,42594,0.0426561695179823,0.00326206347600353,0.0362625251050154,0.0490498139309492,7.76062830782e-39
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHA1,Ephrin type-A receptor 1,42658,0.0423556049084871,0.00324460598964549,0.0359961771687819,0.0487150326481922,1.03353600996232e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,DCXR,L-xylulose reductase,42679,0.0673172989002179,0.00516214186394159,0.0571995008468923,0.0774350969535434,1.23145999680813e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,FOXJ3,Forkhead box protein J3,40199,0.0562048453006677,0.00430904982399607,0.0477591076456354,0.0646505829557,1.33796041049563e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,CHMP1A,Charged multivesicular body protein 1a,42495,0.101127536405324,0.0077595892615529,0.0859187414526799,0.116336331357967,1.37572069958198e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINE1,Plasminogen activator inhibitor 1,42794,0.0845148332730168,0.00648748608019678,0.0717993605558311,0.0972303059902025,1.4546519799464e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,VPS28,Vacuolar protein sorting-associated protein 28 homolog,40302,0.084284259007116,0.00647539329627994,0.0715924881464073,0.0969760298678246,1.89319816754632e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,TREM2,Triggering receptor expressed on myeloid cells 2,42618,0.0669188907320198,0.00514689210099039,0.0568309822140786,0.0770067992499609,2.03818381792499e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM172A,Cotranscriptional regulator FAM172A,40223,0.0780733318547575,0.0060017380530013,0.066309925270875,0.0898367384386401,2.09846039863726e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,ORM1,Alpha-1-acid glycoprotein 1,40483,0.025773699672139,0.00198155693465003,0.021889848080225,0.0296575512640531,2.11233430898571e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,DIABLO,"Diablo homolog, mitochondrial",42603,0.138875931929791,0.0106905088515856,0.117922534580683,0.159829329278899,2.35736503082266e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,40451,0.061259652385411,0.00471463735809184,0.052018963163551,0.070500341607271,2.51127647738915e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,SMAD3,Mothers against decapentaplegic homolog 3,40451,0.0659544355106415,0.00508091294237265,0.0559958461435911,0.0759130248776919,2.95639900424768e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT5,ADP-sugar pyrophosphatase,42611,0.0643525730034705,0.00496549513705732,0.0546202025348381,0.0740849434721028,3.49752466943359e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,STXBP1,Syntaxin-binding protein 1,40482,0.0978481811170051,0.00754791307437223,0.0830542714912355,0.112642090742775,3.68253554564374e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,PMVK,Phosphomevalonate kinase,42303,0.137537000186727,0.0106250777945319,0.116711847709444,0.158362152664009,4.31578753812722e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFBP2,Fibroblast growth factor-binding protein 2,40527,0.0656238750024852,0.00507063812702457,0.055685424273517,0.0755623257314533,4.85191227528772e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,SDC4,Syndecan-4,42636,0.0599761848894537,0.00464039372486766,0.0508810131887131,0.0690713565901943,5.49041170687337e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,CD244,Natural killer cell receptor 2B4,42754,0.0348674178409453,0.00269784498798832,0.0295796416644882,0.0401551940174024,5.51027336418463e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,40283,0.107358984555027,0.00830227052211257,0.0910865343316866,0.123631434778368,5.6377807543437e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,MPI,Mannose-6-phosphate isomerase,42587,0.107120354018629,0.00829372027762539,0.0908646622744837,0.123376045762775,6.17181766450523e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,40283,0.0734617333599574,0.00568640857751664,0.0623163725480248,0.08460709417189,6.61264986114117e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,TMED8,Protein TMED8,40449,0.129561525162442,0.0100331268432403,0.109896596549691,0.149226453775193,7.0259603494479e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,MTDH,Protein LYRIC,40199,0.119249394352172,0.00924445565768067,0.101130261263118,0.137368527441226,8.50144438147449e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,LSP1,Lymphocyte-specific protein 1,42594,0.0504225881301921,0.00391238517018047,0.0427543131966384,0.0580908630637458,8.82294071941846e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,BPIFB2,BPI fold-containing family B member 2,40473,0.0875266168484969,0.00679094971691019,0.0742163554033529,0.100836878293641,9.6183673907329e-38
NMR metabolomics,X23428.Concentration of VLDL Particles,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,40451,0.0483727772447354,0.00375521073276317,0.0410125642085196,0.0557329902809513,1.05583917786432e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,LBR,Delta(14)-sterol reductase LBR,42711,0.0840712799456152,0.00653719554217224,0.0712583766829576,0.0968841832082727,1.24862820715338e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRY2,Protein sprouty homolog 2,42370,0.116292889100361,0.00904375288116436,0.0985671334532784,0.134018644747443,1.29000234623993e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,XIAP,E3 ubiquitin-protein ligase XIAP,40199,0.0721430913606853,0.00560750026909766,0.0611523908332539,0.0831337918881167,1.31380188263725e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R2,Protein phosphatase inhibitor 2,42636,0.0993645808479777,0.00772915193422255,0.0842154430569015,0.114513718639054,1.3284769825241e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,VAV3,Guanine nucleotide exchange factor VAV3,40136,0.125368890752752,0.00974793481203434,0.106262938521164,0.144474842984339,1.39439969510399e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,42346,0.123854321729754,0.00964454099042391,0.104951021388523,0.142757622070984,1.60440436715803e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP5,Fatty acid-binding protein 5,42678,0.0853155909994777,0.00664846973462688,0.072284590319609,0.0983465916793463,1.78934062866765e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,CACYBP,Calcyclin-binding protein,40267,0.128804943092391,0.0100394882885606,0.109127546046812,0.14848234013797,2.06039853561745e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,COCH,Cochlin,40511,0.0592778415938471,0.00462117223671472,0.0502203440098862,0.0683353391778079,2.09623022254294e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP2,Microtubule-associated protein 2,40483,0.05862491845015,0.0045711682918906,0.0496654285980444,0.0675844083022556,2.16757544804578e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",40302,0.0619672512757754,0.00483778844912508,0.0524851859154902,0.0714493166360606,2.67961473290923e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,FIS1,Mitochondrial fission 1 protein,42624,0.0946112325994936,0.0073943059363929,0.0801183929641635,0.109104072234824,2.88013436649544e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,CTF1,Cardiotrophin-1,42357,0.105615331966339,0.00826018864611425,0.0894253622199552,0.121805301712723,3.26517405791227e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,CD36,Platelet glycoprotein 4,40199,0.0565082951859219,0.00441724333663044,0.0478504982461262,0.0651660921257176,3.31574274199414e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,ERP29,Endoplasmic reticulum resident protein 29,40283,0.148948146718013,0.0116480091847735,0.126118048715857,0.171778244720169,3.52677869605807e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,LPP,Lipoma-preferred partner,40116,0.0827755010972762,0.00648598544982773,0.0700629696156138,0.0954880325789385,4.89862911755055e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNDC5,Thioredoxin domain-containing protein 5,42711,0.0836324374187496,0.00657016221524367,0.070754919476872,0.0965099553606272,6.63394237485798e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,42346,0.105634587535221,0.00830356876720755,0.0893595927514944,0.121909582318948,7.39627658768091e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42679,-0.0439357131705819,0.00345421959847741,-0.0507059835835976,-0.0371654427575662,7.50821904406599e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,AMN,Protein amnionless,42370,0.0589592459139765,0.00463740261511471,0.0498699367883516,0.0680485550396013,8.14888504990423e-37
NMR metabolomics,X23428.Concentration of VLDL Particles,SH2D1A,SH2 domain-containing protein 1A,42594,0.0721004758029556,0.00568152536580015,0.0609646860859873,0.0832362655199239,1.08758713754294e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,DGKA,Diacylglycerol kinase alpha,40199,0.0684344026203319,0.00538934488192499,0.057871286651759,0.0789975185889049,1.09536486483487e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL8,C-C motif chemokine 8,42706,0.0754332699906186,0.00594964789088458,0.0637719601244848,0.0870945798567524,1.25591848876544e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,YJU2,Splicing factor YJU2,40451,0.0404926484037524,0.003192435206144,0.0342354753997101,0.0467498214077946,1.29195558909562e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP1,Insulin-like growth factor-binding protein 1,42770,-0.149924577504154,0.0118286653889135,-0.173108761666424,-0.126740393341883,1.3167140603306e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42594,0.123235940247756,0.00973425755804822,0.104156795433982,0.142315085061531,1.59355647919796e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP25,Rho GTPase-activating protein 25,42346,0.0739316495344779,0.00584285687294404,0.0624796500635076,0.0853836490054482,1.74907348527801e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,QDPR,Dihydropteridine reductase,42581,0.0528398223780198,0.00417747774023542,0.0446519660071583,0.0610276787488812,1.83755639670873e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,GRAP2,GRB2-related adapter protein 2,42636,0.157405023759525,0.0124769273860503,0.132950246082867,0.181859801436184,2.77774644120053e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,MESD,LRP chaperone MESD,42611,0.149048002066393,0.0118211036428688,0.125878638926371,0.172217365206416,3.03724423954899e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,AP2B1,AP-2 complex subunit beta,40182,0.0599893235727729,0.00475521085051612,0.0506691103057613,0.0693095368397845,3.09191775353234e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,CD22,B-cell receptor CD22,42754,0.0541462317512268,0.00429521593836459,0.0457276085120322,0.0625648549904214,3.1170980478986e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,THOP1,Thimet oligopeptidase,42571,0.0382863042329933,0.00303705332479466,0.0323336797163957,0.0442389287495908,3.12807006135044e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,SCLY,Selenocysteine lyase,42674,0.0579200253817003,0.00459594927917681,0.0489119647945138,0.0669280859688869,3.27673715770028e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM40,E3 ubiquitin ligase TRIM40,40182,0.089066415279731,0.00706355947515852,0.0752218387084203,0.102910991851042,3.34166902475437e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,C4BPB,C4b-binding protein beta chain,42679,0.0499924702819539,0.0039680348613526,0.0422151219537028,0.057769818610205,3.42775239269519e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,GNPDA2,Glucosamine-6-phosphate isomerase 2,40283,0.0454643084715953,0.00360862634354251,0.038391400838252,0.0525372161049386,3.79055616225463e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,PPIB,Peptidyl-prolyl cis-trans isomerase B,42656,0.115256590429208,0.00915808648749073,0.0973067409137263,0.13320643994469,4.06600359863396e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,HMOX2,Heme oxygenase 2,42311,0.0566077241848075,0.00450080230037783,0.047786151676067,0.0654292966935481,4.54771098923834e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,OTUD6B,Deubiquitinase OTUD6B,40449,0.0724020440880014,0.00575719693253899,0.0611179381002249,0.0836861500757778,5.00172634371509e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,ELAC1,Zinc phosphodiesterase ELAC protein 1,40482,0.105045437917478,0.00835410974730112,0.0886713828127676,0.121419493022188,5.10812119259086e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",40223,0.0548787397199785,0.00436562437559345,0.0463221159438153,0.0634353634961417,5.40222684820936e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,40283,0.0615432749227681,0.00489677722307815,0.0519455915655349,0.0711409582800012,5.5586246699361e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,YWHAQ,14-3-3 protein theta,40283,0.0908290710743595,0.00723542761368347,0.0766476329515399,0.105010509197179,6.67935306927115e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGEF10,Rho guanine nucleotide exchange factor 10,40482,0.114880890178338,0.00915691492648888,0.0969333369224194,0.132828443434256,7.26829976428987e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42594,0.111657812142714,0.00890614857371205,0.0942017609382388,0.12911386334719,7.42820213606339e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,DLK1,Protein delta homolog 1,42794,0.0679059425853535,0.00541794519469627,0.0572867700037488,0.0785251151669582,7.72048440332166e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,PHLDB1,Pleckstrin homology-like domain family B member 1,40449,0.0650094213604069,0.0051853289747136,0.0548461765699682,0.0751726661508455,8.10478792709239e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,NARS1,"Asparagine--tRNA ligase, cytoplasmic",40482,0.0585017658683565,0.00467065338543278,0.0493472852329083,0.0676562465038048,9.36996500358788e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,SUGT1,Protein SGT1 homolog,42346,0.0985697392437429,0.00787532073451122,0.0831341106041009,0.114005367883385,9.71840570537166e-36
NMR metabolomics,X23428.Concentration of VLDL Particles,FARSA,Phenylalanine--tRNA ligase alpha subunit,40182,0.0855224614555386,0.00683475621440226,0.0721263392753102,0.098918583635767,1.11090311149069e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,GPD1,Glycerol-3-phosphate dehydrogenase,40451,0.0638979807527359,0.00510855378770889,0.0538852153288264,0.0739107461766453,1.164176755959e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB9,Serpin B9,42495,0.0404556807934381,0.00323672176081184,0.0341117061422469,0.0467996554446293,1.19916684389822e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,RABGAP1L,Rab GTPase-activating protein 1-like,42370,0.0738127563734873,0.0059104650499397,0.0622282448756055,0.0853972678713691,1.37192530791615e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,EGLN1,Egl nine homolog 1,42594,0.0681111032322794,0.00545629950728999,0.0574167561979911,0.0788054502665678,1.45701070353991e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,IDUA,Alpha-L-iduronidase,42721,0.0566403734309547,0.00456003109516663,0.0477027124844281,0.0655780343774813,3.1265476689291e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,FHIT,Bis(5'-adenosyl)-triphosphatase,42311,0.0892937078761377,0.00719688758676354,0.0751878082060812,0.103399607546194,3.75782817136358e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42495,0.0952535890693373,0.00767983583338419,0.0802011108359043,0.11030606730277,3.9327349908807e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,MATN2,Matrilin-2,42638,0.0361260161973524,0.00291400471164266,0.0304145669625328,0.041837465432172,4.19935349035507e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,SEPTIN9,Septin-9,42587,0.0347290222534727,0.00280342220953604,0.0292343147227821,0.0402237297841633,4.71726799508519e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,PLG,Plasminogen,40285,0.0262058755616107,0.00211662067869676,0.022057299031365,0.0303544520918563,5.63624323709279e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,CRELD1,Protein disulfide isomerase CRELD1,40283,0.046115963580334,0.00373075370082933,0.0388036863267085,0.0534282408339595,7.20319189241154e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,GPKOW,G-patch domain and KOW motifs-containing protein,42311,0.0350321118458401,0.00283691481726012,0.0294717588040102,0.0405924648876699,7.73270047354605e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",40511,0.108681329353478,0.008800087189639,0.0914331584617851,0.12592950024517,8.15780900097974e-35
NMR metabolomics,X23428.Concentration of VLDL Particles,SCPEP1,Retinoid-inducible serine carboxypeptidase,40169,0.0597957477069325,0.00484948142016834,0.0502907641234026,0.0693007312904625,1.05499030758668e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,TBCB,Tubulin-folding cofactor B,42495,0.120566558610508,0.00979193094352224,0.101374373961205,0.139758743259812,1.19274031117835e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,BAG3,BAG family molecular chaperone regulator 3,42475,0.0491654280207593,0.00400485433146494,0.041315913531088,0.0570149425104305,1.86293702966315e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,FGL1,Fibrinogen-like protein 1,40532,-0.0796585831806086,0.00648959615098813,-0.0923781916365453,-0.0669389747246719,2.04470669654296e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPB1,Heat shock protein beta-1,42448,0.0815818698725529,0.00665909784326446,0.0685300380997546,0.0946337016453513,2.53819054751988e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42611,0.0732976872590552,0.00598963066215011,0.061558011161241,0.0850373633568694,2.98621416969376e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,PXN,Paxillin,42311,0.0615066945314245,0.00503748398017551,0.0516332259302805,0.0713801631325685,4.2191585390998e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,RRAS,Ras-related protein R-Ras,40182,0.155597351950658,0.0127497231965482,0.130607894485424,0.180586809415892,4.91392655341144e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,NUB1,NEDD8 ultimate buster 1,42594,0.0995070521129282,0.00816777842026435,0.08349820640921,0.115515897816646,5.79880509635158e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,BIN2,Bridging integrator 2,42611,0.108169183488726,0.00888111690008517,0.0907621943645594,0.125576172612893,6.02485992799842e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,CDNF,Cerebral dopamine neurotrophic factor,42587,0.0403627669164822,0.00331631349975985,0.0338627924569529,0.0468627413760115,6.70053828734388e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINC1,Antithrombin-III,40516,0.0176855866792735,0.00145386402515361,0.0148360131899724,0.0205351601685746,7.80464561703217e-34
NMR metabolomics,X23428.Concentration of VLDL Particles,CERT,Ceramide transfer protein,42311,0.0730373145055965,0.0060174593786411,0.06124309412346,0.0848315348877331,1.01249375314477e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42611,0.0540041166917063,0.00445343587326298,0.0452753823801108,0.0627328510033017,1.14815615462066e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,DNM3,Dynamin-3,40482,0.0655190765331536,0.00540366971985864,0.0549278838822307,0.0761102691840765,1.26073733035874e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,CD226,CD226 antigen,40199,0.0504675129621478,0.00418527487314065,0.0422643742107921,0.0586706517135034,2.8397714743652e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,CD207,C-type lectin domain family 4 member K,42365,0.0472041653711787,0.00391819899355153,0.0395244953438177,0.0548838353985397,2.9927644901322e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42649,0.0254465815422514,0.00211347472179511,0.021304171087533,0.0295889919969698,3.23730747025356e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGA2,Integrin alpha-2,40283,0.041517501973229,0.00344712262157513,0.0347611416349418,0.0482738623115163,3.35592643606923e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT5,"Keratin, type II cytoskeletal 5",42311,0.0609203982450629,0.00506797900530753,0.0509871593946602,0.0708536370954657,4.13125900752447e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42676,0.138992465479513,0.0115829187700015,0.11628994469031,0.161694986268716,5.24625842676835e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42587,0.109808818204361,0.00915403375409578,0.0918669120463329,0.127750724362388,5.52405601145081e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,C1R,Complement C1r subcomponent,40539,0.0230548313275903,0.00192125678417025,0.0192891680306166,0.026820494624564,5.63350639588612e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,CRHBP,Corticotropin-releasing factor-binding protein,42618,0.0323313189090211,0.00269571046467972,0.0270477263982488,0.0376149114197933,5.65656217384274e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL7,C-C motif chemokine 7,42594,0.0698763140584342,0.0058279568394131,0.0584535186531845,0.0812991094636839,5.92117830140982e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",40283,0.122434281805,0.010207601216728,0.102427383420214,0.142441180189787,6.07513238336054e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM24,Transcription intermediary factor 1-alpha,40287,0.0765867329483493,0.00639250694819107,0.0640574193298948,0.0891160465668038,7.15277217368969e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS1,Galectin-1,42636,0.0413617684227251,0.00345632488288978,0.0345873716522611,0.048136165193189,7.76966081178292e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP7,Caspase-7,40483,0.0983757333778805,0.0082211110793075,0.0822623556624378,0.114489111093323,8.42944669152729e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,42346,0.075863458930848,0.00634301770226699,0.0634311442344047,0.0882957736272913,8.49930493654926e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42587,0.0517789832309315,0.00432976181771299,0.043292650068214,0.0602653163936489,8.57178904550272e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,PDIA4,Protein disulfide-isomerase A4,40527,0.0705232379869335,0.00589635960162764,0.0589663731677433,0.0820801028061237,9.01166269535402e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,BAG6,Large proline-rich protein BAG6,42357,0.0418841028716396,0.00350441314914472,0.0350154530993159,0.0487527526439633,9.38332448639876e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPKAPK2,MAP kinase-activated protein kinase 2,40302,0.087033531734243,0.00728062561778967,0.0727635055233752,0.101303557945111,9.80636826212028e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,PF4,Platelet factor 4,40463,0.115751941019968,0.00968436402700167,0.0967705875270444,0.134733294512891,9.93786209629608e-33
NMR metabolomics,X23428.Concentration of VLDL Particles,DFFA,DNA fragmentation factor subunit alpha,42754,0.0783221509131726,0.00656919285738983,0.0654465329126885,0.0911977689136566,1.31259083267969e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42654,0.0995537088224229,0.00835121551194625,0.0831853264190082,0.115922091225838,1.34435542167317e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB6,Serpin B6,42679,0.0678280862772995,0.00569089354719944,0.0566739349247886,0.0789822376298104,1.37831081028088e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42638,0.0303977873196618,0.00255093987086233,0.0253979451727716,0.0353976294665519,1.41972595159472e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,42192,0.100534437978789,0.00843919085997625,0.0839936238932353,0.117075252064342,1.49915960916729e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,GET3,ATPase GET3,40511,0.0634277905967381,0.00533149846198548,0.0529780536112466,0.0738775275822297,1.91899794874986e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT16,U8 snoRNA-decapping enzyme,40429,0.101354798787755,0.0085213204967728,0.0846530106140805,0.11805658696143,1.98400757309593e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,VNN1,Pantetheinase,40532,0.0854158665432191,0.00718342919378628,0.0713363453233979,0.0994953877630402,2.06144845830738e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,IGSF3,Immunoglobulin superfamily member 3,42587,0.0423596444025031,0.00356480334562634,0.0353726298450755,0.0493466589599307,2.11673582390187e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,RP2,Protein XRP2,42587,0.049101309563782,0.00413233913100344,0.0410019248670153,0.0572006942605488,2.13022581934247e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,GLOD4,Glyoxalase domain-containing protein 4,42602,0.040713818626701,0.00343206902825826,0.0339869633313148,0.0474406739220872,2.68013858217542e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,MICALL2,MICAL-like protein 2,40182,0.080460328856721,0.00677882379138859,0.0671738342255994,0.0937468234878426,2.68906137693011e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,KYAT1,Kynurenine--oxoglutarate transaminase 1,42620,0.0659813035164958,0.00557242107927297,0.0550593582011208,0.0769032488318708,3.47672423194352e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,42295,0.0670312188130643,0.00566258735829147,0.055932547590813,0.0781298900353155,3.64033752134101e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,AMBP,Protein AMBP,42706,0.0244091200486284,0.00206278792882383,0.0203660557081337,0.0284521843891231,3.79471762953909e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTD,Deoxycytidylate deaminase,40283,0.10969714019362,0.00926590509832467,0.0915359662009034,0.127858314186336,3.8399197395519e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRC59,Leucine-rich repeat-containing protein 59,40511,0.0566734578022193,0.00479101465425092,0.0472830690798875,0.0660638465245511,4.26524484121304e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,DTD1,D-aminoacyl-tRNA deacylase 1,40283,0.10036578559162,0.00848934436330347,0.0837266706395448,0.117004900543694,4.64804885917078e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB6A,Ras-related protein Rab-6A,42594,0.0535311124715543,0.00453092759794808,0.0446504943795761,0.0624117305635326,4.73174443653515e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,TADA3,Transcriptional adapter 3,40451,0.0459950962199077,0.00389394959139262,0.0383629550207782,0.0536272374190373,5.23170971640178e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB14,DnaJ homolog subfamily B member 14,40449,0.0736426134905643,0.00623651229786029,0.0614190493867581,0.0858661775943704,5.46060365362658e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,TBC1D5,TBC1 domain family member 5,42594,0.0910287444809994,0.00771689613569057,0.0759036280550459,0.106153860906953,5.8874761983648e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,40511,0.0707444470011381,0.00599793211793982,0.058988500049976,0.0825003939523001,6.38297150999795e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,CIAPIN1,Anamorsin,42679,0.0718138932431731,0.00609362615517527,0.0598703859790296,0.0837574005073167,6.68063281415087e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,HGF,Hepatocyte growth factor,42754,0.0404158329397407,0.00342976938537526,0.0336934849444052,0.0471381809350763,6.76602118947546e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,40277,0.0540196439954528,0.00458546478281424,0.0450321330211369,0.0630071549697687,7.60570744477144e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G4A,Cytosolic phospholipase A2,42676,0.100183335001367,0.00851357593893956,0.0834967261610457,0.116869943841689,8.21485424784748e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,SRP14,Signal recognition particle 14 kDa protein,42587,0.0685376102967182,0.00582894043100163,0.057112887051955,0.0799623335414814,9.1852459654778e-32
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL2L1,Bcl-2-like protein 1,40483,0.114624221327524,0.00974989298535118,0.0955144310762353,0.133734011578812,1.00135773260016e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42495,0.107774819815977,0.00919000422073087,0.0897624115433445,0.125787228088609,1.31992891176036e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE4,Ribonuclease 4,40169,0.0338047656169068,0.00288527973556469,0.0281496173352,0.0394599138986136,1.61996036538319e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,EGF,Pro-epidermal growth factor,42597,0.118105877624746,0.0100871680961951,0.0983350281562036,0.137876727093288,1.64100630059837e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC8,Sialic acid-binding Ig-like lectin 8,40223,0.0528559090784325,0.00451238333697425,0.044011637737963,0.061700180418902,1.66947442538061e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,SSNA1,Sjoegren syndrome nuclear autoantigen 1,40449,0.0597577442922121,0.0051055741349736,0.0497508189876639,0.0697646695967604,1.84064431462238e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,TDRKH,Tudor and KH domain-containing protein,42311,0.0973959909292508,0.00832568419769115,0.0810776499017761,0.113714331956725,1.86407940001947e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB1,Leukocyte elastase inhibitor,42569,0.10203439645696,0.00872373460697798,0.0849358766272832,0.119132916286637,1.89659547462915e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,RFC4,Replication factor C subunit 4,40451,0.0243529915575212,0.00208252218693334,0.0202712480711318,0.0284347350439105,2.07796241886794e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,AKT3,RAC-gamma serine/threonine-protein kinase,42297,0.0652549401720978,0.00558649731984505,0.0543054054252015,0.0762044749189941,2.28457574428515e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,PENK,Proenkephalin-A,40283,0.0378229997333951,0.00323815093933882,0.031476223892291,0.0441697755744992,2.44812348214562e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP2,Caspase-2,42594,0.0773162914884432,0.006624364700052,0.0643325366763413,0.0903000463005451,2.52671328692347e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,GPI,Glucose-6-phosphate isomerase,40532,0.0540116827544093,0.00462795011629303,0.0449409005264749,0.0630824649823436,2.71430294673656e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4E,Eukaryotic translation initiation factor 4E,40199,0.103728672996279,0.00889532303511155,0.0862938398474603,0.121163506145097,3.07633714130325e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42667,0.127216876189616,0.0109160069806931,0.105821502507458,0.148612249871774,3.08562524611382e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL3,C-C motif chemokine 3,42594,0.0660363551389346,0.00566754181008305,0.0549279731911718,0.0771447370866974,3.18190410371146e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,40511,0.103646867327031,0.00889228139770883,0.0862179957875219,0.121075738866541,3.23051896565666e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42594,0.109358444321403,0.00939442114226676,0.0909453788825598,0.127771509760245,3.61083549404747e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,THTPA,Thiamine-triphosphatase,40436,0.100785908127375,0.00865379245812293,0.0838244749094543,0.117747341345296,3.61152119625415e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,AKT2,RAC-beta serine/threonine-protein kinase,40482,0.143873885685504,0.0123706763963043,0.119627359948747,0.16812041142226,4.35017709449194e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,LTBP3,Latent-transforming growth factor beta-binding protein 3,42346,0.0597977130369821,0.00514502517787844,0.0497134636883403,0.0698819623856238,4.49622712295169e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,GGCT,Gamma-glutamylcyclotransferase,40500,0.0546311046477223,0.00469853624663051,0.0454219736043265,0.0638402356911181,4.49971542628885e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,MCEMP1,Mast cell-expressed membrane protein 1,40199,0.104447508343758,0.00898757628260085,0.0868318588298602,0.122063157857656,4.87322302050053e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,PKD2,Polycystin-2,40116,0.0668970761363075,0.00575962244927586,0.0556082161357268,0.0781859361368882,5.26906694272779e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,VPS4B,Vacuolar protein sorting-associated protein 4B,40451,0.107564935669072,0.00926389776716893,0.0894076960454209,0.125722175292723,5.42793274571158e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,LACTB2,Endoribonuclease LACTB2,42636,0.0740938432487993,0.00640279208386672,0.0615443707644206,0.0866433157331781,7.9865769860062e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,JPT2,Jupiter microtubule associated homolog 2,40449,0.0990397356141745,0.0085595495180063,0.0822630185588821,0.115816452669467,8.66432926243463e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL24,C-C motif chemokine 24,42654,0.0942301771015499,0.00815323287744239,0.0782498406617628,0.110210513541337,9.45976713859672e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,ADD1,Alpha-adducin,40283,0.0811191678300178,0.00701521506861331,0.0673693462955357,0.0948689893644999,9.486052047486e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,TALDO1,Transaldolase,40499,0.0501902153139758,0.00434129288717112,0.0416812812551204,0.0586991493728312,9.6544587906147e-31
NMR metabolomics,X23428.Concentration of VLDL Particles,PPY,Pancreatic prohormone,42600,0.117850125859282,0.0102036411851614,0.0978509891363661,0.137849262582199,1.03382226907575e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,GMFG,Glia maturation factor gamma,40511,0.081339241023032,0.0070435576413039,0.0675338680460764,0.0951446139999877,1.1218534174086e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",40511,0.0828928450935578,0.00717972201324014,0.0688205899476071,0.0969651002395084,1.15618826153833e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYBB1,Beta-crystallin B1,40511,0.0726216354707714,0.00629149182603201,0.0602903114917486,0.0849529594497941,1.1909764431116e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,TSC22D1,TSC22 domain family protein 1,40482,0.074034089641933,0.00641805312150443,0.0614547055237844,0.0866134737600817,1.30012402776272e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,NPPB,Natriuretic peptides B,42357,-0.161138869254829,0.0139789565722074,-0.188537624136355,-0.133740114373302,1.34859886584379e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,FOXO3,Forkhead box protein O3,42346,0.107706759134278,0.00934634947396081,0.0893879141653146,0.126025604103241,1.4012460930186e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSD,Cathepsin D,41747,0.0478523702855862,0.004157740690934,0.0397031985313556,0.0560015420398169,1.6859218061313e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,40451,0.121983688351592,0.0105977194806449,0.101212158169528,0.142755218533656,1.7322191765964e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,INPP1,Inositol polyphosphate 1-phosphatase,42587,0.0599158062348055,0.00520955941500132,0.0497050697814029,0.0701265426882081,1.80994530607961e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,UROD,Uroporphyrinogen decarboxylase,40283,0.0781143273712025,0.00679494051732314,0.0647962439572491,0.0914324107851558,2.05527612200039e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,KLB,Beta-klotho,42311,-0.0846325089264227,0.00736825110489903,-0.0990742810920248,-0.0701907367608206,2.16493550789456e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,PSME1,Proteasome activator complex subunit 1,42480,0.0419902013769004,0.00366020063371675,0.0348162081348156,0.0491641946189852,2.5307141023073e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,PARP1,Poly [ADP-ribose] polymerase 1,42594,0.065759847724476,0.00573290574114876,0.0545233524718244,0.0769963429771275,2.56760853753758e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,SPARC,SPARC,42679,0.0789248481860907,0.00688455453276892,0.0654311213018636,0.0924185750703178,2.76180537471068e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,A1BG,Alpha-1B-glycoprotein,40539,0.0191930941828459,0.00168009434503234,0.0159001092665825,0.0224860790991093,4.64068800925302e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,ATOX1,Copper transport protein ATOX1,42679,0.0781341634390021,0.00684278001174309,0.0647223146159856,0.0915460122620186,4.64624862479866e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,MOCS2,Molybdopterin synthase catalytic subunit,40283,0.0745173690833518,0.00652341314949166,0.0617314793103481,0.0873032588563554,4.72142837948146e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,FNDC1,Fibronectin type III domain-containing protein 1,40483,0.0530803207458516,0.0046529361430895,0.0439605659053962,0.062200075586307,5.57069281193662e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,CLUL1,Clusterin-like protein 1,42621,-0.0503977082969001,0.00442460309881062,-0.0590699303705689,-0.0417254862232313,6.4094040379372e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42587,0.0311547759374159,0.00273548784517401,0.0257932197608749,0.036516332113957,6.50429386813958e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,EGFR,Epidermal growth factor receptor,42794,0.0182853733532017,0.00160865129696461,0.015132416811151,0.0214383298952523,8.33071780573335e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,SMTN,Smoothelin,40460,0.103216710022946,0.00908788556622508,0.085404454313145,0.121028965732747,9.86187334003561e-30
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA3,Annexin A3,42681,0.0775803195632183,0.00683569843896177,0.0641823506228532,0.0909782885035833,1.01973996736258e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,COL18A1,Collagen alpha-1(XVIII) chain,42692,0.0271015778873698,0.00238895207552171,0.0224192318193473,0.0317839239553924,1.07574407679222e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,ELOA,Elongin-A,42587,0.0597579552078085,0.00527365775823346,0.0494215860016709,0.070094324413946,1.25123259747919e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,FUS,RNA-binding protein FUS,42336,0.0443892121781151,0.00391983371580322,0.0367063380951407,0.0520720862610894,1.36453083856177e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,CD40,Tumor necrosis factor receptor superfamily member 5,42620,0.054862877028156,0.00484504023433304,0.0453665981688632,0.0643591558874488,1.36698180839791e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP3R1,Calcineurin subunit B type 1,42495,0.0447129878644151,0.00395073676429383,0.0369695438063992,0.0524564319224311,1.46511150716487e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,40223,0.0548142456187886,0.00484158937718511,0.0453247304395057,0.0643037607980714,1.49405623823543e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,40482,0.110486442341782,0.00977347564834125,0.0913304300710336,0.129642454612531,1.79051186274151e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,42307,0.0867699858036097,0.00767961476108462,0.0717179408718839,0.101822030735336,1.82130021361265e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42721,0.0682083746995148,0.00604096220112566,0.0563680887853085,0.080048660613721,1.96905275037931e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,40283,0.0668142597617526,0.00591803738997546,0.0552149064774007,0.0784136130461045,2.12854273392353e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP10,Caspase-10,42311,0.0794748490939272,0.00704600473019039,0.0656646798227541,0.0932850183651004,2.26403737695969e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF5,E3 ubiquitin-protein ligase RNF5,40223,0.0815698585529031,0.00722964091601037,0.0673997623575227,0.0957399547482834,2.31359012069603e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,SPOCK1,Testican-1,42495,0.0287088961331572,0.0025459680715519,0.0237187987129155,0.033698993553399,2.33706925453776e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,40482,0.0538276040573687,0.00477429638673633,0.0444699831393655,0.0631852249753719,2.51679194635167e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,ACP5,Tartrate-resistant acid phosphatase type 5,42711,0.0351076419455053,0.0031166845354596,0.0289989402560045,0.0412163436350061,2.6559603726413e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42587,0.0590925313213664,0.00524762573710595,0.0488071848766387,0.069377877766094,2.77353617937539e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42495,0.0483817246629133,0.00429867327945762,0.0399563250351763,0.0568071242906502,2.96572590000383e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42651,0.064639452083036,0.00574356969742096,0.0533820554760909,0.075896848689981,2.98225964364642e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,IMPACT,Protein IMPACT,40483,0.0621149248273091,0.00551828283873374,0.051299090463391,0.0729307591912272,3.08906107759266e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYZL1,Quinone oxidoreductase-like protein 1,40223,0.101678628294552,0.00903441508344041,0.0839711747310084,0.119386081858095,3.17205418199907e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP3,Caspase-3,42794,0.0959749755817744,0.00853338959180286,0.0792495319818408,0.112700419181708,3.22465830173795e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,ASRGL1,Isoaspartyl peptidase/L-asparaginase,40223,0.113074751638192,0.0100511673390333,0.0933744636536867,0.132775039622697,3.34280101316368e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,ATXN3,Ataxin-3,40483,0.0689202522524527,0.00613028936371006,0.056904885099581,0.0809356194053245,3.59899334663243e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,GP1BB,Platelet glycoprotein Ib beta chain,40116,0.0767045305694971,0.00682384697676163,0.0633297904950443,0.0900792706439499,3.72119347098193e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS9,Galectin-9,42620,0.0356496090233258,0.0031746005215643,0.0294273920010598,0.0418718260455919,3.93300699057841e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINE2,Glia-derived nexin,40511,0.0710950461224766,0.00633477337742118,0.0586788903027311,0.0835112019422221,4.47793672998555e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,NT5C3A,Cytosolic 5'-nucleotidase 3A,42570,0.0958054086297281,0.00854740244787454,0.079052499831894,0.112558317427562,4.97711547954506e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,TTF2,Transcription termination factor 2,40182,0.0541319884385345,0.00482780488519761,0.0446694908635472,0.0635944860135218,5.08502778372944e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,CCT5,T-complex protein 1 subunit epsilon,42346,0.0506925691160793,0.0045250054561218,0.0418235584220806,0.0595615798100781,5.3466779918736e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,PKN3,Serine/threonine-protein kinase N3,40302,0.0826762321471996,0.00738646235690576,0.0681987659276643,0.0971536983667349,6.30479153827499e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,FUOM,Fucose mutarotase,40283,0.0698494881774123,0.00624820912647661,0.0576029982895182,0.0820959780653065,7.35935570402986e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,MIF,Macrophage migration inhibitory factor,42586,0.0744324888511638,0.00666386585019348,0.0613713117847846,0.0874936659175431,7.70531881053575e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42711,-0.0519329838695453,0.00465130001410281,-0.0610495318971868,-0.0428164358419038,8.06241343063458e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6AP2,Renin receptor,42346,0.0443906979542993,0.00398026850476481,0.0365893716849603,0.0521920242236383,9.34929052307229e-29
NMR metabolomics,X23428.Concentration of VLDL Particles,COMT,Catechol O-methyltransferase,42214,0.0911641464557412,0.00818203336199418,0.0751273610662326,0.10720093184525,1.05629417053937e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,MYO9B,Unconventional myosin-IXb,42370,0.0723662073624382,0.00650561427744151,0.0596152033786529,0.0851172113462236,1.29058401299395e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,42346,0.072795709673873,0.00655050194164406,0.0599567258682506,0.0856346934794953,1.45346846776894e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,DBN1,Drebrin,40199,0.0549129837257613,0.00493948126712207,0.045231600442202,0.0645943670093205,1.46898549982225e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,40199,0.0875859647270278,0.00788227721303783,0.0721367013894737,0.103035228064582,1.55949710864509e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,F12,Coagulation factor XII,40539,0.0454647861309893,0.00410274076857537,0.0374234142245816,0.053506158037397,2.15562460581723e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,DYNLT1,Dynein light chain Tctex-type 1,40182,0.0879325021194624,0.00794043124842219,0.0723692568725549,0.10349574736637,2.3683621788918e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNDC9,Thioredoxin domain-containing protein 9,40483,0.0574149990929001,0.0051879922595433,0.0472465342641952,0.0675834639216049,2.53871218324405e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,CHM,Rab proteins geranylgeranyltransferase component A 1,40182,0.0664727534768724,0.00600668860764421,0.0546996438058897,0.0782458631478551,2.57458700210635e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,SNCG,Gamma-synuclein,42495,0.0751824701905944,0.00679747490315408,0.0618594193804124,0.0885055210007764,2.59511688869511e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,PLPBP,Pyridoxal phosphate homeostasis protein,42636,0.0727551660113156,0.00657839535667328,0.059861511112236,0.0856488209103952,2.60578771978138e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,BLMH,Bleomycin hydrolase,42794,0.0340882597453994,0.00308594182196334,0.0280398137743512,0.0401367057164475,3.01179129597954e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,MAMDC4,Apical endosomal glycoprotein,40451,0.0599049828865732,0.00542163167027658,0.0492785848128311,0.0705313809603153,3.08703670096108e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC37,Hsp90 co-chaperone Cdc37,42679,0.0905676451700993,0.00820606632657997,0.0744837551700026,0.106651535170196,3.35744865341882e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,42370,0.057841554466089,0.00524176215230615,0.047567700647569,0.0681154082846091,3.45140293677915e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,STK24,Serine/threonine-protein kinase 24,42311,0.0668173907701678,0.0060571481899362,0.0549453803178929,0.0786894012224428,3.59526411854047e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,42346,0.0706174648599082,0.00640308359244314,0.0580674210187196,0.0831675087010967,3.69280380207272e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC26,Anaphase-promoting complex subunit CDC26,40428,0.0751384795348893,0.00682148789556651,0.061768363259579,0.0885085958101997,4.504558810022e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,GIPC3,PDZ domain-containing protein GIPC3,40449,0.105538828533586,0.00958239979684029,0.0867573249317786,0.124320332135393,4.55898612434393e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,LEP,Leptin,42636,0.0719655468646992,0.00653924592729308,0.0591486248472048,0.0847824688821937,4.75332624745215e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,NECAP2,Adaptin ear-binding coat-associated protein 2,40116,0.0744654216310961,0.00678055553571688,0.061175532781091,0.0877553104811012,6.5131584343956e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,CCS,Copper chaperone for superoxide dismutase,42495,0.051456123203017,0.00469138541395075,0.0422610077916736,0.0606512386143605,7.15240811799068e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,CD274,Programmed cell death 1 ligand 1,42495,0.0379307348564774,0.00345927741377,0.0311505511254882,0.0447109185874666,7.41452918793567e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,RRM2,Ribonucleoside-diphosphate reductase subunit M2,42346,0.0550617622124148,0.00503332681966662,0.0451964416458683,0.0649270827789614,9.83042685742035e-28
NMR metabolomics,X23428.Concentration of VLDL Particles,PARK7,Parkinson disease protein 7,42611,0.0557321566672821,0.00510138958664689,0.0457334330774542,0.06573088025711,1.14607418254072e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB2,DnaJ homolog subfamily B member 2,40283,0.0580527396338238,0.00531316830577298,0.0476389297545087,0.0684665495131388,1.1949048900772e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX5,"Peroxiredoxin-5, mitochondrial",42754,0.0710565707212716,0.00650900487204392,0.0582989211720655,0.0838142202704777,1.25041400493747e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASEH2A,Ribonuclease H2 subunit A,40482,0.0515528988831194,0.00472853135413416,0.0422849774290165,0.0608208203372224,1.53767823641896e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,NRGN,Neurogranin,40532,0.0974796156914764,0.00895802966886227,0.0799218775405064,0.115037353842446,1.92305350384352e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42594,0.12785592173522,0.0117774180321025,0.1047721823923,0.150939661078141,2.42622670312612e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,ALDH1A1,Retinal dehydrogenase 1,42611,0.0573278863376082,0.0052819364049311,0.0469752909839432,0.0676804816912731,2.49074657169898e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,BLNK,B-cell linker protein,40199,0.0438466744922149,0.00403797679642314,0.0359322399712255,0.0517611090132042,2.49753980947813e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,PDAP1,28 kDa heat- and acid-stable phosphoprotein,40511,0.104077760166499,0.00959175750487162,0.0852779154569505,0.122877604876047,2.69485310199573e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,SNAP25,Synaptosomal-associated protein 25,40136,0.0508048305812485,0.00468673316956386,0.0416188335689033,0.0599908275935936,3.05473758491697e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP170,Centrosomal protein of 170 kDa,40223,0.0825926982929311,0.00762381910230603,0.0676500128524112,0.0975353837334509,3.27358619016024e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,AFP,Alpha-fetoprotein,42459,0.0715945477395291,0.0066203941303092,0.058618575244123,0.0845705202349351,3.82467405884178e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",42346,0.0867719666727276,0.00803653219310571,0.0710203635742404,0.102523569771215,4.60839072437779e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,FAP,Prolyl endopeptidase FAP,42794,0.0291071172010425,0.00269667981882125,0.0238216247561528,0.0343926096459321,4.74522587175849e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,GZMA,Granzyme A,42754,0.037836539583981,0.00350555363911128,0.0309656544513229,0.0447074247166391,4.7679031880086e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS4,Galectin-4,42618,-0.0600350554153361,0.00557617605345525,-0.0709643604801084,-0.0491057503505638,6.39218927002655e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42594,0.0863419775872592,0.00802195138758429,0.070618952867594,0.102065002306924,6.61452656647899e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,ABHD14B,Protein ABHD14B,42460,0.0605305350626508,0.00562672398855865,0.0495021560450759,0.0715589140802258,7.03761146167251e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,ESYT2,Extended synaptotagmin-2,40483,0.0871964377156123,0.00810289406304483,0.0713147653520444,0.10307811007918,7.08869604782575e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,TMEM106A,Transmembrane protein 106A,40451,0.074292664204762,0.00690743884550591,0.0607540840675705,0.0878312443419536,7.54175989733108e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,AMOT,Angiomotin,40283,0.0411705087103295,0.00382933516458295,0.0336650117877469,0.0486760056329121,7.91766715064116e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,PPCDC,Phosphopantothenoylcysteine decarboxylase,42711,0.048809800865976,0.00454366181985646,0.0399042236990573,0.0577153780328946,8.25615794281132e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,40223,0.0808683364195826,0.00752796888552451,0.0661135174039546,0.0956231554352106,8.73087681045351e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,C2,Complement C2,42663,0.024242977881655,0.00226005561352319,0.0198132688791495,0.0286726868841604,9.77774436947276e-27
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB1BP2,Integrin beta-1-binding protein 2,42357,0.115411024747528,0.010784357647738,0.0942736837579619,0.136548365737095,1.28557400063556e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,CETN2,Centrin-2,42311,0.0709237020986012,0.00662785403999347,0.057933108180214,0.0839142960169884,1.29847950440458e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,C3,Complement C3,39989,0.0498124247324226,0.00465393197011978,0.0406907180709878,0.0589341313938574,1.33520241619965e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,REEP4,Receptor expression-enhancing protein 4,40482,0.0653094958234434,0.00610471270543257,0.0533442589207956,0.0772747327260913,1.39115853984285e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,SMOC2,SPARC-related modular calcium-binding protein 2,42676,0.0414954062699504,0.00388200272369835,0.0338866809315016,0.0491041316083991,1.46128428950461e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,SWAP70,Switch-associated protein 70,40449,0.0376512649420126,0.00352215321618484,0.0307478446382903,0.0445546852457349,1.52245512705806e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,CD69,Early activation antigen CD69,42585,0.0919899630353678,0.00861147604027051,0.0751114699964376,0.108868456074298,1.57608853642903e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,HAVCR1,Hepatitis A virus cellular receptor 1,42706,0.0696976412780164,0.00654073516786343,0.056877800349004,0.0825174822070287,2.08259129923898e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,BMP6,Bone morphogenetic protein 6,42342,0.042652766187498,0.00400314763589307,0.0348065968211475,0.0504989355538484,2.1217964723895e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL1,Growth-regulated alpha protein,42607,0.100163525509312,0.00941026001040344,0.0817194158889212,0.118607635129703,2.36716732684352e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,EPCAM,Epithelial cell adhesion molecule,42616,-0.103747561156582,0.00975616182676711,-0.122869638337045,-0.0846254839761184,2.6331389124174e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB33A,Ras-related protein Rab-33A,40116,0.0689798965176897,0.00648543736328535,0.0562684392856504,0.081691353749729,2.72110058851894e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,STX4,Syntaxin-4,42587,0.0621546462489415,0.00585270591470077,0.0506833426561279,0.073625949841755,3.06509253795029e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,CFHR5,Complement factor H-related protein 5,40382,0.0444426424350987,0.00418370551204112,0.0362425796314981,0.0526427052386993,3.11274575230908e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGB3A2,Secretoglobin family 3A member 2,42654,-0.0910012622767172,0.00857578261898755,-0.107809796209933,-0.0741927283435016,3.34673305238841e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,ANKRD54,Ankyrin repeat domain-containing protein 54,42346,0.0607285285994743,0.00572567819520814,0.0495061993368663,0.0719508578620822,3.55161905649452e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,FADD,FAS-associated death domain protein,42636,0.0788373136315663,0.00743803795403662,0.0642587592416545,0.0934158680214781,3.81102079475281e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,CFHR4,Complement factor H-related protein 4,40509,0.0783506194570505,0.00739077280360851,0.0638647047619778,0.0928365341521231,3.90324806059151e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,POMC,Pro-opiomelanocortin,40223,0.0731729837049031,0.00692314863229433,0.0596036123856062,0.0867423550242,5.50371231767135e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,ARL13B,ADP-ribosylation factor-like protein 13B,40116,0.0720736877702242,0.00682125928650627,0.0587040195686719,0.0854433559717765,5.713611352168e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,PNMA1,Paraneoplastic antigen Ma1,40223,0.0581841693637695,0.00551429489104145,0.0473761513773282,0.0689921873502107,6.64069742826017e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,DPP4,Dipeptidyl peptidase 4,42441,0.029388254178996,0.00278693983379604,0.0239258521047557,0.0348506562532362,6.78539201421555e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,CALCA,Calcitonin,42476,0.0658895751592425,0.00625090042841489,0.0536378103195493,0.0781413399989357,7.08664858940325e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL26,C-C motif chemokine 26,42594,0.0970930179732854,0.00921262792540843,0.0790362672394849,0.115149768707086,7.19927490002028e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42654,0.0785015334429137,0.00745230234341301,0.0638950208498242,0.0931080460360032,7.60190730025664e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",40209,0.0828692832882257,0.00787584092893705,0.0674326350675091,0.0983059315089423,9.06678548508082e-26
NMR metabolomics,X23428.Concentration of VLDL Particles,NHLRC3,NHL repeat-containing protein 3,40013,0.0334578474061752,0.00318567927732624,0.0272139160226157,0.0397017787897346,1.11691360390969e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,PPBP,Platelet basic protein,40471,0.0872572916720522,0.00830982558255496,0.0709700335302444,0.10354454981386,1.12856641657512e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,MIA,Melanoma-derived growth regulatory protein,42679,0.0390365338786619,0.00371969552364677,0.0317459306523143,0.0463271371050096,1.1491334034781e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,HPSE,Heparanase,40408,0.0968112513269078,0.00924048682684775,0.0786998971462862,0.114922605507529,1.44803299735537e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,GP5,Platelet glycoprotein V,40283,0.0373525445417946,0.00357316553572207,0.0303491400917794,0.0443559489918099,1.85172057551484e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA12,Serpin A12,42249,0.106707339452441,0.0102115916886935,0.0866926197426016,0.12672205916228,1.85365251563127e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,DXO,Decapping and exoribonuclease protein,40483,0.0470547478082365,0.00450250236087538,0.0382298431809207,0.0558796524355522,1.89813592841855e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,RAD23B,UV excision repair protein RAD23 homolog B,42346,0.0480977674014347,0.0046052488511502,0.0390714796531803,0.0571240551496891,1.96022312324593e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42711,0.0592499677319498,0.00567512906818112,0.0481267147583148,0.0703732207055847,2.02784745604707e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB2B,Ras-related protein Rab-2B,40451,0.0623417753607964,0.00597268320162721,0.0506353162856071,0.0740482344359857,2.17520463705624e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,MME,Neprilysin,42587,0.083482164815337,0.00800348514317963,0.0677953339347049,0.0991689956959691,2.24535829911115e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,AK2,"Adenylate kinase 2, mitochondrial",40483,0.108351802111518,0.0103953567422506,0.0879769028967069,0.128726701326329,2.53407018250658e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,MZT1,Mitotic-spindle organizing protein 1,42346,0.0530263052881617,0.00509085437976368,0.0430482307038248,0.0630043798724985,2.62907460202387e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,AKR1B1,Aldo-keto reductase family 1 member B1,42346,0.0757542678370813,0.00728346367217856,0.0614786790396113,0.0900298566345513,3.07806626777665e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,C1RL,Complement C1r subcomponent-like protein,40519,0.0203999372593319,0.00196337860123889,0.0165517152009037,0.0242481593177601,3.56422066773827e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,SULT2A1,Bile salt sulfotransferase,42594,0.0573223058495284,0.00553442476103384,0.0464748333179021,0.0681697783811548,4.8142690775197e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,CA13,Carbonic anhydrase 13,42483,0.104817628269871,0.0101207661893402,0.084980926538764,0.124654330000977,4.85916033782556e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,CHRDL2,Chordin-like protein 2,42636,0.0482264022872317,0.0046640350440092,0.0390848936009737,0.0573679109734897,5.75846890412395e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,WDR46,WD repeat-containing protein 46,40451,0.0366985149273094,0.00354799250113709,0.0297444496250807,0.0436525802295381,5.7955150550713e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,40451,0.0350802558481452,0.00339307875543203,0.0284298214874985,0.041730690208792,6.08346049020096e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,IL18,Interleukin-18,42566,0.0472598545042546,0.00457375613793609,0.0382952924738999,0.0562244165346094,6.21268266618757e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,TPK1,Thiamin pyrophosphokinase 1,40511,0.0279434467047627,0.00270709648498448,0.0226375375941931,0.0332493558153323,7.20207331091749e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,STX8,Syntaxin-8,42594,0.0486149196882823,0.00471470378936629,0.0393741002611244,0.0578557391154403,7.75434425659169e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42587,0.0255063305443041,0.0024749062274841,0.0206555143384353,0.030357146750173,8.19658841943976e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSO,Cathepsin O,42754,0.031198158110386,0.00303205404610031,0.0252553321800294,0.0371409840407426,9.6947851820042e-25
NMR metabolomics,X23428.Concentration of VLDL Particles,SCRN1,Secernin-1,42594,0.0560346575207901,0.00545269259453782,0.045347380035496,0.0667219350060842,1.11036325924289e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,TSHB,Thyrotropin subunit beta,42636,0.080388876375572,0.00783484446537443,0.0650325812234381,0.0957451715277059,1.30917742582619e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,TP53I3,Quinone oxidoreductase PIG3,40058,0.0538431841903042,0.00525120856100008,0.0435508154107441,0.0641355529698644,1.47681214597967e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFA,Platelet-derived growth factor subunit A,42794,0.0723412054132835,0.00706364659725281,0.058496458082668,0.086185952743899,1.5888218757029e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42594,0.120856525893122,0.0118047638702461,0.0977191887074401,0.143993863078805,1.650122793282e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,MSR1,Macrophage scavenger receptor types I and II,42711,0.0465806268517855,0.00454994108188647,0.037662742331288,0.055498511372283,1.65245528556388e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,BGLAP,Osteocalcin,40527,0.0915940027063607,0.00895026067447074,0.074051491784398,0.109136513628323,1.79014204104288e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,40199,0.0505873826656331,0.004946806837457,0.0408916412642174,0.0602831240670488,1.94493974291305e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,SDHB,Succinate dehydrogenase,40449,0.0670135354684452,0.00656311128820581,0.0541498373435618,0.0798772335933286,2.26927399477019e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,AMIGO2,Amphoterin-induced protein 2,42587,0.0236502079949073,0.00231852933866436,0.0191058904911252,0.0281945254986894,2.4205841252528e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42721,0.0268343990863047,0.00263155304775906,0.0216765551126969,0.0319922430599125,2.49979280371355e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,RILP,Rab-interacting lysosomal protein,42674,0.0596099828582083,0.00586437819995071,0.0481158015863049,0.0711041641301117,3.4816399365377e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,LARP1,La-related protein 1,40451,0.0614057572071981,0.00604092864821407,0.0495655370566986,0.0732459773576977,3.61439472783545e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,ARFIP1,Arfaptin-1,40482,0.0685287266789116,0.00674383577128678,0.0553108085671895,0.0817466447906337,3.7341065331257e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,F2R,Proteinase-activated receptor 1,42654,0.0558891391909985,0.00550776172716061,0.0450939262057637,0.0666843521762333,4.15787385915028e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,GGACT,Gamma-glutamylaminecyclotransferase,40511,0.0703759583904338,0.00693377584851808,0.0567857577273384,0.0839661590535292,4.21368851351648e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,GP6,Platelet glycoprotein VI,42590,0.0866452344268401,0.00857629467223269,0.069835696869264,0.103454771984416,6.53411537879141e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,MCFD2,Multiple coagulation factor deficiency protein 2,42565,0.0431091510842654,0.00427143867831691,0.0347371312747643,0.0514811708937666,7.26588790405574e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,DTNB,Dystrobrevin beta,40430,0.042628711248949,0.00422337690232463,0.0343508925203927,0.0509065299775052,7.45817981186731e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,PEBP1,Phosphatidylethanolamine-binding protein 1,42611,0.0563581653286734,0.00559050083989922,0.045400783682471,0.0673155469748759,8.14456120700713e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,CPPED1,Serine/threonine-protein phosphatase CPPED1,42711,0.0646028847697078,0.00641136879590945,0.0520366019297253,0.0771691676096903,8.53315002379631e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,40511,0.0400031939143643,0.00397034489776904,0.032221317914737,0.0477850699139917,8.93040741887858e-24
NMR metabolomics,X23428.Concentration of VLDL Particles,MEP1A,Meprin A subunit alpha,40449,0.0720121653069539,0.00715706606793658,0.0579843158137982,0.0860400148001096,1.02763490737761e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,AIF1,Allograft inflammatory factor 1,42346,0.0516781356891362,0.00513809007966977,0.0416074791329834,0.0617487922452889,1.033382909838e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,42370,0.0457744948932894,0.00455673059168319,0.0368433029335903,0.0547056868529885,1.17020266494856e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,ABRAXAS2,BRISC complex subunit Abraxas 2,40116,0.0660967333129068,0.00658447125801386,0.0531911696471996,0.0790022969786139,1.30951944640712e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,TBCA,Tubulin-specific chaperone A,40283,0.0839259086282919,0.0083662050023222,0.0675281468237404,0.100323670432843,1.396231752106e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,RGS10,Regulator of G-protein signaling 10,40482,0.058738892648722,0.00585674752385775,0.0472596675019608,0.0702181177954832,1.42263604538769e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,SELE,E-selectin,42794,0.0501510242986014,0.00500467434511401,0.0403418625821779,0.0599601860150248,1.49004683605117e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,MEP1B,Meprin A subunit beta,42636,0.116857678245294,0.0116644303599575,0.0939953947397769,0.13971996175081,1.53197091310344e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNRD2,Protein ZNRD2,40449,0.0689680410621594,0.00688219762254639,0.0554789337219685,0.0824571484023503,1.54325056274644e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,RASSF2,Ras association domain-containing protein 2,42346,0.0560241834289412,0.00560265171902759,0.0450429860596471,0.0670053807982353,1.85593844937122e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,FRMD4B,FERM domain-containing protein 4B,40116,0.0694016020385939,0.00694165141601209,0.0557959652632102,0.0830072388139776,1.96375211115331e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK7,Kallikrein-7,40009,0.0387157296242364,0.00387403070607168,0.0311226294403359,0.0463088298081369,2.05259004949434e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,GNAS,Neuroendocrine secretory protein 55,40482,0.0847509907972478,0.00848743898086772,0.068115610394747,0.101386371199748,2.20628111464522e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,MDH1,"Malate dehydrogenase, cytoplasmic",40481,0.0391007260842219,0.00392158519351652,0.0314144191049295,0.0467870330635142,2.55827483836823e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,NID1,Nidogen-1,42652,0.0377010116308829,0.00378397988750156,0.0302844110513799,0.045117612210386,2.65605373180878e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL16,C-X-C motif chemokine 16,42778,0.0234446331476336,0.00235768545938359,0.0188235696472418,0.0280656966480255,3.21800040496187e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRN1,Leucine-rich repeat neuronal protein 1,42370,0.039012968533368,0.00392308655501656,0.0313237188855355,0.0467022181812005,3.21883161713387e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL7,Angiopoietin-related protein 7,42721,0.0356889907147745,0.00359037395829505,0.0286518577565162,0.0427261236730328,3.34250282821372e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,GSR,"Glutathione reductase, mitochondrial",40490,0.0221031543457811,0.00222611325684864,0.0177399723623577,0.0264663363292044,3.87144592878257e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,40449,0.0626754506219253,0.00631275341876743,0.0503024539211411,0.0750484473227095,3.89955894541221e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,SFRP1,Secreted frizzled-related protein 1,42457,0.0431987716433568,0.00436980059183789,0.0346339624833545,0.051763580803359,5.76224580558016e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,DBI,Acyl-CoA-binding protein,42562,0.0743463729616868,0.00752470378393009,0.0595979535451838,0.0890947923781897,6.07320454933336e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,SRC,Proto-oncogene tyrosine-protein kinase Src,42664,0.11539605883619,0.0116938070909556,0.0924761969379167,0.138315920734463,6.84173049400078e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,40199,0.0529752453890393,0.00536700196350092,0.0424559215405775,0.0634945692375011,6.95181301709349e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,ATG4A,Cysteine protease ATG4A,42346,0.0572428218140033,0.00580313109776189,0.0458686848623899,0.0686169587656166,7.14907667061667e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,JAM3,Junctional adhesion molecule C,40283,0.0493603378239859,0.00501513008208724,0.0395306828630949,0.0591899927848769,9.17321645256945e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,CNDP1,Beta-Ala-His dipeptidase,42689,0.0447839539035577,0.00455416700104334,0.0358577865815127,0.0537101212256026,9.61838499462126e-23
NMR metabolomics,X23428.Concentration of VLDL Particles,NFAT5,Nuclear factor of activated T-cells 5,40199,0.0841731393080231,0.00855978943871563,0.0673959520081405,0.100950326607906,1.0013519204009e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRF5,Adhesion G protein-coupled receptor F5,40511,0.0276390473733988,0.00281129604278652,0.0221289071295372,0.0331491876172604,1.01652552595916e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,VEGFA,Vascular endothelial growth factor A,42716,0.0567117348407801,0.00577475052450572,0.0453932238127489,0.0680302458688114,1.09276489218398e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,CR1,Complement receptor type 1,40509,0.0351278848486855,0.00357988451780891,0.02811131119378,0.0421444585035909,1.22369781644638e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH7,Protocadherin-7,40449,0.0352153894233865,0.003588832954312,0.028181276832935,0.0422495020138381,1.22606287871584e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,40539,0.0248489992684095,0.00253518457221363,0.0198800375068708,0.0298179610299482,1.36155195641697e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,FMNL1,Formin-like protein 1,42311,0.0598008491815733,0.00610818581985233,0.0478288049746628,0.0717728933884839,1.48082629839974e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,NT5C1A,Cytosolic 5'-nucleotidase 1A,40483,0.0311710217464553,0.00318847937475992,0.0249216021719259,0.0374204413209848,1.7503477058177e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42495,0.0554617657770495,0.00568676675140934,0.0443157029442872,0.0666078286098118,2.13344592939767e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,IFT20,Intraflagellar transport protein 20 homolog,40182,0.0413762725744865,0.00424276144497325,0.033060460142339,0.0496920850066341,2.22443376769397e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,BTC,Probetacellulin,42346,0.0717680337113792,0.00738171621230493,0.0572998699352616,0.0862361974874969,2.87585882691266e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,CORO1A,Coronin-1A,42353,0.0855139252771728,0.0088011109088013,0.0682637478959222,0.102764102658423,3.05300189545452e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,40223,0.0507072008508013,0.0052176021418674,0.0404807006527412,0.0609337010488614,3.08803315023697e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,FAS,Tumor necrosis factor receptor superfamily member 6,42760,0.0320059040167408,0.00329524157776897,0.0255472305243137,0.038464577509168,3.14279127094125e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,PGF,Placenta growth factor,42754,0.0255065082490858,0.0026269186258799,0.0203577477423612,0.0306552687558104,3.23928291846167e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,PQBP1,Polyglutamine-binding protein 1,42346,0.0544751181222243,0.00562046502734547,0.0434590066686272,0.0654912295758214,3.85637155346734e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,HNMT,Histamine N-methyltransferase,42439,0.0459838510291928,0.0047475969770125,0.0366785609542483,0.0552891411041373,4.10576346405582e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,42311,0.0608723298606853,0.00628666557625256,0.0485504653312303,0.0731941943901403,4.23174490805505e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,DNM1,Dynamin-1,40449,0.108964649777127,0.0112554160370041,0.086904034344599,0.131025265209655,4.423626270661e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,BRSK2,Serine/threonine-protein kinase BRSK2,40482,0.0363868756112227,0.0037608053707507,0.0290156970845513,0.043758054137894,4.67680804029797e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,SFTPA2,Pulmonary surfactant-associated protein A2,42346,0.049918278195094,0.00516142702840463,0.0398018812194209,0.060034675170767,4.72301147955499e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL18,C-C motif chemokine 18,42477,0.0663704888896747,0.00687427802554641,0.0528969039596037,0.0798440738197457,5.53363730015966e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,CRLF1,Cytokine receptor-like factor 1,42676,0.0239450958616851,0.00248172329186947,0.019080918209621,0.0288092735137493,5.86902915945853e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJC9,DnaJ homolog subfamily C member 9,40449,0.0730061889164376,0.00757403071580495,0.0581610887134599,0.0878512891194153,6.64765687622647e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,OXT,Oxytocin-neurophysin 1,42711,0.131375193400596,0.0136434040081578,0.104634121544607,0.158116265256585,7.07538255428308e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTN6,Dynactin subunit 6,42311,0.068158217038484,0.00708427964732241,0.054273028929732,0.0820434051472359,7.69311786151689e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,IL6R,Interleukin-6 receptor subunit alpha,42582,0.0323481979648639,0.00336534511597558,0.0257521215375518,0.038944274392176,8.3553690990184e-22
NMR metabolomics,X23428.Concentration of VLDL Particles,CD40LG,CD40 ligand,42754,0.0733742150815522,0.00764898240139951,0.0583822095748091,0.0883662205882952,1.00597890544462e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS27,Serine protease 27,42603,0.0381558395426705,0.00398400672299262,0.030347186365605,0.045964492719736,1.16898664570555e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,BAP18,Chromatin complexes subunit BAP18,40483,0.0639860632404057,0.00668764253951403,0.0508782838629582,0.0770938426178532,1.31864114352532e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,LBP,Lipopolysaccharide-binding protein,42689,-0.0554527245362122,0.00580291531141885,-0.0668264385465932,-0.0440790105258313,1.43207557079667e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42722,0.0268469381065703,0.00281088607781436,0.0213376013940541,0.0323562748190865,1.50117017585432e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,STXBP3,Syntaxin-binding protein 3,42346,0.0408416975431183,0.00427696383292317,0.0324588484305889,0.0492245466556477,1.53458300411006e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,FRZB,Secreted frizzled-related protein 3,42454,0.0235251119947224,0.00246477541700401,0.0186941521773945,0.0283560718120503,1.60321246695074e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPT1,Angiopoietin-1,42554,0.0787008656619116,0.00825920986227462,0.0625128143318533,0.0948889169919698,1.86040720757259e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,SF3B4,Splicing factor 3B subunit 4,42587,0.0682314838932682,0.00717745750634926,0.0541636671808236,0.0822993006057127,2.30583813360425e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL11,C-X-C motif chemokine 11,42711,0.0748564436943547,0.00787718079360304,0.0594171693388927,0.0902957180498166,2.37874111541109e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4A,C-type lectin domain family 4 member A,42594,-0.033029261522151,0.00347648407020438,-0.0398431702997516,-0.0262153527445505,2.43203547362049e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,MTIF3,"Translation initiation factor IF-3, mitochondrial",40449,0.0823125240499589,0.00866991454116226,0.0653194915492809,0.0993055565506369,2.67005629997813e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,40283,0.028146421433397,0.00296614354989273,0.0223327800756072,0.0339600627911867,2.80277471623288e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL4,C-C motif chemokine 4,42642,0.0639004492298621,0.00674538770793125,0.0506794893223169,0.0771214091374074,3.16047851246556e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,FXYD5,FXYD domain-containing ion transport regulator 5,42370,0.061611663451526,0.00650387364563297,0.0488640711060854,0.0743592557969666,3.17444151369685e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42594,0.0572607922275802,0.00604734059360557,0.0454080046641133,0.0691135797910472,3.29891099081614e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,DYNLT3,Dynein light chain Tctex-type 3,40451,0.040638652353396,0.00429195255997521,0.0322264253358446,0.0490508793709474,3.40165674901101e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPING1,Plasma protease C1 inhibitor,40516,0.0171577825184435,0.00181419577285317,0.0136019588036513,0.0207136062332357,3.77408386485885e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,ACYP1,Acylphosphatase-1,40250,0.0612672443570326,0.00647821106818706,0.048569950663386,0.0739645380506792,3.79328412790821e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,TREML2,Trem-like transcript 2 protein,42611,0.0324496689293616,0.00343703470673348,0.025713080904164,0.0391862569545592,4.28544256527993e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL2,C-C motif chemokine 2,42475,0.0494991222123021,0.0052583663873775,0.0391927240930422,0.059805520331562,5.58318930580837e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,CEBPB,CCAAT/enhancer-binding protein beta,42357,0.0353094931536303,0.00375840028475069,0.0279430285955189,0.0426759577117416,6.66331344373138e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,PPM1F,Protein phosphatase 1F,40511,0.0483321775155017,0.00514555524191323,0.0382468892413518,0.0584174657896516,6.94659857172078e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42579,0.0227423498991148,0.00242352811520071,0.0179922347933214,0.0274924650049082,7.36193813395729e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,LRP11,Low-density lipoprotein receptor-related protein 11,42636,0.0346987979807511,0.00370092099523429,0.0274449928300919,0.0419526031314103,7.95319591390073e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMP1,Lysosome-associated membrane glycoprotein 1,40185,0.0258368417629523,0.00275475021603184,0.0204375313395299,0.0312361521863747,7.96489174998021e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17D,Interleukin-17D,42370,0.0319393012763412,0.00340959395964902,0.0252564971154291,0.0386221054372533,8.61998150547533e-21
NMR metabolomics,X23428.Concentration of VLDL Particles,IMPA1,Inositol monophosphatase 1,42495,0.0558628712278835,0.00597465905331876,0.0441525394833787,0.0675732029723883,1.01484559530107e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,TST,Thiosulfate sulfurtransferase,42277,0.0688259692323074,0.00736239313331163,0.0543956786910166,0.0832562597735982,1.03322826944777e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSZ,Cathepsin Z,42648,0.0297252422893205,0.00318079920685251,0.0234908758438896,0.0359596087347515,1.0594470718728e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,RTN4R,Reticulon-4 receptor,42721,0.0317379724260551,0.00339756549240087,0.0250787440609494,0.0383972007911608,1.09733138942906e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL11,Eotaxin,42754,0.0338205502617314,0.00362333710278029,0.026718809540282,0.0409222909831808,1.17468745792519e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,40189,0.0324546691178783,0.00348144897777899,0.0256310291214315,0.0392783091143251,1.35744081108018e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,KCTD5,BTB/POZ domain-containing protein KCTD5,40290,0.0406876278879656,0.00437402682052158,0.0321145353197433,0.0492607204561879,1.63492542749101e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,BPIFA2,BPI fold-containing family A member 2,39838,-0.104185533426874,0.0112152848436547,-0.126167491720437,-0.0822035751333103,1.85036188414074e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,TMSB10,Thymosin beta-10,42611,0.0677858099010732,0.00730588464680682,0.0534662759933318,0.0821053438088146,1.98312957805191e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,42346,0.0531688709503746,0.00573085214104717,0.0419364007539222,0.0644013411468271,1.99975339089663e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42587,0.0311558560194744,0.00335897392220178,0.0245722671319589,0.0377394449069898,2.03683325198944e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJC21,DnaJ homolog subfamily C member 21,40483,0.0350423187027906,0.003784066231638,0.0276255488887801,0.0424590885168011,2.40188829545643e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,MRI1,Methylthioribose-1-phosphate isomerase,40182,0.0628511197079393,0.00679275693914768,0.0495373161072099,0.0761649233086688,2.59470504461463e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,GDNF,Glial cell line-derived neurotrophic factor,42311,0.0349473730475545,0.00377838035323646,0.027541747555211,0.0423529985398979,2.60476192264105e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,40482,0.0609893555771248,0.00660426887252712,0.0480449885869716,0.0739337225672779,3.04780904311052e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,LONP1,"Lon protease homolog, mitochondrial",40223,0.0791399985808988,0.00857932639928603,0.0623245188382982,0.0959554783234994,3.36701864122736e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,C19orf12,Protein C19orf12,42311,0.057937946983795,0.00628417212880586,0.0456209696113356,0.0702549243562545,3.42936734263689e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,SETMAR,Histone-lysine N-methyltransferase SETMAR,42459,0.027197407834053,0.00295009605915775,0.0214152195581038,0.0329795961100022,3.44000668838203e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,ECE1,Endothelin-converting enzyme 1,42311,0.0324542716339838,0.00352123167830495,0.0255526575445061,0.0393558857234616,3.52353780921035e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX6,Peroxiredoxin-6,42721,-0.055233921633768,0.00599404309814827,-0.0669822461061386,-0.0434855971613974,3.57216674437427e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,MAGED1,Melanoma-associated antigen D1,42346,0.0439440042344458,0.00477271485157542,0.034589483125358,0.0532985253435337,3.84247834173213e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRD1,Adhesion G-protein coupled receptor D1,40283,0.0349252334889056,0.00379227048782099,0.0274923833327765,0.0423580836450347,3.8618134005387e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,SLMAP,Sarcolemmal membrane-associated protein,40449,0.0750557283883162,0.00815122405539629,0.0590793292397395,0.0910321275368929,3.91259061602055e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP1,Rho GTPase-activating protein 1,42346,0.0410739576676831,0.0044628056915453,0.0323268585122543,0.0498210568231119,3.9770806638455e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,PODXL,Podocalyxin,42587,0.0138905114331337,0.00151037415110305,0.0109301780969717,0.0168508447692956,4.2278982467129e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX9,Sorting nexin-9,42636,0.0606106588847335,0.0066058933935477,0.04766310783338,0.073558209936087,5.15365634618235e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT18,"Keratin, type I cytoskeletal 18",42587,0.0728179942554242,0.00795536027586183,0.057225488114735,0.0884105003961134,6.30983159330249e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,40283,0.0379686346737266,0.00414997052107991,0.0298346924524099,0.0461025768950432,6.74118707965374e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,LAP3,Cytosol aminopeptidase,42370,0.0436871967251646,0.0047863840632468,0.0343058839612008,0.0530685094891283,8.02536521824672e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,APP,Amyloid-beta precursor protein,42592,0.0598201061114154,0.00655462306153781,0.0469730449108013,0.0726671673120295,8.08079231754148e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB10,Ras-related protein Rab-10,40511,0.0482296932528382,0.00528612476597682,0.0378688887115236,0.0585904977941527,8.47573672205952e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRC,Receptor-type tyrosine-protein phosphatase C,40527,0.0210291226858861,0.00230532713320728,0.0165106815047998,0.0255475638669723,8.61945566875948e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,CD5,T-cell surface glycoprotein CD5,42706,0.0324644388811204,0.00356160614063272,0.0254836908454802,0.0394451869167605,8.95220366621476e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",42357,0.0789204469509104,0.00865825518445666,0.0619502667893753,0.0958906271124454,8.98797783468802e-20
NMR metabolomics,X23428.Concentration of VLDL Particles,MVK,Mevalonate kinase,42370,0.0717605587202132,0.00788761533762628,0.0563008326584657,0.0872202847819607,1.05171639553042e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK2,Serine protease inhibitor Kazal-type 2,40283,0.0340140116368445,0.00373793459389769,0.0266876598328051,0.041340363440884,1.06053370575338e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,XPNPEP2,Xaa-Pro aminopeptidase 2,42679,0.0873651177910289,0.00962690314114033,0.0684963876343939,0.106233847947664,1.29114887608818e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP7,Matrilysin,42333,0.0452533259026268,0.00498767988583322,0.0354774733263937,0.0550291784788599,1.32031697266153e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,40449,0.0412996510051431,0.00455774328239017,0.0323664741716583,0.0502328278386278,1.49990129315125e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,SCRG1,Scrapie-responsive protein 1,40511,0.0256147048430843,0.00282821505499303,0.0200714033352979,0.0311580063508706,1.5624503804944e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,LRG1,Leucine-rich alpha-2-glycoprotein,40539,-0.0239385357627926,0.00264879272425678,-0.0291301695023359,-0.0187469020232493,1.8616697566577e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,SLAMF6,SLAM family member 6,42346,0.0346592300374857,0.00383671167413428,0.0271392751561825,0.0421791849187888,1.89053938190929e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,CST3,Cystatin-C,42659,0.0269203025270995,0.00298272045338119,0.0210741704384724,0.0327664346157266,2.02985813453238e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,CDCP1,CUB domain-containing protein 1,42495,0.0485084822141318,0.00537547370334538,0.0379725537555748,0.0590444106726887,2.05863256746245e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,PARD3,Partitioning defective 3 homolog,40302,0.0663284044665199,0.0073547731168264,0.0519130491575402,0.0807437597754996,2.22105895688564e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,CEMIP2,Cell surface hyaluronidase,40199,0.0307251102194381,0.00341251660551337,0.024036577672632,0.0374136427662443,2.54226735176688e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,MARCO,Macrophage receptor MARCO,42636,0.0232851949199106,0.00259297675634317,0.018202960477478,0.0283674293623432,3.06057969615867e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,SH3BP1,SH3 domain-binding protein 1,40449,0.0424342891169517,0.00472872014276283,0.0331659976371365,0.0517025805967668,3.31977551134999e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42495,0.0323834290202741,0.00361180851906348,0.0253042843229097,0.0394625737176385,3.48100822172492e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,C5,Complement C5,40539,0.0133797974700135,0.00149286424019344,0.0104537835592343,0.0163058113807926,3.66930993557639e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,40116,0.0359337806982201,0.00401102570437998,0.0280721703176354,0.0437953910788049,3.81658799420835e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRD1,Natural killer cells antigen CD94,42754,0.0416490483414621,0.00465191402040552,0.0325312968614673,0.0507667998214569,3.90067452158926e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,CCDC134,Coiled-coil domain-containing protein 134,40451,0.0431413280031626,0.00481937602112073,0.033695351001766,0.0525873050045592,4.05068761863508e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,CA5A,"Carbonic anhydrase 5A, mitochondrial",42357,0.0815262750485197,0.00911159276467064,0.0636675532297652,0.0993849968672741,4.11610172337081e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,ACAN,Aggrecan core protein,42488,0.0245865530298361,0.00274897963542625,0.0191985529444006,0.0299745531152716,4.24836803089695e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,DARS1,"Aspartate--tRNA ligase, cytoplasmic",42476,0.0642747653273558,0.00720081817793843,0.0501611616985965,0.0783883689561152,4.98828469234184e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",40482,0.0809266004673225,0.00906823374585637,0.063152862325444,0.098700338609201,5.18175773312726e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,NBN,Nibrin,42370,0.0471970660663585,0.0052903863774027,0.0368279087666492,0.0575662233660678,5.21060086278198e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,KLF4,Krueppel-like factor 4,40136,0.035447259054822,0.0039738851293427,0.0276584442013103,0.0432360739083337,5.40175284328762e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",40283,0.0776641643235089,0.00872529965096753,0.0605625770076126,0.0947657516394053,6.3924636186426e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,DNER,Delta and Notch-like epidermal growth factor-related receptor,42587,0.0219467035053953,0.00246817553752207,0.0171090794518521,0.0267843275589386,6.76913422453793e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",40527,0.0556070222785252,0.00625404962235714,0.0433490850187052,0.0678649595383452,6.94829919390746e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,ACRBP,Acrosin-binding protein,40451,0.0344306973631295,0.00387456809544136,0.0268365438960645,0.0420248508301946,7.27465963725024e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,AMOTL2,Angiomotin-like protein 2,40404,0.0424039705592193,0.00477361278873118,0.0330476894933062,0.0517602516251324,7.49925733972265e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB6,Integrin beta-6,42370,0.0274539664467342,0.00309159348704676,0.0213944432121226,0.0335134896813459,7.52866215387028e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,CLSTN3,Calsyntenin-3,40483,0.0269624491970143,0.00303593766931718,0.0210120113651527,0.032912887028876,7.61997447983524e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42611,0.0207969255371151,0.00234907246746271,0.0161927435008881,0.025401107573342,9.5550691936886e-19
NMR metabolomics,X23428.Concentration of VLDL Particles,LY75,Lymphocyte antigen 75,42594,0.0340921886753361,0.00385335900048132,0.0265396050343927,0.0416447723162795,1.00681695180955e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,ARAF,Serine/threonine-protein kinase A-Raf,40302,0.0600552481305304,0.00678832717903454,0.0467501268596227,0.0733603694014381,1.03635080294704e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42794,0.020595855218908,0.00233206429837616,0.0160250091940907,0.0251667012437253,1.15679426614853e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,BDNF,Brain-derived neurotrophic factor,40527,0.0732165064548561,0.00829078072112017,0.0569665762414606,0.0894664366682516,1.18892561127324e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,FASLG,Tumor necrosis factor ligand superfamily member 6,42754,0.0318999812267598,0.00361720565671674,0.024810258139595,0.0389897043139246,1.29473246366282e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,PSPN,Persephin,42594,0.081202092927138,0.00920956184057872,0.0631513517196037,0.0992528341346723,1.31744732005365e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,MSTN,Growth/differentiation factor 8,42357,0.0464317528081053,0.00527100884700933,0.036100575467967,0.0567629301482436,1.42051270021439e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42673,-0.0282352588426408,0.00320902453577939,-0.0345249469327684,-0.0219455707525132,1.55052822519316e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN4,CCN family member 4,42721,0.0347397999585767,0.00395727907239161,0.0269835329766891,0.0424960669404642,1.84991850707497e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,ECHS1,"Enoyl-CoA hydratase, mitochondrial",40223,0.0842154084100723,0.00959842317518265,0.0654024989867143,0.10302831783343,1.97991119361693e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,BOLA2_BOLA2B,BolA-like protein 2,40223,0.0470311634755837,0.0053628660299231,0.0365199460569344,0.057542380894233,2.05279484388216e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,RBP2,Retinol-binding protein 2,42587,-0.0668895169347471,0.00763783684012043,-0.0818596771413832,-0.0519193567281111,2.2303608926651e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARF1,Scavenger receptor class F member 1,42794,0.0361008166677816,0.00412936228300729,0.0280072665930873,0.0441943667424759,2.54533842872436e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPYL1,Testis-specific Y-encoded-like protein 1,40199,0.0349118940571693,0.00399508747336586,0.0270815226093722,0.0427422655049664,2.699592306202e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42587,-0.0169962661598583,0.00194566349792593,-0.0208097666157931,-0.0131827657039235,2.71182695902852e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,TSNAX,Translin-associated protein X,40116,0.0341706998929503,0.00391230444502186,0.0265025831807075,0.0418388166051931,2.81243620347294e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,ENO2,Gamma-enolase,42711,0.0553738349505069,0.00635956033521263,0.0429090966934902,0.0678385732075237,3.4729860946063e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,FXN,"Frataxin, mitochondrial",42721,0.0628177539489216,0.00722122544097206,0.0486641520846164,0.0769713558132268,3.72943929017834e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,PCYT2,Ethanolamine-phosphate cytidylyltransferase,40449,0.0651233930768936,0.00749568747964987,0.0504318456167799,0.0798149405370073,4.19376502466501e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNAR1,Interferon alpha/beta receptor 1,40449,0.0220674892328373,0.00254363514367705,0.0170819643512303,0.0270530141144443,4.67940035767529e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,CD84,SLAM family member 5,42594,0.0268461634612569,0.00309940098762793,0.0207713375255061,0.0329209893970076,5.17356679736211e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,PAGR1,PAXIP1-associated glutamate-rich protein 1,40223,0.0374101902955573,0.00432231426815859,0.0289384543299664,0.0458819262611481,5.60700965706023e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,CD72,B-cell differentiation antigen CD72,40283,0.03797358423577,0.00439218284940441,0.0293649058509373,0.0465822626206026,6.08130884574949e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP8,Caspase-8,42674,0.0522026838004723,0.00605026810372077,0.0403441583171796,0.0640612092837651,6.92589596373067e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGA6,Integrin alpha-6,42594,0.0433294253334707,0.00502671848589131,0.0334770571011237,0.0531817935658177,7.45087827867053e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,STX16,Syntaxin-16,42346,0.04922645573251,0.00571623027475892,0.0380226443939825,0.0604302670710374,8.01109857650539e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,CBLN4,Cerebellin-4,42721,0.0276993339010647,0.00321716566765639,0.0213936891924582,0.0340049786096713,8.11621645240367e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,40421,0.0257599088491342,0.00299578445556358,0.0198881713162296,0.0316316463820388,9.12950090028262e-18
NMR metabolomics,X23428.Concentration of VLDL Particles,TPMT,Thiopurine S-methyltransferase,42346,0.0617463194923267,0.00719181140360658,0.0476503691412578,0.0758422698433956,1.00399033158976e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",40449,0.088572282324994,0.0103269610574806,0.068331438652332,0.108813125997656,1.10306893718574e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42594,0.0687335282680591,0.0080532637288177,0.0529491313595764,0.0845179251765418,1.55282024766347e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,MAN2B2,Epididymis-specific alpha-mannosidase,40511,0.0508186344544096,0.00595847782833463,0.0391400179108738,0.0624972509979455,1.66662925511777e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,C7orf50,Uncharacterized protein C7orf50,40483,0.0191998803770037,0.00225137200466295,0.0147871912478643,0.0236125695061431,1.67738669585325e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ASPN,Asporin,40511,0.0237742797522478,0.00278813291040636,0.0183095392478513,0.0292390202566443,1.69318886758646e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ASGR2,Asialoglycoprotein receptor 2,40532,0.0227680189766413,0.00267116207478334,0.0175325413100659,0.0280034966432166,1.74168700818619e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,GFRA1,GDNF family receptor alpha-1,42689,0.024985217554725,0.00293656622905724,0.0192295477457728,0.0307408873636772,1.9492910581473e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,NOTCH1,Neurogenic locus notch homolog protein 1,42794,0.0134228702572198,0.00157803839834275,0.010329914996468,0.0165158255179716,1.98596648680718e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,GRK5,G protein-coupled receptor kinase 5,42357,0.0427078947904816,0.00502089202171363,0.0328669464279229,0.0525488431530403,1.99263135206573e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,42346,0.0506766014966513,0.00595785555030206,0.0389992046180593,0.0623539983752433,1.99607217739694e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,NAA10,N-alpha-acetyltransferase 10,40116,0.0433646429010753,0.00509762538060407,0.0333732971550913,0.0533559886470593,2.02069837581893e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,CYB5R2,NADH-cytochrome b5 reductase 2,40329,0.0469360521483517,0.00552292671387731,0.0361111157891522,0.0577609885075512,2.1668637174989e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",40511,0.0255296194325908,0.0030057887596461,0.0196382734636844,0.0314209654014971,2.25565305183498e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,RBKS,Ribokinase,42317,0.04164179779043,0.00491517973918582,0.0320080455016258,0.0512755500792342,2.66532873551451e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ASAH1,Acid ceramidase,40418,0.0383157394263218,0.00452219634337554,0.0294522345933058,0.0471792442593379,2.69386958224579e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS2,Trypsin-2,42689,0.0467062811759019,0.00551597761350765,0.0358949650534269,0.0575175972983769,2.76511306501468e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,CLU,Clusterin,40539,0.0265036709148886,0.00312999657902016,0.0203688776200091,0.0326384642097681,2.8120915958722e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF2,Fibroblast growth factor 2,42594,0.0572132347185602,0.00676037529983887,0.043962899130876,0.0704635703062444,2.87355447331026e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMB1,Laminin subunit beta-1,40223,0.0255137017280966,0.00301400239634408,0.0196062570312622,0.031421146424931,2.88413069802469e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRG2,Adhesion G-protein coupled receptor G2,42636,0.0226514988856011,0.00267740647665666,0.0174037821913541,0.0278992155798482,2.94180728130583e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42638,0.0265611694780987,0.00314254768188438,0.0204017760216053,0.0327205629345921,3.15279261481562e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,SOD1,Superoxide dismutase [Cu-Zn],42365,0.0399357883715636,0.00473825394088947,0.0306488106474203,0.049222766095707,3.86625675392945e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMA4,Laminin subunit alpha-4,42676,0.0275651592289258,0.00327063597611768,0.0211547127157351,0.0339756057421164,3.86750641875928e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA4,Annexin A4,42584,0.0594190946523411,0.0070527712464169,0.045595663009364,0.0732425262953182,3.97484086007117e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,UXS1,UDP-glucuronic acid decarboxylase 1,42346,0.0440143834524884,0.00524070135093803,0.0337426088046499,0.054286158100327,4.97942435100897e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ITPA,Inosine triphosphate pyrophosphatase,40116,0.0558351598423502,0.00665376050045927,0.04279378926145,0.0688765304232504,5.39037392160053e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTSL4,ADAMTS-like protein 4,40223,0.0197474712067206,0.00235718083015351,0.0151273967796197,0.0243675456338215,6.05711564595034e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,40283,0.0584807264268227,0.00698415899417941,0.044791774798231,0.0721696780554143,6.27397783291828e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,SCRIB,Protein scribble homolog,40223,0.0751592031509297,0.00899694016376175,0.0575252004299566,0.0927932058719027,7.39746146759599e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP3,Stromelysin-1,42611,-0.0416374232740145,0.00499546535895555,-0.0514285353775673,-0.0318463111704616,8.49507769568168e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,PCSK9,Proprotein convertase subtilisin/kexin type 9,42794,0.0324522921350782,0.00390128056306563,0.0248057822314696,0.0400988020386868,9.76037001088334e-17
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL1,Angiopoietin-related protein 1,42439,0.0238924994202676,0.00287573296201867,0.018256062814711,0.0295289360258242,1.06445633647129e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,HPCAL1,Hippocalcin-like protein 1,42754,0.0593363266541914,0.00714899428689206,0.045324297851883,0.0733483554564999,1.13927486883125e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,PTX3,Pentraxin-related protein PTX3,42594,-0.0401723818972311,0.00484077118541041,-0.0496602934206355,-0.0306844703738267,1.15198823657447e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,PRG2,Bone marrow proteoglycan,40527,-0.0434712038839558,0.00523751649587313,-0.0537367362158672,-0.0332056715520445,1.15935316414218e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGAL,Integrin alpha-L,40199,0.0365640407283817,0.00442578847358132,0.0278894953201623,0.0452385861366011,1.60215608452138e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CD164,Sialomucin core protein 24,42611,0.0222913740788891,0.00270429182288139,0.0169909621060416,0.0275917860517366,1.83497866726242e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP2,"Fatty acid-binding protein, intestinal",42636,-0.064488330432495,0.0078256818409733,-0.0798266668408027,-0.0491499940241873,1.87104304503527e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CRIM1,Cysteine-rich motor neuron 1 protein,42676,-0.0168843551891044,0.00204927191668803,-0.020900928145813,-0.0128677822323959,1.89254090311983e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,OPLAH,5-oxoprolinase,40223,0.0550591545028499,0.00669882180730237,0.0419294637605373,0.0681888452451626,2.27731466065604e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN5,CCN family member 5,42611,0.0313567924209523,0.00382155522189939,0.0238665441860294,0.0388470406558751,2.50956590091643e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CPXM1,Probable carboxypeptidase X1,42679,0.056224649692003,0.00686242612841525,0.0427742944803092,0.0696750049036969,2.77334554350164e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,ING1,Inhibitor of growth protein 1,42292,0.0380940982182684,0.00466289485279293,0.0289548243067942,0.0472333721297425,3.37558910121583e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,BMPER,BMP-binding endothelial regulator protein,40283,0.0187803950015213,0.0022998470259303,0.0142726948306979,0.0232880951723447,3.53504817659092e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,PYY,Peptide YY,40116,0.082929716358901,0.0101628680733675,0.0630104949351007,0.102848937782701,3.71563168123221e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CD276,CD276 antigen,42618,-0.0295263733502928,0.00362864555628634,-0.036638518640614,-0.0224142280599715,4.40534994503648e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARA5,Scavenger receptor class A member 5,42711,0.0247443254086528,0.00305107729753102,0.018764213905492,0.0307244369118136,5.49413450875358e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,ESM1,Endothelial cell-specific molecule 1,42618,-0.0275050162733258,0.00339365758560784,-0.0341565851411172,-0.0208534474055344,5.73631708218363e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,EGFL7,Epidermal growth factor-like protein 7,42346,0.0318902100786029,0.00393636195399748,0.0241749406487678,0.0396054795084379,5.90755321620841e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,UNC79,Protein unc-79 homolog,40080,0.0445849702202912,0.00550955965765756,0.0337862332912824,0.0553837071493,6.47789943167828e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,IL10RB,Interleukin-10 receptor subunit beta,42676,0.024052844935302,0.00297384783437702,0.018224103179923,0.029881586690681,6.57368037555735e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,40116,0.0228134459505463,0.00282440358280589,0.0172776149282467,0.0283492769728458,7.32038486334627e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,C7,Complement component C7,40251,-0.0264098120838566,0.00327167083379184,-0.0328222869180887,-0.0199973372496246,7.61490133188462e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,STK4,Serine/threonine-protein kinase 4,42636,0.0682387991217413,0.00845684499258661,0.0516633829362715,0.084814215307211,7.68169095278681e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,42346,0.0381011589199667,0.00472279727297773,0.0288444762649304,0.0473578415750031,7.79399947381635e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,PECAM1,Platelet endothelial cell adhesion molecule,42611,0.0239495281596049,0.00297090745858055,0.018126549540787,0.0297725067784228,8.1808565541078e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,PDIA3,Protein disulfide-isomerase A3,40283,0.0197747757356234,0.00245311111879627,0.0149666779427827,0.0245828735284641,8.33729438112767e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,IGF1R,Insulin-like growth factor 1 receptor,42587,0.0172962291892939,0.0021494972785648,0.0130832145233069,0.0215092438552809,9.22230317341113e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC27A4,Long-chain fatty acid transport protein 4,42311,0.0530046804144994,0.00659036154104761,0.040087571794046,0.0659217890349527,9.53386993688786e-16
NMR metabolomics,X23428.Concentration of VLDL Particles,ENAH,Protein enabled homolog,42370,0.0375096019173409,0.00467255217409643,0.0283513996561119,0.0466678041785699,1.07738580614394e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,FEN1,Flap endonuclease 1,42346,0.0504953192602784,0.0062928523894521,0.0381613285769522,0.0628293099436045,1.10778233473347e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CLTA,Clathrin light chain A,42357,0.0378080852492971,0.00471234277833109,0.0285718934037682,0.0470442770948261,1.11699671252009e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,IDS,Iduronate 2-sulfatase,42754,0.00693736059615223,0.000864892128496914,0.00524217202429828,0.00863254916800618,1.1337972426794e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,SMS,Spermine synthase,40136,0.0507313191198802,0.00632318661432591,0.0383378733558014,0.063124764883959,1.13671116062347e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRR,Receptor-type tyrosine-protein phosphatase R,40483,0.0299880798554325,0.00374178866568588,0.0226541740706882,0.0373219856401768,1.21593292288354e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,ACE2,Angiotensin-converting enzyme 2,42357,0.0423979760607716,0.00530496298257378,0.032000248614927,0.0527957035066162,1.43616891820297e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42587,0.0440999094464524,0.00552070836283053,0.0332793210553045,0.0549204978376002,1.48182358843874e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42658,0.0403993876133738,0.00505878563692411,0.0304841677650025,0.050314607461745,1.50657690014025e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGAV,Integrin alpha-V,42721,0.0129354319307389,0.00162161807152941,0.00975706051054128,0.0161138033509366,1.62095895932968e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,PTP4A3,Protein tyrosine phosphatase type IVA 3,40199,0.0420387572090137,0.00527515050166511,0.0316994622257501,0.0523780521922774,1.75460630081924e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,ACP6,Lysophosphatidic acid phosphatase type 6,42689,0.0539673012467811,0.00677530370671008,0.0406877059816294,0.0672468965119329,1.77962464366171e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,40483,0.0369888465700102,0.00464882931858843,0.0278771411055769,0.0461005520344436,1.93726404098952e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,40302,0.071572895901605,0.00900339868187919,0.0539262344851217,0.0892195573180882,2.05315745108844e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,COX6B1,Cytochrome c oxidase subunit 6B1,40511,0.0257411712386874,0.00324037234646115,0.0193900414396235,0.0320923010377513,2.1447160964513e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,GBP1,Guanylate-binding protein 1,40466,0.0515058252684098,0.00648980897744445,0.0387857996726187,0.064225850864201,2.27803238339137e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINI1,Neuroserpin,40267,0.0237513170898451,0.00300134124709509,0.0178686882455387,0.0296339459341514,2.73947437393744e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,DGKZ,Diacylglycerol kinase zeta,42370,0.0272496631399292,0.00345216056889145,0.020483428424902,0.0340158978549564,3.16931735314574e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,MEGF10,Multiple epidermal growth factor-like domains protein 10,42618,0.0295678971880291,0.00375236451407435,0.0222132627404434,0.0369225316356149,3.53033278624931e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,SIT1,Signaling threshold-regulating transmembrane adapter 1,42370,0.0433079584399807,0.00550613275430794,0.0325159382415371,0.0540999786384242,3.96449929923049e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,ACOT13,Acyl-coenzyme A thioesterase 13,40449,0.0879315573076089,0.0111936362961912,0.0659920301670741,0.109871084448144,4.34385923400677e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300LF,CMRF35-like molecule 1,42721,0.0473341888122736,0.00602992389466676,0.0355155379787267,0.0591528396458204,4.47617386673914e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,APRT,Adenine phosphoribosyltransferase,42480,0.0366921624706307,0.00468131396708182,0.0275167870951503,0.0458675378461111,4.92471312228871e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX58,Antiviral innate immune response receptor RIG-I,42346,0.0437875079252362,0.00559409313311706,0.0328230853843268,0.0547519304661457,5.35786966325462e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,NEK7,Serine/threonine-protein kinase Nek7,40302,0.0590149444799675,0.00754831346262931,0.0442202500932141,0.073809638866721,5.8381628689382e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,PDZD2,PDZ domain-containing protein 2,40116,0.0467168193207375,0.00599201428866387,0.0349724713149563,0.0584611673265187,6.94270300845672e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS7_LGALS7B,Galectin-7,42524,0.033360387073279,0.00429022189391564,0.0249515521612043,0.0417692219853536,8.03859246926581e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,ANG,Angiogenin,42618,0.0257472483642189,0.00331445118030774,0.0192509240508157,0.0322435726776221,8.5382455658621e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,WAS,Wiskott-Aldrich syndrome protein,42370,0.0509801320089111,0.00656359844476705,0.0381154790571677,0.0638447849606545,8.62212338581167e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,ERI1,3'-5' exoribonuclease 1,40302,0.0264726201029849,0.00341145664097498,0.0197861650866739,0.0331590751192958,9.2431955922206e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,42370,0.0332159871001344,0.00428578058239399,0.0248158571586421,0.0416161170416266,9.83906766727933e-15
NMR metabolomics,X23428.Concentration of VLDL Particles,DDC,Aromatic-L-amino-acid decarboxylase,42613,-0.036394108314262,0.00470275207514374,-0.0456115023815438,-0.0271767142469803,1.07430258894828e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB103A_DEFB103B,Beta-defensin 103,40135,0.0327176421812474,0.00423473660599724,0.0244175584334929,0.041017725929002,1.20666881927496e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,LTA,Lymphotoxin-alpha,42594,0.0312053937755474,0.00404091116666144,0.023285207888891,0.0391255796622038,1.22268879369151e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,DSCAM,Down syndrome cell adhesion molecule,40482,0.0276731301035172,0.00358406784759417,0.0206483571222326,0.0346979030848018,1.25016700607486e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC5A,C-type lectin domain family 5 member A,42603,-0.0230359637866191,0.00298430173850472,-0.0288851951940883,-0.0171867323791499,1.25474789409408e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42587,0.0520717235590566,0.00677767974084464,0.0387874712670011,0.0653559758511121,1.6640690525556e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,TLR3,Toll-like receptor 3,42754,0.0463658820743262,0.00603824440399897,0.0345309230424882,0.0582008411061642,1.71683618793207e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL1,Fc receptor-like protein 1,42636,0.0356420452510229,0.00465140249390201,0.026525296362975,0.0447587941390709,1.94588305848722e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,PON3,Serum paraoxonase/lactonase 3,42676,-0.0214508461542129,0.00280932826837507,-0.026957129560228,-0.0159445627481977,2.39904703163314e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,40451,0.0416502924405821,0.00546225387763909,0.0309442748404095,0.0523563100407547,2.63439357974088e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,HAO1,Hydroxyacid oxidase 1,42721,0.0940933998063511,0.0123434249266285,0.0699002869501593,0.118286512662543,2.64409410542738e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,40449,0.0882699105670841,0.0115776363267522,0.0655777433666498,0.110962077767518,2.65354183584277e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,TNF,Tumor necrosis factor,42339,0.0290130225185932,0.00380676269882534,0.0215517676288955,0.0364742774082909,2.68017019539194e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,VCAM1,Vascular cell adhesion protein 1,42663,-0.0210562797869564,0.00276661279512885,-0.0264788408654089,-0.0156337187085039,2.90358851774437e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,DDT,D-dopachrome decarboxylase,40527,0.0312821768644273,0.00411374813663159,0.0232192305166294,0.0393451232122252,3.09079333885426e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM1,Intercellular adhesion molecule 1,42595,0.0219214655323961,0.00288417192588235,0.0162684885576667,0.0275744425071255,3.14285765462433e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,BOLA1,BolA-like protein 1,40136,0.0408388800165329,0.0053725941211349,0.0303085955391085,0.0513691644939573,3.1706906920886e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42495,-0.0901116258969809,0.0118581573544759,-0.113353614311754,-0.0668696374822082,3.18048646088428e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS3BP,Galectin-3-binding protein,40539,0.0230814770094793,0.00303806274770167,0.017126874023984,0.0290360799949745,3.2581347583667e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,MUC13,Mucin-13,42311,0.0392151636323168,0.00516550938136598,0.0290907652448395,0.0493395620197942,3.36957324878053e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,ARSA,Arylsulfatase A,42611,0.0334054819615826,0.0044010150994768,0.024779492366608,0.0420314715565571,3.39919570408046e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,CA4,Carbonic anhydrase 4,42794,-0.0180831921271231,0.00238624729259734,-0.0227602368206139,-0.0134061474336323,3.73317938024998e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,COL15A1,Collagen alpha-1(XV) chain,40527,0.0210494684740935,0.00277767966989883,0.0156052163210917,0.0264937206270952,3.78036172549086e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,DENR,Density-regulated protein,40199,0.0427929067255476,0.00565301349339345,0.0317130002784965,0.0538728131725988,4.03286255564716e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,MEPE,Matrix extracellular phosphoglycoprotein,42618,0.0192511265430838,0.00254441522025267,0.0142640727113885,0.024238180374779,4.09806300156841e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,GDF15,Growth/differentiation factor 15,42794,-0.0345748711116144,0.0045801070333115,-0.043551880896905,-0.0255978613263239,4.66761841442092e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,DHPS,Deoxyhypusine synthase,40451,0.0301653886403711,0.00400401993246308,0.0223175095727435,0.0380132677079987,5.30691333009113e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,PTN,Pleiotrophin,42357,0.0367923969475596,0.00489504430094144,0.0271981101177144,0.0463866837774048,6.00074567880573e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,ROBO2,Roundabout homolog 2,42711,0.0174047615471151,0.00231738907871215,0.0128626789528393,0.0219468441413909,6.25890198491641e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,TREML1,Trem-like transcript 1 protein,40532,0.0390239175794836,0.00519672265012888,0.028838341185231,0.0492094939737362,6.38884056690783e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,SNRPB2,U2 small nuclear ribonucleoprotein B'',40483,0.0320420428880293,0.0042758812563564,0.0236613156255707,0.0404227701504878,7.19786047450761e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,EFCAB2,Dynein regulatory complex protein 8,40302,0.0258940876237281,0.00345872949202879,0.0191149778193517,0.0326731974281046,7.60367204221689e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42636,0.0363584059374947,0.00486131586296333,0.0268302268460866,0.0458865850289028,7.9450953926579e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA9,Serpin A9,42538,0.05305634828277,0.00709455866888965,0.0391510132917462,0.0669616832737937,7.98916464257425e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,MYOM3,Myomesin-3,40283,-0.068603755779636,0.00919354789143007,-0.0866231096468389,-0.050584401912433,9.14817634078093e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,PRELP,Prolargin,42618,0.0179561588481671,0.00240824738994902,0.013235993963867,0.0226763237324672,9.45724253866766e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,ZHX2,Zinc fingers and homeoboxes protein 2,40483,0.024039173676964,0.00322345643223902,0.0177211990697755,0.0303571482841525,9.45855202563479e-14
NMR metabolomics,X23428.Concentration of VLDL Particles,SUOX,"Sulfite oxidase, mitochondrial",40482,0.0457322536359246,0.00614991022399358,0.0336784295968972,0.057786077674952,1.11088506586913e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,FCN1,Ficolin-1,40515,0.040984003462547,0.00552067738456598,0.0301634757887977,0.0518045311362963,1.22036134184743e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP4,"Fatty acid-binding protein, adipocyte",42794,0.0375768450391455,0.00506531958685631,0.0276488186489072,0.0475048714293839,1.25511100541468e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,SPAG1,Sperm-associated antigen 1,40482,0.0420637439784466,0.00567443372068675,0.0309418538859006,0.0531856340709926,1.32449966255495e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42636,0.0461902560208045,0.00623508981802976,0.0339694799774661,0.0584110320641428,1.35742458387893e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,SDK2,Protein sidekick-2,40283,0.0297249181070202,0.00401360826176708,0.0218582459139567,0.0375915903000837,1.3957538075883e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP9,Caspase-9,40199,0.0457869613835108,0.00620716151210022,0.0336209248197944,0.0579529979472273,1.74232711032221e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42689,0.0311244050968953,0.00422437183738048,0.0228446362956296,0.0394041738981611,1.835126178926e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,SMARCA2,Probable global transcription activator SNF2L2,42311,0.0529969836405341,0.00719626881650493,0.0388922967601844,0.0671016705208838,1.88409655982211e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,ERMAP,Erythroid membrane-associated protein,40199,0.0326859472836469,0.004438950099813,0.0239856050880134,0.0413862894792804,1.92033044714222e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,CD14,Monocyte differentiation antigen CD14,42416,0.0303837986938762,0.00413374612217759,0.0222816562944081,0.0384859410933443,2.09555079676961e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMP1,Metalloproteinase inhibitor 1,42501,0.0212700539084678,0.00289446303579881,0.0155969063583021,0.0269432014586334,2.12074924143419e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,CPQ,Carboxypeptidase Q,40516,0.0260141885400389,0.00354125732497835,0.0190733241830813,0.0329550528969964,2.18208119597469e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,GNLY,Granulysin,42611,0.0389313193456563,0.00530210870882434,0.0285391862763606,0.0493234524149521,2.21533375554807e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,XCL1,Lymphotactin,42721,0.0407601761037369,0.00555132944226529,0.0298795703968969,0.0516407818105769,2.21751926079492e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300A,CMRF35-like molecule 8,40283,0.0227129003343505,0.0030936162709491,0.0166494124432903,0.0287763882254107,2.25398257431897e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,CTRB1,Chymotrypsinogen B,42611,0.0419933373952376,0.00573903745748558,0.0307448239785659,0.0532418508119093,2.67701079174311e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,VSNL1,Visinin-like protein 1,40483,0.0277928550077719,0.00379927040352262,0.0203462850168676,0.0352394249986763,2.74180500290277e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,TCOF1,Treacle protein,40511,0.0233559623261502,0.00319338345036045,0.0170969307634437,0.0296149938888567,2.77103989791889e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,RPE,Ribulose-phosphate 3-epimerase,40302,0.0505641946670919,0.00692231914691473,0.036996449139139,0.0641319401950447,2.97323187299681e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42495,0.0422938008599782,0.00580427120644926,0.0309174292953376,0.0536701724246187,3.35617142952743e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,GPRC5C,G-protein coupled receptor family C group 5 member C,40451,0.0409020129115535,0.00562249811328345,0.0298819166095179,0.051922109213589,3.70247340383072e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,40199,0.0422892738233172,0.00581391496470702,0.0308940004924914,0.053684547154143,3.73263154379821e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,IDO1,"Indoleamine 2,3-dioxygenase 1",40223,0.0464157948427365,0.00638861560982538,0.0338941082474788,0.0589374814379942,3.97068867923688e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,CD34,Hematopoietic progenitor cell antigen CD34,42674,0.0174633018295619,0.00240417260554235,0.0127511235226989,0.0221754801364249,3.9717644805115e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,CD200R1,Cell surface glycoprotein CD200 receptor 1,42558,0.0253179136164447,0.00348582191208783,0.0184857026687526,0.0321501245641369,3.99224971184351e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,CPA1,Carboxypeptidase A1,42794,0.0445563924765212,0.00617426632361169,0.0324548304822423,0.0566579544708002,5.61820419865287e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,HDGF,Hepatoma-derived growth factor,42700,0.0661944350298012,0.00919632155077898,0.0481696447902744,0.084219225269328,6.43639508614412e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,INSR,Insulin receptor,40199,0.0124207608297193,0.00172634666930249,0.00903712135788639,0.0158044003015522,6.66088356295232e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,C8B,Complement component C8 beta chain,40539,0.0216940037141989,0.00301676535328699,0.0157811436217564,0.0276068638066414,6.8290730662691e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,BRDT,Bromodomain testis-specific protein,40116,0.0265683796618547,0.00369481209749176,0.0193265479507708,0.0338102113729385,6.86625258645926e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,HRG,Histidine-rich glycoprotein,40479,0.0219987900066754,0.0030652976519053,0.015990806608941,0.0280067734044098,7.58820995964834e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,STAM,Signal transducing adapter molecule 1,40451,0.026592629227763,0.00370626974208192,0.0193283405332825,0.0338569179222436,7.68290196772521e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,STX6,Syntaxin-6,42346,0.0468209834570857,0.00654180642690778,0.0339990428603464,0.0596429240538249,8.6711818188578e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP6,Gastrotropin,42334,0.0415847152488927,0.0058175845242811,0.0301822495813018,0.0529871809164837,9.26296763374814e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,NAP1L4,Nucleosome assembly protein 1-like 4,40428,0.0293452535146258,0.00410546649120681,0.0212985391918604,0.0373919678373911,9.36145764891781e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRC37A2,Leucine-rich repeat-containing protein 37A2,40449,0.0307402646692994,0.0043035288406281,0.0223053481416683,0.0391751811969305,9.69261190268904e-13
NMR metabolomics,X23428.Concentration of VLDL Particles,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,40302,0.0269765092741241,0.00378674987613856,0.0195544795168925,0.0343985390313557,1.11390951445918e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,MCAM,Cell surface glycoprotein MUC18,42689,-0.0236475211362975,0.0033215877899941,-0.0301578332046859,-0.017137209067909,1.1392685455453e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,LTBP2,Latent-transforming growth factor beta-binding protein 2,42794,-0.0231614248583542,0.00325928743145172,-0.0295496282239995,-0.0167732214927088,1.25144857270837e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,PMM2,Phosphomannomutase 2,40116,0.04236727367035,0.00596146285256897,0.0306828064793148,0.0540517408613852,1.26117713779942e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,40482,0.0465847318,0.00655579497357624,0.0337353736517906,0.0594340899482095,1.26757031867215e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6V1F,V-type proton ATPase subunit F,42292,0.0466935216027334,0.00657568122440677,0.0338051864028961,0.0595818568025707,1.30303971920124e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,GPR15L,Protein GPR15L,40449,0.0428145774683458,0.00603130739847876,0.0309932149673274,0.0546359399693641,1.33494635102659e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,APOB,Apolipoprotein B-100,40532,0.0156800463254033,0.0022152438157358,0.0113381684465611,0.0200219242042454,1.54608204039506e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,ABCA2,ATP-binding cassette sub-family A member 2,40116,0.025375737393217,0.00358631624038321,0.0183465575620659,0.0324049172243681,1.5779435347517e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,AHCY,Adenosylhomocysteinase,42636,0.0469246801825094,0.00663378587139421,0.0339224598745767,0.0599269004904421,1.58445488533354e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,EPPK1,Epiplakin,40223,0.0509124825159737,0.00719923744783379,0.0368019771182195,0.0650229879137279,1.62045357290589e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,DAPK2,Death-associated protein kinase 2,40199,0.0379852617443266,0.00537386280726181,0.0274524906420934,0.0485180328465597,1.66075023558736e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP1,"Fatty acid-binding protein, liver",42618,-0.0658880384209388,0.00932384644855315,-0.084162777460103,-0.0476132993817747,1.66592004473167e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CPB1,Carboxypeptidase B,42794,0.0423142023710717,0.00599840819119455,0.0305573223163304,0.0540710824258131,1.81939850010279e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,40182,0.038549045220626,0.00546397598873201,0.0278396522827112,0.0492584381585407,1.82820788154409e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,40482,0.0405244360169066,0.00574871052108489,0.0292569633955802,0.051791908638233,1.90299772349041e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINT2,Kunitz-type protease inhibitor 2,42676,0.0279599364323849,0.00398805436610819,0.0201433498748128,0.0357765229899569,2.48021400149926e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",40511,0.0511901721778993,0.00731155748607538,0.0368595195051915,0.065520824850607,2.6801645855244e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMG3,Proteasome assembly chaperone 3,42594,0.0353933469295185,0.00506000512011401,0.025475736894095,0.0453109569649419,2.78389706127947e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CFB,Complement factor B,40344,0.022394285722502,0.00321252376784094,0.0160977391375338,0.0286908323074703,3.32631567163222e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,MCTS1,Malignant T-cell-amplified sequence 1,40449,0.0189027393092677,0.00271189085345648,0.013587433236493,0.0242180453820424,3.33912346089707e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,AK1,Adenylate kinase isoenzyme 1,42636,0.0434105619756216,0.00623023548622711,0.0311993004226164,0.0556218235286267,3.37109780927719e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA2,Annexin A2,40054,0.0501198142967565,0.00720066037507518,0.0360065199616092,0.0642331086319039,3.58760015882652e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CSNK1D,Casein kinase I isoform delta,40199,0.0433882293862135,0.00624217045727741,0.0311535752899498,0.0556228834824772,3.8370788123767e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,FUT8,"Alpha-(1,6)-fucosyltransferase",42495,0.0403994581927769,0.00582787020715212,0.0289768325867588,0.0518220837987951,4.33719116440045e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",40223,0.0628865921769638,0.00907155348411312,0.0451063473481021,0.0806668370058255,4.37227179612096e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,NPDC1,Neural proliferation differentiation and control protein 1,42636,0.0237705326294975,0.0034316734349886,0.0170444526969199,0.0304966125620752,4.50030095912571e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,40182,0.0374518783233999,0.00541320673981923,0.0268419931133542,0.0480617635334456,4.8145995416879e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,FES,Tyrosine-protein kinase Fes/Fps,42346,0.0324918792444149,0.0047051854474701,0.0232697157673735,0.0417140427214563,5.2307755328426e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,SLITRK6,SLIT and NTRK-like protein 6,42357,-0.0242981938600127,0.00352085169172519,-0.0311990631757941,-0.0173973245442313,5.39160212051401e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,40199,0.0240688654842572,0.00349175235122547,0.0172250308758552,0.0309127000926591,5.75918871289855e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",42370,0.0487270899470648,0.00707895937444794,0.0348523295731469,0.0626018503209828,6.10993062834517e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSL,Cathepsin L1,42636,0.0168868898190218,0.00245523526390118,0.0120746287017755,0.0216991509362682,6.34218922921624e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,THBD,Thrombomodulin,42636,0.0205614612560074,0.00298997763534066,0.0147011050907397,0.0264218174212751,6.3919086049109e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CHGA,Chromogranin-A,40527,-0.0667191052993342,0.00971669884988839,-0.0857638350451155,-0.047674375553553,6.92662464523634e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,CCDC80,Coiled-coil domain-containing protein 80,42636,0.0255242587223765,0.00372345755189273,0.0182262819206667,0.0328222355240862,7.44296045017245e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,42292,0.0327480047396268,0.00479956412434223,0.023340859055916,0.0421551504233376,9.3000603918288e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,TINAGL1,Tubulointerstitial nephritis antigen-like,42607,0.0150369907686618,0.00220661602144628,0.0107120233666271,0.0193619581706965,9.86293485229723e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,PALM,Paralemmin-1,40384,0.0213118319342632,0.00312741349052527,0.0151821014928337,0.0274415623756927,9.94355948768472e-12
NMR metabolomics,X23428.Concentration of VLDL Particles,SLIT2,Slit homolog 2 protein,42311,0.0353712701745533,0.00520623256462406,0.0251670543478902,0.0455754860012165,1.13754439622081e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB1,Integrin beta-1,42638,0.0143742268764998,0.00211636165670563,0.0102261580293567,0.0185222957236428,1.15276878700233e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARB2,Lysosome membrane protein 2,42302,0.0235236358601204,0.0034653812911636,0.0167314885294398,0.0303157831908011,1.18443566951181e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CHRDL1,Chordin-like protein 1,42654,0.021704460606608,0.00319792313383395,0.0154365312642935,0.0279723899489226,1.19242089642885e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,DMD,Dystrophin,40223,0.0347101728432066,0.00511451270681823,0.0246857279378429,0.0447346177485704,1.20691778339123e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G15,Phospholipase A2 group XV,42679,0.0178340675779668,0.00262869896146542,0.0126818176134946,0.0229863175424391,1.21458285610575e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,MOG,Myelin-oligodendrocyte glycoprotein,42721,0.0228158050649409,0.00336355884596313,0.0162232297268532,0.0294083804030287,1.22399634631705e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,DPT,Dermatopontin,42794,0.0169663892978289,0.00250341529585778,0.0120596953179476,0.0218730832777101,1.27488478573928e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CARHSP1,Calcium-regulated heat-stable protein 1,42311,0.034956400488464,0.00516115803132715,0.0248405307470628,0.0450722702298652,1.31537515940232e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,MYL3,Myosin light chain 3,40223,-0.0493347164243946,0.00729384987909119,-0.0636306621874134,-0.0350387706613759,1.41143796124663e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTN2,Dynactin subunit 2,42587,0.062482246287961,0.00925461927409485,0.044343192510735,0.0806213000651869,1.52389620214085e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CD28,T-cell-specific surface glycoprotein CD28,42346,0.0253746193177502,0.0037603815570725,0.0180042714658881,0.0327449671696123,1.56300149996945e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42594,0.0263177661662594,0.00390289226550935,0.0186680973258611,0.0339674350066578,1.61346944631026e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,40116,0.0448482289896976,0.00665210485263136,0.0318101034785401,0.057886354500855,1.64146777688582e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA6,Corticosteroid-binding globulin,40539,0.0105159995034513,0.00156009066007005,0.00745822180971399,0.0135737771971886,1.65344180856813e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,PTGES2,Prostaglandin E synthase 2,40102,0.0363843814223151,0.00539767990466553,0.0258049288091707,0.0469638340354595,1.6553131929413e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,NGRN,Neugrin,40483,0.0154178446397826,0.00229477659781574,0.0109200825080637,0.0199156067715014,1.9221347692814e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,TXN,Thioredoxin,40384,0.0295920119597496,0.00441466216872091,0.0209392741090566,0.0382447498104426,2.13826171597311e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,WASF3,Wiskott-Aldrich syndrome protein family member 3,42311,0.0559881163462368,0.00835847388723713,0.039605507527252,0.0723707251652216,2.19358502607175e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,SGSH,N-sulphoglucosamine sulphohydrolase,40332,0.0377293672161009,0.00565446038627618,0.0266466248589996,0.0488121095732022,2.6341883034112e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CELA3A,Chymotrypsin-like elastase family member 3A,42781,0.0391446005583247,0.00588129918068421,0.0276172541641836,0.0506719469524657,2.9262248051123e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,PALM2,Paralemmin-2,40483,0.024859378805755,0.00373776954419406,0.0175333504991347,0.0321854071123754,3.04846010035657e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,TPP1,Tripeptidyl-peptidase 1,42545,0.0295933192122711,0.00445444062324829,0.0208626155907045,0.0383240228338378,3.18077043777917e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,40223,0.0274206103366243,0.00413419474226044,0.0193175886417939,0.0355236320314548,3.4517035133331e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CHAD,Chondroadherin,40283,0.0340809725525643,0.00516184651368135,0.0239637533857489,0.0441981917193798,4.2281713506035e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,40199,0.0287041479498775,0.0043494470535609,0.0201792317248982,0.0372290641748569,4.31525546638702e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,THBS4,Thrombospondin-4,42652,0.0298913094027061,0.00453100673769575,0.0210105361968225,0.0387720826085898,4.3508121578608e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42495,0.0466081144887162,0.00710695129413779,0.0326784899522062,0.0605377390252263,5.65108240018477e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,TCL1A,T-cell leukemia/lymphoma protein 1A,42490,0.0656868922297777,0.0100165413457059,0.0460544711921941,0.0853193132673613,5.661014810702e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,DSG3,Desmoglein-3,42651,0.0228476825236914,0.00348445349265687,0.0160181536780839,0.0296772113692988,5.68915658192845e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,40511,0.0209282080280171,0.00319377539039681,0.0146684082628394,0.0271880077931948,5.89153734943592e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,IL12A_IL12B,Interleukin-12,42587,0.0530663071466139,0.00810707307685333,0.0371764439159813,0.0689561703772464,6.1382411174443e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,HGFAC,Hepatocyte growth factor activator,40428,0.0179840068175687,0.00275316218298169,0.0125878089389246,0.0233802046962128,6.76428408054438e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,REG1A,Lithostathine-1-alpha,42575,-0.033764843375419,0.00517164390888798,-0.0439012654368395,-0.0236284213139986,6.86720701335058e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,ENTR1,Endosome-associated-trafficking regulator 1,40223,0.0378232669361825,0.00579777828375779,0.0264596215000173,0.0491869123723478,7.15728403006995e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,TPR,Nucleoprotein TPR,40116,0.0314243026336751,0.00482023926287116,0.0219766336784476,0.0408719715889026,7.37806218856076e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,LTB,Lymphotoxin-beta,40451,0.0231590440097701,0.00355303443186157,0.0161950965233215,0.0301229914962188,7.42452734583855e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,NTRK2,BDNF/NT-3 growth factors receptor,42636,0.0165057335707261,0.0025342632683418,0.0115385775647762,0.0214728895766761,7.62696371943451e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CSDE1,Cold shock domain-containing protein E1,40116,0.0752871237359056,0.0115760053438221,0.0525981532620143,0.0979760942097968,8.17797756060058e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH17,Cadherin-17,42636,-0.0447235501436707,0.00688870469001465,-0.0582254113360994,-0.031221688951242,8.75040418993756e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,NID2,Nidogen-2,42611,0.0473747621697614,0.0073153818398972,0.0330366137635629,0.0617129105759599,9.74370039713567e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,VGF,Neurosecretory protein VGF,40482,0.0202611031099739,0.00312836203329301,0.0141295135247196,0.0263926926952282,9.77197368551462e-11
NMR metabolomics,X23428.Concentration of VLDL Particles,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,40449,-0.0227963773269544,0.00352437134579682,-0.0297041451647162,-0.0158886094891926,1.03281307843333e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,GLO1,Lactoylglutathione lyase,42357,0.0370126123830042,0.00573209998181764,0.0257776964186416,0.0482475283473667,1.10492702865988e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CDA,Cytidine deaminase,40494,0.029953037472186,0.00465143193353473,0.0208362308824579,0.0390698440619141,1.2470510159904e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,40302,0.0466602581746752,0.0072593742149459,0.0324318847133813,0.0608886316359692,1.3495764859948e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSS,Cathepsin S,39872,0.0155926391463387,0.00242854936060647,0.01083268239955,0.0203525958931273,1.41543077327181e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,AFAP1,Actin filament-associated protein 1,40283,0.0529155961043727,0.00824922157033867,0.036747121826509,0.0690840703822365,1.46925702161532e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,40482,-0.0247931725706953,0.00387661958767215,-0.0323913469625327,-0.0171949981788578,1.66275519629186e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,PRTG,Protogenin,42721,0.0157638469187488,0.00246557253179777,0.0109313247564251,0.0205963690810724,1.67362833095958e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CD74,HLA class II histocompatibility antigen gamma chain,42711,0.0224427563546405,0.0035146021695244,0.0155541361023727,0.0293313766069083,1.76338669860028e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,SFTPA1,Pulmonary surfactant-associated protein A1,42346,0.036492520537245,0.00571645767843773,0.025288263487507,0.047696777586983,1.78589820126616e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42638,0.0227259103262599,0.00356019599971172,0.0157479261668249,0.0297038944856948,1.78966523538619e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSH,Pro-cathepsin H,42332,0.0470564243178637,0.00737734114812457,0.0325968356675396,0.0615160129681879,1.84815173852046e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,DSC2,Desmocollin-2,42488,-0.0223220253187084,0.00351213078463797,-0.0292058016565988,-0.015438248980818,2.14262746649037e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF23,Fibroblast growth factor 23,42711,0.0342335691558393,0.00538870071615817,0.0236717157521693,0.0447954225595093,2.18144614225503e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSV,Cathepsin L2,42677,0.026287306895832,0.00414982390084634,0.0181536520501731,0.0344209617414908,2.45579733006411e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CABP2,Calcium-binding protein 2,40182,0.0405995456796276,0.00640904709243292,0.0280378133784591,0.0531612779807962,2.47062340803331e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,REPS1,RalBP1-associated Eps domain-containing protein 1,40199,0.0244316473428707,0.0038585054582401,0.0168689766447201,0.0319943180410213,2.51606583756089e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",40511,0.0329024652213563,0.00520980876002096,0.0226912400517152,0.0431136903909974,2.79412574197897e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,ICOSLG,ICOS ligand,42587,0.012079884942367,0.00191743092472252,0.00832172032991085,0.0158380495548231,3.06887038196428e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,RGMB,RGM domain family member B,42711,0.0177608321158485,0.00282091127294489,0.0122318460208765,0.0232898182108205,3.14599929914787e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,40173,0.0171586785556252,0.00272515126045958,0.0118173820851244,0.022499975026126,3.1624711414425e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMP3,Lysosome-associated membrane glycoprotein 3,42746,0.0326463860405699,0.00519857624942508,0.0224571765916967,0.042835595489443,3.49200018453598e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42706,0.0183431865349127,0.00292119703368635,0.0126176403488874,0.0240687327209379,3.50423538345311e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CPXM2,Inactive carboxypeptidase-like protein X2,40511,0.0166682776549665,0.00265449543849956,0.0114654665955074,0.0218710887144257,3.52643639688033e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,LGMN,Legumain,42676,0.0221318445039493,0.00352645836752372,0.0152199861036028,0.0290437029042958,3.58165215868765e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,GGH,Gamma-glutamyl hydrolase,42437,0.0212331523695873,0.00338436564520718,0.0145997957049813,0.0278665090341934,3.63090604445775e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,ECI2,Enoyl-CoA delta isomerase 2,40116,0.0381884591239278,0.00611687954756447,0.0261993752107015,0.0501775430371542,4.44830321691141e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CST5,Cystatin-D,42357,0.0351875707008163,0.00565653720233406,0.0241007577842416,0.0462743836173911,5.09960742505202e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,GFAP,Glial fibrillary acidic protein,42326,0.030122822341372,0.004848765768162,0.0206192414357745,0.0396264032469695,5.37326118406283e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CD83,CD83 antigen,42594,0.0217341941446166,0.0034993930861336,0.0148753836957948,0.0285930045934385,5.42575724989843e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,VIT,Vitrin,40511,0.023746197251684,0.00382721872027082,0.0162448485599532,0.0312475459434148,5.67676477418208e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB8,Serpin B8,42754,0.0354066186079792,0.00571025749126788,0.0242145139250942,0.0465987232908643,5.79063068808897e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,LACRT,Extracellular glycoprotein lacritin,40419,0.0317317366068855,0.00511763256061706,0.0217011767880761,0.0417622964256949,5.82722460836068e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,KIF22,Kinesin-like protein KIF22,40116,0.0769125013887775,0.0124049217792534,0.0525988547014408,0.101226148076114,5.84432122226611e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,MENT,Protein MENT,40283,-0.0142613700204071,0.00230019366050794,-0.0187697495950027,-0.00975299044581156,5.84440665261529e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIG10,V-set and immunoglobulin domain-containing protein 10,40451,0.0205833795571285,0.0033224287760463,0.0140714191560778,0.0270953399581793,6.02129376261865e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",40451,0.023146574318003,0.00373619889775059,0.0158236244784119,0.0304695241575942,6.02361287053876e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,PVALB,Parvalbumin alpha,42654,0.0672441958592714,0.0108710818200684,0.0459368754919373,0.0885515162266055,6.36568374748788e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYGD,Gamma-crystallin D,40483,0.0596450483691816,0.00964621195610757,0.0407384729352108,0.0785516238031524,6.496033609601e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,PPM1A,Protein phosphatase 1A,42346,0.019467081187413,0.00315506935052609,0.0132831452603819,0.0256510171144441,7.0251480933624e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,EDF1,Endothelial differentiation-related factor 1,40482,0.0408860007064688,0.0066351493085658,0.0278811080616799,0.0538908933512578,7.42656312516708e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,MDM1,Nuclear protein MDM1,40182,0.0190926284940827,0.00310730331715536,0.0130023139924581,0.0251829429957072,8.30274786228156e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,FGR,Tyrosine-protein kinase Fgr,42311,0.0347501823422052,0.00566729544057201,0.023642283278684,0.0458580814057263,8.94385083114413e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,NFIC,Nuclear factor 1 C-type,40482,0.0288817353505186,0.00471171071719882,0.0196467823448089,0.0381166883562283,9.09405876753218e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSB,Cathepsin B,42659,0.0325403157703481,0.00531942143091325,0.0221142497657581,0.042966381774938,9.78313269669373e-10
NMR metabolomics,X23428.Concentration of VLDL Particles,GLRX,Glutaredoxin-1,42546,0.0338740207247239,0.00554406108881442,0.0230076609906476,0.0447403804588002,1.02423782500178e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CD46,Membrane cofactor protein,42580,0.0174094373129972,0.00286252570264671,0.0117988869358096,0.0230199876901847,1.22043079609575e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,ROBO1,Roundabout homolog 1,42638,0.0147483131990433,0.00242610895339339,0.00999313965039225,0.0195034867476943,1.2420845531984e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CD302,CD302 antigen,42587,0.0192917138900455,0.00317447390607086,0.0130697450341466,0.0255136827459444,1.25667045596147e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,SLITRK2,SLIT and NTRK-like protein 2,42721,0.0238536096135001,0.00393000237465888,0.0161508049591687,0.0315564142678315,1.31643240575906e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,BCAN,Brevican core protein,42495,0.0208449313761659,0.00343630482888216,0.0141097739115569,0.0275800888407749,1.3461824035035e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,XRCC4,DNA repair protein XRCC4,42311,0.02214331420091,0.00365134603092089,0.0149866759803051,0.029299952421515,1.36066428059628e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,40483,0.0513504040154329,0.0084721371410236,0.0347450152190266,0.0679557928118391,1.39517025182646e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,PER3,Period circadian protein homolog 3,40199,0.0739928092796798,0.0122329674749969,0.0500161930286858,0.0979694255306737,1.50821306747679e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,IL32,Interleukin-32,42594,-0.0264953693481091,0.00438391914747502,-0.0350878508771601,-0.017902887819058,1.545561396014e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,NCAN,Neurocan core protein,42711,0.0227394360969415,0.00376458591478014,0.0153608477039724,0.0301180244899105,1.57811664971263e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGB1A1,Uteroglobin,42646,0.0332703768744012,0.00551874491735719,0.0224536368363811,0.0440871169124213,1.69701441949954e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",42476,0.0569527531313882,0.00944761612757473,0.0384354255213417,0.0754700807414346,1.70120064452899e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,S100P,Protein S100-P,42357,0.032487548730079,0.00539440502999402,0.0219145148712907,0.0430605825888673,1.76371679231967e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJB8,DnaJ homolog subfamily B member 8,42357,0.0346860039023909,0.00576415280000964,0.023388264414372,0.0459837433904098,1.81794619532352e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,NME3,Nucleoside diphosphate kinase 3,42638,0.0142541920484086,0.00237172649457623,0.00960560811903923,0.018902775977778,1.90266220003038e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,TFPI2,Tissue factor pathway inhibitor 2,42635,0.0223902277284233,0.00372629978664117,0.0150866801466066,0.0296937753102399,1.91849245626443e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,OCLN,Occludin,40482,0.0267829789646488,0.00445859575014756,0.0180441312943596,0.035521826634938,1.94759752388559e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,40511,0.0198474818187126,0.00330627622540032,0.013367180416928,0.0263277832204972,1.99678243546967e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,PBK,Lymphokine-activated killer T-cell-originated protein kinase,40080,-0.0183569562144469,0.00305838381662122,-0.0243513884950245,-0.0123625239338693,2.00896200684602e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",40449,0.0604277144884375,0.0101011640469422,0.0406294329564307,0.0802259960204442,2.26765171523956e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,PPME1,Protein phosphatase methylesterase 1,42587,0.0352708933904129,0.00589872505638258,0.023709392279903,0.0468323945009227,2.29648430750946e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",40199,0.0257540910095317,0.00430987087548339,0.0173067440935843,0.0342014379254792,2.3633654110611e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSC,Dipeptidyl peptidase 1,42616,0.0260119935171364,0.00435688690760548,0.0174724951782297,0.0345514918560432,2.42772403874547e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARF2,Scavenger receptor class F member 2,42711,-0.0178589876601722,0.00300116646004029,-0.0237412739218512,-0.0119767013984933,2.73634876587148e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYM,Ketimine reductase mu-crystallin,40136,0.0446685996770961,0.00752949423217024,0.0299107909820424,0.0594264083721498,3.07420480389121e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,ELOB,Elongin-B,40116,0.0236341292925441,0.00398619845142993,0.0158211803277414,0.0314470782573468,3.1402821541659e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,USP47,Ubiquitin carboxyl-terminal hydrolase 47,40116,0.0493135909769338,0.00831859441787278,0.0330091459179032,0.0656180360359645,3.15698085978159e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,GC,Vitamin D-binding protein,40539,0.015233252347144,0.00257117754013657,0.0101937443684763,0.0202727603258117,3.22106976436354e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM5,Intercellular adhesion molecule 5,42636,0.0269079523673695,0.00454502147053138,0.017999710285128,0.035816194449611,3.29164979915016e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300C,CMRF35-like molecule 6,42711,0.0210655156144514,0.00355979190788198,0.0140883234750027,0.0280427077539001,3.34529445286107e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,LY9,T-lymphocyte surface antigen Ly-9,42443,0.0179246866548528,0.0030355217990849,0.0119750639286464,0.0238743093810592,3.61335346378455e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSE,Cathepsin E,40283,0.0300318846986514,0.00508764234430366,0.0200601057038163,0.0400036636934866,3.6760898162876e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,IMMT,MICOS complex subunit MIC60,40451,0.0263801032679971,0.00447602806187933,0.0176070882667136,0.0351531182692806,3.88606229195272e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,42357,-0.0181236815765353,0.00307857248177708,-0.0241576836408184,-0.0120896795122522,4.02751078371124e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,NADK,NAD kinase,42636,0.0318572552140641,0.00541268144130726,0.0212483995891019,0.0424661108390264,4.05893141645946e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL3,Fc receptor-like protein 3,42370,0.0328793428765191,0.00559929572269095,0.0219047232600448,0.0438539624929934,4.40811738755653e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,RARRES1,Retinoic acid receptor responder protein 1,42346,0.0191521920112093,0.00326661507444529,0.0127496264652965,0.0255547575571221,4.6546197792126e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A11,Protein S100-A11,42531,0.0264458463934375,0.00451225743956844,0.0176018218118834,0.0352898709749917,4.71268627413051e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH1,Protocadherin-1,42721,0.0126080410887796,0.00215192842719671,0.008390261371474,0.0168258208060851,4.76637380772648e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL12,Stromal cell-derived factor 1,42370,0.0233665842075299,0.0039885384637869,0.0155490488185076,0.0311841195965523,4.78412754587905e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,MTPN,Myotrophin,42357,0.0192586098626382,0.00329106120698235,0.0128081298969528,0.0257090898283236,4.97872299621926e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE3,Eosinophil cationic protein,42578,0.0636086013444457,0.0108771261425114,0.0422894341051234,0.084927768583768,5.09363494736862e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,ZBP1,Z-DNA-binding protein 1,40199,0.0232575391032813,0.00397760975732714,0.0154614239789201,0.0310536542276425,5.14392316306137e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A12,Protein S100-A12,42434,0.0434853207034304,0.00744445917184561,0.028894180726613,0.0580764606802478,5.30115753718301e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,RABEPK,Rab9 effector protein with kelch motifs,42346,0.033207408345626,0.00569350708070564,0.0220481344674429,0.044366682223809,5.58849304844845e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,ESAM,Endothelial cell-selective adhesion molecule,42794,0.0187375962581898,0.00321351490509855,0.0124391070441966,0.025036085472183,5.6389932415135e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,RANBP1,Ran-specific GTPase-activating protein,40223,0.0303447423528313,0.00520391139722936,0.0201450760142618,0.0405444086914008,5.65942866242239e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,IGHMBP2,DNA-binding protein SMUBP-2,40116,0.0317144119763816,0.00545638480393427,0.0210198977606705,0.0424089261920928,6.33259626379281e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,SCT,Secretin,40182,0.0288080280816067,0.0049602153218331,0.0190860060508138,0.0385300501123996,6.50470337083749e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,GAS2,Growth arrest-specific protein 2,40302,0.0303609616325738,0.00523109317632232,0.020108019006982,0.0406139042581655,6.65452470896864e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,ECM1,Extracellular matrix protein 1,40269,0.0215326072682702,0.00371206400489798,0.0142569618186702,0.0288082527178702,6.78422032686679e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,RPL14,60S ribosomal protein L14,40223,0.0230639443347094,0.00397733419028884,0.0152683693217433,0.0308595193476756,6.86063688304614e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,COL2A1,Collagen alpha-1(II) chain,40223,0.0464710727275162,0.00802831361043961,0.0307355780510545,0.0622065674039778,7.29980155165722e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42587,0.0261232615269935,0.00451534375480733,0.0172731877675711,0.0349733352864159,7.39386120926139e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,GCLM,Glutamate--cysteine ligase regulatory subunit,40116,0.026304544723816,0.00454678564897311,0.0173928448518287,0.0352162445958032,7.43689818421232e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,FLT1,Vascular endothelial growth factor receptor 1,42559,0.012397707476522,0.00214418269660653,0.00819510939117322,0.0166003055618708,7.54586818949267e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,42357,0.0331408767957024,0.00573436762967322,0.0219015162415429,0.0443802373498619,7.66920895328437e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,PVR,Poliovirus receptor,42711,0.0209692535593386,0.00363628722932386,0.0138421305898638,0.0280963765288133,8.26233368950816e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CHCHD6,MICOS complex subunit MIC25,40451,0.0164795397225569,0.00286420314119133,0.0108657015658219,0.0220933778792919,8.96294833740752e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42654,0.0501480280592317,0.00873618231274851,0.0330251107262446,0.0672709453922188,9.65657899415984e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,CWC15,Spliceosome-associated protein CWC15 homolog,40383,0.0338559739357104,0.00589942556003547,0.0222930998380409,0.0454188480333799,9.77917725601595e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,REG3A,Regenerating islet-derived protein 3-alpha,42794,-0.0371870785907401,0.00648194293668448,-0.0498916867466417,-0.0244824704348385,9.84053911548981e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,PPL,Periplakin,40199,0.0190057291666944,0.00331286086188914,0.0125125218773917,0.0254989364559971,9.89371078918926e-09
NMR metabolomics,X23428.Concentration of VLDL Particles,SELL,L-selectin,40539,0.0136055996112264,0.00237248170607735,0.00895553546731481,0.018255663755138,1.00147721688542e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,C2orf69,UPF0565 protein C2orf69,40182,0.0346847673906885,0.0060490521592818,0.0228286251584962,0.0465409096228808,1.00724037371397e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,TOR1AIP1,Torsin-1A-interacting protein 1,40223,0.0297034244692762,0.00518182797713171,0.0195470416340981,0.0398598073044544,1.01719487819233e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,PKD1,Polycystin-1,40511,0.015277255078044,0.00266620270672385,0.0100514977728653,0.0205030123832227,1.03013121215128e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGN,Secretagogin,42370,-0.0256667903834414,0.00448780838123473,-0.0344628948106615,-0.0168706859562214,1.09335078599993e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1R1,Interleukin-1 receptor type 1,42590,-0.0133178711904015,0.00233569952355796,-0.0178958422565751,-0.00873990012422789,1.2099691625291e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,NCF2,Neutrophil cytosol factor 2,42578,0.046754398665617,0.00820628334621583,0.030670083307034,0.0628387140242,1.24217886728795e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",40223,0.0189690286721363,0.00333272104284601,0.0124368954281581,0.0255011619161145,1.28948696280013e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,FGA,Fibrinogen alpha chain,40284,0.0175075626015311,0.00307796906918342,0.0114747432259316,0.0235403819771306,1.31769668648824e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CD86,T-lymphocyte activation antigen CD86,40449,0.0171331460607919,0.00301495909654157,0.0112238262315705,0.0230424658900134,1.35867876873222e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMTOR5,Ragulator complex protein LAMTOR5,40451,0.0225225080011178,0.00398561051573654,0.0147107113902742,0.0303343046119614,1.63434468307801e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,FOLR2,Folate receptor beta,42711,-0.0165511805104003,0.00293284010940006,-0.0222995471248244,-0.0108028138959762,1.70077232390187e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,TREH,Trehalase,40527,0.0414291032268173,0.00736214503117303,0.0269992989657181,0.0558589074879164,1.87381447310783e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,ATXN2,Ataxin-2,40136,0.0617037511581219,0.0109818006693257,0.0401794218462435,0.0832280804700004,1.97070708426608e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX5,Sorting nexin-5,40223,0.016191730951985,0.00288717262597421,0.0105328726050755,0.0218505892988944,2.09409134263847e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,HIP1R,Huntingtin-interacting protein 1-related protein,40449,0.0247639430217133,0.0044255612916606,0.0160898428900586,0.0334380431533681,2.24920032657939e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,PSAP,Prosaposin,40440,0.0160728641217976,0.00287583716004013,0.010436223288119,0.0217095049554763,2.33787843015315e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRH,Receptor-type tyrosine-protein phosphatase H,40449,0.0272006437329975,0.00487620899304417,0.0176432741066309,0.0367580133593641,2.48581006988356e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRC25,Leucine-rich repeat-containing protein 25,42587,0.0216588241772401,0.00388753669995016,0.0140392522453378,0.0292783961091424,2.57648514693275e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,COL24A1,Collagen alpha-1(XXIV) chain,40449,0.0307515779906684,0.00553039857166381,0.0199119967902074,0.0415911591911295,2.75195616274742e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,COPB2,Coatomer subunit beta',40116,0.0239503134022275,0.00431021961313336,0.0155022829604861,0.0323983438439689,2.81474238583375e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,MDK,Midkine,42638,0.0280452563630111,0.00505045523702978,0.0181463640984327,0.0379441486275894,2.86107660480705e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL2,Fc receptor-like protein 2,42681,0.0289656828061246,0.00521753539082133,0.0187393134401148,0.0391920521721344,2.88407764953864e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,DKK4,Dickkopf-related protein 4,42477,0.0255192806406988,0.00459782405107322,0.0165075455005953,0.0345310157808023,2.90651316229589e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,VIPR1,Vasoactive intestinal polypeptide receptor 1,40223,-0.0130231427773919,0.00234715242601776,-0.0176235615323867,-0.00842272402239711,2.94804712863077e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,GIP,Gastric inhibitory polypeptide,40223,0.0323004576591676,0.00582291806548216,0.0208875382508226,0.0437133770675126,2.97100737985408e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL19,C-C motif chemokine 19,42711,0.0719570507733259,0.0129766749282671,0.0465227679139223,0.0973913336327295,2.99284247027696e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,PZP,Pregnancy zone protein,40539,0.0280951024139287,0.00506611269985177,0.0181655215222193,0.0380246833056382,2.9934844418446e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,GRSF1,G-rich sequence factor 1,40014,0.0443793291207114,0.00800557592311813,0.0286884003113998,0.0600702579300229,3.03346461134456e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,NXPH3,Neurexophilin-3,40199,0.0169089899160641,0.00305892141738656,0.0109135039379865,0.0229044758941418,3.31734952251446e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,TPM3,Tropomyosin alpha-3 chain,40116,-0.0241190435347349,0.00436335365051994,-0.032671216689754,-0.0155668703797158,3.32023988004069e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CSTB,Cystatin-B,42437,0.0233085850430935,0.00421746705918145,0.0150423496070978,0.0315748204790891,3.32517455334203e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,ACE,Angiotensin-converting enzyme,40532,-0.0147426155758763,0.00266784300617333,-0.019971587867976,-0.00951364328377658,3.34769762450692e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,DPP7,Dipeptidyl peptidase 2,42551,0.0329433715147547,0.00596728621656367,0.0212474905302899,0.0446392524992195,3.44025092635895e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,RSPO1,R-spondin-1,42495,0.0185837125918894,0.00336625090614461,0.011985860815846,0.0251815643679328,3.44180447063538e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42611,0.0212075792317197,0.00385290626964773,0.0136558829432102,0.0287592755202293,3.77426878275454e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,TDP1,Tyrosyl-DNA phosphodiesterase 1,40451,0.0367951275294255,0.00668449861229298,0.0236935102493313,0.0498967448095197,3.7823321963479e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42587,0.029707928367008,0.0054014468721549,0.0191210924975844,0.0402947642364316,3.86766526093823e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,RCOR1,REST corepressor 1,42357,0.0241153867292531,0.00439023656718313,0.0155105230575742,0.0327202504009321,4.02593614188285e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CD8A,T-cell surface glycoprotein CD8 alpha chain,42711,0.0282691418147052,0.00515183533337863,0.0181715445612831,0.0383667390681273,4.15709394086632e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,40116,-0.030469097232333,0.0055535510368659,-0.0413540572645902,-0.0195841372000759,4.19316376436234e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,PNLIPRP1,Inactive pancreatic lipase-related protein 1,40483,0.0446009747610028,0.0081326166465657,0.028661046133734,0.0605409033882716,4.24267529024938e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX1,Peroxiredoxin-1,42261,-0.048658429724808,0.00887430988985419,-0.0660520771089222,-0.0312647823406937,4.25778908604658e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHB4,Ephrin type-B receptor 4,42794,-0.0143400127951205,0.00261559197967122,-0.0194665730752761,-0.00921345251496485,4.2680671452914e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,DMP1,Dentin matrix acidic phosphoprotein 1,40223,-0.0329953009955833,0.00601976399768439,-0.0447940384310447,-0.0211965635601219,4.31838912323105e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42683,0.0167244419739854,0.00305469858632932,0.01073723274478,0.0227116512031909,4.45362048348546e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS22,Brain-specific serine protease 4,40199,0.0198838436585389,0.00363671485295088,0.0127558825467552,0.0270118047703227,4.66318432319971e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,40199,0.0240769680025463,0.00441995873671463,0.0154138488785856,0.032740087126507,5.22324618867379e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,BSG,Basigin,42746,0.011728321895876,0.00215386824339764,0.00750674013881667,0.0159499036529354,5.26380128455732e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,42346,0.0235804829205449,0.00433481134634857,0.0150842526817017,0.0320767131593881,5.42961795753259e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",42346,0.0416605833804084,0.00766180600585387,0.0266434436089348,0.0566777231518819,5.50178025961012e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CFHR2,Complement factor H-related protein 2,40451,0.0312753603318824,0.00575169191160049,0.0200020441851454,0.0425486764786193,5.51333352014288e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL20,C-C motif chemokine 20,42754,0.0492777242454647,0.00907977047080038,0.031481374122696,0.0670740743682335,5.82291347699033e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,WFDC1,WAP four-disulfide core domain protein 1,40229,0.0303251000924772,0.00559314187728717,0.0193625420129944,0.04128765817196,6.02330207423518e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CYTL1,Cytokine-like protein 1,40527,0.013739516692695,0.00254003797690531,0.00876104225796058,0.0187179911274294,6.46018909795139e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,NAGA,Alpha-N-acetylgalactosaminidase,40166,0.0301150779392544,0.0055792991796791,0.0191796515470834,0.0410505043314254,6.89275586229817e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,EGFLAM,Pikachurin,40449,0.0165990773483839,0.00307719454330638,0.0105677760435034,0.0226303786532644,7.02138572710601e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,L1CAM,Neural cell adhesion molecule L1,42679,0.0156228113825225,0.00290000747312385,0.00993879673519972,0.0213068260298452,7.2780682986029e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,EFNA4,Ephrin-A4,42475,0.0181387286045618,0.00336920105059583,0.011535094545394,0.0247423626637296,7.42160099742585e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,COL9A1,Collagen alpha-1(IX) chain,42594,0.0258744811674546,0.00482021487512484,0.0164268600122099,0.0353221023226993,8.09815601270388e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,NXPH1,Neurexophilin-1,42311,0.0207205117058188,0.0038611175365369,0.0131527213342065,0.0282883020774312,8.16652304287092e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,LUZP2,Leucine zipper protein 2,40451,0.0244135982034496,0.00456281290544447,0.0154704849087784,0.0333567114981208,8.94028872348197e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,STX7,Syntaxin-7,40199,0.0265685755257105,0.00496846633209554,0.0168303815148032,0.0363067695366177,9.09929607445178e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP1,Interstitial collagenase,42136,0.0483560465234467,0.00904513065551675,0.0306275904386339,0.0660845026082596,9.14031945255579e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,LEPR,Leptin receptor,42636,-0.0164772188716607,0.00308556800514666,-0.0225249321617481,-0.0104295055815732,9.44114234157487e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,CALB2,Calretinin,42311,0.0169685372767108,0.00317777811668233,0.0107400921680135,0.0231969823854082,9.46279770992703e-08
NMR metabolomics,X23428.Concentration of VLDL Particles,INSL3,Insulin-like 3,40483,0.0413576263068821,0.007762856346377,0.0261424278679832,0.056572824745781,1.0141621029521e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,LCP1,Plastin-2,40527,0.0253467144062121,0.0047633338528347,0.0160105800546561,0.0346828487577681,1.0504295831826e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QA,Complement C1q subcomponent subunit A,42701,-0.0116019070121938,0.0021835602925765,-0.0158816851856437,-0.00732212883874385,1.09368844112955e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,MNDA,Myeloid cell nuclear differentiation antigen,42611,0.05104797977324,0.00961227646652779,0.0322079178988455,0.0698880416476345,1.10944135061023e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42611,0.0187177418960015,0.00352528936100233,0.011808174748437,0.0256273090435661,1.11641702976508e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,LPA,Apolipoprotein(a),40324,-0.0955061087290407,0.0180643787963915,-0.130912291169968,-0.0600999262881133,1.26702961975576e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ENSA,Alpha-endosulfine,40451,0.0278254986719265,0.00526874552736047,0.0174987574383,0.038152239905553,1.30705691176809e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,40080,0.034271237095786,0.00649038995633458,0.0215500727813702,0.0469924014102018,1.31454007532621e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42582,-0.0356122406747199,0.00674720666083424,-0.0488367657299551,-0.0223877156194848,1.32589227685419e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,MYOM2,Myomesin-2,40116,-0.0264425809464309,0.00501822720683705,-0.0362783062718315,-0.0166068556210302,1.39547915410988e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA7A,Semaphorin-7A,42760,0.0148335891305349,0.00281944445315416,0.00930747800235279,0.0203597002587171,1.45316687493496e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CEBPA,CCAAT/enhancer-binding protein alpha,40199,0.0193724731028978,0.00368220082934904,0.0121553594773737,0.0265895867284219,1.458765203243e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,TEK,Angiopoietin-1 receptor,42679,0.0114127722650326,0.00217312033241512,0.00715345641349893,0.0156720881165662,1.52918316432868e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,GRPEL1,"GrpE protein homolog 1, mitochondrial",42587,0.0307214571728833,0.00586520816955043,0.0192256491605644,0.0422172651852021,1.64862546767615e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",42346,0.0258214510680924,0.00493077487053323,0.0161571323218473,0.0354857698143375,1.65909657254273e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF3R,Granulocyte colony-stimulating factor receptor,40199,0.0156875516604337,0.0029980431573997,0.00981138707193025,0.0215637162489371,1.702193467864e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,LIPF,Gastric triacylglycerol lipase,40223,0.0323393698829361,0.00619315833706831,0.0202007795422822,0.04447796022359,1.80428428644881e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SART1,U4/U6.U5 tri-snRNP-associated protein 1,40116,0.0194158453730571,0.00371910795545416,0.0121263937803669,0.0267052969657472,1.81654609590862e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPAN1,Tetraspanin-1,42357,0.0350634003636253,0.00673031114589303,0.0218719905176749,0.0482548102095756,1.91925779940114e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,DUSP3,Dual specificity protein phosphatase 3,42311,0.0439581769803578,0.00849087384374973,0.0273160642466083,0.0606002897141073,2.28683234510156e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,NELL1,Protein kinase C-binding protein NELL1,42679,0.0223617776330186,0.00433227929841967,0.013870510208116,0.0308530450579211,2.4824140008819e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNGR2,Interferon gamma receptor 2,42495,0.0266285650339073,0.00516410820375047,0.0165069129545564,0.0367502171132582,2.55262678974221e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK6,Kallikrein-6,42656,0.0161863389585927,0.00314181236811312,0.010028386717091,0.0223442912000945,2.61489574264458e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ACTN2,Alpha-actinin-2,40116,-0.0304823246654874,0.00592228277965986,-0.0420899989136207,-0.018874650417354,2.69204866123481e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39983,0.0251420630731378,0.00488507691481159,0.0155673123201071,0.0347168138261685,2.69761779758141e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,VWC2,Brorin,42456,0.0210211835967355,0.00408787178740836,0.0130089548934151,0.0290334123000559,2.75218456551578e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,RELT,Tumor necrosis factor receptor superfamily member 19L,42611,0.0156881078779484,0.00305391017809013,0.00970244392889177,0.0216737718270051,2.82989631495861e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,AMFR,E3 ubiquitin-protein ligase AMFR,42311,0.0319796526516554,0.00622548758903698,0.0197776969771429,0.0441816083261678,2.8332749839001e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42495,0.035127518506212,0.00684346502470453,0.0217143270577911,0.0485407099546328,2.8917908772996e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,LYPD3,Ly6/PLAUR domain-containing protein 3,42572,0.0173592709288192,0.00338709731329124,0.0107205601947683,0.02399798166287,3.01497467651404e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,MANSC1,MANSC domain-containing protein 1,42679,-0.014246822527968,0.0027819371328833,-0.0196994193084193,-0.00879422574751672,3.0780297964244e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",40223,0.0246855570478343,0.00483073303102388,0.0152173203070275,0.0341537937886411,3.2736710300316e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,IL12B,Interleukin-12 subunit beta,42754,0.0286945527414181,0.00561948192298064,0.0176803681723761,0.0397087373104602,3.3304649049874e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42754,0.0180547901895896,0.00353898739300158,0.0111183748993065,0.0249912054798727,3.41194663305115e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CIT,Citron Rho-interacting kinase,40182,0.022857849345345,0.00449888462240171,0.0140400354854376,0.0316756632052524,3.82060231658671e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,FLT3LG,Fms-related tyrosine kinase 3 ligand,42754,0.0174382450284294,0.00343354254756656,0.0107085016351989,0.0241679884216598,3.84886511805791e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF16,Fibroblast growth factor 16,40199,0.0239336638655907,0.00471332745084412,0.0146955420619362,0.0331717856692452,3.87936226151599e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,C2CD2L,Phospholipid transfer protein C2CD2L,42292,0.0216555128650779,0.00426996997030544,0.0132863717232793,0.0300246540068766,3.99910290187226e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CD5L,CD5 antigen-like,40479,0.0239537200445116,0.00474735094315715,0.0146489121959236,0.0332585278930996,4.58892500773068e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,GIMAP8,GTPase IMAP family member 8,40080,0.0263735700389065,0.00523444265984915,0.0161140624256022,0.0366330776522109,4.76806425880587e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,DLL4,Delta-like protein 4,40223,0.042944259145568,0.00853255890521397,0.0262204436913486,0.0596680745997873,4.90513523536545e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,MUC16,Mucin-16,42587,0.0956483801772279,0.0190285028980411,0.0583525144970672,0.132944245857389,5.05739359129375e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",40223,0.0345790914117361,0.00687864404372635,0.0210969490860325,0.0480612337374398,5.05979148257312e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,TAFA5,Chemokine-like protein TAFA-5,42587,0.0192142765946749,0.00382319428116545,0.0117208158035906,0.0267077373857591,5.08038099361716e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,VEGFB,Vascular endothelial growth factor B,40199,0.0147749650103311,0.00294339571848676,0.00900590940209704,0.0205440206185651,5.25619532760582e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX2,Sorting nexin-2,40451,0.0408490011559158,0.00814319860003771,0.0248883318998419,0.0568096704119897,5.34703448639579e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PECR,Peroxisomal trans-2-enoyl-CoA reductase,40223,0.0140921509189771,0.0028115201484113,0.00858157142809097,0.0196027304098633,5.46214394882681e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,IL5RA,Interleukin-5 receptor subunit alpha,42594,-0.0285652864198115,0.0057261552248982,-0.0397885506606119,-0.017342022179011,6.1592339630628e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CA7,Carbonic anhydrase 7,40302,-0.0174748141552508,0.00350319979717606,-0.0243410857577159,-0.0106085425527857,6.18525096514187e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42611,0.0266940806675217,0.0053549700476225,0.0161983393741816,0.0371898219608619,6.2762065073404e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP4,Insulin-like growth factor-binding protein 4,42408,0.0237253841559211,0.00476017663819543,0.014395437945058,0.0330553303667841,6.30264310625144e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,LYAR,Cell growth-regulating nucleolar protein,42346,0.0268376830438512,0.00538664593960532,0.0162798570022248,0.0373955090854776,6.36437021471399e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CILP,Cartilage intermediate layer protein 1,40527,0.0273084859310404,0.00548154209741782,0.0165646634201014,0.0380523084419793,6.38924336655117e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTT2B,Glutathione S-transferase theta-2B,40483,0.118464871465852,0.0237971525352736,0.0718224524967159,0.165107290434988,6.51559854104821e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,40449,0.0201842660812216,0.00405839568650831,0.0122298105356653,0.0281387216267779,6.67392528203007e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42689,0.0212625068703122,0.00428461944552035,0.0128646527570924,0.0296603609835321,7.0433068682036e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ALCAM,CD166 antigen,42794,0.0096521505494964,0.00194788912074648,0.00583428787283331,0.0134700132261595,7.31308220546178e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SAA4,Serum amyloid A-4 protein,40539,0.0159540050130718,0.00322119364248982,0.00964046547379172,0.0222675445523518,7.41979500177935e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QL2,Complement C1q-like protein 2,40199,0.0217315874282949,0.00438789373586577,0.013131315705998,0.0303318591505918,7.43069045652353e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,IGSF21,Immunoglobulin superfamily member 21,40223,0.0195035071215934,0.00393965864787953,0.0117817761717495,0.0272252380714373,7.50960780002201e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CLPS,Colipase,42590,0.035761141997367,0.00722799613663816,0.0215942695695562,0.0499280144251778,7.6051250618335e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",40482,0.0235152616653791,0.00475566122294045,0.0141941656684159,0.0328363576623424,7.73631957466528e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,BGN,Biglycan,42328,-0.0587802215823442,0.0119060795711815,-0.08211613754186,-0.0354443056228284,8.03110518722887e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1B,Interleukin-1 beta,42293,0.0278439779695457,0.00564125892103707,0.0167871104843131,0.0389008454547784,8.08157865793639e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,NPHS1,Nephrin,40199,0.0165106860754741,0.00334509905688705,0.00995429192397544,0.0230670802269727,8.09995817109174e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,40223,-0.0173234749584107,0.00351285228154099,-0.0242086654302311,-0.0104382844865904,8.2808813968743e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CRH,Corticoliberin,42322,0.0419872244294023,0.00851620694634205,0.0252954588145719,0.0586789900442328,8.31184912430211e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,FOSB,Protein fosB,42311,0.0187663046273774,0.00380636408739651,0.0113058310160803,0.0262267782386746,8.3131514361579e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A13,Protein S100-A13,40199,0.0174487706178791,0.0035410372430039,0.0105083376215914,0.0243892036141667,8.44636110072626e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,CD101,Immunoglobulin superfamily member 2,40449,0.0212190843592662,0.00432635097772649,0.0127394364429223,0.0296987322756101,9.49198747427272e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PROK1,Prokineticin-1,42594,0.0268767791590407,0.00548097721674,0.0161340638142303,0.0376194945038511,9.51763546360897e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS53,Serine protease 53,40483,0.018149789483,0.00370510393084567,0.0108877857785425,0.0254117931874575,9.7865463188277e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,AGER,Advanced glycosylation end product-specific receptor,42587,0.0203656026293464,0.00415929790677926,0.012213378732059,0.0285178265266337,9.87448423649661e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,SV2A,Synaptic vesicle glycoprotein 2A,40182,0.0303958301814218,0.00620889282354523,0.0182264002472731,0.0425652601155704,9.94347289165804e-07
NMR metabolomics,X23428.Concentration of VLDL Particles,COL9A2,Collagen alpha-2(IX) chain,40302,0.0217718237005818,0.00444898861829756,0.0130518060087185,0.030491841392445,1.00369675365939e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,PEPD,Xaa-Pro dipeptidase,40532,0.0128539552589214,0.00262721399677134,0.0077046158252496,0.0180032946925933,1.00871322871705e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRF1,Killer cell lectin-like receptor subfamily F member 1,40199,0.0218775838787585,0.00447462443879308,0.0131073199787241,0.030647847778793,1.02648009234507e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,HLA_E,,42594,0.0149207143010866,0.00305540810846531,0.00893211440849459,0.0209093141936786,1.05486701862494e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ADA,Adenosine deaminase,42754,0.0167481536691657,0.00343244803596765,0.0100205555186691,0.0234757518196623,1.0763965424775e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42594,0.0185096884401026,0.00379437897909382,0.0110727056410787,0.0259466712391265,1.0829596873986e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CA12,Carbonic anhydrase 12,42587,-0.0160000895497353,0.00328194867303461,-0.0224327089488832,-0.00956747015058748,1.09956336862738e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,NECTIN1,Nectin-1,40199,0.0158733704671031,0.00325620233863865,0.00949121388337131,0.0222555270508348,1.10434109525527e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCD1,Programmed cell death protein 1,42689,0.0217122705722356,0.00446504835557816,0.0129607757953024,0.0304637653491688,1.17089780154415e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT7,N-acetylgalactosaminyltransferase 7,42587,0.0102026068157532,0.00210369069518679,0.00607937305318709,0.0143258405783193,1.24937047165194e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINI2,Serpin I2,40449,0.0268951750396303,0.00555928741848507,0.0159989716993996,0.037791378379861,1.32970350997137e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,BRD1,Bromodomain-containing protein 1,40302,-0.014717463444659,0.00304302130159995,-0.0206817851957949,-0.00875314169352312,1.33943014991313e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRG1,Adhesion G-protein coupled receptor G1,42587,-0.0388625571079699,0.00804397898405334,-0.0546287559167145,-0.0230963582992254,1.37174048349472e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT19,"Keratin, type I cytoskeletal 19",42562,-0.0337688846451787,0.00699636282740047,-0.0474817557868836,-0.0200560135034737,1.40394913761455e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42562,0.0323046281158252,0.00669363714885875,0.0191850993040621,0.0454241569275884,1.40722139404941e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,LETM1,Mitochondrial proton/calcium exchanger protein,40482,0.0253280919614643,0.00525126004218291,0.0150356222787858,0.0356205616441428,1.43089926623235e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TDO2,"Tryptophan 2,3-dioxygenase",40182,0.0185395705511212,0.00384390364642666,0.011005519404125,0.0260736216981175,1.43234279842212e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,AARSD1,Alanyl-tRNA editing protein Aarsd1,42587,0.0261803839731812,0.00543133845735103,0.0155349605967732,0.0368258073495892,1.44955844009266e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CA14,Carbonic anhydrase 14,42721,0.0171813795499939,0.00356558534276815,0.0101928322781683,0.0241699268218195,1.46087056103924e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH5,Cadherin-5,42794,-0.0143829434303697,0.0029854679833954,-0.0202344606778247,-0.00853142618291475,1.46825039795877e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,GUCA2A,Guanylin,42563,-0.0174065256932895,0.00361383636417523,-0.0244896449670729,-0.010323406419506,1.47601484699952e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CAT,Catalase,40361,0.0259305262423926,0.00538645845509488,0.0153730676704066,0.0364879848143785,1.49862564013063e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,REG1B,Lithostathine-1-beta,42794,-0.0278098254788471,0.00580601745003118,-0.0391896196809082,-0.016430031276786,1.68685184511041e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP12,Macrophage metalloelastase,42592,0.026569839099733,0.00555914511286055,0.0156739146785263,0.0374657635209397,1.77613019804049e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,DIPK2B,Divergent protein kinase domain 2B,40283,0.0132467042119726,0.00277465607659773,0.00780837830184108,0.0186850301221042,1.82749406625167e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,VWF,von Willebrand factor,42794,-0.0339725352363399,0.00712198786095676,-0.0479316314438152,-0.0200134390288646,1.86053903387293e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,COL28A1,Collagen alpha-1(XXVIII) chain,40182,0.0360460025428619,0.00755886386138022,0.0212306293745566,0.0508613757111671,1.87794907063607e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,MTUS1,Microtubule-associated tumor suppressor 1,40302,0.0267397863172534,0.00560990731013183,0.015744367989395,0.0377352046451117,1.89804492609562e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CAPG,Macrophage-capping protein,42461,0.0274771735742042,0.00580034213562773,0.0161085029883738,0.0388458441600345,2.18975505794685e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CD55,Complement decay-accelerating factor,42201,0.0127943773175038,0.0027014487768796,0.00749953771481975,0.0180892169201878,2.20152929830188e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,GRN,Progranulin,42552,0.0114917855306064,0.00243275604772878,0.00672358367705794,0.0162599873841548,2.33866577791513e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42618,0.0136889527789725,0.00290446466242436,0.00799620204062075,0.0193817035173242,2.46459606866419e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNDC15,Thioredoxin domain-containing protein 15,42679,0.0128591767780841,0.00272851765919881,0.00751128216605442,0.0182070713901138,2.46681005306991e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,XG,Glycoprotein Xg,42734,0.016085114350257,0.00341760927412315,0.00938660017297565,0.0227836285275384,2.54451759950458e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,COMP,Cartilage oligomeric matrix protein,42511,0.0156731864628609,0.00333739742428204,0.00913188751126807,0.0222144854144537,2.67652846682639e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,DSG4,Desmoglein-4,42543,0.0232560229976466,0.00496516054764494,0.0135243083242626,0.0329877376710307,2.8432422915152e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CLASP1,CLIP-associating protein 1,40080,0.0336750895362113,0.00722815073259359,0.0195079141003279,0.0478422649720948,3.21702644034715e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",40483,0.0193349847242678,0.00415236725485551,0.011196344904751,0.0274736245437846,3.25493846931646e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,SLAMF7,SLAM family member 7,42594,-0.0274508325220055,0.00590093056958096,-0.0390166564383842,-0.0158850086056269,3.3195681939674e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,AOC3,Membrane primary amine oxidase,42689,-0.013928523274817,0.00299473479562249,-0.0197982034742371,-0.00805884307539692,3.33458342085165e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,GBA,Lysosomal acid glucosylceramidase,40182,0.0255659918736079,0.0055088998131992,0.0147685482397375,0.0363634355074783,3.50988806332006e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,HYAL1,Hyaluronidase-1,42544,-0.0106583638195475,0.00229880240575686,-0.015164016534831,-0.00615271110426411,3.57742831496376e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CREBZF,CREB/ATF bZIP transcription factor,40080,-0.0120463139035546,0.00260235106101576,-0.0171469219831455,-0.0069457058239637,3.71663380269934e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIG4,V-set and immunoglobulin domain-containing protein 4,42591,-0.0200814888252113,0.00434127518470185,-0.0285903881872269,-0.0115725894631957,3.76808889489049e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",42292,0.0215372116371561,0.00465741311992918,0.0124086819220949,0.0306657413522173,3.79486094024444e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,PCSK7,Proprotein convertase subtilisin/kexin type 7,40451,0.0209786461825841,0.00453768040578972,0.0120847925872362,0.0298724997779319,3.82052455895387e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKD2,Serine/threonine-protein kinase D2,40116,0.0209858688290581,0.00454528797541761,0.0120771043972396,0.0298946332608766,3.93655491361462e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42594,0.0194118034702644,0.00421439432715051,0.0111515905890494,0.0276720163514794,4.14125142395888e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB1BP1,Integrin beta-1-binding protein 1,42346,0.0187917770142788,0.00408032701245629,0.0107943360698645,0.0267892179586931,4.15417486337616e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC14A,C-type lectin domain family 14 member A,42611,-0.0152329973801011,0.00330872502507852,-0.021718098429255,-0.00874789633094724,4.18483505429544e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42619,0.026624872763011,0.00579122133840262,0.0152740789397419,0.0379756665862801,4.31588099384602e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP6,Insulin-like growth factor-binding protein 6,42595,0.0146685017897864,0.00320832372051774,0.00838018729757165,0.0209568162820012,4.87380783049219e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,NAAA,N-acylethanolamine-hydrolyzing acid amidase,42439,0.0271613400601011,0.00594139419697686,0.0155162074340264,0.0388064726861757,4.88527438961201e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,HSD17B3,Testosterone 17-beta-dehydrogenase 3,40116,0.0223232655393639,0.00488918048981918,0.0127404717793183,0.0319060592994095,5.0291212309572e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ODAM,Odontogenic ameloblast-associated protein,42292,0.025476615080059,0.00558550060091052,0.0145290339022744,0.0364241962578436,5.1322298512296e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,GFRA2,GDNF family receptor alpha-2,42587,0.00962198585022522,0.00211174653106972,0.00548296264932856,0.0137610090511219,5.24948255927588e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTSL2,ADAMTS-like protein 2,40527,0.0154137616320622,0.00338921401119954,0.00877090217011107,0.0220566210940133,5.474945491241e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,EFHD1,EF-hand domain-containing protein D1,40482,0.0162959014740797,0.00358512887426433,0.00926904888052165,0.0233227540676378,5.53968146289743e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,IL31RA,Interleukin-31 receptor subunit alpha,40145,0.0173374421750549,0.00381574262650024,0.00985858662711447,0.0248162977229954,5.58770102610694e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRE1,Adhesion G protein-coupled receptor E1,40449,0.0252698557641736,0.00557893239047732,0.0143351482788381,0.0362045632495092,5.97274306027924e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM171B,Protein FAM171B,40451,0.0118367295993906,0.00262452139654003,0.00669266766217219,0.0169807915366091,6.54671201390816e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CD93,Complement component C1q receptor,42141,-0.0144195190862131,0.00319994421110625,-0.0206914097399813,-0.00814762843244482,6.65839352623393e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ADM,Pro-adrenomedullin,42721,0.0119296783215963,0.0026578433710745,0.00672030531429026,0.0171390513289023,7.23253909456545e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,TF,Serotransferrin,40539,0.00947950736719875,0.00211872164699102,0.00532681293909635,0.0136322017953011,7.74576023711543e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,BMP10,Bone morphogenetic protein 10,40283,0.0127815876693146,0.00286010272396569,0.00717578633034184,0.0183873890082873,7.93926466384752e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,IL12RB1,Interleukin-12 receptor subunit beta-1,42370,0.017228031984925,0.00385784078155117,0.00966666405308471,0.0247893999167653,8.04639706783239e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRK1,NKG2-D type II integral membrane protein,40483,0.0216345809916926,0.00484797381207583,0.0121325523200239,0.0311366096633612,8.17542769430825e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,ASS1,Argininosuccinate synthase,40116,0.0344447948099545,0.00772585272607772,0.0193021234668421,0.0495874661530668,8.34047856791139e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA7,Thyroxine-binding globulin,40539,0.00814781437580963,0.00183691680504951,0.00454745743791259,0.0117481713137067,9.26838667293145e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CRTAC1,Cartilage acidic protein 1,42794,0.0131184114186896,0.00296185761993729,0.00731317048361254,0.0189236523537667,9.53585964356706e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4M,C-type lectin domain family 4 member M,40504,0.0217506424217547,0.00491324037060107,0.0121206912953766,0.0313805935481328,9.64732214464052e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL8,Interleukin-8,42494,0.0305417511784401,0.00690369111812171,0.0170105165869216,0.0440729857699587,9.76716343394666e-06
NMR metabolomics,X23428.Concentration of VLDL Particles,NPC2,NPC intracellular cholesterol transporter 2,40367,0.0149926761513544,0.00339746779547016,0.00833363927223293,0.021651713030476,1.02952548975123e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,40182,0.0471302997138839,0.0106806884473963,0.0261961503569871,0.0680644490707807,1.03079062237483e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",40223,0.0334506067591784,0.00759205877488163,0.0185701715604104,0.0483310419579464,1.06291245721366e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SORBS1,Sorbin and SH3 domain-containing protein 1,40482,0.0179162824948037,0.00408214825748756,0.0099152719101281,0.0259172930794793,1.14942241019282e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNG,Interferon gamma,42370,0.0491884970110146,0.0112085884534932,0.0272196636421679,0.0711573303798612,1.15041386923252e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,NFYA,Nuclear transcription factor Y subunit alpha,40116,0.0170733598538894,0.00389045194335435,0.0094480740449149,0.024698645662864,1.15191547642691e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGB3A1,Secretoglobin family 3A member 1,40283,-0.0116590598740466,0.00265814603184138,-0.0168690260964557,-0.00644909365163752,1.16432654967758e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ACVRL1,Serine/threonine-protein kinase receptor R3,42475,0.0116063050652251,0.00264882352385267,0.00641461095847385,0.0167979991719763,1.18669358543246e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PRL,Prolactin,42711,-0.0325071263267007,0.00741983655980538,-0.0470500059839192,-0.0179642466694821,1.18965162250341e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6V1D,V-type proton ATPase subunit D,42587,0.0113558002350525,0.00259255429232672,0.00627439382209215,0.0164372066480129,1.19493509984948e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SCG2,Secretogranin-2,42636,0.0147998166011902,0.00339036262143262,0.00815470586318232,0.0214449273391982,1.27919730147825e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,APLP1,Amyloid-like protein 1,42636,-0.0223125560493189,0.00511305978054406,-0.0323341532191852,-0.0122909588794525,1.28754690284738e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,NPR1,Atrial natriuretic peptide receptor 1,40116,-0.0178204757188935,0.00408842698289408,-0.0258337926053659,-0.00980715883242109,1.31997367513871e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ARID4B,AT-rich interactive domain-containing protein 4B,42311,0.0181079894231518,0.0041572092203484,0.00995985935126893,0.0262561194950347,1.33585830565154e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK8,Kallikrein-8,42154,0.0161288761050206,0.00370719213408697,0.00886277952221013,0.0233949726878311,1.36742560117211e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF5,Fibroblast growth factor 5,42370,-0.0142458504503303,0.00328099659444253,-0.0206766037754376,-0.00781509712522294,1.42292480459152e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PNLIP,Pancreatic triacylglycerol lipase,40532,0.0281357565748885,0.00648177827936765,0.0154314711473279,0.0408400420024491,1.43230840891105e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,BAX,Apoptosis regulator BAX,42292,0.0381911527175313,0.00880206070387586,0.0209391137379346,0.055443191697128,1.44278441242541e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,GSAP,Gamma-secretase-activating protein,42346,0.0367922606187311,0.00849443235594272,0.0201431732010834,0.0534413480363788,1.4930403145305e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CBLIF,Cobalamin binding intrinsic factor,42613,0.034681946182435,0.0080256459930811,0.018951680035996,0.0504122123288739,1.56165585808312e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,BRK1,Protein BRICK1,42311,0.0192642668534805,0.00445945843364685,0.0105237283235327,0.0280048053834283,1.57271700372557e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,COLEC12,Collectin-12,42618,0.0119675576460987,0.00277082515438672,0.00653674034350069,0.0173983749486966,1.57769612290757e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PDIA5,Protein disulfide-isomerase A5,40080,0.026329442238203,0.0060984403628913,0.0143764991269361,0.03828238534947,1.59270654105681e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDHB15,Protocadherin beta-15,40451,-0.0172298200598669,0.00400318714629259,-0.0250760668666003,-0.00938357325313338,1.69140347247099e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,NEO1,Neogenin,40482,0.0094813457665208,0.00220756439001412,0.00515451956209313,0.0138081719709485,1.76205988118355e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ALPP,"Alkaline phosphatase, placental type",42587,0.0427797951109108,0.00999054941695132,0.0231983182536862,0.0623612719681354,1.86489066386983e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PLAU,Urokinase-type plasminogen activator,42611,0.0124936750659031,0.00292321358863611,0.00676417643217632,0.0182231736996299,1.93363851683086e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CD80,T-lymphocyte activation antigen CD80,40511,0.0147993304510199,0.00346542595677258,0.00800709557574567,0.0215915653262942,1.96569030163017e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CR2,Complement receptor type 2,42689,0.0201494420935803,0.00474984919869228,0.0108397376641434,0.0294591465230172,2.22892564659771e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH3,Cadherin-3,42711,0.0157674679479775,0.00371742219534558,0.0084813204451002,0.0230536154508549,2.2350271827577e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA3,Alpha-1-antichymotrypsin,40502,0.00640643336173757,0.00151202931251117,0.00344285590921568,0.00937001081425947,2.28345139387382e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,GZMH,Granzyme H,42357,0.0325828984088828,0.00769727434624544,0.0174962406902418,0.0476695561275239,2.32113461956842e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,IL22RA1,Interleukin-22 receptor subunit alpha-1,42370,0.0181295727424055,0.0042834042269054,0.0097341004576709,0.0265250450271401,2.32657596884777e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CALCB,Calcitonin gene-related peptide 2,40483,0.0172282987225616,0.00407369455186037,0.00924385740091524,0.0252127400442079,2.36416732941142e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CA2,Carbonic anhydrase 2,42573,0.0290298967156001,0.00688132740719672,0.0155424949974945,0.0425172984337056,2.4739067092946e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,RALY,RNA-binding protein Raly,40451,0.0198442941752791,0.00470371742357935,0.0106250080250635,0.0290635803254946,2.47471344271387e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,AKR1C4,Aldo-keto reductase family 1 member C4,42357,0.0225836872438356,0.00535452555766097,0.0120888171508201,0.0330785573368511,2.48477414180562e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA1,Alpha-1-antitrypsin,40327,-0.00343225611070498,0.000814519564598335,-0.00502871445731771,-0.00183579776409224,2.53043467171107e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,MB,Myoglobin,42794,-0.0221193895119789,0.00526336122157606,-0.032435577506268,-0.0118032015176899,2.6564348532298e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,DCC,Netrin receptor DCC,40182,0.0096386561384618,0.00230408470116049,0.00512265012418723,0.0141546621527364,2.89552246459743e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,MILR1,Allergin-1,42370,-0.0213461674527494,0.00511289225961148,-0.0313674362815879,-0.0113248986239109,2.99942218935957e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SNU13,NHP2-like protein 1,40116,0.0262834287630781,0.0063087531688622,0.0139182725521082,0.038648584974048,3.12124175648296e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,IL4R,Interleukin-4 receptor subunit alpha,42594,-0.0156137675288374,0.00376298896796803,-0.0229892259060547,-0.00823830915162002,3.35553434065523e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PI3,Elafin,42446,0.0233743293161581,0.00563451679929743,0.0123306763895352,0.0344179822427811,3.36869432916181e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN5,Contactin-5,42640,0.0156575215650758,0.00377943307954031,0.00824983272917675,0.0230652104009748,3.45155166693869e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFA,Protransforming growth factor alpha,42594,0.0194467739329514,0.00470071494120692,0.0102333726481859,0.028660175217717,3.54051542197919e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17C,Interleukin-17C,42370,-0.0306443105781762,0.00741690868594528,-0.045181451602629,-0.0161071695537235,3.62342699311805e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ERBB4,Receptor tyrosine-protein kinase erbB-4,42679,-0.00980278494599988,0.00237803040113147,-0.0144637245322176,-0.0051418453597822,3.77469811993109e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LMNB1,Lamin-B1,40434,0.0244443663302487,0.00593612624683481,0.0128095588864525,0.036079173774045,3.85077780686875e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,GZMB,Granzyme B,42594,0.0270914599167247,0.0065841974067874,0.0141864329994214,0.039996486834028,3.90139446480115e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,RPA2,Replication protein A 32 kDa subunit,40199,0.0129782557820856,0.00315494791310658,0.00679455787239666,0.0191619536917745,3.92337647665018e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL14,C-C motif chemokine 14,42618,0.0163860665590417,0.00399435523969441,0.00855713028924064,0.0242150028288427,4.11467118739054e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,40116,0.0213957795707029,0.00522175074953417,0.0111611481016159,0.0316304110397899,4.2077286415256e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,VAMP5,Vesicle-associated membrane protein 5,42357,0.0225343212726822,0.00550208118928459,0.0117502421416844,0.03331840040368,4.23595763316784e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL7B,B-cell CLL/lymphoma 7 protein family member B,40451,0.0180545303100231,0.00441041794509236,0.00941011113764208,0.0266989494824041,4.27674695811613e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP6V1G2,V-type proton ATPase subunit G 2,40116,0.0409164685656416,0.0100004165536732,0.0213156521204422,0.060517285010841,4.31714847696159e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42587,0.0160043864950477,0.00392404312424151,0.00831326197153438,0.0236955110185611,4.5580629366541e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,ZBTB17,Zinc finger and BTB domain-containing protein 17,42357,0.0169887310174856,0.00418042184628254,0.00879510419877177,0.0251823578361993,4.85439967445093e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CRISP2,Cysteine-rich secretory protein 2,42721,0.0239202796793525,0.00588922732150288,0.0123773941292069,0.0354631652294982,4.89911838953206e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,OMG,Oligodendrocyte-myelin glycoprotein,42587,0.0266263684221393,0.00656340888814901,0.0137620870013672,0.0394906498429114,5.00339374494009e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CD27,CD27 antigen,42679,-0.0177965998928059,0.00438817360195048,-0.0263974201526288,-0.00919577963298295,5.02907883803781e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42754,0.0160942905921245,0.00396869507002388,0.00831564825487765,0.0238729329293713,5.03477185481414e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,BST2,Bone marrow stromal antigen 2,42711,0.0205273818829352,0.00506823046376669,0.0105936501739525,0.0304611135919179,5.14580503694065e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LYZL2,Lysozyme-like protein 2,40080,0.0144510218347613,0.00358035932017082,0.00743351756722647,0.0214685261022961,5.4697323525033e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHB6,Ephrin type-B receptor 6,42476,0.0134663930196405,0.00333749923228183,0.00692489452436809,0.0200078915149128,5.49372735591314e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF8,Tumor necrosis factor ligand superfamily member 8,40527,0.0148228902995724,0.00367480688475322,0.00762026880545614,0.0220255117936887,5.52769014694872e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,MAEA,E3 ubiquitin-protein transferase MAEA,42346,0.0158280560177181,0.0039246703573902,0.00813570211723329,0.0235204099182029,5.53885657867497e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TPPP3,Tubulin polymerization-promoting protein family member 3,42311,0.0158294609190293,0.00392886229739694,0.00812889081613133,0.0235300310219273,5.63259718804558e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN4B,Sodium channel subunit beta-4,40223,0.0176379309260215,0.00437942768079066,0.00905425267167185,0.0262216091803712,5.67625698743446e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,RCC1,Regulator of chromosome condensation,40451,0.0209120318439017,0.00521473090692439,0.0106911592663299,0.0311329044214735,6.10631900531484e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TFF3,Trefoil factor 3,42613,-0.0171115084318225,0.00427053484715092,-0.0254817567322383,-0.00874126013140665,6.18590016270993e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,40171,0.0156281564352627,0.00390182024405338,0.00798058875691806,0.0232757241136073,6.2333933029122e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,NAMPT,Nicotinamide phosphoribosyltransferase,42346,0.0207570052307728,0.00518787058719831,0.0105887788798641,0.0309252315816815,6.34035813188957e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",42311,0.0119496421187285,0.00298719887828275,0.00609473231729433,0.0178045519201627,6.36139168846874e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,KIF1C,Kinesin-like protein KIF1C,40116,0.014301690243787,0.0035771472397125,0.00729048165395051,0.0213128988336235,6.42809085629602e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TCN2,Transcobalamin-2,42771,-0.0122123513394929,0.00305785416486661,-0.0182057455026315,-0.0062189571763544,6.53749810373595e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SFTPD,Pulmonary surfactant-associated protein D,42636,0.0268939075788952,0.00673421041494868,0.0136948551655958,0.0400929599921946,6.54171955207189e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LGALS3,Galectin-3,42669,0.0118098479709433,0.00296193499482008,0.00600445538109593,0.0176152405607906,6.72084607204992e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,CRTAP,Cartilage-associated protein,40182,0.0189774805557447,0.00476275063170406,0.00964248931760474,0.0283124717938847,6.80409306893836e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,BCAM,Basal cell adhesion molecule,42611,-0.00970224461066921,0.00244500167922675,-0.0144944479019536,-0.00491004131938477,7.2795810993682e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17RB,Interleukin-17 receptor B,42416,-0.0210064836269841,0.00529449983174863,-0.0313837032972114,-0.0106292639567568,7.29817430545884e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,TIE1,Tyrosine-protein kinase receptor Tie-1,42794,0.0161810029759153,0.00407993171494634,0.00818433681462043,0.0241776691372101,7.34637932736132e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,YAP1,Transcriptional coactivator YAP1,40483,0.0113244421023295,0.00285597092117681,0.00572673909682295,0.0169221451078361,7.37927088231399e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM3C,Protein FAM3C,42613,0.0122083381725915,0.00308371174062087,0.00616426316097464,0.0182524131842084,7.56603080661366e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,NRP2,Neuropilin-2,42611,-0.0112705390131893,0.00284755753048369,-0.0168517517729373,-0.00568932625344127,7.59799339271256e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNGR1,Interferon gamma receptor 1,42676,0.00855743278642924,0.0021702030627974,0.00430383478334634,0.0128110307895121,8.08254804184436e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,PFDN2,Prefoldin subunit 2,42311,0.0216313432075002,0.0054966511948655,0.0108579068655638,0.0324047795494366,8.34979626623138e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SIL1,Nucleotide exchange factor SIL1,40223,0.0121183796714856,0.00308164321538958,0.006078358969322,0.0181584003736492,8.46022973401235e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,LIF,Leukemia inhibitory factor,42311,0.0200578701531275,0.00510585175535276,0.0100504007126361,0.0300653395936189,8.59481302262101e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,INHBB,Inhibin beta B chain,40283,0.0212046649539805,0.00542713800098858,0.0105674744720429,0.0318418554359182,9.39442987808823e-05
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK6,Serine protease inhibitor Kazal-type 6,42721,0.0205868991361562,0.00529608040623469,0.0102065815399362,0.0309672167323762,0.000101893291295095
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK1,Serine protease inhibitor Kazal-type 1,42611,-0.0175961318401096,0.00452821205555338,-0.0264714274689942,-0.00872083621122494,0.000102445998884898
NMR metabolomics,X23428.Concentration of VLDL Particles,CKAP4,Cytoskeleton-associated protein 4,42713,0.0111439019464783,0.00286990153443517,0.00551889493898537,0.0167689089539712,0.000103655409025104
NMR metabolomics,X23428.Concentration of VLDL Particles,SORCS2,VPS10 domain-containing receptor SorCS2,42346,0.0144300274059007,0.00372107607497739,0.00713671829894498,0.0217233365128564,0.000105866968054291
NMR metabolomics,X23428.Concentration of VLDL Particles,SEL1L,Protein sel-1 homolog 1,40223,0.0125659895244926,0.00324725120821466,0.00620137715639184,0.0189306018925933,0.000109582844138685
NMR metabolomics,X23428.Concentration of VLDL Particles,ROBO4,Roundabout homolog 4,40223,-0.00700909134176893,0.00181228728079768,-0.0105611744121324,-0.00345700827140548,0.000110571118430336
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFRA,Platelet-derived growth factor receptor alpha,42636,-0.0110574936375226,0.00286825610253882,-0.0166792755984987,-0.00543571167654654,0.000116207821319187
NMR metabolomics,X23428.Concentration of VLDL Particles,QSOX1,Sulfhydryl oxidase 1,40342,0.0165905078625521,0.00431426918420318,0.00813454026151387,0.0250464754635903,0.000120977835094209
NMR metabolomics,X23428.Concentration of VLDL Particles,GPNMB,Transmembrane glycoprotein NMB,42315,0.0111025960074137,0.00289064415458432,0.0054369334644284,0.0167682585503989,0.000123174443650149
NMR metabolomics,X23428.Concentration of VLDL Particles,GM2A,Ganglioside GM2 activator,40269,0.0156027090936047,0.00406382141093167,0.00763761912817865,0.0235677990590308,0.00012401285898161
NMR metabolomics,X23428.Concentration of VLDL Particles,CNPY2,Protein canopy homolog 2,42357,0.0234869410483825,0.00612143282030088,0.0114889327205928,0.0354849493761722,0.000125211131798281
NMR metabolomics,X23428.Concentration of VLDL Particles,GBP4,Guanylate-binding protein 4,42311,0.0187505497043187,0.00490164822467452,0.00914331918395666,0.0283577802246808,0.000131188375863246
NMR metabolomics,X23428.Concentration of VLDL Particles,GPC1,Glypican-1,42721,0.011319848493376,0.00296403249581152,0.00551034480158538,0.0171293521851665,0.000134553799243142
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB39B,Ras-related protein Rab-39B,40116,0.035120322039894,0.00919677594876447,0.0170946411803156,0.0531460028994723,0.000134863556888803
NMR metabolomics,X23428.Concentration of VLDL Particles,CD300E,CMRF35-like molecule 2,42677,0.0162998293411171,0.00428558909765387,0.00790007470971547,0.0246995839725187,0.000143350567964762
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPB6,Heat shock protein beta-6,42721,0.0148081367541175,0.00390955763999933,0.00714540377971883,0.0224708697285162,0.000152721368011019
NMR metabolomics,X23428.Concentration of VLDL Particles,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42570,0.068754466577267,0.0181689005937994,0.0331434214134201,0.104365511741114,0.000154886358352483
NMR metabolomics,X23428.Concentration of VLDL Particles,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42679,0.0105541037538166,0.00279140272164618,0.00508295441939013,0.0160252530882431,0.000156916299456842
NMR metabolomics,X23428.Concentration of VLDL Particles,CENPJ,Centromere protein J,40302,0.0266008328751419,0.00705110919781,0.0127806588474343,0.0404210069028495,0.000162411148552524
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42721,0.0127386248067604,0.00339358066378293,0.00608720670574581,0.0193900429077749,0.000174943487757346
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMP2,Metalloproteinase inhibitor 2,40511,-0.0103800453628099,0.0027700470680798,-0.0158093376162463,-0.00495075310937351,0.00017967602704298
NMR metabolomics,X23428.Concentration of VLDL Particles,STC2,Stanniocalcin-2,42591,0.00923497742696115,0.00246703870308,0.00439958156892434,0.014070373284998,0.000182345778537084
NMR metabolomics,X23428.Concentration of VLDL Particles,GBP2,Guanylate-binding protein 2,42370,0.0225264764597926,0.00602804150983906,0.010711515100508,0.0343414378190771,0.000187054417367258
NMR metabolomics,X23428.Concentration of VLDL Particles,COL6A3,Collagen alpha-3(VI) chain,42794,0.0140233546441499,0.00376287819880544,0.0066481133744912,0.0213985959138085,0.000194740425602421
NMR metabolomics,X23428.Concentration of VLDL Particles,PNMA2,Paraneoplastic antigen Ma2,40136,0.0164839820418963,0.00442329079337282,0.00781433208688557,0.025153631996907,0.000195031756376019
NMR metabolomics,X23428.Concentration of VLDL Particles,RHOC,Rho-related GTP-binding protein RhoC,42443,0.0423983862579301,0.0113930161529664,0.0200680745981159,0.0647286979177442,0.000198911928862548
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1RL1,Interleukin-1 receptor-like 1,42760,-0.016879129738707,0.00453872114913017,-0.0257750231910021,-0.00798323628641185,0.000200884388977503
NMR metabolomics,X23428.Concentration of VLDL Particles,CA6,Carbonic anhydrase 6,42581,-0.0230370935160401,0.00620132316194361,-0.0351916869134496,-0.0108825001186306,0.000204136884303414
NMR metabolomics,X23428.Concentration of VLDL Particles,POSTN,Periostin,40527,-0.0141913785587562,0.00382964932573283,-0.0216974912371926,-0.00668526588031988,0.000211844395118503
NMR metabolomics,X23428.Concentration of VLDL Particles,PRUNE2,Protein prune homolog 2,40302,0.0110768237220542,0.00299154243022135,0.00521340055882036,0.0169402468852881,0.000214338652622101
NMR metabolomics,X23428.Concentration of VLDL Particles,CLGN,Calmegin,40182,0.0170939752577705,0.00461728324127861,0.00804410010486439,0.0261438504106766,0.000214807540328939
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42721,0.0127312483277057,0.0034539668828904,0.0059614732372405,0.0195010234181709,0.000228715615463394
NMR metabolomics,X23428.Concentration of VLDL Particles,LXN,Latexin,42461,-0.0247147847008178,0.00672273139956467,-0.0378913382439646,-0.0115382311576711,0.000237573739494494
NMR metabolomics,X23428.Concentration of VLDL Particles,HEPH,Hephaestin,40511,0.0096670188600979,0.00263150435700517,0.00450927032036777,0.014824767399828,0.000240287205669619
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,40527,-0.0144428523764308,0.00393653593520082,-0.0221584628094244,-0.00672724194343715,0.000244689813599277
NMR metabolomics,X23428.Concentration of VLDL Particles,TMPRSS11D,Transmembrane protease serine 11D,40470,0.0148951261191074,0.00407035984097152,0.00691722083080317,0.0228730314074115,0.000253947507924839
NMR metabolomics,X23428.Concentration of VLDL Particles,EXTL1,Exostosin-like 1,40116,0.0172172541485707,0.00471602994948287,0.00797383544758433,0.0264606728495572,0.000262651546378258
NMR metabolomics,X23428.Concentration of VLDL Particles,TMEM25,Transmembrane protein 25,40482,-0.0165161293566118,0.00453244901881666,-0.0253997294334924,-0.00763252927973112,0.000269664246845989
NMR metabolomics,X23428.Concentration of VLDL Particles,MNAT1,CDK-activating kinase assembly factor MAT1,40302,0.0159615731782926,0.00438047725581646,0.00737583775689233,0.0245473085996929,0.000269869090464672
NMR metabolomics,X23428.Concentration of VLDL Particles,HSBP1,Heat shock factor-binding protein 1,40223,0.0342706494402766,0.00940528617798831,0.0158362885314195,0.0527050103491336,0.000269912546139269
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL46,"39S ribosomal protein L46, mitochondrial",42311,0.0101442568183033,0.00278665202360387,0.00468241885203972,0.0156060947845669,0.00027336488847203
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGBL1,Integrin beta-like protein 1,40527,0.0140262205528666,0.00386581067013744,0.00644923163939726,0.021603209466336,0.000286576747836725
NMR metabolomics,X23428.Concentration of VLDL Particles,NEDD9,Enhancer of filamentation 1,40199,0.0120228880933926,0.00331585386639381,0.00552381451526075,0.0185219616715245,0.000289279808045729
NMR metabolomics,X23428.Concentration of VLDL Particles,MST1,Hepatocyte growth factor-like protein,40370,0.0235768601454907,0.00650425357648012,0.0108285231355897,0.0363251971553918,0.000290428122887472
NMR metabolomics,X23428.Concentration of VLDL Particles,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,40451,0.023682224622767,0.00655036480016901,0.0108435096144357,0.0365209396310982,0.000301187690007092
NMR metabolomics,X23428.Concentration of VLDL Particles,MELTF,Melanotransferrin,40511,0.0108469828448652,0.00300234147383158,0.00496239355615529,0.0167315721335751,0.000304172535248198
NMR metabolomics,X23428.Concentration of VLDL Particles,CA1,Carbonic anhydrase 1,42362,0.0215240611787781,0.00596454488010215,0.00983355321377791,0.0332145691437783,0.000308914328435477
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42681,0.0107369875885083,0.0029789678115531,0.00489821067786422,0.0165757644991524,0.000314166081132979
NMR metabolomics,X23428.Concentration of VLDL Particles,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",42370,0.0211360235280308,0.00590479263822858,0.00956262995710283,0.0327094170989588,0.00034553009269431
NMR metabolomics,X23428.Concentration of VLDL Particles,NPTXR,Neuronal pentraxin receptor,42636,0.0120616377497257,0.00337050179069908,0.00545545423995553,0.0186678212594959,0.000346671125869483
NMR metabolomics,X23428.Concentration of VLDL Particles,POF1B,Protein POF1B,40199,-0.0166174690249162,0.00464686900257183,-0.0257253322699569,-0.00750960577987537,0.000350311298710864
NMR metabolomics,X23428.Concentration of VLDL Particles,FUCA1,Tissue alpha-L-fucosidase,42721,0.0298322454758024,0.00834300775408162,0.0134799502778024,0.0461845406738023,0.000350485376697496
NMR metabolomics,X23428.Concentration of VLDL Particles,EBI3_IL27,Interleukin-27,42689,-0.010931101565621,0.003059310920349,-0.0169273509695051,-0.004934852161737,0.000354063547676684
NMR metabolomics,X23428.Concentration of VLDL Particles,NGF,Beta-nerve growth factor,42495,0.00424878109736643,0.00119210773427488,0.00191224993818766,0.00658531225654519,0.000366397539296509
NMR metabolomics,X23428.Concentration of VLDL Particles,AGXT,Serine--pyruvate aminotransferase,42636,0.0265801871189161,0.00746058555104233,0.0119574394388731,0.041202934798959,0.00036826306369311
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,42370,0.0152243849174147,0.00427509963265148,0.00684518963741775,0.0236035801974116,0.000370498199765595
NMR metabolomics,X23428.Concentration of VLDL Particles,TSC1,Hamartin,40199,0.0259886089110012,0.00731220197431312,0.0116566930413474,0.0403205247806549,0.000380802670086464
NMR metabolomics,X23428.Concentration of VLDL Particles,PMS1,PMS1 protein homolog 1,40182,0.0183354619806966,0.00516939820565558,0.00820344149761169,0.0284674824637816,0.000391380699821276
NMR metabolomics,X23428.Concentration of VLDL Particles,CTRL,Chymotrypsin-like protease CTRL-1,40483,-0.0248983862726866,0.00702366954780134,-0.0386647785863773,-0.011131993958996,0.000394312713931814
NMR metabolomics,X23428.Concentration of VLDL Particles,B4GALT1,"Beta-1,4-galactosyltransferase 1",42676,0.00990418794839386,0.00280006308603716,0.00441606429976103,0.0153923115970267,0.000405858851905366
NMR metabolomics,X23428.Concentration of VLDL Particles,AZU1,Azurocidin,42216,0.0266907734827175,0.00756908728616324,0.0118553624018376,0.0415261845635975,0.000422879124637264
NMR metabolomics,X23428.Concentration of VLDL Particles,UBAC1,Ubiquitin-associated domain-containing protein 1,42587,0.0120021199059362,0.0034038553910424,0.00533056333949311,0.0186736764723793,0.000423237863880962
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPA2,Heat shock-related 70 kDa protein 2,40451,0.0120188645130924,0.00340990894570755,0.00533544297950557,0.0187022860466792,0.000425665897301938
NMR metabolomics,X23428.Concentration of VLDL Particles,MZB1,Marginal zone B- and B1-cell-specific protein,42660,-0.0184626352118269,0.0052389928430374,-0.0287310611841802,-0.00819420923947355,0.000426363877114568
NMR metabolomics,X23428.Concentration of VLDL Particles,HMOX1,Heme oxygenase 1,42500,-0.0168881270551654,0.00479371243305161,-0.0262838034239466,-0.00749245068638427,0.00042816311917988
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF3,Granulocyte colony-stimulating factor,42370,0.0170772786324323,0.00484984168896246,0.00757158892206591,0.0265829683427988,0.00043104501890274
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP5,Rho GTPase-activating protein 5,40080,0.0278973759265895,0.00794173716402931,0.0123315710850921,0.043463180768087,0.000445284805178196
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM3B,Protein FAM3B,42587,0.0122426302639843,0.00349635983958163,0.00538976497840427,0.0190954955495643,0.000464090487675151
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC51B,Organic solute transporter subunit beta,40116,-0.0268187711170555,0.00767753393563367,-0.0418667376308975,-0.0117708046032135,0.000479249249483184
NMR metabolomics,X23428.Concentration of VLDL Particles,TLR4,Toll-like receptor 4,40199,0.0101848537596653,0.00291935398893592,0.00446291994135092,0.0159067875779797,0.000487208622294122
NMR metabolomics,X23428.Concentration of VLDL Particles,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42495,0.0105133328017276,0.00301570948743649,0.00460254220635212,0.0164241233971032,0.00049153524544502
NMR metabolomics,X23428.Concentration of VLDL Particles,PTGDS,Prostaglandin-H2 D-isomerase,42555,0.0112599398489518,0.00323793030795476,0.00491359644536052,0.0176062832525432,0.00050770129205537
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCD6,Programmed cell death protein 6,42636,-0.0242773310437945,0.00698694878907594,-0.0379717506703834,-0.0105829114172057,0.000513097314598462
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42676,0.0095122253883626,0.0027391861533911,0.00414342052771605,0.0148810302490091,0.000516969740090928
NMR metabolomics,X23428.Concentration of VLDL Particles,PDRG1,p53 and DNA damage-regulated protein 1,40182,0.0176817572911476,0.00509471478827525,0.00769611630612806,0.027667398276167,0.000521275936674348
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,42370,0.0127534316470373,0.0036823500470968,0.00553602555472755,0.019970837739347,0.000535100081656369
NMR metabolomics,X23428.Concentration of VLDL Particles,FMR1,Synaptic functional regulator FMR1,42346,0.0121641886230058,0.00351649461214468,0.00527185918320219,0.0190565180628093,0.000543539063383153
NMR metabolomics,X23428.Concentration of VLDL Particles,CD109,CD109 antigen,42611,-0.0115267437120234,0.00333763517728915,-0.0180685086595102,-0.00498497876453668,0.000554934645053409
NMR metabolomics,X23428.Concentration of VLDL Particles,STX3,Syntaxin-3,40483,0.0132890227860421,0.00385524597900848,0.00573274066718544,0.0208453049048987,0.000568919646366132
NMR metabolomics,X23428.Concentration of VLDL Particles,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",40268,-0.0217779112207129,0.00632865472380658,-0.0341820744793738,-0.009373747962052,0.000581364806573109
NMR metabolomics,X23428.Concentration of VLDL Particles,C1GALT1C1,C1GALT1-specific chaperone 1,40116,0.0111649133332188,0.00324559027631602,0.0048035563916394,0.0175262702747982,0.000583833716849838
NMR metabolomics,X23428.Concentration of VLDL Particles,GLYR1,Putative oxidoreductase GLYR1,40451,0.0200883474463164,0.00584483670518137,0.00863246750416094,0.0315442273884719,0.00059045463380393
NMR metabolomics,X23428.Concentration of VLDL Particles,MFAP4,Microfibril-associated glycoprotein 4,40283,-0.0111266747947795,0.00323850466259899,-0.0174741439334735,-0.00477920565608545,0.000593093456338449
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42611,-0.0130515534677901,0.00380033518353096,-0.0205002104275108,-0.00560289650806944,0.00059584651565374
NMR metabolomics,X23428.Concentration of VLDL Particles,SOX9,Transcription factor SOX-9,40182,0.00945193594491966,0.00275452922671369,0.00405305866056082,0.0148508132292785,0.00060264914503566
NMR metabolomics,X23428.Concentration of VLDL Particles,CD59,CD59 glycoprotein,42130,0.00849918192654292,0.00247936385001704,0.00363962878050953,0.0133587350725763,0.000610009385869726
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK14,Kallikrein-14,42721,0.0160227788413494,0.00467669941920012,0.0068564479797172,0.0251891097029817,0.000614164416135041
NMR metabolomics,X23428.Concentration of VLDL Particles,CPTP,Ceramide-1-phosphate transfer protein,40116,-0.0136127708887811,0.00398386133200909,-0.0214211390995189,-0.00580440267804331,0.000635509911371531
NMR metabolomics,X23428.Concentration of VLDL Particles,ERC2,ERC protein 2,40182,0.0257695540279124,0.00754585161714008,0.0109796848583179,0.040559423197507,0.000639980044715573
NMR metabolomics,X23428.Concentration of VLDL Particles,AOC1,Amiloride-sensitive amine oxidase [copper-containing],42370,0.0191979547955029,0.0056439213471115,0.00813586895516432,0.0302600406358414,0.000672094226718899
NMR metabolomics,X23428.Concentration of VLDL Particles,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,40223,-0.00866689048725497,0.00255287205952268,-0.0136705197239194,-0.00366326125059051,0.000688813376636143
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM4,Intercellular adhesion molecule 4,42594,-0.0176924156353316,0.00523385748601583,-0.0279507763079226,-0.00743405496274056,0.000725928676485885
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX25,ATP-dependent RNA helicase DDX25,40182,-0.0127267182115628,0.00376946936377513,-0.020114878164562,-0.00533855825856351,0.000737324258052812
NMR metabolomics,X23428.Concentration of VLDL Particles,MYBPC1,"Myosin-binding protein C, slow-type",40511,-0.0240722886243477,0.00713098884141866,-0.0380490267535282,-0.0100955504951671,0.000738678724611732
NMR metabolomics,X23428.Concentration of VLDL Particles,CD48,CD48 antigen,42654,0.0103298750591914,0.00307296443455217,0.00430686476746913,0.0163528853509136,0.00077726479689115
NMR metabolomics,X23428.Concentration of VLDL Particles,YY1,Transcriptional repressor protein YY1,40199,0.00941775256824329,0.00280870569579093,0.00391268940449306,0.0149228157319935,0.000801935856436228
NMR metabolomics,X23428.Concentration of VLDL Particles,CLIC5,Chloride intracellular channel protein 5,40182,-0.0105455122638201,0.00314628832898487,-0.0167122373886305,-0.0043787871390098,0.000805788875624478
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF1R,Macrophage colony-stimulating factor 1 receptor,40532,0.013541992421865,0.00404159577225619,0.00562046470824291,0.0214635201354872,0.000808839520496603
NMR metabolomics,X23428.Concentration of VLDL Particles,GUK1,Guanylate kinase,40116,-0.0128219711450261,0.00382858228917412,-0.0203259924318074,-0.00531794985824486,0.000813744342590546
NMR metabolomics,X23428.Concentration of VLDL Particles,QPCT,Glutaminyl-peptide cyclotransferase,42681,0.00905490559119342,0.00270598298083113,0.0037511789487644,0.0143586322336224,0.000821351094015403
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB37,Ras-related protein Rab-37,42370,0.0268399995704672,0.00802358509892224,0.0111137727765796,0.0425662263643548,0.000824712557193694
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA1,Annexin A1,40235,0.0138219567213944,0.00413231562672388,0.00572261809301557,0.0219212953497732,0.000826027309790345
NMR metabolomics,X23428.Concentration of VLDL Particles,KIAA0319,Dyslexia-associated protein KIAA0319,40483,0.0104211702538004,0.00311634560564208,0.00431313286674194,0.0165292076408589,0.000828379597371901
NMR metabolomics,X23428.Concentration of VLDL Particles,STX5,Syntaxin-5,40199,0.0136716461302915,0.00408874389104384,0.00565770810384561,0.0216855841567374,0.000829367699098684
NMR metabolomics,X23428.Concentration of VLDL Particles,GAL,Galanin peptides,42676,0.0212589026910228,0.00636621519259391,0.00878112091353874,0.0337366844685069,0.000842079707663688
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,40116,-0.0108012842636961,0.00323617074164124,-0.0171441789173129,-0.00445838961007929,0.000847649410458081
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42636,0.0115111457814432,0.00346136946388713,0.00472686163222439,0.0182954299306619,0.000884632939917762
NMR metabolomics,X23428.Concentration of VLDL Particles,ANPEP,Aminopeptidase N,42666,0.0091290874649476,0.00275059253301457,0.00373792610023903,0.0145202488296562,0.000905952622946482
NMR metabolomics,X23428.Concentration of VLDL Particles,BTN2A1,Butyrophilin subfamily 2 member A1,42676,0.00920740230832322,0.00277751957150971,0.00376346394816418,0.0146513406684823,0.000918938068126753
NMR metabolomics,X23428.Concentration of VLDL Particles,PREB,Prolactin regulatory element-binding protein,42370,0.00968421545639356,0.00292680585795783,0.00394767597479621,0.0154207549379909,0.00093947936733394
NMR metabolomics,X23428.Concentration of VLDL Particles,TRIM26,Tripartite motif-containing protein 26,40080,0.0185102784776569,0.00559707173888726,0.00754001786943783,0.0294805390858759,0.000945604187760099
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL28,C-C motif chemokine 28,42538,0.0192592073153049,0.00582465070459175,0.0078428919343051,0.0306755226963048,0.000947188213444248
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF149,E3 ubiquitin-protein ligase RNF149,40223,0.0106503317069051,0.00322543479063156,0.00432847951726727,0.016972183896543,0.000963090187302539
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",40483,0.0178118042304117,0.00540237251088282,0.0072231541090814,0.0284004543517421,0.00098013584440397
NMR metabolomics,X23428.Concentration of VLDL Particles,INSL5,Insulin-like peptide INSL5,40449,0.0322750151589773,0.00979087047620134,0.0130849090256226,0.0514651212923319,0.000982217548490912
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB44,Ras-related protein Rab-44,40451,0.0137305646767716,0.00416704023465468,0.00556316581684848,0.0218979635366948,0.000987117758843649
NMR metabolomics,X23428.Concentration of VLDL Particles,RPS10,40S ribosomal protein S10,40116,-0.0133679365540565,0.00405731476678616,-0.0213202734969574,-0.00541559961115565,0.000988144276786462
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,40199,0.0101806297329272,0.00309383063911285,0.004116721680266,0.0162445377855884,0.00100280319356965
NMR metabolomics,X23428.Concentration of VLDL Particles,NFASC,Neurofascin,42754,0.00943761872377161,0.00287600950497703,0.00380064009401663,0.0150745973535266,0.00103518226604063
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42794,0.0228607715774702,0.0069691035356479,0.00920132864760032,0.0365202145073401,0.00103956499797016
NMR metabolomics,X23428.Concentration of VLDL Particles,AKR7L,Aflatoxin B1 aldehyde reductase member 4,40199,0.0222275586799093,0.0068068603956762,0.00888611230438398,0.0355690050554347,0.00109618990492025
NMR metabolomics,X23428.Concentration of VLDL Particles,SULT1A1,Sulfotransferase 1A1,42711,-0.0412364522482822,0.0126363903440294,-0.0660037773225798,-0.0164691271739846,0.00110392621276017
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42676,0.0136715652355307,0.00419033481574831,0.00545850899666406,0.0218846214743974,0.00110653160722962
NMR metabolomics,X23428.Concentration of VLDL Particles,CST1,Cystatin-SN,39042,0.0357830849658659,0.010981848187027,0.014258662519293,0.0573075074124387,0.00112428276600641
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPT2,Angiopoietin-2,42721,-0.0121783409376062,0.003747255451801,-0.0195229616231361,-0.0048337202520762,0.00115713005250771
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH12,Protocadherin-12,40482,0.00832164627597831,0.00256341703381144,0.00329734888970788,0.0133459436622487,0.00117252476370756
NMR metabolomics,X23428.Concentration of VLDL Particles,DGCR6,Protein DGCR6,40136,0.0142943779841215,0.00441202550183681,0.00564680800052138,0.0229419479677217,0.00119942472116286
NMR metabolomics,X23428.Concentration of VLDL Particles,SPTLC1,Serine palmitoyltransferase 1,40483,0.0124306839967848,0.00384505412463126,0.00489437791250755,0.0199669900810621,0.00122891466161954
NMR metabolomics,X23428.Concentration of VLDL Particles,ANGPTL4,Angiopoietin-related protein 4,42654,-0.0143207285571144,0.00443708597624421,-0.023017417070553,-0.00562404004367572,0.00125172668976534
NMR metabolomics,X23428.Concentration of VLDL Particles,ACP1,Low molecular weight phosphotyrosine protein phosphatase,40199,0.0143358973630013,0.00444442425304605,0.00562482582703106,0.0230469688989716,0.00126079940595807
NMR metabolomics,X23428.Concentration of VLDL Particles,VIM,Vimentin,42357,0.0370180972567874,0.0114982696773781,0.0144814886891263,0.0595547058244485,0.0012874854583835
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB7,Integrin beta-7,42721,0.0146998535667359,0.00457078061021551,0.00574112357071353,0.0236585835627583,0.00130274268844803
NMR metabolomics,X23428.Concentration of VLDL Particles,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,40199,0.0111453491237897,0.00346539685654523,0.00435317128496104,0.0179375269626183,0.00130283648385342
NMR metabolomics,X23428.Concentration of VLDL Particles,LAYN,Layilin,42476,-0.0120845814716503,0.00376137849982139,-0.0194568833313002,-0.00471227961200033,0.00131758343954792
NMR metabolomics,X23428.Concentration of VLDL Particles,SLITRK1,SLIT and NTRK-like protein 1,40199,0.0104890525297613,0.00326871904721738,0.00408236319721528,0.0168957418623074,0.00133617248740119
NMR metabolomics,X23428.Concentration of VLDL Particles,F3,Tissue factor,42636,-0.00868335272050202,0.00270672257972276,-0.0139885289767586,-0.00337817646424542,0.0013394270329701
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK11,Kallikrein-11,42543,0.0104058123372071,0.00324411687149351,0.00404734326907983,0.0167642814053344,0.001341657358239
NMR metabolomics,X23428.Concentration of VLDL Particles,MPO,Myeloperoxidase,42611,0.0147701559148352,0.0046093357725524,0.00573585780063246,0.0238044540290379,0.00135660788171325
NMR metabolomics,X23428.Concentration of VLDL Particles,NDRG1,Protein NDRG1,42311,0.0207051774321377,0.00646784435437816,0.00802820249755646,0.0333821523667188,0.00137159588362689
NMR metabolomics,X23428.Concentration of VLDL Particles,NOTCH2,Neurogenic locus notch homolog protein 2,40527,0.00675579693992374,0.00211072625377738,0.00261877348252007,0.0108928203973274,0.00137473234427101
NMR metabolomics,X23428.Concentration of VLDL Particles,SPESP1,Sperm equatorial segment protein 1,40511,0.0101009399969018,0.00316009791151009,0.003907148090342,0.0162947319034616,0.00139535922334152
NMR metabolomics,X23428.Concentration of VLDL Particles,EP300,Histone acetyltransferase p300,40199,0.00985585879028874,0.00308433407627298,0.0038105640007937,0.0159011535797838,0.00140003329597616
NMR metabolomics,X23428.Concentration of VLDL Particles,DDI2,Protein DDI1 homolog 2,40283,0.0249030228521615,0.0077942592185055,0.00962627478389071,0.0401797709204323,0.00140199598452778
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRPB1,Signal-regulatory protein beta-1,42600,0.0152375335581,0.00477174998306095,0.00588490359130055,0.0245901635248995,0.00140991551988782
NMR metabolomics,X23428.Concentration of VLDL Particles,SPP1,Osteopontin,42771,-0.0149455074766207,0.00468430761953571,-0.0241267504109107,-0.0057642645423307,0.00142326321108408
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP9,Matrix metalloproteinase-9,42594,-0.0190114699928261,0.00595898821689347,-0.0306910868979373,-0.00733185308771488,0.00142410472663596
NMR metabolomics,X23428.Concentration of VLDL Particles,BATF,Basic leucine zipper transcriptional factor ATF-like,40182,0.0266670226892318,0.00836068983687287,0.010280070608961,0.0430539747695026,0.00142883658194037
NMR metabolomics,X23428.Concentration of VLDL Particles,GOT1,"Aspartate aminotransferase, cytoplasmic",40527,0.01301039015036,0.00408014448023699,0.00501330696909553,0.0210074733316245,0.00143298687908217
NMR metabolomics,X23428.Concentration of VLDL Particles,HMCN2,Hemicentin-2,40269,-0.0185480349295567,0.0058204499575556,-0.0299561168463657,-0.00713995301274776,0.00144304884827194
NMR metabolomics,X23428.Concentration of VLDL Particles,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,40302,0.0166763299786159,0.00523315803289879,0.0064193402341343,0.0269333197230976,0.00144320942824516
NMR metabolomics,X23428.Concentration of VLDL Particles,MSLN,Mesothelin,42553,0.0188218318549,0.00591180571328091,0.00723469265686947,0.0304089710529306,0.00145703701605052
NMR metabolomics,X23428.Concentration of VLDL Particles,CGREF1,Cell growth regulator with EF hand domain protein 1,42636,0.0136815038978157,0.00429876204939506,0.00525593028100138,0.02210707751463,0.00146260377430806
NMR metabolomics,X23428.Concentration of VLDL Particles,ARG1,Arginase-1,42488,0.0163203379557304,0.00513951933495025,0.00624688005922793,0.0263937958522329,0.00149940647103225
NMR metabolomics,X23428.Concentration of VLDL Particles,NECTIN2,Nectin-2,42613,0.00992745430891733,0.00312656154068713,0.00379939368917056,0.0160555149286641,0.00150072413150489
NMR metabolomics,X23428.Concentration of VLDL Particles,AIF1L,Allograft inflammatory factor 1-like,40223,0.0174941672351792,0.00554329311102483,0.0066293127375705,0.0283590217327878,0.00160425336398537
NMR metabolomics,X23428.Concentration of VLDL Particles,SUSD2,Sushi domain-containing protein 2,42611,-0.00895280648184305,0.00286335594296372,-0.014564984130052,-0.00334062883363415,0.00177168130325565
NMR metabolomics,X23428.Concentration of VLDL Particles,CTRC,Chymotrypsin-C,42626,0.0203966782575183,0.00655943775745121,0.00754018025291392,0.0332531762621227,0.00187785899178251
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP9,Fatty acid-binding protein 9,42594,0.0174382241842876,0.00563548312621803,0.00639267725690022,0.0284837711116749,0.00197642885250093
NMR metabolomics,X23428.Concentration of VLDL Particles,KIF20B,Kinesin-like protein KIF20B,40136,0.0241009088018623,0.00779451846187841,0.00882365261658065,0.039378164987144,0.00199290680891791
NMR metabolomics,X23428.Concentration of VLDL Particles,MYL4,Myosin light chain 4,40223,-0.0160185981119865,0.0051956210932604,-0.0262020154547769,-0.00583518076919614,0.00205364893942264
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF1,Macrophage colony-stimulating factor 1,42676,0.00849398521812203,0.00275776355840326,0.00308876864365165,0.0138992017925924,0.00207398542276865
NMR metabolomics,X23428.Concentration of VLDL Particles,AGT,Angiotensinogen,40532,0.00731631195371969,0.00237568612287584,0.00265996715288305,0.0119726567545563,0.00207730795423456
NMR metabolomics,X23428.Concentration of VLDL Particles,SPON1,Spondin-1,42638,0.0103101286019046,0.00335917972686982,0.00372613633723976,0.0168941208665695,0.00215031635948882
NMR metabolomics,X23428.Concentration of VLDL Particles,TK1,"Thymidine kinase, cytosolic",40302,0.0138427740103048,0.00451763837726467,0.00498820279086605,0.0226973452297436,0.0021880409378752
NMR metabolomics,X23428.Concentration of VLDL Particles,LSM1,U6 snRNA-associated Sm-like protein LSm1,42346,0.0172182968462205,0.00562098229709733,0.00620117154390969,0.0282354221485312,0.00219412799924076
NMR metabolomics,X23428.Concentration of VLDL Particles,SSH3,Protein phosphatase Slingshot homolog 3,40080,0.00881787577817666,0.00288051828317551,0.00317205994315267,0.0144636916132007,0.00220980483548061
NMR metabolomics,X23428.Concentration of VLDL Particles,CA9,Carbonic anhydrase 9,42721,-0.0146998759459171,0.00480794878124814,-0.0241234555571634,-0.0052762963346707,0.00223693640199273
NMR metabolomics,X23428.Concentration of VLDL Particles,APOH,Beta-2-glycoprotein 1,42611,-0.0110479922332906,0.0036138770396182,-0.0181311912309423,-0.00396479323563897,0.00223927547947372
NMR metabolomics,X23428.Concentration of VLDL Particles,TRAF3,"TNF receptor-associated factor 3, Isoform 2",40199,0.0110789728778986,0.00362704436205674,0.00396996592826735,0.0181879798275298,0.00225940650719489
NMR metabolomics,X23428.Concentration of VLDL Particles,NELL2,Protein kinase C-binding protein NELL2,42676,0.00875386784203679,0.00287064463964168,0.0031274043483391,0.0143803313357345,0.00229710697788777
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF43,E3 ubiquitin-protein ligase RNF43,40302,0.017368712088229,0.00570394688292816,0.00618897619768983,0.0285484479787682,0.00233198947231537
NMR metabolomics,X23428.Concentration of VLDL Particles,SDC1,Syndecan-1,42636,0.0122763239508435,0.00403322421129134,0.00437120449671248,0.0201814434049745,0.00234062580989471
NMR metabolomics,X23428.Concentration of VLDL Particles,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42586,0.0181754902778716,0.0060018426079954,0.00641187876620058,0.0299391017895426,0.00246387031740259
NMR metabolomics,X23428.Concentration of VLDL Particles,NRTN,Neurturin,42370,0.0147963337870432,0.00488736974814568,0.0052170890806777,0.0243755784934088,0.00247092168288643
NMR metabolomics,X23428.Concentration of VLDL Particles,MATN3,Matrilin-3,42475,0.00984321572552282,0.00325236621409485,0.00346857794589692,0.0162178535051487,0.00247894516972749
NMR metabolomics,X23428.Concentration of VLDL Particles,NINJ1,Ninjurin-1,42346,0.0161687134764664,0.0053574698004685,0.00566807266754814,0.0266693542853847,0.00254956513236308
NMR metabolomics,X23428.Concentration of VLDL Particles,PROCR,Endothelial protein C receptor,40116,-0.0105046637690601,0.00348162639315993,-0.0173286514996536,-0.00368067603846666,0.00255733144457041
NMR metabolomics,X23428.Concentration of VLDL Particles,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,40223,0.0194227817752753,0.00644632865965772,0.00678797760234617,0.0320575859482044,0.00259266843807705
NMR metabolomics,X23428.Concentration of VLDL Particles,CCDC28A,Coiled-coil domain-containing protein 28A,40182,0.00901331617105726,0.00299218474069029,0.0031486340793043,0.0148779982628102,0.00259878328801275
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17A,Interleukin-17A,42347,-0.012886121451976,0.00428936234340355,-0.0212932716450469,-0.00447897125890502,0.00266777613968174
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL14,C-X-C motif chemokine 14,42370,0.0168017772475479,0.00560665563150419,0.00581273220979972,0.0277908222852962,0.00273377464400381
NMR metabolomics,X23428.Concentration of VLDL Particles,NME1,Nucleoside diphosphate kinase A,40199,-0.00656962814068817,0.00219323391950163,-0.0108683666229114,-0.00227088965846498,0.00274689085236838
NMR metabolomics,X23428.Concentration of VLDL Particles,NMI,N-myc-interactor,40421,0.0214005918385561,0.00714819138527263,0.00739013672342178,0.0354110469536905,0.00276084020739654
NMR metabolomics,X23428.Concentration of VLDL Particles,DPP6,Dipeptidyl aminopeptidase-like protein 6,42587,-0.0100647079408589,0.00336340954667238,-0.0166569906523367,-0.00347242522938101,0.0027728665262948
NMR metabolomics,X23428.Concentration of VLDL Particles,LEO1,RNA polymerase-associated protein LEO1,40482,0.00966822429087447,0.00323204921253692,0.00333340783430212,0.0160030407474468,0.00278337266368475
NMR metabolomics,X23428.Concentration of VLDL Particles,SEPTIN7,Septin-7,40302,0.016175254284094,0.00541693285294353,0.00555806589232464,0.0267924426758633,0.00283218934207609
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP152,Centrosomal protein of 152 kDa,40080,0.0123082261392238,0.00415056060056084,0.00417312736212458,0.0204433249163231,0.00302908967287231
NMR metabolomics,X23428.Concentration of VLDL Particles,GSN,Gelsolin,40488,0.00571674187633079,0.00193043766154148,0.0019330840597095,0.00950039969295209,0.00306910152618766
NMR metabolomics,X23428.Concentration of VLDL Particles,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",40483,-0.00768870370742107,0.00259674254654042,-0.0127783190986403,-0.00259908831620185,0.00307376332307645
NMR metabolomics,X23428.Concentration of VLDL Particles,DPEP2,Dipeptidase 2,42587,0.00866452818606831,0.00292774076313345,0.00292615629032674,0.0144029000818099,0.00308719322918068
NMR metabolomics,X23428.Concentration of VLDL Particles,CAPS,Calcyphosin,40483,0.0302908437472107,0.0102892809718172,0.0101238530424489,0.0504578344519725,0.00324741601869835
NMR metabolomics,X23428.Concentration of VLDL Particles,CTSF,Cathepsin F,42679,0.011543870678382,0.00392287278739622,0.00385504001508543,0.0192327013416786,0.00325908751338545
NMR metabolomics,X23428.Concentration of VLDL Particles,TTN,Titin,40116,-0.0192185469413854,0.0065409389091283,-0.0320387872032768,-0.00639830667949389,0.00330820736246752
NMR metabolomics,X23428.Concentration of VLDL Particles,SEZ6L,Seizure 6-like protein,42679,0.00817620663739441,0.0027829150715174,0.0027216930972203,0.0136307201775685,0.00330895437727763
NMR metabolomics,X23428.Concentration of VLDL Particles,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",40199,0.0103285721549582,0.00351661824785297,0.00343600038916634,0.01722114392075,0.00332010371606255
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC28A1,Sodium/nucleoside cotransporter 1,40080,0.0172344081026371,0.00588307646155058,0.00570357823799797,0.0287652379672762,0.00340224381553347
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP1,Caspase-1,42311,0.0200635256468429,0.0068629093516063,0.00661222331769458,0.0335148279759913,0.00346742674497199
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB2,Integrin beta-2,42569,0.00828480777376119,0.00283785404815214,0.00272261383938299,0.0138470017081394,0.00351300094762246
NMR metabolomics,X23428.Concentration of VLDL Particles,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42711,0.0206408686064414,0.00707627416087483,0.00677137125112673,0.0345103659617561,0.00354097184516018
NMR metabolomics,X23428.Concentration of VLDL Particles,CPE,Carboxypeptidase E,42588,0.0111553338071267,0.00383075299897761,0.00364705792913061,0.0186636096851229,0.00359660874377223
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,40199,0.00970385136372906,0.00333408197176185,0.00316905069907584,0.0162386520283823,0.0036157242797779
NMR metabolomics,X23428.Concentration of VLDL Particles,IL34,Interleukin-34,42292,0.0105677725633592,0.00363147868843282,0.00345007433403088,0.0176854707926875,0.00361983107082541
NMR metabolomics,X23428.Concentration of VLDL Particles,MBL2,Mannose-binding protein C,40379,0.0314732148616266,0.0108396012726192,0.010227596367293,0.0527188333559601,0.00369691475242439
NMR metabolomics,X23428.Concentration of VLDL Particles,CPA4,Carboxypeptidase A4,40060,0.0127052150344815,0.00439852111314114,0.00408411365272491,0.0213263164162382,0.00387824342758232
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,40223,0.0106282469766148,0.00369219993758242,0.00339153509895326,0.0178649588542763,0.00400253503257983
NMR metabolomics,X23428.Concentration of VLDL Particles,NTF4,Neurotrophin-4,42346,0.0111430464815669,0.00387442099725694,0.00354918132694329,0.0187369116361905,0.00403326911010217
NMR metabolomics,X23428.Concentration of VLDL Particles,PTGR1,Prostaglandin reductase 1,40511,0.0238971580203976,0.00832540273872387,0.00757936865249886,0.0402149473882964,0.00410724993436043
NMR metabolomics,X23428.Concentration of VLDL Particles,SATB1,DNA-binding protein SATB1,40482,0.00833950234174762,0.00291065577919576,0.00263461701452394,0.0140443876689713,0.00417564596355202
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL2,Apoptosis regulator Bcl-2,40449,0.0162583998156597,0.00568573621838454,0.005114356827626,0.0274024428036934,0.00425080786677643
NMR metabolomics,X23428.Concentration of VLDL Particles,AHNAK2,Protein AHNAK2,40223,0.00860149433370697,0.003009344150623,0.0027031797984859,0.0144998088689281,0.00426766344095632
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42778,0.00809419847937037,0.00283680179804216,0.00253406695520773,0.013654330003533,0.00433354533288004
NMR metabolomics,X23428.Concentration of VLDL Particles,SCGB2A2,Mammaglobin-A,40116,-0.00903863722505654,0.00316821284810756,-0.0152483344073473,-0.00282894004276572,0.00434018034593299
NMR metabolomics,X23428.Concentration of VLDL Particles,CD79B,B-cell antigen receptor complex-associated protein beta chain,42754,-0.0135191450908392,0.00475379498436169,-0.0228365832601881,-0.00420170692149029,0.00446367788155143
NMR metabolomics,X23428.Concentration of VLDL Particles,FDX2,"Ferredoxin-2, mitochondrial",40116,0.0159805567854758,0.00562529957589631,0.00495496961671901,0.0270061439542325,0.00450786151277942
NMR metabolomics,X23428.Concentration of VLDL Particles,RBPMS,RNA-binding protein with multiple splicing,40199,0.0180505538307071,0.00635968773903056,0.00558556586220721,0.030515541799207,0.0045440854344839
NMR metabolomics,X23428.Concentration of VLDL Particles,WIF1,Wnt inhibitory factor 1,42721,0.00969313238856996,0.0034200694660316,0.00298979623514802,0.0163964685419919,0.00460098155745175
NMR metabolomics,X23428.Concentration of VLDL Particles,DDR1,Epithelial discoidin domain-containing receptor 1,42711,0.00654448303284336,0.00231015049707455,0.00201658805857723,0.0110723780071095,0.00461924685310344
NMR metabolomics,X23428.Concentration of VLDL Particles,CBS,Cystathionine beta-synthase,40223,0.0144454949718121,0.00510842601229594,0.00443297998771203,0.0244580099559121,0.00469567530204475
NMR metabolomics,X23428.Concentration of VLDL Particles,LHB,Lutropin subunit beta,42346,0.0236356722770832,0.00836257446429716,0.0072450263270608,0.0400263182271056,0.00471508652108588
NMR metabolomics,X23428.Concentration of VLDL Particles,IL2RA,Interleukin-2 receptor subunit alpha,42517,-0.0116756071773039,0.0041348441992238,-0.0197799018077826,-0.00357131254682528,0.0047541531542381
NMR metabolomics,X23428.Concentration of VLDL Particles,TMOD4,Tropomodulin-4,40080,-0.0115959996500107,0.004108792023177,-0.0196492320154376,-0.0035427672845838,0.0047775834345538
NMR metabolomics,X23428.Concentration of VLDL Particles,NPTX1,Neuronal pentraxin-1,42611,0.0112107486149666,0.00397657582464855,0.00341665999865547,0.0190048372312778,0.00482145654440666
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP112,Centrosomal protein of 112 kDa,40116,0.0126042242792121,0.00447109577293273,0.00384087656426398,0.0213675719941603,0.00482532985177565
NMR metabolomics,X23428.Concentration of VLDL Particles,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,42346,0.0100934633857469,0.00358329232152691,0.00307021043555412,0.0171167163359396,0.00485750643773472
NMR metabolomics,X23428.Concentration of VLDL Particles,FOLH1,Glutamate carboxypeptidase 2,40199,0.0285149580024929,0.0101231540920447,0.00867357598208532,0.0483563400229006,0.00485902320459375
NMR metabolomics,X23428.Concentration of VLDL Particles,APOBR,Apolipoprotein B receptor,40223,-0.0119512810079058,0.00424327632725265,-0.020268102609321,-0.00363445940649063,0.0048632949778284
NMR metabolomics,X23428.Concentration of VLDL Particles,FBP1,"Fructose-1,6-bisphosphatase 1",42636,0.0203865406597377,0.00724151148406777,0.00619317815096483,0.0345799031685105,0.00488128210103688
NMR metabolomics,X23428.Concentration of VLDL Particles,BRD3,Bromodomain-containing protein 3,40116,0.0139419103880033,0.00495623463939234,0.00422769049479436,0.0236561302812123,0.00491685971914932
NMR metabolomics,X23428.Concentration of VLDL Particles,FSTL1,Follistatin-related protein 1,40223,-0.00634146078566297,0.00225505355164064,-0.0107613657468786,-0.00192155582444732,0.00493044484750546
NMR metabolomics,X23428.Concentration of VLDL Particles,LMOD1,Leiomodin-1,40482,-0.00996709971964975,0.00355245179267036,-0.0169299052332837,-0.00300429420601584,0.00502939662241156
NMR metabolomics,X23428.Concentration of VLDL Particles,CCND2,G1/S-specific cyclin-D2,40302,0.0102957109921687,0.00367450565397575,0.00309367991037625,0.0174977420739612,0.00508856690322491
NMR metabolomics,X23428.Concentration of VLDL Particles,LIFR,Leukemia inhibitory factor receptor,42594,-0.00670933211551801,0.0023963426082134,-0.0114061636276163,-0.00201250060341975,0.00512039891401613
NMR metabolomics,X23428.Concentration of VLDL Particles,LCN2,Neutrophil gelatinase-associated lipocalin,42240,-0.0111906555527045,0.0040034011282469,-0.0190373217640685,-0.00334398934134058,0.00519293997894789
NMR metabolomics,X23428.Concentration of VLDL Particles,WASL,Neural Wiskott-Aldrich syndrome protein,40199,-0.0170997629338716,0.00612945577270807,-0.0291134962483794,-0.00508602961936379,0.0052836442847566
NMR metabolomics,X23428.Concentration of VLDL Particles,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,42346,0.033850403769578,0.0121891025572148,0.00995976275743699,0.057741044781719,0.00549232844553087
NMR metabolomics,X23428.Concentration of VLDL Particles,IL6ST,Interleukin-6 receptor subunit beta,42636,0.00481875213205016,0.00173580054478941,0.00141658306426292,0.00822092119983741,0.00550917456432616
NMR metabolomics,X23428.Concentration of VLDL Particles,MANSC4,MANSC domain-containing protein 4,40116,0.0197923920518474,0.00713533259759309,0.0058071401605649,0.0337776439431298,0.00554900600906277
NMR metabolomics,X23428.Concentration of VLDL Particles,CHRM1,Muscarinic acetylcholine receptor M1,40182,-0.0102144267226335,0.00369947652558612,-0.0174654007127823,-0.00296345273248476,0.00577120779790293
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRT1,NAD-dependent protein deacetylase sirtuin-1,40199,0.0228346389621862,0.00829589834937984,0.00657467819740171,0.0390945997269707,0.00592351494198894
NMR metabolomics,X23428.Concentration of VLDL Particles,CENPF,Centromere protein F,40302,0.014919285746294,0.00542130287739828,0.00429353210659337,0.0255450393859946,0.00593332722204872
NMR metabolomics,X23428.Concentration of VLDL Particles,WFDC2,WAP four-disulfide core domain protein 2,41948,0.0119461279027717,0.00434679518315449,0.00342640934378888,0.0204658464617545,0.00599965130682617
NMR metabolomics,X23428.Concentration of VLDL Particles,RSPO3,R-spondin-3,42721,0.00809613892263225,0.00294896551644425,0.00231616651040152,0.013876111334863,0.00605139291617917
NMR metabolomics,X23428.Concentration of VLDL Particles,UNG,Uracil-DNA glycosylase,40451,0.00929859099897702,0.00339194107799212,0.00265038648611246,0.0159467955118416,0.00612787462834577
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA6C,Semaphorin-6C,40199,0.00714593106376691,0.00261530268976494,0.00201993779182764,0.0122719243357062,0.00629840014305624
NMR metabolomics,X23428.Concentration of VLDL Particles,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42689,-0.0120097731503883,0.00439769366006848,-0.0206292527241226,-0.00339029357665409,0.00632387965002
NMR metabolomics,X23428.Concentration of VLDL Particles,GABARAP,Gamma-aminobutyric acid receptor-associated protein,40451,0.0135619812117336,0.00496855950709551,0.00382360457782634,0.0233003578456408,0.00635174773445567
NMR metabolomics,X23428.Concentration of VLDL Particles,TACSTD2,Tumor-associated calcium signal transducer 2,40980,-0.00861124718922216,0.00316218812749839,-0.014809135919119,-0.00241335845932532,0.00647495341780891
NMR metabolomics,X23428.Concentration of VLDL Particles,NMRK2,Nicotinamide riboside kinase 2,40080,-0.0115078772516071,0.00422846979807978,-0.0197956780558435,-0.00322007644737071,0.00650852279611703
NMR metabolomics,X23428.Concentration of VLDL Particles,KIAA1549L,UPF0606 protein KIAA1549L,40302,-0.00784544242146646,0.00288400377349445,-0.0134980898175156,-0.00219279502541734,0.00653182452141962
NMR metabolomics,X23428.Concentration of VLDL Particles,KIAA1549,UPF0606 protein KIAA1549,40302,0.0191665329336696,0.00704773389330549,0.00535297450279083,0.0329800913645484,0.00654761243854595
NMR metabolomics,X23428.Concentration of VLDL Particles,DKK3,Dickkopf-related protein 3,42794,-0.00811879536540376,0.0029929658710359,-0.0139850084726341,-0.0022525822581734,0.00668364825768803
NMR metabolomics,X23428.Concentration of VLDL Particles,SAT2,Thialysine N-epsilon-acetyltransferase,40302,0.0181820617407845,0.00671987513901711,0.00501110646831094,0.031353017013258,0.00682616958558986
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF5,Eukaryotic translation initiation factor 5,40116,0.0118472028943065,0.00438974138668012,0.00324330977641342,0.0204510960121995,0.00696889680115502
NMR metabolomics,X23428.Concentration of VLDL Particles,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",42311,0.0135920256690276,0.00504582754202622,0.00370220368665622,0.023481847651399,0.00707502521111267
NMR metabolomics,X23428.Concentration of VLDL Particles,IL5,Interleukin-5,42370,0.0372764739584978,0.0138493767405057,0.0101316955471067,0.0644212523698889,0.0071207801028455
NMR metabolomics,X23428.Concentration of VLDL Particles,SRPX,Sushi repeat-containing protein SRPX,40511,-0.00990370216082575,0.00367955461151368,-0.0171156291993926,-0.00269177512225894,0.00712255685482925
NMR metabolomics,X23428.Concentration of VLDL Particles,CFC1,Cryptic protein,42346,0.0126419458108872,0.0046990840099742,0.00343174115133779,0.0218521504704366,0.00714779573841797
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,42172,0.0177977386789757,0.00662307638551162,0.0048165089633729,0.0307789683945784,0.00721388532788602
NMR metabolomics,X23428.Concentration of VLDL Particles,DPP10,Inactive dipeptidyl peptidase 10,42594,0.00956534877611039,0.0035667515067867,0.00257451582280847,0.0165561817294123,0.00733148385846191
NMR metabolomics,X23428.Concentration of VLDL Particles,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42611,-0.00799234772698821,0.00298214073891568,-0.0138373435752629,-0.00214735187871348,0.00736965145304656
NMR metabolomics,X23428.Concentration of VLDL Particles,GGT5,Glutathione hydrolase 5 proenzyme,42495,0.00627302685219296,0.00234295773635618,0.00168082968893484,0.0108652240154511,0.007428783747332
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL5,Fc receptor-like protein 5,42611,-0.0156596261167419,0.00585081119871749,-0.0271272160662281,-0.00419203616725559,0.00744886377878602
NMR metabolomics,X23428.Concentration of VLDL Particles,DDA1,DET1- and DDB1-associated protein 1,40116,0.0107402094164875,0.00401276346523721,0.00287519302462252,0.0186052258083524,0.00745039800688738
NMR metabolomics,X23428.Concentration of VLDL Particles,HMBS,Porphobilinogen deaminase,42721,0.011454191276847,0.00428028350965511,0.00306483559792297,0.019843546955771,0.00745884646237535
NMR metabolomics,X23428.Concentration of VLDL Particles,IL10RA,Interleukin-10 receptor subunit alpha,42370,0.0154182018816146,0.00576177692806099,0.00412511910261505,0.0267112846606141,0.00746108794865523
NMR metabolomics,X23428.Concentration of VLDL Particles,LAG3,Lymphocyte activation gene 3 protein,42587,-0.0108937254035636,0.00407280685325039,-0.0188764268359343,-0.0029110239711928,0.0074876636783081
NMR metabolomics,X23428.Concentration of VLDL Particles,APOF,Apolipoprotein F,40532,0.00632658324806556,0.00236676263480757,0.00168772848384273,0.0109654380122884,0.00752623817582466
NMR metabolomics,X23428.Concentration of VLDL Particles,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,40539,-0.00525769849392106,0.00196816159703783,-0.0091152952241152,-0.00140010176372692,0.00756489433330415
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF31,E3 ubiquitin-protein ligase RNF31,40199,0.00942552511381303,0.00353191544424345,0.00250297084309586,0.0163480793845302,0.00762633551532391
NMR metabolomics,X23428.Concentration of VLDL Particles,GLP1R,Glucagon-like peptide 1 receptor,40136,-0.0100851334004339,0.00377973843489192,-0.0174934207328221,-0.00267684606804572,0.00763691154800969
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTP1,Glutathione S-transferase P,42237,-0.0185285529107954,0.00696760866397422,-0.0321850658921849,-0.00487203992940598,0.00784125105139536
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",42311,0.013937524607534,0.00525671352189257,0.00363436610462456,0.0242406831104434,0.00802608647579771
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP164,Centrosomal protein of 164 kDa,42370,0.0173462487315939,0.00655675826470961,0.0044950025327631,0.0301974949304247,0.00816544289468833
NMR metabolomics,X23428.Concentration of VLDL Particles,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42658,0.0170600708962657,0.00644892538023393,0.00442017715100723,0.0296999646415242,0.00816860378568558
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX53,Probable ATP-dependent RNA helicase DDX53,40182,0.00952718218202446,0.00360937735173374,0.00245280257262632,0.0166015617914226,0.00831299918478575
NMR metabolomics,X23428.Concentration of VLDL Particles,EDA2R,Tumor necrosis factor receptor superfamily member 27,42721,-0.010739807656314,0.00407890955278271,-0.0187344703797681,-0.00274514493285988,0.00847281899504497
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC12A2,Solute carrier family 12 member 2,40116,-0.00713732693646956,0.00271481006539331,-0.0124583546646405,-0.00181629920829867,0.00857478164168761
NMR metabolomics,X23428.Concentration of VLDL Particles,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42587,0.00914662297593904,0.00349638462589677,0.00229370910918137,0.0159995368426967,0.00890603520428793
NMR metabolomics,X23428.Concentration of VLDL Particles,CD209,CD209 antigen,42668,0.0100668409374688,0.00384873972834054,0.0025233110699213,0.0176103708050162,0.0089164873779663
NMR metabolomics,X23428.Concentration of VLDL Particles,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,40302,0.016966916352955,0.00648764756959855,0.00425112711654186,0.0296827055893682,0.00892787989108414
NMR metabolomics,X23428.Concentration of VLDL Particles,CST6,Cystatin-M,42332,0.0130942363835228,0.00502750284562666,0.0032403308060945,0.022948141960951,0.00921063952121308
NMR metabolomics,X23428.Concentration of VLDL Particles,CCAR2,Cell cycle and apoptosis regulator protein 2,40483,0.0139384863851218,0.00537375565041503,0.00340592531030835,0.0244710474599353,0.00950422598261575
NMR metabolomics,X23428.Concentration of VLDL Particles,IL31,Interleukin-31,40199,0.0145603152044384,0.00561605328361466,0.00355285076855369,0.0255677796403232,0.00953727741249578
NMR metabolomics,X23428.Concentration of VLDL Particles,SAFB2,Scaffold attachment factor B2,40482,0.00707612958565344,0.00273008231325435,0.00172516825167491,0.012427090919632,0.00955674843235072
NMR metabolomics,X23428.Concentration of VLDL Particles,IL25,Interleukin-25,40036,0.00901728510749191,0.00348219918781361,0.00219217469937723,0.0158423955156066,0.00962334459951618
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK4,Serine protease inhibitor Kazal-type 4,42594,-0.0178275710812244,0.00688604303306645,-0.0313242154260347,-0.00433092673641417,0.00963751370566761
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,40116,-0.0100029999791285,0.003872844081617,-0.0175937743790979,-0.00241222557915922,0.00981149435682406
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKCQ,Protein kinase C theta type,42370,0.0112205427425144,0.00435196443098877,0.00269069245777639,0.0197503930272524,0.00994036897155193
NMR metabolomics,X23428.Concentration of VLDL Particles,MUC2,Mucin-2,40527,0.0238321239899303,0.00924498206927897,0.00571195913414353,0.0419522888457171,0.00995439041901393
NMR metabolomics,X23428.Concentration of VLDL Particles,SLAMF8,SLAM family member 8,42346,0.0141387593903875,0.00549169045667454,0.00337504609530539,0.0249024726854696,0.0100472167736493
NMR metabolomics,X23428.Concentration of VLDL Particles,GBP6,Guanylate-binding protein 6,40116,-0.0117727345407552,0.00459846802973041,-0.0207857318790268,-0.0027597372024836,0.010476249877511
NMR metabolomics,X23428.Concentration of VLDL Particles,RANBP2,E3 SUMO-protein ligase RanBP2,40136,-0.00827648496349289,0.00323455712680168,-0.0146162169320242,-0.00193675299496159,0.0105176821645334
NMR metabolomics,X23428.Concentration of VLDL Particles,SEPTIN3,Neuronal-specific septin-3,40482,-0.0189691106033026,0.00744670101724295,-0.0335646445970987,-0.00437357660950638,0.0108686139868459
NMR metabolomics,X23428.Concentration of VLDL Particles,TDGF1,Teratocarcinoma-derived growth factor 1,42311,0.0377628071435571,0.0148281028217953,0.00869972561283818,0.0668258886742759,0.0108858482261327
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G1B,Phospholipase A2,42782,-0.0114630280175199,0.00452402911085107,-0.020330125074788,-0.00259593096025179,0.0112941442785278
NMR metabolomics,X23428.Concentration of VLDL Particles,REG3G,Regenerating islet-derived protein 3-gamma,40451,0.0102918197145654,0.00407447072698369,0.00230585708967742,0.0182777823394535,0.0115529140802908
NMR metabolomics,X23428.Concentration of VLDL Particles,PADI4,Protein-arginine deiminase type-4,42292,0.018011971157884,0.00713455592530114,0.00402824154429374,0.0319957007714742,0.0115943869190851
NMR metabolomics,X23428.Concentration of VLDL Particles,AREG,Amphiregulin,42587,-0.0106285582062192,0.00422311698379687,-0.0189058674944611,-0.00235124891797737,0.0118556403428476
NMR metabolomics,X23428.Concentration of VLDL Particles,IL20RB,Interleukin-20 receptor subunit beta,40199,0.0102966555732513,0.00409432103460199,0.00227178634543146,0.0183215248010712,0.0119220081955054
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",40482,0.0181059168276435,0.00720112088271273,0.00399171989752655,0.0322201137577605,0.0119400343434213
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,40283,0.00943230273233975,0.00375542235594534,0.00207167491468688,0.0167929305499926,0.012030948624979
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP1B4,Protein ATP1B4,40080,-0.0105586388415522,0.00421119536553467,-0.0188125817580002,-0.00230469592510425,0.012180932963153
NMR metabolomics,X23428.Concentration of VLDL Particles,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",40116,-0.0101751693527591,0.00406579407959594,-0.0181441257487671,-0.00220621295675103,0.0123420038891942
NMR metabolomics,X23428.Concentration of VLDL Particles,IL11,Interleukin-11,42370,0.0155324276206819,0.00622590498220289,0.00332965385556424,0.0277352013857996,0.0126147334330792
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT6C,"Keratin, type II cytoskeletal 6C",40116,-0.00973812884900181,0.00390479426321736,-0.0173915256049078,-0.00208473209309579,0.0126498286718646
NMR metabolomics,X23428.Concentration of VLDL Particles,GPA33,Cell surface A33 antigen,42587,-0.0342814760379218,0.0137787801443929,-0.0612878851209318,-0.00727506695491181,0.0128587756272287
NMR metabolomics,X23428.Concentration of VLDL Particles,GIMAP7,GTPase IMAP family member 7,40283,-0.00787513667446638,0.00316789930966805,-0.0140842193214158,-0.00166605402751701,0.0129364013570587
NMR metabolomics,X23428.Concentration of VLDL Particles,BABAM1,BRISC and BRCA1-A complex member 1,40199,0.00719932105498014,0.00289881583558931,0.0015176420172251,0.0128810000927352,0.0130231969415503
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42594,0.00869047707109419,0.00350169772444661,0.00182714953117883,0.0155538046110096,0.0130846051791977
NMR metabolomics,X23428.Concentration of VLDL Particles,TMPRSS11B,Transmembrane protease serine 11B,40136,0.0192546332842834,0.00776387808438701,0.00403743223888482,0.0344718343296819,0.0131521462590017
NMR metabolomics,X23428.Concentration of VLDL Particles,MKI67,Proliferation marker protein Ki-67,40199,0.00956054702489947,0.00385853653524108,0.00199781541582695,0.017123278633972,0.0132357089921972
NMR metabolomics,X23428.Concentration of VLDL Particles,TERF1,Telomeric repeat-binding factor 1,40199,-0.00729167287670453,0.00294682659247097,-0.0130674529979476,-0.00151589275546142,0.0133604064170034
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP13,Collagenase 3,42311,-0.0081950521668407,0.00331329536420646,-0.0146891110806854,-0.00170099325299604,0.0133965894132906
NMR metabolomics,X23428.Concentration of VLDL Particles,CLC,Galectin-10,42611,-0.0161265069902585,0.00653246311519354,-0.0289301346960379,-0.00332287928447921,0.0135739245882415
NMR metabolomics,X23428.Concentration of VLDL Particles,KEL,Kell blood group glycoprotein,42311,0.00885579267733001,0.00360132421666808,0.00179719721266057,0.0159143881419995,0.0139438096720612
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42662,-0.0120256722937132,0.00489370183502058,-0.0216173278903535,-0.00243401669707282,0.0140080691408333
NMR metabolomics,X23428.Concentration of VLDL Particles,CDKL5,Cyclin-dependent kinase-like 5,40136,-0.0131843171705517,0.00538240352270001,-0.0237338280750438,-0.00263480626605971,0.0143201519698987
NMR metabolomics,X23428.Concentration of VLDL Particles,ENOPH1,Enolase-phosphatase E1,40451,0.013387708324163,0.00546698523027398,0.00267241727282597,0.0241029993755,0.0143473169612136
NMR metabolomics,X23428.Concentration of VLDL Particles,ATXN10,Ataxin-10,42311,0.0175483726082846,0.00716953285406321,0.00349608821432071,0.0316006570022485,0.0143928907072639
NMR metabolomics,X23428.Concentration of VLDL Particles,TNPO1,Transportin-1,40302,0.00862794650338637,0.00352839358320568,0.00171229508030323,0.0155435979264695,0.0144889791970501
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL52,"39S ribosomal protein L52, mitochondrial",40059,0.00643460898509454,0.00263785479830945,0.00126441358040802,0.011604804389781,0.0147302494278879
NMR metabolomics,X23428.Concentration of VLDL Particles,UNC5D,Netrin receptor UNC5D,40199,0.00634770964921161,0.00260724044673592,0.00123751837360921,0.011457900924814,0.0149221163394991
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,40449,0.00520763983287648,0.00214004768559701,0.00101314636910634,0.00940213329664663,0.0149723030454651
NMR metabolomics,X23428.Concentration of VLDL Particles,DUOX2,Dual oxidase 2,42357,0.0172603699559384,0.0070996697952343,0.0033450171572792,0.0311757227545977,0.015064194439633
NMR metabolomics,X23428.Concentration of VLDL Particles,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,40511,0.00685787310683195,0.00282501483171734,0.00132084403666597,0.0123949021769979,0.0152165610878695
NMR metabolomics,X23428.Concentration of VLDL Particles,NLGN2,Neuroligin-2,40136,-0.0116243395556705,0.0047889162606369,-0.0210106154265188,-0.00223806368482216,0.0152259221066563
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGAM,Integrin alpha-M,42611,-0.00760061216255702,0.00313857558741479,-0.01375222031389,-0.00144900401122402,0.0154623006309547
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC4A1,Band 3 anion transport protein,40527,-0.0112803535354359,0.00466401556372737,-0.0204218240403416,-0.0021388830305303,0.0155963329660976
NMR metabolomics,X23428.Concentration of VLDL Particles,GART,Trifunctional purine biosynthetic protein adenosine-3,40482,0.00652622977132635,0.00270182538277797,0.00123065202108153,0.0118218075215712,0.0157298721284596
NMR metabolomics,X23428.Concentration of VLDL Particles,DLL1,Delta-like protein 1,42679,-0.00753507699857606,0.00311986114178625,-0.0136500048364771,-0.00142014916067502,0.0157399459302388
NMR metabolomics,X23428.Concentration of VLDL Particles,HAVCR2,Hepatitis A virus cellular receptor 2,42611,-0.00878636663206538,0.00364553230825317,-0.0159316099562416,-0.00164112330788917,0.0159582872456902
NMR metabolomics,X23428.Concentration of VLDL Particles,DCTPP1,dCTP pyrophosphatase 1,42636,0.00757162380521594,0.00314163395408187,0.00141402125521547,0.0137292263552164,0.0159618839500191
NMR metabolomics,X23428.Concentration of VLDL Particles,MAG,Myelin-associated glycoprotein,40182,0.0117638907800217,0.00488133614502228,0.002196471935778,0.0213313096242653,0.0159700051745079
NMR metabolomics,X23428.Concentration of VLDL Particles,INSL4,Early placenta insulin-like peptide,40451,-0.011618286531888,0.00484169639418542,-0.0211080114644914,-0.00212856159928454,0.0164277381412806
NMR metabolomics,X23428.Concentration of VLDL Particles,TPSAB1,Tryptase alpha/beta-1,42741,0.0124500687783592,0.00519782994393231,0.00226232208825188,0.0226378154684665,0.0166228204844944
NMR metabolomics,X23428.Concentration of VLDL Particles,CPVL,Probable serine carboxypeptidase CPVL,42698,0.0098168573531204,0.0041007359391826,0.0017794149123225,0.0178542997939183,0.0166826815401799
NMR metabolomics,X23428.Concentration of VLDL Particles,NFKB2,Nuclear factor NF-kappa-B p100 subunit,40302,0.0124725750850055,0.00521134826508954,0.00225833248543002,0.022686817684581,0.0167118482917334
NMR metabolomics,X23428.Concentration of VLDL Particles,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,40136,0.0147375550245396,0.00615995199702853,0.00266404911036372,0.0268110609387155,0.0167517558939679
NMR metabolomics,X23428.Concentration of VLDL Particles,TBR1,T-box brain protein 1,40182,0.0115434874141619,0.00482777224786268,0.00208105380835107,0.0210059210199728,0.0168165853475739
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN2A,Sodium channel protein type 2 subunit alpha,40136,0.0118840954633162,0.00497587309482058,0.00213138419746788,0.0216368067291646,0.0169413548016959
NMR metabolomics,X23428.Concentration of VLDL Particles,TEF,Thyrotroph embryonic factor,40116,0.0103388563952148,0.00432977839744776,0.00185249073621717,0.0188252220542124,0.0169642032746933
NMR metabolomics,X23428.Concentration of VLDL Particles,IL18BP,Interleukin-18-binding protein,42689,0.00763044386424766,0.00320499993781999,0.00134864398612047,0.0139122437423748,0.0172891738833443
NMR metabolomics,X23428.Concentration of VLDL Particles,NOS1,"Nitric oxide synthase, brain",42311,-0.0128294886406838,0.00538938103324883,-0.0233926754658516,-0.00226630181551613,0.0173027725950825
NMR metabolomics,X23428.Concentration of VLDL Particles,UROS,Uroporphyrinogen-III synthase,40182,0.0160419683184997,0.00674771081872205,0.00281645511380453,0.029267481523195,0.017452458205249
NMR metabolomics,X23428.Concentration of VLDL Particles,SOX2,Transcription factor SOX-2,40461,0.00564927790347321,0.00237949101937757,0.00098547550549318,0.0103130803014532,0.0176058750029485
NMR metabolomics,X23428.Concentration of VLDL Particles,CRHR1,Corticotropin-releasing factor receptor 1,42357,0.0141148862983744,0.00594557124184436,0.00246156666435948,0.0257682059323894,0.0176100082245597
NMR metabolomics,X23428.Concentration of VLDL Particles,JCHAIN,Immunoglobulin J chain,42370,-0.0147446660389003,0.00622199355668268,-0.0269397734099984,-0.00254955866780227,0.0178136891191409
NMR metabolomics,X23428.Concentration of VLDL Particles,TNXB,Tenascin-X,42611,0.00606676269706182,0.00256173427436621,0.00104576351930405,0.0110877618748196,0.0178877618526697
NMR metabolomics,X23428.Concentration of VLDL Particles,DBH,Dopamine beta-hydroxylase,40515,0.0257767416285741,0.0109055272185641,0.00440190828018853,0.0471515749769597,0.0181131763365467
NMR metabolomics,X23428.Concentration of VLDL Particles,AGBL2,Cytosolic carboxypeptidase 2,40136,0.0212900239953347,0.00905166307930435,0.00354876435989817,0.0390312836307712,0.0186875553947558
NMR metabolomics,X23428.Concentration of VLDL Particles,FLT3,Receptor-type tyrosine-protein kinase FLT3,42346,0.00716143118695026,0.00304882527494545,0.00118573364805717,0.0131371287258434,0.0188429245244113
NMR metabolomics,X23428.Concentration of VLDL Particles,TBC1D17,TBC1 domain family member 17,42311,0.0105674675004178,0.00450111397684165,0.00174528410580818,0.0193896508950274,0.0189022270342973
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB118,Beta-defensin 118,40136,0.0133358382612446,0.00568116377329774,0.002200757265581,0.0244709192569081,0.0189237904913912
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH4,Cadherin-4,40136,0.0116335331502987,0.00495667318929254,0.00191845369928535,0.0213486126013121,0.0189407171709083
NMR metabolomics,X23428.Concentration of VLDL Particles,PRR4,Proline-rich protein 4,40198,-0.016240005580456,0.00692582828235947,-0.0298146290138806,-0.00266538214703148,0.019052579598769
NMR metabolomics,X23428.Concentration of VLDL Particles,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",40080,0.0120218139729022,0.00513010559665339,0.00196680700346153,0.0220768209423428,0.0191275358801551
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX39A,ATP-dependent RNA helicase DDX39A,40199,0.00567479602411922,0.00242448492444761,0.000922805572201898,0.0104267864760365,0.0192695536126287
NMR metabolomics,X23428.Concentration of VLDL Particles,CYB5A,Cytochrome b5,40080,0.0170379037662953,0.00728049511892459,0.0027681333332031,0.0313076741993875,0.0192907501580317
NMR metabolomics,X23428.Concentration of VLDL Particles,NRXN3,Neurexin-3,40182,0.00826019193292185,0.00353704165529457,0.00132759028854449,0.0151927935772992,0.0195436117187064
NMR metabolomics,X23428.Concentration of VLDL Particles,ALPI,Intestinal-type alkaline phosphatase,40199,-0.0291598556219059,0.012493032958526,-0.0536462002206168,-0.00467351102319495,0.0196089431471784
NMR metabolomics,X23428.Concentration of VLDL Particles,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,40451,0.0108106444751914,0.00464347420101761,0.00170943504119693,0.019911853909186,0.0199224492514841
NMR metabolomics,X23428.Concentration of VLDL Particles,TP73,Tumor protein p73,40182,0.00798238948761486,0.00343997887627546,0.00124003089011497,0.0147247480851147,0.0203333421842851
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC11A,C-type lectin domain family 11 member A,42592,0.0112846789861764,0.00487128270287475,0.00173696488854189,0.0208323930838109,0.0205420448462233
NMR metabolomics,X23428.Concentration of VLDL Particles,UMOD,Uromodulin,42764,-0.0126695387303009,0.00547195430322528,-0.0233945691646225,-0.00194450829597938,0.0206081307401479
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42794,0.00631642557238268,0.00273055540688041,0.000964536974897083,0.0116683141698683,0.0207243781470258
NMR metabolomics,X23428.Concentration of VLDL Particles,ARTN,Artemin,42370,0.0102717600912564,0.00444183732063465,0.00156575894281244,0.0189777612397003,0.0207653378745735
NMR metabolomics,X23428.Concentration of VLDL Particles,PPM1B,Protein phosphatase 1B,40199,0.0139841119707472,0.00607963780810162,0.00206802186686802,0.0259002020746264,0.0214580336806303
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRL6,Fc receptor-like protein 6,42594,0.0159983840524014,0.00695560215067478,0.00236540383707883,0.029631364267724,0.0214594468366541
NMR metabolomics,X23428.Concentration of VLDL Particles,TFF1,Trefoil factor 1,42556,-0.0189313675095632,0.00823111239565429,-0.0350643478050456,-0.00279838721408077,0.0214648715873802
NMR metabolomics,X23428.Concentration of VLDL Particles,CRISP3,Cysteine-rich secretory protein 3,40439,-0.00623849591608193,0.00271809951952972,-0.0115659709743602,-0.000911020857803692,0.0217418036805858
NMR metabolomics,X23428.Concentration of VLDL Particles,MYOM1,Myomesin-1,40136,0.0109861517629347,0.00479579358677642,0.00158639633285288,0.0203859071930164,0.0219945375575542
NMR metabolomics,X23428.Concentration of VLDL Particles,ART3,Ecto-ADP-ribosyltransferase 3,42689,-0.00816641541938625,0.0035693857801421,-0.0151624115484648,-0.00117041929030773,0.0221584499397675
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINT1,Kunitz-type protease inhibitor 1,42565,0.00590330542344398,0.00259488827328678,0.000817324407801895,0.0109892864390861,0.0229232019412619
NMR metabolomics,X23428.Concentration of VLDL Particles,MRC1,Macrophage mannose receptor 1,40532,0.0066063028827467,0.00290545997991888,0.000911601322105703,0.0123010044433877,0.0229993590040504
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC15,Sialic acid-binding Ig-like lectin 15,42311,0.0174394367532651,0.00767586436196547,0.0023947426038128,0.0324841309027175,0.0231036284552865
NMR metabolomics,X23428.Concentration of VLDL Particles,CALB1,Calbindin,42587,0.0102674844420617,0.00452522009625263,0.00139805305340651,0.0191369158307168,0.0232873891072277
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP350,Centrosome-associated protein 350,40080,0.00858416861772546,0.00378670147366341,0.00116223372934518,0.0160061035061057,0.0234143309022041
NMR metabolomics,X23428.Concentration of VLDL Particles,TCN1,Transcobalamin-1,40337,0.00769314114459689,0.00339544129840308,0.00103807619972685,0.0143482060894669,0.0234872409892991
NMR metabolomics,X23428.Concentration of VLDL Particles,TYRO3,Tyrosine-protein kinase receptor TYRO3,42636,0.00636812324637688,0.00281670695678212,0.000847377611083912,0.0118888688816698,0.0237850978391391
NMR metabolomics,X23428.Concentration of VLDL Particles,CD70,CD70 antigen,42594,0.00970985099118771,0.00429776390836003,0.00128623373080205,0.0181334682515734,0.0238819851450157
NMR metabolomics,X23428.Concentration of VLDL Particles,PDGFRB,Platelet-derived growth factor receptor beta,42794,0.00774554319254201,0.00342951552272999,0.00102369276799122,0.0144673936170928,0.0239305992311565
NMR metabolomics,X23428.Concentration of VLDL Particles,LTO1,Protein LTO1 homolog,42370,0.00944555749626515,0.0041825448979295,0.00124776949632334,0.017643345496207,0.023941514553499
NMR metabolomics,X23428.Concentration of VLDL Particles,LTA4H,Leukotriene A-4 hydrolase,42721,0.0131029092758682,0.00580222279183915,0.00173055260386342,0.0244752659478729,0.0239455157264634
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42794,0.00611762127895535,0.0027193302873039,0.000787733915839716,0.011447508642071,0.024485229405162
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN2,Contactin-2,42721,0.00994822222050853,0.00442406299846191,0.00127705874352319,0.0186193856974939,0.0245500378031145
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFB2,Transforming growth factor beta-2 proprotein,40451,0.0116519303066702,0.0051829543182015,0.00149333984299529,0.0218105207703452,0.0245874770997443
NMR metabolomics,X23428.Concentration of VLDL Particles,KIT,Mast/stem cell growth factor receptor Kit,42663,0.00670648695310732,0.00298481216594704,0.000856255107851118,0.0125567187983635,0.024664419733309
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,42357,0.00702395815538293,0.00314093331256463,0.00086772886275626,0.0131801874480096,0.0253511270386441
NMR metabolomics,X23428.Concentration of VLDL Particles,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,40116,0.00995653331269684,0.00445679915443212,0.00122120697000988,0.0186918596553838,0.0255025818720503
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC16A1,Monocarboxylate transporter 1,42311,0.0127256767977242,0.00570539442987875,0.00154310371516186,0.0239082498802866,0.0257335025090505
NMR metabolomics,X23428.Concentration of VLDL Particles,SUMF1,Formylglycine-generating enzyme,40199,0.0141894093833858,0.00639493461571963,0.00165533753657534,0.0267234812301963,0.0265171593933284
NMR metabolomics,X23428.Concentration of VLDL Particles,STOML2,"Stomatin-like protein 2, mitochondrial",40080,0.0203155603223183,0.00920354676134853,0.00227660867007521,0.0383545119745615,0.027309554908933
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN2B,Sodium channel subunit beta-2,40182,-0.00638421249127515,0.00289890397704707,-0.0120660642862874,-0.000702360696262888,0.0276658840315884
NMR metabolomics,X23428.Concentration of VLDL Particles,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,42357,0.00605589463302112,0.00275204741739652,0.000661881694923927,0.0114499075711183,0.0277883774682401
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGAP30,Rho GTPase-activating protein 30,40302,0.00831942764372646,0.00379608970552749,0.000879091820892579,0.0157597634665603,0.0284306623966246
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRR3,Small proline-rich protein 3,40483,0.0152474186204142,0.00696151824932976,0.00160284285172784,0.0288919943891005,0.0285269809627856
NMR metabolomics,X23428.Concentration of VLDL Particles,CRNN,Cornulin,42209,0.0150059547574888,0.0068664992573755,0.00154761621303284,0.0284642933019448,0.028878284149813
NMR metabolomics,X23428.Concentration of VLDL Particles,LTBR,Tumor necrosis factor receptor superfamily member 3,42566,0.00654113615668996,0.00299476660239878,0.000671393615988346,0.0124108786973916,0.0289656755383117
NMR metabolomics,X23428.Concentration of VLDL Particles,LRRC38,Leucine-rich repeat-containing protein 38,40182,0.0104906559857745,0.00480956423052651,0.00106391009394256,0.0199174018776065,0.0291892233581182
NMR metabolomics,X23428.Concentration of VLDL Particles,ID4,DNA-binding protein inhibitor ID-4,40302,-0.00939227732900459,0.00432450917380516,-0.0178683153096627,-0.000916239348346466,0.0298864584986502
NMR metabolomics,X23428.Concentration of VLDL Particles,TP53INP1,Tumor protein p53-inducible nuclear protein 1,42357,0.00662128283710759,0.00304895818134602,0.000645324801669384,0.0125972408725458,0.029899553239702
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN4,Contactin-4,42611,-0.00515192591056474,0.00238672418923257,-0.00982990532146058,-0.000473946499668906,0.0309007417766784
NMR metabolomics,X23428.Concentration of VLDL Particles,SLURP1,Secreted Ly-6/uPAR-related protein 1,40457,0.00810564806348567,0.00377048934061849,0.000715488955873422,0.0154958071710979,0.0315954153779144
NMR metabolomics,X23428.Concentration of VLDL Particles,CD99,CD99 antigen,42611,-0.00430690600822616,0.00200515433897941,-0.00823700851262581,-0.000376803503826504,0.0317381654272754
NMR metabolomics,X23428.Concentration of VLDL Particles,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,40482,0.00565974317315316,0.00266323713085744,0.00043979839667258,0.0108796879496337,0.0335968606815606
NMR metabolomics,X23428.Concentration of VLDL Particles,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42495,0.0226244146789098,0.0106516639630246,0.00174715331138157,0.0435016760464381,0.0336863412113588
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42711,0.00598215638074087,0.00282425123819979,0.000446623953869275,0.0115176888076125,0.0341815056100271
NMR metabolomics,X23428.Concentration of VLDL Particles,IGLON5,IgLON family member 5,40080,-0.0198684805815604,0.0094401637702128,-0.0383712015711775,-0.00136575959194335,0.0353424339819783
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXNB2,Plexin-B2,42743,0.0050282816014216,0.00239201633930824,0.000339929576377454,0.00971663362646574,0.0355620445773979
NMR metabolomics,X23428.Concentration of VLDL Particles,CSPG4,Chondroitin sulfate proteoglycan 4,40527,-0.006924602364724,0.00329464656199201,-0.0133821096262283,-0.00046709510321967,0.0355950952910306
NMR metabolomics,X23428.Concentration of VLDL Particles,PGLYRP4,Peptidoglycan recognition protein 4,40116,0.0123655223408743,0.00590113306594045,0.000799301531631002,0.0239317431501176,0.0361540785599433
NMR metabolomics,X23428.Concentration of VLDL Particles,COL1A1,Collagen alpha-1(I) chain,42794,-0.00520696799774529,0.00248748444367128,-0.010082437507341,-0.000331498488149575,0.0363438429787116
NMR metabolomics,X23428.Concentration of VLDL Particles,OFD1,Oral-facial-digital syndrome 1 protein,40302,0.0136771122644981,0.0065528677147028,0.000833491543680598,0.0265207329853156,0.0368932545164844
NMR metabolomics,X23428.Concentration of VLDL Particles,PRR5,Proline-rich protein 5,40199,0.00993873473969186,0.00476350007175041,0.000602274599061059,0.0192751948803227,0.0369621735536434
NMR metabolomics,X23428.Concentration of VLDL Particles,RGMA,Repulsive guidance molecule A,42711,-0.00662654128363714,0.00317774802614997,-0.0128549274148911,-0.000398155152383197,0.0370612673130668
NMR metabolomics,X23428.Concentration of VLDL Particles,VASN,Vasorin,42449,0.00565455942889976,0.00273129540725245,0.000301220430684968,0.0110078984271146,0.038444998569578
NMR metabolomics,X23428.Concentration of VLDL Particles,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",40223,0.00762575336393413,0.00368399848014895,0.000405116342842189,0.0148463903850261,0.0384787074682372
NMR metabolomics,X23428.Concentration of VLDL Particles,PTTG1,Securin,40302,0.00844276608317358,0.00407889966143401,0.000448122746762916,0.0164374094195842,0.0384881767046667
NMR metabolomics,X23428.Concentration of VLDL Particles,COL3A1,Collagen alpha-1(III) chain,40527,-0.00479655198660705,0.00232229817468405,-0.00934825640898779,-0.00024484756422631,0.038904703293825
NMR metabolomics,X23428.Concentration of VLDL Particles,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",40136,-0.011280337086064,0.00546969777821714,-0.0220009447313696,-0.000559729440758399,0.0391996146423766
NMR metabolomics,X23428.Concentration of VLDL Particles,NPTX2,Neuronal pentraxin-2,40527,-0.00671377007946187,0.00326675691835665,-0.0131166136394409,-0.000310926519482834,0.0398845899861142
NMR metabolomics,X23428.Concentration of VLDL Particles,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42674,-0.0145208506129635,0.00711094145413049,-0.0284582958630592,-0.000583405362867705,0.0411666536255749
NMR metabolomics,X23428.Concentration of VLDL Particles,SKIV2L,Helicase SKI2W,40116,-0.00803710450488997,0.00396875187379261,-0.0158158581775235,-0.000258350832256458,0.0428817587468276
NMR metabolomics,X23428.Concentration of VLDL Particles,PSME2,Proteasome activator complex subunit 2,42441,0.00723550495344092,0.00358909738268578,0.000200874083376787,0.0142701358235051,0.0438234861971809
NMR metabolomics,X23428.Concentration of VLDL Particles,IDI2,Isopentenyl-diphosphate delta-isomerase 2,42311,-0.00967034332645741,0.00480645187956659,-0.0190909890104079,-0.000249697642506895,0.0442455615176764
NMR metabolomics,X23428.Concentration of VLDL Particles,IL9,Interleukin-9,40302,0.0112527906461324,0.00560120862287187,0.000274421745303568,0.0222311595469613,0.0445619931730773
NMR metabolomics,X23428.Concentration of VLDL Particles,THAP12,52 kDa repressor of the inhibitor of the protein kinase,40065,0.0175218619537779,0.008734144931042,0.000402937888935532,0.0346407860186202,0.0448667182996438
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",40482,0.0143791479287372,0.00716868562993955,0.000328524094055642,0.0284297717634187,0.0448984566498916
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL2L15,Bcl-2-like protein 15,40199,0.0112279723712171,0.00560313241572519,0.000245832836395765,0.0222101119060385,0.0451080046829443
NMR metabolomics,X23428.Concentration of VLDL Particles,ENO1,Alpha-enolase,42588,0.0156011414772276,0.00780061997394163,0.000311926328302008,0.0308903566261532,0.045521782817225
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF9,Fibroblast growth factor 9,40065,0.00816644059088796,0.00410474629804994,0.000121137846710079,0.0162117433350658,0.0466697714635428
NMR metabolomics,X23428.Concentration of VLDL Particles,MTR,Methionine synthase,40116,0.0131442873013086,0.00661496168055139,0.000178962407427888,0.0261096121951893,0.0469413318922328
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,40136,0.0114888362069814,0.00578303970303783,0.000154078389027212,0.0228235940249355,0.0469868568698386
NMR metabolomics,X23428.Concentration of VLDL Particles,METAP1,Methionine aminopeptidase 1,42311,0.00575933690077037,0.00290104228079493,7.32940304122975e-05,0.0114453797711284,0.0471358179091046
NMR metabolomics,X23428.Concentration of VLDL Particles,FGFR4,Fibroblast growth factor receptor 4,40283,0.0104966885505482,0.00528858708064826,0.000131057872477559,0.0208623192286188,0.0471934147399512
NMR metabolomics,X23428.Concentration of VLDL Particles,NAPRT,Nicotinate phosphoribosyltransferase,40483,0.00666867288879564,0.00336631388315299,7.06976778157781e-05,0.0132666480997755,0.0476153317742948
NMR metabolomics,X23428.Concentration of VLDL Particles,AKR1B10,Aldo-keto reductase family 1 member B10,40182,0.0126693941449372,0.00639585186805814,0.000133524483543219,0.0252052638063311,0.0476299924889124
NMR metabolomics,X23428.Concentration of VLDL Particles,FRMD7,FERM domain-containing protein 7,40182,0.00659038387013098,0.00333057873290339,6.24495536403272e-05,0.0131183181866216,0.0478690486860445
NMR metabolomics,X23428.Concentration of VLDL Particles,RBM19,Probable RNA-binding protein 19,40116,-0.00951276296705338,0.00481302378290388,-0.018946289581545,-7.92363525617904e-05,0.04812749089892
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,40449,0.0155418142420977,0.00786502401179924,0.000126367178971158,0.0309572613052242,0.0481715727151555
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHX2,Bifunctional epoxide hydrolase 2,42357,0.0121933400280688,0.00617760201007597,8.5240088319942e-05,0.0243014399678178,0.0484255662711154
NMR metabolomics,X23428.Concentration of VLDL Particles,CELA2A,Chymotrypsin-like elastase family member 2A,40527,0.0124285999887747,0.00630692042839586,6.70359491187662e-05,0.0247901640284305,0.0487906329056378
NMR metabolomics,X23428.Concentration of VLDL Particles,CXCL9,C-X-C motif chemokine 9,42676,0.0132278834164838,0.00671356403408499,6.92979096771872e-05,0.0263864689232904,0.0488219009201535
NMR metabolomics,X23428.Concentration of VLDL Particles,B2M,Beta-2-microglobulin,40539,0.00614392410799863,0.00312448901845021,1.99256318362245e-05,0.012267922584161,0.0492793919721637
NMR metabolomics,X23428.Concentration of VLDL Particles,RAD51,DNA repair protein RAD51 homolog 1,40302,0.010620177424138,0.00540701949410264,2.2419215696793e-05,0.0212179356325791,0.0495380236168822
NMR metabolomics,X23428.Concentration of VLDL Particles,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,40451,0.0123932985042586,0.00633618461565341,-2.5623342422041e-05,0.0248122203509393,0.0504950309955792
NMR metabolomics,X23428.Concentration of VLDL Particles,ELAVL4,ELAV-like protein 4,40136,0.016472275087213,0.00846317356404843,-0.000115545098321925,0.0330600952727479,0.0516385957843175
NMR metabolomics,X23428.Concentration of VLDL Particles,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,40482,-0.00458434086793683,0.00235997286164876,-0.0092098876767684,4.12059408947361e-05,0.0520966402807347
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB104A_DEFB104B,Beta-defensin 104,40136,0.0103659590881284,0.00534005752228301,-0.000100553655546259,0.0208324718318032,0.0522633120888245
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF2,Granulocyte-macrophage colony-stimulating factor,40116,0.00709147438217653,0.0036570903819776,-7.64227664995674e-05,0.0142593715308526,0.0525145380924659
NMR metabolomics,X23428.Concentration of VLDL Particles,CFD,Complement factor D,40539,0.00404523160045505,0.00208747508364313,-4.62195634854754e-05,0.00813668276439558,0.0526652546896746
NMR metabolomics,X23428.Concentration of VLDL Particles,CRTAM,Cytotoxic and regulatory T-cell molecule,42495,0.0100013635696189,0.00516731418956519,-0.000126572241928911,0.0201292993811666,0.0529494967830066
NMR metabolomics,X23428.Concentration of VLDL Particles,LEG1,Protein LEG1 homolog,39926,-0.013490939926325,0.00697334539506262,-0.0271586969006478,0.000176817047997694,0.0530602610540395
NMR metabolomics,X23428.Concentration of VLDL Particles,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",40116,0.0169566189852394,0.00877050300686089,-0.000233566908207902,0.0341468048786868,0.0532165638658655
NMR metabolomics,X23428.Concentration of VLDL Particles,OSBPL2,Oxysterol-binding protein-related protein 2,40483,0.00766291652960685,0.00396888227020024,-0.000116092719985621,0.0154419257791993,0.0535390787721502
NMR metabolomics,X23428.Concentration of VLDL Particles,SELENOP,Selenoprotein P,40539,0.00441586060417551,0.00229160332427422,-7.56819114019706e-05,0.00890740311975299,0.0540077826006626
NMR metabolomics,X23428.Concentration of VLDL Particles,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,42173,-0.0163424654048071,0.00852856387671807,-0.0330584506031745,0.000373519793560307,0.0553611169706303
NMR metabolomics,X23428.Concentration of VLDL Particles,LMOD2,Leiomodin-2,40136,0.011907947975085,0.0062160325034141,-0.000275475731606667,0.0240913716817766,0.0554314869101714
NMR metabolomics,X23428.Concentration of VLDL Particles,CCDC50,Coiled-coil domain-containing protein 50,40482,0.0143300423970216,0.00750285712611489,-0.00037555757016355,0.0290356423642068,0.0561656480655565
NMR metabolomics,X23428.Concentration of VLDL Particles,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,40482,-0.00559319271356661,0.00292918625175247,-0.0113343977670015,0.000148012339868225,0.0562268370836219
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,42458,0.00658225899772856,0.00345128749293561,-0.000182264488425238,0.0133467824838824,0.0565176420178175
NMR metabolomics,X23428.Concentration of VLDL Particles,PCARE,Photoreceptor cilium actin regulator,40136,0.0159704307162937,0.00837625944855626,-0.000447037802876533,0.032387899235464,0.0565946352694254
NMR metabolomics,X23428.Concentration of VLDL Particles,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42545,0.00534189934470846,0.00280536954446009,-0.000156624962433311,0.0108404236518502,0.0569095769877216
NMR metabolomics,X23428.Concentration of VLDL Particles,VCPKMT,Protein-lysine methyltransferase METTL21D,40080,0.0163526931699907,0.00862358644072457,-0.000549536253829405,0.0332549225938109,0.0579501148418848
NMR metabolomics,X23428.Concentration of VLDL Particles,NOP56,Nucleolar protein 56,40116,0.0211015966629572,0.011154704313352,-0.000761623791212598,0.0429648171171271,0.0585544948166869
NMR metabolomics,X23428.Concentration of VLDL Particles,TXNL1,Thioredoxin-like protein 1,40124,0.0185509479525284,0.00982029442259788,-0.000696829115763464,0.0377987250208202,0.0589126584642765
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMD1,26S proteasome non-ATPase regulatory subunit 1,40482,0.00923744670390346,0.0049142938046429,-0.000394569153196626,0.0188694625610036,0.06017336125418
NMR metabolomics,X23428.Concentration of VLDL Particles,JUN,Transcription factor AP-1,42370,0.00890430081006934,0.00475758474417317,-0.000420565288510076,0.0182291669086488,0.061283951363668
NMR metabolomics,X23428.Concentration of VLDL Particles,ULBP2,UL16-binding protein 2,42495,0.00742973156083163,0.00397017484804966,-0.000351811141345693,0.015211274263009,0.061313464237578
NMR metabolomics,X23428.Concentration of VLDL Particles,ACSL1,Long-chain-fatty-acid--CoA ligase 1,40116,-0.00727696561927977,0.00388852908758291,-0.0148984826309423,0.000344551392382737,0.0613173573053674
NMR metabolomics,X23428.Concentration of VLDL Particles,ATF2,Cyclic AMP-dependent transcription factor ATF-2,42311,0.012389631005532,0.00664336483489517,-0.000631364070862487,0.0254106260819266,0.0622088742520358
NMR metabolomics,X23428.Concentration of VLDL Particles,CA11,Carbonic anhydrase-related protein 11,42346,0.0060076461113151,0.00322473842945546,-0.000312841210417599,0.0123281334330478,0.0624863558280214
NMR metabolomics,X23428.Concentration of VLDL Particles,CEP290,Centrosomal protein of 290 kDa,40302,0.0101125664792932,0.0054303687410968,-0.000530956253256498,0.020756089211843,0.0625978167873117
NMR metabolomics,X23428.Concentration of VLDL Particles,APOA1,Apolipoprotein A-I,40539,-0.00511297561494446,0.00274665254480719,-0.0104964146027665,0.000270463372877621,0.062695235548605
NMR metabolomics,X23428.Concentration of VLDL Particles,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",40136,0.00601371570615728,0.00323079415505672,-0.000318640837753893,0.0123460722500684,0.0627181986198057
NMR metabolomics,X23428.Concentration of VLDL Particles,PLB1,"Phospholipase B1, membrane-associated",40483,0.0110855443667836,0.00597371178795257,-0.000622930737603436,0.0227940194711706,0.0635193327771823
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFBR2,TGF-beta receptor type-2,42679,0.00659556185998929,0.00355610434993499,-0.000374402665883279,0.0135655263858619,0.0636586768987962
NMR metabolomics,X23428.Concentration of VLDL Particles,LMNB2,Lamin-B2,40483,0.00527189512032421,0.00284787907454943,-0.000309947865792671,0.0108537381064411,0.0641718663436246
NMR metabolomics,X23428.Concentration of VLDL Particles,CD7,T-cell antigen CD7,40166,0.00820672798465697,0.00445275416501124,-0.000520670178765073,0.016934126148079,0.065346063025954
NMR metabolomics,X23428.Concentration of VLDL Particles,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,40451,0.0176572247798303,0.00960817551211581,-0.00117479922391668,0.0364892487835773,0.0661286557793724
NMR metabolomics,X23428.Concentration of VLDL Particles,BAMBI,BMP and activin membrane-bound inhibitor homolog,42346,0.00544167587640745,0.00297280637159524,-0.000385024611919224,0.0112683763647341,0.0672001444111433
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,40449,-0.00562336649957115,0.00307371700108459,-0.011647851821697,0.000401118822554654,0.0673511186593906
NMR metabolomics,X23428.Concentration of VLDL Particles,SBSN,Suprabasin,40511,-0.0063648827798009,0.00347975069618545,-0.0131851941443244,0.000455428584722589,0.0674078819651346
NMR metabolomics,X23428.Concentration of VLDL Particles,HLA_DRA,,42549,-0.00669785527448865,0.00366603029325172,-0.013883274649262,0.000487564100284723,0.067721340949944
NMR metabolomics,X23428.Concentration of VLDL Particles,SEZ6L2,Seizure 6-like protein 2,42587,0.00429526215309223,0.00235568074637899,-0.000321872109810589,0.00891239641599506,0.0682706422580355
NMR metabolomics,X23428.Concentration of VLDL Particles,JAM2,Junctional adhesion molecule B,42711,0.00512713586193931,0.00282013333287478,-0.000400325470495257,0.0106545971943739,0.0690790244874539
NMR metabolomics,X23428.Concentration of VLDL Particles,RPGR,X-linked retinitis pigmentosa GTPase regulator,40182,0.00774447529504616,0.00426032405004018,-0.000605759843032586,0.0160947104331249,0.0691198362122764
NMR metabolomics,X23428.Concentration of VLDL Particles,MYO6,Unconventional myosin-VI,40482,0.00656846810152089,0.00361399876426305,-0.000514969476434682,0.0136519056794765,0.0691660149467567
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A16,Protein S100-A16,42292,-0.0109333614724818,0.00603353738855378,-0.0227590947540472,0.000892371809083657,0.0699939334920387
NMR metabolomics,X23428.Concentration of VLDL Particles,LCN15,Lipocalin-15,40482,-0.0112762808264203,0.00622375897779022,-0.0234748484228891,0.000922286770048582,0.0700418223552696
NMR metabolomics,X23428.Concentration of VLDL Particles,CD58,Lymphocyte function-associated antigen 3,42600,0.00318469276196614,0.00175857480771605,-0.00026211386115732,0.00663149938508959,0.0701708149580023
NMR metabolomics,X23428.Concentration of VLDL Particles,TLR1,Toll-like receptor 1,40199,0.00479777931503376,0.00266817231397372,-0.000431838420354729,0.0100273970504223,0.072180323966711
NMR metabolomics,X23428.Concentration of VLDL Particles,LSM8,U6 snRNA-associated Sm-like protein LSm8,40302,0.0154592862611615,0.00859783729967064,-0.00139247484619293,0.032311047368516,0.0721972434133848
NMR metabolomics,X23428.Concentration of VLDL Particles,BOC,Brother of CDO,42357,-0.00418006681936321,0.00232569455642832,-0.00873842814996272,0.000378294511236302,0.0723043694299764
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNW1,Interferon omega-1,40116,-0.00658963622217877,0.00367462029984137,-0.0137918920098679,0.000612619565510321,0.0729552493378693
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,42346,-0.0143180196636926,0.00799181942874373,-0.0299819857440303,0.00134594641664508,0.0732225331601784
NMR metabolomics,X23428.Concentration of VLDL Particles,CHP1,Calcineurin B homologous protein 1,40136,0.0132324261543093,0.00738604631578637,-0.00124422462463202,0.0277090769332505,0.0732336824871387
NMR metabolomics,X23428.Concentration of VLDL Particles,IGLC2,Immunoglobulin lambda constant 2,40519,-0.00451441492310176,0.00252260504901274,-0.00945872081916673,0.000429890972963207,0.0735474405855723
NMR metabolomics,X23428.Concentration of VLDL Particles,ITM2A,Integral membrane protein 2A,42594,-0.0108953157860665,0.00612790679224491,-0.0229060130988665,0.00111538152673353,0.0754292730772411
NMR metabolomics,X23428.Concentration of VLDL Particles,GPR158,Probable G-protein coupled receptor 158,40482,0.00635286165177942,0.00358085391127696,-0.000665612014323428,0.0133713353178823,0.0760703869823997
NMR metabolomics,X23428.Concentration of VLDL Particles,FSTL3,Follistatin-related protein 3,42574,0.0059465615279778,0.00335458305982685,-0.000628421269282832,0.0125215443252384,0.0763065102729229
NMR metabolomics,X23428.Concentration of VLDL Particles,NEFL,Neurofilament light polypeptide,42262,0.0081372798213153,0.00459482487342037,-0.000868576930588632,0.0171431365732192,0.0765896178200612
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL25,C-C motif chemokine 25,42754,0.00837269094223806,0.00475210231923654,-0.000941429603465554,0.0176868114879417,0.0781100803197775
NMR metabolomics,X23428.Concentration of VLDL Particles,PRG3,Proteoglycan 3,40527,0.00869661392338862,0.00495471666136085,-0.00101463073287864,0.0184078585796559,0.0792488335537431
NMR metabolomics,X23428.Concentration of VLDL Particles,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,40080,0.0102526403879744,0.00584857195552323,-0.00121056064485111,0.0217158414207999,0.0796274013665683
NMR metabolomics,X23428.Concentration of VLDL Particles,CHGB,Secretogranin-1,42664,-0.00747900509474176,0.00426766893671936,-0.0158436362107117,0.000885626021228182,0.0797140306475347
NMR metabolomics,X23428.Concentration of VLDL Particles,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,40116,0.0124971827327029,0.00714446197774428,-0.00150596274367592,0.0265003282090817,0.0802823681921544
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42679,0.00777179084410964,0.00444608672141472,-0.000942539129863203,0.0164861208180825,0.0804855674555538
NMR metabolomics,X23428.Concentration of VLDL Particles,KIAA2013,Uncharacterized protein KIAA2013,40451,0.00932407540111644,0.00533839603778453,-0.00113918083294123,0.0197873316351741,0.0807329514568063
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH23,Cadherin-23,40483,-0.00452489427610061,0.00259613184257403,-0.00961331268754571,0.000563524135344493,0.0813718449295617
NMR metabolomics,X23428.Concentration of VLDL Particles,ZPR1,Zinc finger protein ZPR1,40136,0.0168601275038776,0.00971583203161409,-0.00218290327808604,0.0359031582858412,0.0827113871976381
NMR metabolomics,X23428.Concentration of VLDL Particles,BTLA,B- and T-lymphocyte attenuator,40080,0.0151569625409699,0.00877306758175834,-0.00203824991927643,0.0323521750012163,0.0840758307286244
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42495,0.00665802049258029,0.00385815926488212,-0.000903971666588656,0.0142200126517492,0.0844248540904739
NMR metabolomics,X23428.Concentration of VLDL Particles,AMPD3,AMP deaminase 3,40483,0.0121331325662372,0.00703162297249504,-0.00164884845985304,0.0259151135923275,0.0844630506948207
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC12A,C-type lectin domain family 12 member A,40199,0.00355634854475013,0.00206351308898775,-0.000488137109665869,0.00760083419916612,0.0848364138744709
NMR metabolomics,X23428.Concentration of VLDL Particles,IL4,Interleukin-4,42370,0.0160109805642273,0.00930703065143649,-0.00223079951258823,0.0342527606410428,0.0853995347392956
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH15,Cadherin-15,42692,0.0106256886587926,0.00618708894524152,-0.00150100567388074,0.022752382991466,0.0859295776259589
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA3G,Semaphorin-3G,40283,0.00765303293491509,0.00445629804550063,-0.00108131123426616,0.0163873771040963,0.0859427739634531
NMR metabolomics,X23428.Concentration of VLDL Particles,PGA4,Pepsin A-4,40532,0.0137112241861773,0.00802868584981201,-0.00202500007945422,0.0294474484518089,0.0877046609937296
NMR metabolomics,X23428.Concentration of VLDL Particles,SYT1,Synaptotagmin-1,40483,0.00718816499197353,0.00421199067237239,-0.00106733672587635,0.0154436667098234,0.0879247352096836
NMR metabolomics,X23428.Concentration of VLDL Particles,AIDA,"Axin interactor, dorsalization-associated protein",40182,0.0141700619639927,0.00836550323849014,-0.00222632438344795,0.0305664483114334,0.0903186257766912
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK15,Kallikrein-15,40429,0.00898284300598927,0.00530803657002753,-0.00142090867126469,0.0193865946832432,0.0906146233384491
NMR metabolomics,X23428.Concentration of VLDL Particles,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",40080,0.00975795209246209,0.00578358761619562,-0.00157787963528134,0.0210937838202055,0.0915974374715953
NMR metabolomics,X23428.Concentration of VLDL Particles,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,40182,-0.0053206219595894,0.00315496812836094,-0.0115043594911769,0.000863115571998052,0.091742062997959
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42711,-0.00778378702270786,0.00461751669105524,-0.0168341197371761,0.00126654569176042,0.0918750441014704
NMR metabolomics,X23428.Concentration of VLDL Particles,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",40182,-0.00835110868335555,0.00496478598203757,-0.0180820892081492,0.00137987184143808,0.092584028065685
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFL4,Insulin growth factor-like family member 4,40199,0.0123144796774487,0.00733710306773313,-0.0020662423353082,0.0266952016902057,0.093300464067665
NMR metabolomics,X23428.Concentration of VLDL Particles,MYH7B,Myosin-7B,40080,-0.0074950923770985,0.00446842823813127,-0.0162532117238358,0.00126302696963879,0.0935038945014475
NMR metabolomics,X23428.Concentration of VLDL Particles,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",40116,-0.0100089822835448,0.00597758760162751,-0.0217250539827347,0.00170708941564516,0.0940770424423811
NMR metabolomics,X23428.Concentration of VLDL Particles,DRAXIN,Draxin,42495,0.00728934234373567,0.00435614767324737,-0.00124870709582917,0.0158273917833005,0.0942827138870278
NMR metabolomics,X23428.Concentration of VLDL Particles,ACTN4,Alpha-actinin-4,42370,0.0054296747724799,0.00325316514422512,-0.000946528910201331,0.0118058784551611,0.095132478078562
NMR metabolomics,X23428.Concentration of VLDL Particles,DCUN1D2,DCN1-like protein 2,40080,0.0133137947103487,0.00798351420922463,-0.00233389313973156,0.028961482560429,0.0954118184978139
NMR metabolomics,X23428.Concentration of VLDL Particles,DNPEP,Aspartyl aminopeptidase,40483,0.00944369437278629,0.00567383021784447,-0.00167701285418887,0.0205644015997615,0.0960542409827299
NMR metabolomics,X23428.Concentration of VLDL Particles,GH2,Growth hormone variant,42346,0.0275690522625156,0.0165653381091132,-0.00489901043134631,0.0600371149563776,0.0960840308360844
NMR metabolomics,X23428.Concentration of VLDL Particles,CD33,Myeloid cell surface antigen CD33,42679,0.013224963654651,0.00794831011819111,-0.00235372417700352,0.0288036514863056,0.0961614227831662
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,40449,0.00843801647402125,0.00507686108901523,-0.0015126312604486,0.0183886642084911,0.0965298273701829
NMR metabolomics,X23428.Concentration of VLDL Particles,NECTIN4,Nectin-4,42679,-0.00567233598966794,0.00342384654707756,-0.01238307522194,0.00103840324260407,0.0976004878006909
NMR metabolomics,X23428.Concentration of VLDL Particles,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,40065,-0.00858109491299144,0.00518450839231495,-0.0187427313619287,0.00158054153594587,0.0979246674015196
NMR metabolomics,X23428.Concentration of VLDL Particles,ENDOU,Poly(U)-specific endoribonuclease,39633,0.00898948821020415,0.00545108110563596,-0.00169463075684233,0.0196736071772506,0.099153092131339
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRF,Receptor-type tyrosine-protein phosphatase F,42794,-0.00473251913960371,0.00287234700068123,-0.0103623192609389,0.000897280981731491,0.0994550063095495
NMR metabolomics,X23428.Concentration of VLDL Particles,THSD1,Thrombospondin type-1 domain-containing protein 1,40110,0.00563765359215887,0.00342654743809957,-0.00107837938651629,0.012353686570834,0.0999394526421739
NMR metabolomics,X23428.Concentration of VLDL Particles,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42653,0.00801103336242175,0.00487982250497268,-0.0015534187473247,0.0175754854721682,0.100682831893607
NMR metabolomics,X23428.Concentration of VLDL Particles,GAGE2A,G antigen 2A,40080,0.0108993153259606,0.00664092650783627,-0.00211690062939847,0.0239155312813197,0.100777708671888
NMR metabolomics,X23428.Concentration of VLDL Particles,EFNA1,Ephrin-A1,42590,0.00493068550396832,0.0030070159833588,-0.000963065823414923,0.0108244368313516,0.101085408351725
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN3B,Sodium channel subunit beta-3,40136,0.00785952349481561,0.00479818499333734,-0.00154491909212559,0.0172639660817568,0.101446252507346
NMR metabolomics,X23428.Concentration of VLDL Particles,TLR2,Toll-like receptor 2,40302,0.00381226478675484,0.0023320301031803,-0.000758514215478554,0.00838304378898823,0.102131728809768
NMR metabolomics,X23428.Concentration of VLDL Particles,SH3GL3,Endophilin-A3,40250,0.0138658062245001,0.00849986396635968,-0.0027939271495649,0.030525539598565,0.102856057792177
NMR metabolomics,X23428.Concentration of VLDL Particles,PEAR1,Platelet endothelial aggregation receptor 1,42794,0.00368028170613601,0.0022572621086626,-0.000743952026842691,0.0081045154391147,0.103036252298055
NMR metabolomics,X23428.Concentration of VLDL Particles,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42636,0.00534292288283035,0.0032814867215312,-0.0010887910913708,0.0117746368570315,0.103505519469456
NMR metabolomics,X23428.Concentration of VLDL Particles,GID8,Glucose-induced degradation protein 8 homolog,40482,0.00552376644078916,0.00340583374070974,-0.00115166769100194,0.0121992005725803,0.104862455051872
NMR metabolomics,X23428.Concentration of VLDL Particles,DKKL1,Dickkopf-like protein 1,42587,-0.0141424148335972,0.00872386349165317,-0.0312411872772374,0.002956357610043,0.105015808488787
NMR metabolomics,X23428.Concentration of VLDL Particles,MFAP3,Microfibril-associated glycoprotein 3,42357,0.00781477888922658,0.00482102097068492,-0.00163442221331586,0.017263979991769,0.105045866147608
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4C,C-type lectin domain family 4 member C,42594,0.00771028232655776,0.00476139908673252,-0.00162205988343797,0.0170426245365535,0.10539954350158
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHA4,Ephrin type-A receptor 4,40283,0.00470054295248738,0.00290291491237384,-0.000989170275765347,0.0103902561807401,0.105422070827862
NMR metabolomics,X23428.Concentration of VLDL Particles,IL21R,Interleukin-21 receptor,40199,0.00902479562274988,0.0055773833103973,-0.00190687566562883,0.0199564669111286,0.105668482147553
NMR metabolomics,X23428.Concentration of VLDL Particles,VSTM2B,V-set and transmembrane domain-containing protein 2B,40302,0.00652314095103616,0.0040353942700816,-0.00138623181832378,0.0144325137203961,0.106018605851562
NMR metabolomics,X23428.Concentration of VLDL Particles,DLGAP5,Disks large-associated protein 5,40482,0.00813618147310182,0.00505217096729969,-0.00176607362280558,0.0180384365690092,0.107331381238958
NMR metabolomics,X23428.Concentration of VLDL Particles,AMBN,Ameloblastin,42370,-0.00457657188306454,0.00284666663520896,-0.0101560384880741,0.00100289472194502,0.107925941501943
NMR metabolomics,X23428.Concentration of VLDL Particles,RALB,Ras-related protein Ral-B,40199,0.00479908150537424,0.00298748906091506,-0.00105639705401928,0.0106545600647678,0.1082162787566
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC4D,C-type lectin domain family 4 member D,42594,0.00990155890814618,0.00617446252352856,-0.0022003876379698,0.0220035054542621,0.108819002727578
NMR metabolomics,X23428.Concentration of VLDL Particles,CX3CL1,Fractalkine,42495,-0.00547814609529708,0.00341980354912482,-0.0121809610515817,0.00122466886098757,0.109203877570928
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK3,Prostate-specific antigen,40527,0.0155455910203235,0.00976783528711673,-0.00359936614242533,0.0346905481830722,0.11152311759089
NMR metabolomics,X23428.Concentration of VLDL Particles,PMCH,Pro-MCH,40116,-0.0133231074461497,0.0084476072886455,-0.0298804177318949,0.00323420283959552,0.114790966665089
NMR metabolomics,X23428.Concentration of VLDL Particles,DOCK9,Dedicator of cytokinesis protein 9,40136,0.0189576110949601,0.0120279682934313,-0.00461720676016514,0.0425324289500854,0.115025341399833
NMR metabolomics,X23428.Concentration of VLDL Particles,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,40136,-0.00965264700677402,0.00613989574931406,-0.0216868426754296,0.00238154866188155,0.115951859901864
NMR metabolomics,X23428.Concentration of VLDL Particles,UPK3A,Uroplakin-3a,40136,0.00799403118716242,0.00509379752623105,-0.00198981196425045,0.0179778743385753,0.116591663831804
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT14,"Keratin, type I cytoskeletal 14",41948,0.00456134153615036,0.00291007159281344,-0.00114239878576399,0.0102650818580647,0.11703838103281
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,40482,0.00505682306549931,0.00323004844928718,-0.00127407189510357,0.0113877180261022,0.117480532207214
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCL2,Phosducin-like protein 2,40080,0.00825869401263466,0.00528513853917541,-0.00210017752414915,0.0186175655494185,0.118169696474493
NMR metabolomics,X23428.Concentration of VLDL Particles,ADA2,Adenosine deaminase 2,42572,-0.00685909410114573,0.00440176384292523,-0.0154865512332792,0.00176836303098771,0.119195196706105
NMR metabolomics,X23428.Concentration of VLDL Particles,NCAM2,Neural cell adhesion molecule 2,42611,-0.00419788673224203,0.00269673795451164,-0.00948349312308483,0.00108771965860078,0.119576346583293
NMR metabolomics,X23428.Concentration of VLDL Particles,SOD3,Extracellular superoxide dismutase,40532,-0.00903844424254449,0.00581264915853049,-0.0204312365932642,0.00235434810817527,0.119983207702576
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRING1,SREBP regulating gene protein,40080,0.00915443614529731,0.00589425304338616,-0.00239829981973957,0.0207071721103342,0.120425408624023
NMR metabolomics,X23428.Concentration of VLDL Particles,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",40199,0.00990837167177338,0.00641852372147424,-0.00267193482231613,0.0224886781658629,0.122686131713081
NMR metabolomics,X23428.Concentration of VLDL Particles,CSPG5,Chondroitin sulfate proteoglycan 5,40136,-0.00789292963508746,0.00511884474510459,-0.0179258653354925,0.00214000606531754,0.123118128812575
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA10,Annexin A10,42311,-0.0131962431708374,0.00857211326287239,-0.0299975851660672,0.00360509882439252,0.123721346020424
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK4,Kallikrein-4,42721,-0.00968140963382379,0.0063084672417392,-0.0220460054276326,0.00268318615998504,0.124888521286709
NMR metabolomics,X23428.Concentration of VLDL Particles,UBE2B,Ubiquitin-conjugating enzyme E2 B,40451,0.00439494725111519,0.0028663431097462,-0.00122308524398736,0.0100129797462177,0.125231486318954
NMR metabolomics,X23428.Concentration of VLDL Particles,EPN1,Epsin-1,40302,0.00678109521726781,0.00443284131898962,-0.00190727376795184,0.0154694642024875,0.126109543578017
NMR metabolomics,X23428.Concentration of VLDL Particles,DOC2B,Double C2-like domain-containing protein beta,40182,0.00549525577601831,0.0036026546920716,-0.00156594742044203,0.0125564589724787,0.127204309576383
NMR metabolomics,X23428.Concentration of VLDL Particles,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,40182,0.00770495659873361,0.00506948329556037,-0.00223123066056471,0.0176411438580319,0.128572373498244
NMR metabolomics,X23428.Concentration of VLDL Particles,GFRA3,GDNF family receptor alpha-3,42474,0.00433626079108101,0.00285935384430952,-0.00126807274376566,0.00994059432592767,0.129412293470289
NMR metabolomics,X23428.Concentration of VLDL Particles,CD3E,T-cell surface glycoprotein CD3 epsilon chain,40302,0.00555529956108583,0.0036689902113233,-0.00163592125310783,0.0127465203752795,0.130023298658211
NMR metabolomics,X23428.Concentration of VLDL Particles,NOS2,"Nitric oxide synthase, inducible",40116,-0.00600741524023328,0.00397111719297195,-0.0137908049384583,0.00177597445799174,0.13036521541965
NMR metabolomics,X23428.Concentration of VLDL Particles,SNX18,Sorting nexin-18,40449,0.00657503282242585,0.00435746007687422,-0.00196558892824762,0.0151156545730993,0.131348813332087
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGAX,Integrin alpha-X,40302,0.0081719120123486,0.00542040254902745,-0.00245207698374521,0.0187959010084424,0.131680026383876
NMR metabolomics,X23428.Concentration of VLDL Particles,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,40116,0.00799902109194986,0.00532131483956934,-0.00243075599360605,0.0184287981775058,0.132815390780694
NMR metabolomics,X23428.Concentration of VLDL Particles,MAMDC2,MAM domain-containing protein 2,40511,0.00543281675713339,0.0036336869535586,-0.00168920967184147,0.0125548431861083,0.134909665650091
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC13A1,Solute carrier family 13 member 1,40451,0.00928246198749584,0.00622211292034203,-0.00291287933637455,0.0214778033113662,0.135766375804018
NMR metabolomics,X23428.Concentration of VLDL Particles,LY96,Lymphocyte antigen 96,42495,-0.00527260516588287,0.0035475395849785,-0.0122257827524407,0.00168057242067499,0.137231158829392
NMR metabolomics,X23428.Concentration of VLDL Particles,GSTM4,Glutathione S-transferase Mu 4,40116,-0.0110321460290144,0.00742582629214806,-0.0255867655616246,0.00352247350359581,0.137401753490112
NMR metabolomics,X23428.Concentration of VLDL Particles,CEND1,Cell cycle exit and neuronal differentiation protein 1,40136,0.00875380647003652,0.00590100735894923,-0.00281216795350396,0.020319780893577,0.137985623566124
NMR metabolomics,X23428.Concentration of VLDL Particles,KCNC4,Potassium voltage-gated channel subfamily C member 4,40136,0.00828881348173716,0.00559985632859375,-0.0026869049223066,0.0192645318857809,0.138853142746953
NMR metabolomics,X23428.Concentration of VLDL Particles,HNF1A,Hepatocyte nuclear factor 1-alpha,40182,0.0105488576985912,0.00713600289355502,-0.00343770797277662,0.0245354233699591,0.139367235654099
NMR metabolomics,X23428.Concentration of VLDL Particles,MET,Hepatocyte growth factor receptor,42654,0.00290170393412209,0.00196930130192753,-0.000958126617655876,0.00676153448590006,0.140648067900873
NMR metabolomics,X23428.Concentration of VLDL Particles,CCN3,CCN family member 3,42779,0.00516926078588014,0.00352005247311352,-0.00173004206142237,0.0120685636331826,0.141986695629876
NMR metabolomics,X23428.Concentration of VLDL Particles,AHSP,Alpha-hemoglobin-stabilizing protein,42590,0.01208682207884,0.00825291568615217,-0.0040888926660182,0.0282625368236983,0.143066721887635
NMR metabolomics,X23428.Concentration of VLDL Particles,GRIK2,"Glutamate receptor ionotropic, kainate 2",40482,0.00651650496990977,0.00445234107032444,-0.00221008352792613,0.0152430934677457,0.14332752046067
NMR metabolomics,X23428.Concentration of VLDL Particles,SCG3,Secretogranin-3,42638,-0.00494241178021241,0.00338726521095162,-0.0115814515936776,0.00169662803325276,0.144556634540236
NMR metabolomics,X23428.Concentration of VLDL Particles,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,42357,0.00484138548669924,0.0033258000311743,-0.00167718257440237,0.0113599535478009,0.145497890137763
NMR metabolomics,X23428.Concentration of VLDL Particles,CBLN1,Cerebellin-1,40136,0.0137635767199284,0.00945723851567658,-0.00477261077079769,0.0322997642106545,0.14560152803272
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,40527,-0.0205132257870975,0.0141266391304243,-0.0482014384827291,0.00717498690853416,0.146502801330602
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM3D,Protein FAM3D,40449,-0.01228260077101,0.00852699341648544,-0.0289955078673215,0.00443030632530144,0.149771486858947
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMD5,26S proteasome non-ATPase regulatory subunit 5,40182,-0.00801264794079789,0.00556796363996048,-0.0189258566751204,0.00290056079352465,0.150161286515897
NMR metabolomics,X23428.Concentration of VLDL Particles,SHISA5,Protein shisa-5,40527,0.00398187141745669,0.00276737066385649,-0.00144217508370203,0.00940591791861542,0.150216532516856
NMR metabolomics,X23428.Concentration of VLDL Particles,LPO,Lactoperoxidase,42134,-0.00863740450409819,0.00604061701034245,-0.0204770138443694,0.00320220483617301,0.152773370167916
NMR metabolomics,X23428.Concentration of VLDL Particles,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,40136,0.0107738701806413,0.00753529368572016,-0.00399530544337021,0.0255430458046528,0.152806513038565
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE10,Inactive ribonuclease-like protein 10,40223,-0.00704331288787209,0.00492770787647049,-0.0167016203257542,0.00261499455001007,0.152938185649898
NMR metabolomics,X23428.Concentration of VLDL Particles,RAC3,Ras-related C3 botulinum toxin substrate 3,40182,0.0101149751123978,0.0070929586507666,-0.00378722384310476,0.0240171740679003,0.153879819109206
NMR metabolomics,X23428.Concentration of VLDL Particles,PLAUR,Urokinase plasminogen activator surface receptor,42547,-0.00396840038709024,0.00278336451235933,-0.00942379483131452,0.00148699405713405,0.153961981702337
NMR metabolomics,X23428.Concentration of VLDL Particles,COL5A1,Collagen alpha-1(V) chain,40283,-0.00585740380346664,0.00411135045011443,-0.0139156506856909,0.00220084307875764,0.154274696348456
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17RA,Interleukin-17 receptor A,42611,0.00621633131687183,0.00436612026852957,-0.00234126440944613,0.0147739270431898,0.154537626017887
NMR metabolomics,X23428.Concentration of VLDL Particles,SHPK,Sedoheptulokinase,40302,-0.00582349076879384,0.0040903617297706,-0.0138405997591442,0.00219361822155653,0.154558392953697
NMR metabolomics,X23428.Concentration of VLDL Particles,BCL7A,B-cell CLL/lymphoma 7 protein family member A,40080,0.00902573021916256,0.00637702278947924,-0.00347323444821675,0.0215246948865419,0.15699400185698
NMR metabolomics,X23428.Concentration of VLDL Particles,HDAC8,Histone deacetylase 8,40199,0.00830715252590493,0.00589134241705445,-0.00323987861152178,0.0198541836633316,0.158549915664884
NMR metabolomics,X23428.Concentration of VLDL Particles,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,40136,0.00704449566865842,0.00501273704595948,-0.00278046894142217,0.016869460278739,0.15995476899049
NMR metabolomics,X23428.Concentration of VLDL Particles,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,42357,-0.00298248602779447,0.00212337209030879,-0.0071442953247997,0.00117932326921075,0.160164190468027
NMR metabolomics,X23428.Concentration of VLDL Particles,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",40302,0.00979448294419455,0.00704092215745174,-0.00400572448441086,0.0235946903728,0.16422916200836
NMR metabolomics,X23428.Concentration of VLDL Particles,DENND2B,DENN domain-containing protein 2B,40116,-0.00692072575474419,0.00497966012140887,-0.0166808595927056,0.0028394080832172,0.164618303039382
NMR metabolomics,X23428.Concentration of VLDL Particles,BRD2,Bromodomain-containing protein 2,40136,0.00494813346111106,0.00356377379770435,-0.00203686318238946,0.0119331301046116,0.165027322008559
NMR metabolomics,X23428.Concentration of VLDL Particles,HRAS,GTPase Hras,40286,0.0137380149403579,0.00992479966266807,-0.00571459239847154,0.0331906222791873,0.166321763495363
NMR metabolomics,X23428.Concentration of VLDL Particles,FABP3,"Fatty acid-binding protein, heart",40511,0.00718726088768169,0.005219088771299,-0.00304215310406434,0.0174166748794277,0.16850538708257
NMR metabolomics,X23428.Concentration of VLDL Particles,RGS8,Regulator of G-protein signaling 8,42370,0.00880513629834446,0.0064072249759361,-0.00375302465449029,0.0213632972511792,0.169387100148566
NMR metabolomics,X23428.Concentration of VLDL Particles,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42618,-0.00545383401178967,0.00397117899773949,-0.0132373448473591,0.00232967682377974,0.169665302000022
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFA1_DEFA1B,Neutrophil defensin 1,42351,0.00749012132272274,0.00545710496006926,-0.003205804399013,0.0181860470444585,0.169917281969537
NMR metabolomics,X23428.Concentration of VLDL Particles,LY6D,Lymphocyte antigen 6D,42548,0.00554946010943826,0.00404768862603166,-0.00238400959758379,0.0134829298164603,0.170391911585479
NMR metabolomics,X23428.Concentration of VLDL Particles,CLSTN2,Calsyntenin-2,42754,-0.00538669509143565,0.00393568732643922,-0.0131006422512565,0.00232725206838522,0.171122112300715
NMR metabolomics,X23428.Concentration of VLDL Particles,NUP50,Nuclear pore complex protein Nup50,40116,-0.00473659964151399,0.00346072858654917,-0.0115196276711504,0.00204642838812239,0.171130217581546
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASET2,Ribonuclease T2,42749,0.00374315113371178,0.00274177810451999,-0.00163073395114741,0.00911703621857096,0.172204183859633
NMR metabolomics,X23428.Concentration of VLDL Particles,RAB6B,Ras-related protein Rab-6B,42311,0.00665918712042185,0.00489665532460558,-0.00293825731580508,0.0162566315566488,0.173870366640881
NMR metabolomics,X23428.Concentration of VLDL Particles,PRND,Prion-like protein doppel,40483,-0.00705625577133871,0.00520390459585273,-0.0172559087792101,0.00314339723653264,0.175140894411458
NMR metabolomics,X23428.Concentration of VLDL Particles,NTF3,Neurotrophin-3,42594,0.00481700494783591,0.00356202461025187,-0.00216456328825776,0.0117985731839296,0.17629508731945
NMR metabolomics,X23428.Concentration of VLDL Particles,ART5,Ecto-ADP-ribosyltransferase 5,40136,0.00863729116527437,0.00641341666798724,-0.00393300550398062,0.0212075878345294,0.178087537444913
NMR metabolomics,X23428.Concentration of VLDL Particles,PAPPA,Pappalysin-1,42370,0.0062503448987516,0.00464268058476508,-0.00284930904738794,0.0153499988448912,0.178235609909879
NMR metabolomics,X23428.Concentration of VLDL Particles,CGA,Glycoprotein hormones alpha chain,42611,-0.00840614948190187,0.00625386507347126,-0.0206637250259055,0.0038514260621018,0.178921747569123
NMR metabolomics,X23428.Concentration of VLDL Particles,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",40199,0.00632102748593163,0.00470401185898468,-0.00289883575767834,0.0155408907295416,0.1790561524141
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,40177,0.00508129371692589,0.0037870844900987,-0.00234139188366756,0.0125039793175193,0.17970711199634
NMR metabolomics,X23428.Concentration of VLDL Particles,SMPD1,Sphingomyelin phosphodiesterase,42644,-0.00655102244799792,0.00489614899872787,-0.0161474744855045,0.00304542958950871,0.180920715845716
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42754,0.00550184864215032,0.00411806579657308,-0.00256956031913291,0.0135732576034336,0.181562745928922
NMR metabolomics,X23428.Concentration of VLDL Particles,THRAP3,Thyroid hormone receptor-associated protein 3,40116,0.0146759927734587,0.0109894021014059,-0.00686323534529691,0.0362152208922144,0.181751113424323
NMR metabolomics,X23428.Concentration of VLDL Particles,CLINT1,Clathrin interactor 1,40080,0.00614526633987502,0.00460188604495965,-0.00287443030824589,0.0151649629879959,0.181779945771022
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42495,-0.00449824642824788,0.00338208864977184,-0.0111271401818007,0.00213064732530493,0.183534401260911
NMR metabolomics,X23428.Concentration of VLDL Particles,TRPV3,Transient receptor potential cation channel subfamily V member 3,40116,-0.00643946722623103,0.00484761050580328,-0.0159407838176055,0.0030618493651434,0.184080468559723
NMR metabolomics,X23428.Concentration of VLDL Particles,LYPLA2,Acyl-protein thioesterase 2,40136,0.0147458370228588,0.0111624219833961,-0.00713251006459749,0.0366241841103151,0.186520697398546
NMR metabolomics,X23428.Concentration of VLDL Particles,CSRP3,Cysteine and glycine-rich protein 3,40116,-0.0130981404674066,0.00996386183108883,-0.0326273096563408,0.00643102872152746,0.188683862739475
NMR metabolomics,X23428.Concentration of VLDL Particles,IL2,Interleukin-2,42370,-0.00419077842832363,0.00318805421759837,-0.0104393646948164,0.00205780783816917,0.188692317748891
NMR metabolomics,X23428.Concentration of VLDL Particles,OGN,Mimecan,42611,0.00576695019763032,0.00439887171285448,-0.00285483835956446,0.0143887387548251,0.189877944191082
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL15,C-C motif chemokine 15,42794,0.00579805604235175,0.00443437829718171,-0.0028933254201244,0.0144894375048279,0.191056912892796
NMR metabolomics,X23428.Concentration of VLDL Particles,MLLT1,Protein ENL,40080,0.00864362438115933,0.00661357268278817,-0.00431897807710549,0.0216062268394241,0.191256500715156
NMR metabolomics,X23428.Concentration of VLDL Particles,ENG,Endoglin,42794,0.00225411524868203,0.00172516449942233,-0.00112720717018574,0.0056354376675498,0.1913676748087
NMR metabolomics,X23428.Concentration of VLDL Particles,IL15,Interleukin-15,42594,-0.00427902640861625,0.00329410102081304,-0.0107354644094098,0.0021774115921773,0.193967406957083
NMR metabolomics,X23428.Concentration of VLDL Particles,SCARB1,Scavenger receptor class B member 1,42311,0.00749832862610402,0.00577820860397579,-0.00382696023768854,0.0188236174898966,0.19441639768203
NMR metabolomics,X23428.Concentration of VLDL Particles,FCAR,Immunoglobulin alpha Fc receptor,42594,0.00625762995791278,0.00484250615811215,-0.00323368211198703,0.0157489420278126,0.196299916017271
NMR metabolomics,X23428.Concentration of VLDL Particles,CDK1,Cyclin-dependent kinase 1,40080,0.00473935996377594,0.00367121153931932,-0.00245621465328992,0.0119349345808418,0.196747539539225
NMR metabolomics,X23428.Concentration of VLDL Particles,M6PR,Cation-dependent mannose-6-phosphate receptor,40223,0.00513122819790123,0.0039840581441818,-0.0026775257646951,0.0129399821604976,0.19779384093534
NMR metabolomics,X23428.Concentration of VLDL Particles,TMPRSS5,Transmembrane protease serine 5,42438,0.0048728925059288,0.00378485969554346,-0.00254543249733638,0.012291217509194,0.197953091390002
NMR metabolomics,X23428.Concentration of VLDL Particles,SAT1,Diamine acetyltransferase 1,40116,-0.00659254304220927,0.00512274491251332,-0.0166331230707354,0.00344803698631684,0.198150797148451
NMR metabolomics,X23428.Concentration of VLDL Particles,RRP15,RRP15-like protein,40136,-0.0117663364839645,0.00915238737440303,-0.0297050157377945,0.00617234276986542,0.198608863400305
NMR metabolomics,X23428.Concentration of VLDL Particles,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,40532,0.00481793998197807,0.00375377686582523,-0.00253946267503938,0.0121753426389955,0.199346233934174
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC39A14,Zinc transporter ZIP14,42311,-0.0043906352465581,0.00342984484468057,-0.011113131142132,0.00233186064901582,0.200523291248801
NMR metabolomics,X23428.Concentration of VLDL Particles,PPIE,Peptidyl-prolyl cis-trans isomerase E,40302,0.00811134003640762,0.00633844179819621,-0.00431200588805696,0.0205346859608722,0.200675389629015
NMR metabolomics,X23428.Concentration of VLDL Particles,IL36G,Interleukin-36 gamma,40154,0.00876014114449513,0.00686206106723933,-0.00468949854729396,0.0222097808362842,0.2017688004853
NMR metabolomics,X23428.Concentration of VLDL Particles,PRSS8,Prostasin,42568,0.00528414772005498,0.00415264507356296,-0.00285503662412843,0.0134233320642384,0.203225609906568
NMR metabolomics,X23428.Concentration of VLDL Particles,SPRR1B,Cornifin-B,40302,-0.0105167508879973,0.00827208758736732,-0.0267300425592373,0.0056965407832426,0.203629392138693
NMR metabolomics,X23428.Concentration of VLDL Particles,LRP2,Low-density lipoprotein receptor-related protein 2,40182,0.00465293584602513,0.00366839317449103,-0.00253711477597729,0.0118429864680275,0.204687273112177
NMR metabolomics,X23428.Concentration of VLDL Particles,SCP2,Non-specific lipid-transfer protein,42346,0.00930387578858768,0.00734238483887652,-0.0050871984956103,0.0236949500727857,0.205125419248408
NMR metabolomics,X23428.Concentration of VLDL Particles,TNC,Tenascin,42689,-0.00600534319934036,0.00479013611625867,-0.0153940099872073,0.00338332358852663,0.209976615349054
NMR metabolomics,X23428.Concentration of VLDL Particles,VCAN,Versican core protein,42711,0.00379557700602979,0.00303234460861913,-0.0021478184268637,0.00973897243892328,0.210701910828249
NMR metabolomics,X23428.Concentration of VLDL Particles,C9orf40,Uncharacterized protein C9orf40,40449,0.0100555668884919,0.00808010138000993,-0.00578143181632753,0.0258925655933114,0.213346943103237
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE6,Ribonuclease K6,40468,0.00420872348109378,0.00338336708026415,-0.00242267599622395,0.0108401229584115,0.213545568851841
NMR metabolomics,X23428.Concentration of VLDL Particles,TCL1B,T-cell leukemia/lymphoma protein 1B,42357,0.00953072885203552,0.00772012382491619,-0.00560071384480021,0.0246621715488712,0.217027301344685
NMR metabolomics,X23428.Concentration of VLDL Particles,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,40482,0.0141241960981684,0.0114603943689518,-0.0083381768649772,0.036586569061314,0.217812140333173
NMR metabolomics,X23428.Concentration of VLDL Particles,VWA5A,von Willebrand factor A domain-containing protein 5A,40080,0.00949469824639453,0.00774218073012743,-0.00567997598465524,0.0246693724774443,0.220089879365929
NMR metabolomics,X23428.Concentration of VLDL Particles,AMIGO1,Amphoterin-induced protein 1,40182,0.00614289476082642,0.00503207697001895,-0.00371997610041071,0.0160057656220636,0.222207878657689
NMR metabolomics,X23428.Concentration of VLDL Particles,SLK,STE20-like serine/threonine-protein kinase,40302,0.00970576324976662,0.00795749129836527,-0.0058909196950293,0.0253024461945625,0.222603988217352
NMR metabolomics,X23428.Concentration of VLDL Particles,PALM3,Paralemmin-3,40116,0.00868500239257407,0.0071326344701432,-0.00529496116890661,0.0226649659540547,0.223385974273428
NMR metabolomics,X23428.Concentration of VLDL Particles,ACRV1,Acrosomal protein SP-10,40199,0.00972684953995567,0.00798991543859002,-0.00593338471968077,0.0253870837995921,0.223481665523313
NMR metabolomics,X23428.Concentration of VLDL Particles,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",42370,0.0137635522663872,0.0113231216005221,-0.00842976607063614,0.0359568706034106,0.224187197329361
NMR metabolomics,X23428.Concentration of VLDL Particles,ARID3A,AT-rich interactive domain-containing protein 3A,40136,0.00492042832184472,0.00404883963773743,-0.00301529736812064,0.0128561540118101,0.22428982418764
NMR metabolomics,X23428.Concentration of VLDL Particles,CDSN,Corneodesmosin,42710,0.00537167175228241,0.00442126203058567,-0.00329400182766551,0.0140373453322303,0.224401257179096
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPK13,Mitogen-activated protein kinase 13,40080,0.00504371223998836,0.0041631645774227,-0.00311609033176013,0.0132035148117368,0.225726603235358
NMR metabolomics,X23428.Concentration of VLDL Particles,CCNE1,G1/S-specific cyclin-E1,40199,0.0106463904197379,0.00883351741511959,-0.00666730371389649,0.0279600845533723,0.228141739729032
NMR metabolomics,X23428.Concentration of VLDL Particles,STX1B,Syntaxin-1B,40182,0.00485136423244622,0.00403751830605948,-0.00306217164743035,0.0127649001123228,0.22955574478529
NMR metabolomics,X23428.Concentration of VLDL Particles,CST7,Cystatin-F,42642,0.01105048645907,0.00928747864086597,-0.00715297167702731,0.0292539445951673,0.234135670736153
NMR metabolomics,X23428.Concentration of VLDL Particles,CPA2,Carboxypeptidase A2,42670,0.00770745421759179,0.00654729482650174,-0.00512524364235163,0.0205401520775352,0.239137774734717
NMR metabolomics,X23428.Concentration of VLDL Particles,REXO2,"Oligoribonuclease, mitochondrial",40116,-0.00561339393667302,0.00477789233268168,-0.0149780629087291,0.00375127503538308,0.240073048257751
NMR metabolomics,X23428.Concentration of VLDL Particles,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",40482,0.00500633557798834,0.00426296517619396,-0.00334907616735181,0.0133617473233285,0.240268140247832
NMR metabolomics,X23428.Concentration of VLDL Particles,GPHA2,Glycoprotein hormone alpha-2,40449,0.00541357950367062,0.00463242119208944,-0.00366596603282468,0.0144931250401659,0.242578085553436
NMR metabolomics,X23428.Concentration of VLDL Particles,ESPL1,Separin,40080,0.00666657953186065,0.00573061278840387,-0.00456542153341094,0.0178985805971322,0.244722144847565
NMR metabolomics,X23428.Concentration of VLDL Particles,EPO,Erythropoietin,42594,-0.00853174357336084,0.00733586023521958,-0.0229100296343912,0.00584654248766953,0.244842573833741
NMR metabolomics,X23428.Concentration of VLDL Particles,GIPR,Gastric inhibitory polypeptide receptor,40199,0.00566763008041472,0.00488097467946154,-0.00389908029132989,0.0152343404521593,0.245598897937702
NMR metabolomics,X23428.Concentration of VLDL Particles,MUCL3,Mucin-like protein 3,40080,-0.00492052284523821,0.00424111380326592,-0.0132331058996394,0.00339206020916298,0.245994499559702
NMR metabolomics,X23428.Concentration of VLDL Particles,ISM2,Isthmin-2,40527,0.00498532519311552,0.00431109983632148,-0.00346443048607459,0.0134350808723056,0.247544864640765
NMR metabolomics,X23428.Concentration of VLDL Particles,RTKN2,Rhotekin-2,40116,-0.00594531967944872,0.00514459450478784,-0.0160287249088329,0.00413808554993545,0.247852089689742
NMR metabolomics,X23428.Concentration of VLDL Particles,TNR,Tenascin-R,42495,0.00485453006452512,0.00421105377246502,-0.00339913532950633,0.0131081954585566,0.249010542168868
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,40511,0.00851801687037564,0.00741290458507418,-0.00601127611636976,0.023047309857121,0.250547475415139
NMR metabolomics,X23428.Concentration of VLDL Particles,KCNH2,Potassium voltage-gated channel subfamily H member 2,40182,0.00898114518123776,0.00781969310403436,-0.00634545330266958,0.0243077436651451,0.250775203754883
NMR metabolomics,X23428.Concentration of VLDL Particles,PODXL2,Podocalyxin-like protein 2,42679,0.0032182460217571,0.00280544716058737,-0.00228043041299414,0.00871692245650835,0.251343326265261
NMR metabolomics,X23428.Concentration of VLDL Particles,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42638,0.0038828240385915,0.00338697537604744,-0.00275564769846148,0.0105212957756445,0.251650639623396
NMR metabolomics,X23428.Concentration of VLDL Particles,CADPS,Calcium-dependent secretion activator 1,40182,0.00488438293224761,0.00426261015644606,-0.00347033297438668,0.0132390988388819,0.251875275721625
NMR metabolomics,X23428.Concentration of VLDL Particles,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,40223,-0.00452169141604566,0.00394663842339704,-0.0122571027259038,0.00321371989381253,0.251941249706235
NMR metabolomics,X23428.Concentration of VLDL Particles,CD3D,T-cell surface glycoprotein CD3 delta chain,40136,-0.003871296550985,0.00339052491685185,-0.0105167253880146,0.00277413228604463,0.253562736646483
NMR metabolomics,X23428.Concentration of VLDL Particles,USP28,Ubiquitin carboxyl-terminal hydrolase 28,40483,0.00429951770365445,0.00377685942350421,-0.00310312676641381,0.0117021621737227,0.254984178856368
NMR metabolomics,X23428.Concentration of VLDL Particles,MED21,Mediator of RNA polymerase II transcription subunit 21,40116,0.00545019625919057,0.00478814757096928,-0.00393457297990922,0.0148349654982904,0.255033463144902
NMR metabolomics,X23428.Concentration of VLDL Particles,AMY2B,Alpha-amylase 2B,41779,-0.00566660360390085,0.00498338035703066,-0.0154340291036809,0.00410082189587924,0.255517982535849
NMR metabolomics,X23428.Concentration of VLDL Particles,PGM2,Phosphoglucomutase-2,40182,0.00671848075943429,0.0059503790213738,-0.00494426212245836,0.0183812236413269,0.258886835701398
NMR metabolomics,X23428.Concentration of VLDL Particles,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,40223,0.00235660870815266,0.002092022700339,-0.00174375578451179,0.0064569732008171,0.259989544313269
NMR metabolomics,X23428.Concentration of VLDL Particles,EDN1,Endothelin-1,40223,0.00340188542750913,0.00303040106085621,-0.00253770065176905,0.00934147150678731,0.26163785415349
NMR metabolomics,X23428.Concentration of VLDL Particles,FBN2,Fibrillin-2,40182,0.00675819087716759,0.00605987206942536,-0.00511915837890613,0.0186355401332413,0.264773453441876
NMR metabolomics,X23428.Concentration of VLDL Particles,TOP1,DNA topoisomerase 1,40449,0.0124427651949147,0.0111607070227859,-0.00943222056974578,0.0343177509595751,0.264928873147654
NMR metabolomics,X23428.Concentration of VLDL Particles,TPSG1,Tryptase gamma,40199,0.00294541398692838,0.00265024203994361,-0.00224906041136111,0.00813988838521786,0.266431046756631
NMR metabolomics,X23428.Concentration of VLDL Particles,OMD,Osteomodulin,42676,0.00463831631088261,0.00418646709200923,-0.00356715918945548,0.0128437918112207,0.267911418618538
NMR metabolomics,X23428.Concentration of VLDL Particles,SHH,Sonic hedgehog protein,40199,-0.00466083358622242,0.00421070096086728,-0.0129138074695223,0.00359214029707745,0.268360467280585
NMR metabolomics,X23428.Concentration of VLDL Particles,CORO6,Coronin-6,40136,-0.00409565308587666,0.00370830735848037,-0.0113639355084982,0.00317262933674487,0.269420744937641
NMR metabolomics,X23428.Concentration of VLDL Particles,HIP1,Huntingtin-interacting protein 1,40116,0.00364455261399907,0.00333105054732972,-0.00288430645876717,0.0101734116867653,0.273928641000305
NMR metabolomics,X23428.Concentration of VLDL Particles,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,40116,-0.00529866166909614,0.00484863783003261,-0.0148019918159601,0.00420466847776778,0.274499362104636
NMR metabolomics,X23428.Concentration of VLDL Particles,TFAP2A,Transcription factor AP-2-alpha,40136,0.0066283335197835,0.00607931739631041,-0.00528712857698489,0.0185437956165519,0.275601130488697
NMR metabolomics,X23428.Concentration of VLDL Particles,PLA2G2A,"Phospholipase A2, membrane associated",42602,0.00616400857651759,0.00565890850954871,-0.00492745210219787,0.0172554692552331,0.276059922489969
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK8,Serine protease inhibitor Kazal-type 8,40116,0.00410067378713325,0.00376885216269518,-0.00328627645174929,0.0114876240260158,0.276600066542404
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPAN7,Tetraspanin-7,40136,-0.0101429615067488,0.00939348212807544,-0.0285541864777766,0.0082682634642791,0.280260764654132
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGB5,Integrin beta-5,42679,0.00397022136829229,0.00368788198690509,-0.00325802732604169,0.0111984700626263,0.28169673094836
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,40116,-0.00546023386776354,0.00507469225856315,-0.0154066306945473,0.00448616295902023,0.281962920978659
NMR metabolomics,X23428.Concentration of VLDL Particles,HEBP1,Heme-binding protein 1,42357,0.00561363635850309,0.00523712763848098,-0.00465113381291964,0.0158784065299258,0.283788097922651
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH6,Cadherin-6,42636,-0.0040908934583943,0.00384089762841369,-0.0116190528100851,0.00343726589329652,0.286855300710795
NMR metabolomics,X23428.Concentration of VLDL Particles,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,40136,0.00642634802223855,0.00603467495266075,-0.00540161488497652,0.0182543109294536,0.286942983341101
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42613,-0.00340358600072814,0.00322573151816845,-0.00972601977633829,0.00291884777488202,0.291382047934803
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1RAP,Interleukin-1 receptor accessory protein,42611,-0.0046936748360661,0.00445074915821217,-0.013417143186162,0.00402979351402976,0.291636055088784
NMR metabolomics,X23428.Concentration of VLDL Particles,AXL,Tyrosine-protein kinase receptor UFO,42689,0.00289582214219161,0.00274697801219028,-0.00248825476170134,0.00827989904608455,0.291817245117889
NMR metabolomics,X23428.Concentration of VLDL Particles,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,42311,0.00475602305467164,0.00453164839556738,-0.00412600780064043,0.0136380539099837,0.293961497277553
NMR metabolomics,X23428.Concentration of VLDL Particles,MFAP3L,Microfibrillar-associated protein 3-like,40182,0.00703273609431096,0.00671670512320301,-0.00613200594716695,0.0201974781357889,0.295098862933624
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINB5,Serpin B5,42357,0.00504459724652397,0.00483355305660049,-0.00442916674441298,0.0145183612374609,0.296660810353546
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXDC1,Plexin domain-containing protein 1,42346,-0.00326281158364022,0.00313105429357028,-0.00939967799903798,0.00287405483175753,0.297393371009697
NMR metabolomics,X23428.Concentration of VLDL Particles,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,40116,-0.00215696307293368,0.00207126798082084,-0.00621664831534253,0.00190272216947517,0.297725402082223
NMR metabolomics,X23428.Concentration of VLDL Particles,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,40539,0.00193816477240651,0.00186524684054535,-0.00171771903506238,0.00559404857987539,0.298783671332834
NMR metabolomics,X23428.Concentration of VLDL Particles,KIRREL2,Kin of IRRE-like protein 2,42311,0.00416915326500266,0.00401519501233248,-0.00370062895916899,0.0120389354891743,0.299129115317817
NMR metabolomics,X23428.Concentration of VLDL Particles,CASP4,Caspase-4,40302,0.0177985736529502,0.0172036033462396,-0.0159204889056793,0.0515176362115798,0.300885727878345
NMR metabolomics,X23428.Concentration of VLDL Particles,GHRHR,Growth hormone-releasing hormone receptor,42311,0.00577661478186709,0.00558800130547535,-0.00517586777686459,0.0167290973405988,0.30127056773021
NMR metabolomics,X23428.Concentration of VLDL Particles,PGR,Progesterone receptor,40199,0.0100768615939773,0.00974973617511435,-0.00903262130924687,0.0291863444972014,0.30136825161666
NMR metabolomics,X23428.Concentration of VLDL Particles,TMEM132A,Transmembrane protein 132A,40223,0.00643631527946216,0.00624355638815488,-0.0058010552413214,0.0186736858002457,0.30262286671868
NMR metabolomics,X23428.Concentration of VLDL Particles,IL17F,Interleukin-17F,42370,0.00772238563563553,0.00751022797140236,-0.0069976611883131,0.0224424324595842,0.303851512457775
NMR metabolomics,X23428.Concentration of VLDL Particles,SEPTIN8,Septin-8,40470,0.00331215584933465,0.0032244567900334,-0.00300777945913081,0.0096320911578001,0.304349232121006
NMR metabolomics,X23428.Concentration of VLDL Particles,OBP2B,Odorant-binding protein 2b,42462,0.00621721107075298,0.00610162728500611,-0.005741978407859,0.018176400549365,0.308248555493853
NMR metabolomics,X23428.Concentration of VLDL Particles,S100G,Protein S100-G,40482,0.00488540883381759,0.0047966284674643,-0.00451598296241243,0.0142868006300476,0.308457997129322
NMR metabolomics,X23428.Concentration of VLDL Particles,IL2RG,Cytokine receptor common subunit gamma,40451,0.00370585474478475,0.00364105869385278,-0.00343062029516671,0.0108423297847362,0.308796817013116
NMR metabolomics,X23428.Concentration of VLDL Particles,DIPK1C,Divergent protein kinase domain 1C,40182,0.00423372193615204,0.00418241104957176,-0.0039638037210086,0.0124312475933127,0.311432098063456
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRB3,Adhesion G protein-coupled receptor B3,42475,-0.00343532321688619,0.00340938039644437,-0.0101177087939172,0.00324706236014477,0.313660444631918
NMR metabolomics,X23428.Concentration of VLDL Particles,ARHGEF5,Rho guanine nucleotide exchange factor 5,40136,-0.00743862184436746,0.00741191083616663,-0.0219659670832541,0.00708872339451913,0.315591817554011
NMR metabolomics,X23428.Concentration of VLDL Particles,ZP3,Zona pellucida sperm-binding protein 3,40223,0.0270716501888981,0.0269958537664522,-0.0258402231933483,0.0799835235711444,0.315975650535284
NMR metabolomics,X23428.Concentration of VLDL Particles,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,40182,-0.00458842230559554,0.00458660335178721,-0.0135781648750985,0.00440132026390739,0.317140654153457
NMR metabolomics,X23428.Concentration of VLDL Particles,EDDM3B,Epididymal secretory protein E3-beta,40451,0.0052212665005359,0.00524019153556845,-0.00504950890917826,0.0154920419102501,0.319082843017951
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPAN8,Tetraspanin-8,40449,0.010125269226092,0.0101852411530404,-0.00983780343386724,0.0300883418860512,0.320189774006568
NMR metabolomics,X23428.Concentration of VLDL Particles,RNASE1,Ribonuclease pancreatic,40532,0.00261325405933585,0.00262959078865071,-0.00254074388641954,0.00776725200509124,0.320347614492704
NMR metabolomics,X23428.Concentration of VLDL Particles,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42495,-0.00286076245888306,0.00288288587336419,-0.00851121877067687,0.00278969385291075,0.321056600655644
NMR metabolomics,X23428.Concentration of VLDL Particles,SAP18,Histone deacetylase complex subunit SAP18,40302,-0.00725861867666734,0.00737545760550196,-0.0217145155834512,0.00719727823011651,0.325059063453771
NMR metabolomics,X23428.Concentration of VLDL Particles,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,40483,0.00626400395767971,0.00637250252392921,-0.00622610098922155,0.018754108904581,0.325641327072325
NMR metabolomics,X23428.Concentration of VLDL Particles,PGLYRP1,Peptidoglycan recognition protein 1,42737,-0.00414798855089145,0.0042227919444477,-0.0124246607620089,0.00412868366022603,0.325976616936928
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,40116,-0.00331379126246094,0.0033836477132915,-0.00994574078051228,0.0033181582555904,0.327426447858723
NMR metabolomics,X23428.Concentration of VLDL Particles,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",40182,0.00767809840833667,0.00784415652341883,-0.00769644837756425,0.0230526451942376,0.327685365109808
NMR metabolomics,X23428.Concentration of VLDL Particles,CCL21,C-C motif chemokine 21,42676,0.00409148920656976,0.00418279400898916,-0.00410678705104899,0.0122897654641885,0.32800714185907
NMR metabolomics,X23428.Concentration of VLDL Particles,BTN1A1,Butyrophilin subfamily 1 member A1,40429,0.00383108528385956,0.00392441244599547,-0.00386076311029157,0.0115229336780107,0.328977057943024
NMR metabolomics,X23428.Concentration of VLDL Particles,IL15RA,Interleukin-15 receptor subunit alpha,42370,0.00350713877055628,0.00359330599123469,-0.00353574097226372,0.0105500185133763,0.329072436594109
NMR metabolomics,X23428.Concentration of VLDL Particles,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,40302,0.00685356523948344,0.00702204581199434,-0.00690964455202547,0.0206167750309924,0.329082294013621
NMR metabolomics,X23428.Concentration of VLDL Particles,CD177,CD177 antigen,42595,-0.0127488522392486,0.0130819261862484,-0.0383894275642955,0.0128917230857984,0.32980638633877
NMR metabolomics,X23428.Concentration of VLDL Particles,CALY,Neuron-specific vesicular protein calcyon,40116,-0.00380246636338818,0.00390457195774529,-0.0114554274005689,0.00385049467379258,0.330152722092647
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK12,Kallikrein-12,42346,0.0134257899850875,0.0138643099557557,-0.0137482575281937,0.0405998374983687,0.332877129923151
NMR metabolomics,X23428.Concentration of VLDL Particles,IKZF2,Zinc finger protein Helios,42346,0.00842531124014919,0.00873572694145523,-0.00869671356510305,0.0255473360454014,0.334830101248843
NMR metabolomics,X23428.Concentration of VLDL Particles,CA3,Carbonic anhydrase 3,42770,-0.00568986723595126,0.00591206569187731,-0.0172775159920308,0.00589778152012826,0.335857768213209
NMR metabolomics,X23428.Concentration of VLDL Particles,GLI2,Zinc finger protein GLI2,40199,-0.00307493043815646,0.00319903275129052,-0.00934503463068589,0.00319517375437296,0.336469566981932
NMR metabolomics,X23428.Concentration of VLDL Particles,ABO,Histo-blood group ABO system transferase,40532,0.0138884513738828,0.0144577761874346,-0.0144487899534891,0.0422256927012546,0.336762974131599
NMR metabolomics,X23428.Concentration of VLDL Particles,UBQLN3,Ubiquilin-3,40116,-0.00518776685372637,0.00540853235748219,-0.0157884902743915,0.00541295656693872,0.337488301725654
NMR metabolomics,X23428.Concentration of VLDL Particles,SEZ6,Seizure protein 6 homolog,40182,-0.00298431806342726,0.0031223439301494,-0.00910411216652009,0.00313547603966557,0.339197271529971
NMR metabolomics,X23428.Concentration of VLDL Particles,VWC2L,von Willebrand factor C domain-containing protein 2-like,40482,0.00430136542892162,0.00450662362873354,-0.00453161688339612,0.0131343477412394,0.339874267877534
NMR metabolomics,X23428.Concentration of VLDL Particles,GUCY2C,Heat-stable enterotoxin receptor,40302,-0.00762147182772987,0.00802494590906802,-0.0233503658095032,0.00810742215404345,0.342273927448607
NMR metabolomics,X23428.Concentration of VLDL Particles,OTOA,Otoancorin,40136,-0.00515859632286869,0.00544580654126198,-0.0158323771437422,0.00551518449800478,0.343527075280733
NMR metabolomics,X23428.Concentration of VLDL Particles,OLFM4,Olfactomedin-4,39870,0.0116397014110456,0.0122922713121226,-0.0124531503607147,0.0357325531828059,0.343704963018638
NMR metabolomics,X23428.Concentration of VLDL Particles,ZP4,Zona pellucida sperm-binding protein 4,40080,-0.00294916047289328,0.0031425731915656,-0.00910860392836185,0.00321028298257529,0.348031951821517
NMR metabolomics,X23428.Concentration of VLDL Particles,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,40182,-0.00382518205886135,0.00407913991436333,-0.0118202962910135,0.00416993217329079,0.348397468989744
NMR metabolomics,X23428.Concentration of VLDL Particles,DCN,Decorin,42357,0.00222606263537346,0.00238686320141953,-0.00245218923940881,0.00690431451015572,0.351027623267346
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF3,Fibroblast growth factor 3,40199,0.00269789164581974,0.00290033367062886,-0.00298676234861283,0.00838254564025231,0.352287719701966
NMR metabolomics,X23428.Concentration of VLDL Particles,APOD,Apolipoprotein D,40033,-0.00403272145677043,0.00433925228684005,-0.0125376559389769,0.00447221302543606,0.352723968549977
NMR metabolomics,X23428.Concentration of VLDL Particles,GGA1,ADP-ribosylation factor-binding protein GGA1,42311,0.00604178981102435,0.00652285303332662,-0.00674300213429583,0.0188265817563445,0.35433333867094
NMR metabolomics,X23428.Concentration of VLDL Particles,IL6,Interleukin-6,42587,0.00704632950969938,0.00762853815551367,-0.00790560527510742,0.0219982642945062,0.35566949401049
NMR metabolomics,X23428.Concentration of VLDL Particles,TG,Thyroglobulin,40451,-0.0105748690243728,0.0114534153615114,-0.033023563132935,0.0118738250841895,0.35587383295249
NMR metabolomics,X23428.Concentration of VLDL Particles,TCP11,T-complex protein 11 homolog,40302,0.0054298125608681,0.00589592325871572,-0.00612619702621471,0.0169858221479509,0.357099894234803
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,40080,-0.00773557497217011,0.00842637568841776,-0.0242512713214689,0.0087801213771287,0.358629133767784
NMR metabolomics,X23428.Concentration of VLDL Particles,FZD8,Frizzled-8,40136,0.00417163636100449,0.00456009834810979,-0.00476615640129069,0.0131094291232997,0.360310069931248
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,40302,0.00635770282015654,0.00695653078643408,-0.00727709752125426,0.0199925031615673,0.360779460216764
NMR metabolomics,X23428.Concentration of VLDL Particles,CUZD1,CUB and zona pellucida-like domain-containing protein 1,40182,0.00360764076144833,0.00397412024351872,-0.00418163491584836,0.011396916438745,0.364012528768882
NMR metabolomics,X23428.Concentration of VLDL Particles,IL18RAP,Interleukin-18 receptor accessory protein,42425,0.0155174116910798,0.0171220549799926,-0.0180418160697057,0.0490766394518653,0.36480306895634
NMR metabolomics,X23428.Concentration of VLDL Particles,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,42113,0.00337641476082313,0.00374134909791079,-0.00395662947108202,0.0107094589927283,0.366829832428902
NMR metabolomics,X23428.Concentration of VLDL Particles,DTX2,Probable E3 ubiquitin-protein ligase DTX2,40182,0.00569014185417937,0.00631008288189818,-0.00667762059434107,0.0180579043026998,0.367207378289475
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC123,Cell division cycle protein 123 homolog,40080,0.00564105524288628,0.0062902234377713,-0.00668778269514548,0.017969893180918,0.369846933287661
NMR metabolomics,X23428.Concentration of VLDL Particles,PLIN3,Perilipin-3,42636,-0.00373686753920421,0.00417116177949276,-0.01191234462701,0.0044386095486016,0.370331987303372
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC1,Sialoadhesin,42676,0.00383489665207088,0.00428224607302473,-0.0045583056510576,0.0122280989551993,0.370517725107247
NMR metabolomics,X23428.Concentration of VLDL Particles,RBP1,Retinol-binding protein 1,40182,0.00609024827911626,0.00680115098403034,-0.00724000764958322,0.0194205042078157,0.3705538138758
NMR metabolomics,X23428.Concentration of VLDL Particles,SERPINA11,Serpin A11,42794,0.00362748552390411,0.00405539276807056,-0.00432108430151419,0.0115760553493224,0.371078607803768
NMR metabolomics,X23428.Concentration of VLDL Particles,CTLA4,Cytotoxic T-lymphocyte protein 4,40527,0.00266988959295786,0.00298969098477251,-0.00318990473719625,0.00852968392311197,0.371859021065468
NMR metabolomics,X23428.Concentration of VLDL Particles,IL20RA,Interleukin-20 receptor subunit alpha,42370,0.0039849407577314,0.00446767944329149,-0.00477171095111992,0.0127415924665827,0.372436731692089
NMR metabolomics,X23428.Concentration of VLDL Particles,NTRK3,NT-3 growth factor receptor,42711,0.00192495621888972,0.00215891981508853,-0.00230652661868379,0.00615643905646323,0.372607517419187
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC2L,C-type lectin domain family 2 member L,40182,0.00435611366142758,0.00490296296220631,-0.00525369374449679,0.0139659210673519,0.374309829866466
NMR metabolomics,X23428.Concentration of VLDL Particles,ACTA2,"Actin, aortic smooth muscle",42357,-0.00387311142440198,0.00436463562800684,-0.0124277972552954,0.00468157440649144,0.374887963800416
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINK5,Serine protease inhibitor Kazal-type 5,42611,0.00303423413704557,0.00341973330805943,-0.00366844314675092,0.00973691142084206,0.374948298079149
NMR metabolomics,X23428.Concentration of VLDL Particles,CLSPN,Claspin,42292,0.00309063438836836,0.00348638758435296,-0.00374268527696346,0.00992395405370017,0.375371877314845
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC44A4,Choline transporter-like protein 4,40182,-0.00627893708121343,0.00709726863241452,-0.0201895836007459,0.00763170943831904,0.376339066391375
NMR metabolomics,X23428.Concentration of VLDL Particles,PON1,Serum paraoxonase/arylesterase 1,40532,0.00240071695293147,0.00271909260939758,-0.00292870456148778,0.00773013846735072,0.377303043544784
NMR metabolomics,X23428.Concentration of VLDL Particles,ANXA5,Annexin A5,42261,-0.00268913260893402,0.00304794102298875,-0.00866309701399197,0.00328483179612393,0.377642489515899
NMR metabolomics,X23428.Concentration of VLDL Particles,SUSD5,Sushi domain-containing protein 5,40235,0.0030536584617657,0.00346311481859007,-0.00373404658267083,0.00984136350620224,0.377922313027188
NMR metabolomics,X23428.Concentration of VLDL Particles,IL24,Interleukin-24,42370,0.00440507965715279,0.00502242451538915,-0.00543887239300995,0.0142490317073155,0.380457927677453
NMR metabolomics,X23428.Concentration of VLDL Particles,TEX101,Testis-expressed protein 101,40182,0.00458838104196724,0.00526618422600222,-0.00573334004099711,0.0149101021249316,0.383614099247362
NMR metabolomics,X23428.Concentration of VLDL Particles,EXOSC10,Exosome component 10,40116,0.00524213212572838,0.00602146632118061,-0.00655994186378562,0.0170442061152424,0.384005921869877
NMR metabolomics,X23428.Concentration of VLDL Particles,CD2,T-cell surface antigen CD2,40116,0.0033209004126452,0.00384057545098174,-0.00420662747127901,0.0108484282965694,0.387228918314571
NMR metabolomics,X23428.Concentration of VLDL Particles,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",40136,-0.00384192673256775,0.00444503385215344,-0.0125541930827885,0.004870339617653,0.387431681730724
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A3,Protein S100-A3,40451,0.00373242502868521,0.00432794890763777,-0.00475035483028481,0.0122152048876552,0.388485571458319
NMR metabolomics,X23428.Concentration of VLDL Particles,KCNIP4,Kv channel-interacting protein 4,42311,0.00421632121255975,0.00490140566671848,-0.00539043389420848,0.013823076319328,0.389679677629769
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,40451,-0.00771906888598073,0.00900935442896871,-0.0253774035667594,0.00993926579479794,0.39158262099805
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC7A,C-type lectin domain family 7 member A,42754,-0.00516464607562441,0.0060360198721414,-0.0169952450250216,0.00666595287377273,0.392213336185871
NMR metabolomics,X23428.Concentration of VLDL Particles,MORN4,MORN repeat-containing protein 4,40080,-0.00654409275848749,0.00766030700126857,-0.0215582944809739,0.00847010896399891,0.3929653604808
NMR metabolomics,X23428.Concentration of VLDL Particles,LAMA1,Laminin subunit alpha-1,40116,-0.00458828188799879,0.00537539847848043,-0.0151240629058204,0.00594749912982285,0.393361695805993
NMR metabolomics,X23428.Concentration of VLDL Particles,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",40116,0.0042038541830126,0.0049394767034271,-0.00547752015570451,0.0138852285217297,0.394747581664148
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,42346,0.0106715223619825,0.0125991360982875,-0.0140227843906609,0.035365829114626,0.397008140588196
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT17,"Keratin, type I cytoskeletal 17",40116,0.00332633667725337,0.0039302006998036,-0.00437685669436168,0.0110295300488684,0.397374459650526
NMR metabolomics,X23428.Concentration of VLDL Particles,COMMD9,COMM domain-containing protein 9,40451,0.00333080652150471,0.00394689512493005,-0.00440510792335819,0.0110667209663676,0.398740144672895
NMR metabolomics,X23428.Concentration of VLDL Particles,S100A14,Protein S100-A14,40482,0.00459549351574443,0.00544987797147964,-0.00608626730835566,0.0152772543398445,0.399118417632933
NMR metabolomics,X23428.Concentration of VLDL Particles,SPARCL1,SPARC-like protein 1,42644,-0.00231426145586387,0.00274604623738165,-0.0076965120811319,0.00306798916940417,0.3993769502786
NMR metabolomics,X23428.Concentration of VLDL Particles,FH,"Fumarate hydratase, mitochondrial",40136,0.00718396174076032,0.00853094682322511,-0.00953669403276089,0.0239046175142815,0.399747012471799
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF12,Fibroblast growth factor 12,40199,0.00391348558470414,0.00466752306564749,-0.00523485962396495,0.0130618307933732,0.40179612368037
NMR metabolomics,X23428.Concentration of VLDL Particles,THBS2,Thrombospondin-2,42611,0.00322436426220018,0.00385260095972234,-0.0043267336188556,0.010775462143256,0.402645809757322
NMR metabolomics,X23428.Concentration of VLDL Particles,RBP7,Retinoid-binding protein 7,40449,0.00483921770530107,0.0059669993463098,-0.00685610101346613,0.0165345364240683,0.417384625507627
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42611,-0.00259745076549821,0.00320574440228642,-0.00888070979397959,0.00368580826298318,0.417811528127066
NMR metabolomics,X23428.Concentration of VLDL Particles,PITHD1,PITH domain-containing protein 1,40065,-0.0065166771838887,0.0080436385618184,-0.0222822087650528,0.00924885439727536,0.417862887879415
NMR metabolomics,X23428.Concentration of VLDL Particles,SHD,SH2 domain-containing adapter protein D,40083,-0.00708052987219829,0.00876380014492772,-0.0242575781562566,0.01009651841186,0.419149000706446
NMR metabolomics,X23428.Concentration of VLDL Particles,DPEP1,Dipeptidase 1,42476,-0.0039679692943314,0.00496555647849869,-0.0137004599921888,0.00576452140352604,0.424247523183838
NMR metabolomics,X23428.Concentration of VLDL Particles,MSMB,Beta-microseminoprotein,42559,-0.00573260686206834,0.00718040332913683,-0.0198061973871765,0.00834098366303984,0.424670941813085
NMR metabolomics,X23428.Concentration of VLDL Particles,PRRT3,Proline-rich transmembrane protein 3,40223,0.00318021470421638,0.00398511132765537,-0.00463060349798815,0.0109910329064209,0.424873712325472
NMR metabolomics,X23428.Concentration of VLDL Particles,POLR2A,DNA-directed RNA polymerase II subunit RPB1,40199,0.00232469045382275,0.0029216556268123,-0.00340175457472936,0.00805113548237485,0.426237702376679
NMR metabolomics,X23428.Concentration of VLDL Particles,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,40080,0.00213006541128594,0.00267976526848033,-0.0031222745149355,0.00738240533750739,0.426706370639783
NMR metabolomics,X23428.Concentration of VLDL Particles,MORF4L2,Mortality factor 4-like protein 2,40080,-0.00291041490065887,0.00366211623968603,-0.0100881627304435,0.00426733292912574,0.426784525198447
NMR metabolomics,X23428.Concentration of VLDL Particles,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39845,0.0040592057414646,0.00511661055767701,-0.00596935095158233,0.0140877624345115,0.427598122149875
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH22,Cadherin-22,40302,-0.00221199347594165,0.0027990882759368,-0.00769820649677778,0.00327421954489447,0.42939573755206
NMR metabolomics,X23428.Concentration of VLDL Particles,MORC3,MORC family CW-type zinc finger protein 3,40483,-0.00222037337599635,0.00281255756630334,-0.00773298620595089,0.00329223945395819,0.429865662866951
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNL2,Interferon lambda-2,40136,0.00486451152468552,0.00616998428517702,-0.00722865767426145,0.0169576807236325,0.430470761122908
NMR metabolomics,X23428.Concentration of VLDL Particles,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,40080,0.00454084932927345,0.0057691203343461,-0.00676662652604491,0.0158483251845918,0.431243030189617
NMR metabolomics,X23428.Concentration of VLDL Particles,STEAP4,Metalloreductase STEAP4,40136,0.00570993321558483,0.00725777746489985,-0.00851531061561888,0.0199351770467886,0.431455206133523
NMR metabolomics,X23428.Concentration of VLDL Particles,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",40080,-0.00433550780473804,0.00553209555193192,-0.0151784150865246,0.00650739947704853,0.43323273348739
NMR metabolomics,X23428.Concentration of VLDL Particles,IL7R,Interleukin-7 receptor subunit alpha,42611,-0.00407173704804238,0.0052216244852058,-0.0143061210390457,0.00616264694296098,0.435532026235186
NMR metabolomics,X23428.Concentration of VLDL Particles,DCLRE1C,Protein artemis,40080,0.00242533903881481,0.00311341551222789,-0.00367695536515186,0.00852763344278147,0.435998851213751
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC1A,C-type lectin domain family 1 member A,42357,-0.0027124984151228,0.0034855561327087,-0.00954418843523186,0.00411919160498626,0.436458571554387
NMR metabolomics,X23428.Concentration of VLDL Particles,VSTM1,V-set and transmembrane domain-containing protein 1,42311,0.00389054280876711,0.00501641740734209,-0.00594163530962339,0.0137227209271576,0.438021615761828
NMR metabolomics,X23428.Concentration of VLDL Particles,FOLR1,Folate receptor alpha,42600,0.00233419923667908,0.00301277839951624,-0.00357084642637275,0.0082392448997309,0.438491418039462
NMR metabolomics,X23428.Concentration of VLDL Particles,BLVRB,Flavin reductase,42611,0.00497320950290978,0.00652074712952584,-0.00780745487096087,0.0177538738767804,0.445670771920119
NMR metabolomics,X23428.Concentration of VLDL Particles,GFRAL,GDNF family receptor alpha-like,40109,-0.00476790910545728,0.00625436746287609,-0.0170264693326944,0.00749065112177985,0.445877909188521
NMR metabolomics,X23428.Concentration of VLDL Particles,OLR1,Oxidized low-density lipoprotein receptor 1,42521,-0.00436739618665076,0.00573910802348452,-0.0156160479126804,0.0068812555393789,0.446677298227749
NMR metabolomics,X23428.Concentration of VLDL Particles,PRDX2,Peroxiredoxin-2,40333,0.00471171637199192,0.00621766927528008,-0.00747491540755703,0.0168983481515409,0.448589969955336
NMR metabolomics,X23428.Concentration of VLDL Particles,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,40080,-0.00339386106906434,0.00450561703226109,-0.0122248704522961,0.0054371483141674,0.451315316228695
NMR metabolomics,X23428.Concentration of VLDL Particles,HDAC9,Histone deacetylase 9,40136,0.00492578613553707,0.0065404364926492,-0.00789346939005537,0.0177450416611295,0.451389177639825
NMR metabolomics,X23428.Concentration of VLDL Particles,DEFB116,Beta-defensin 116,40136,0.00574131644534677,0.00767434078310238,-0.00930039148953389,0.0207830243802274,0.454404752523257
NMR metabolomics,X23428.Concentration of VLDL Particles,IGFBP7,Insulin-like growth factor-binding protein 7,42794,0.00231859903916515,0.00311933640709421,-0.0037953003187395,0.00843249839706979,0.45731363165348
NMR metabolomics,X23428.Concentration of VLDL Particles,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,40302,0.00274729462214289,0.00370197087881958,-0.00450856830034349,0.0100031575446293,0.458032289271369
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,40116,-0.00358098372515228,0.00482544137627987,-0.0130388488226608,0.00587688137235627,0.458039734948174
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,40136,0.00233717773727623,0.00315454059049441,-0.0038457218200928,0.00852007729464527,0.458774085212238
NMR metabolomics,X23428.Concentration of VLDL Particles,OMP,Olfactory marker protein,40136,-0.00370704936511649,0.00501545579782019,-0.0135373427288441,0.00612324399861107,0.459846879748434
NMR metabolomics,X23428.Concentration of VLDL Particles,CTNNA1,Catenin alpha-1,40136,-0.00259069077383907,0.00350534789222492,-0.00946117264259991,0.00427979109492176,0.459881505231684
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX4,Probable ATP-dependent RNA helicase DDX4,40199,0.00391796509230098,0.00534795455731231,-0.00656402584003115,0.0143999560246331,0.463811921123872
NMR metabolomics,X23428.Concentration of VLDL Particles,BMP4,Bone morphogenetic protein 4,42475,-0.00336318734614709,0.00462841895633505,-0.0124348885005638,0.00570851380826961,0.467460251599049
NMR metabolomics,X23428.Concentration of VLDL Particles,AGR2,Anterior gradient protein 2 homolog,42215,-0.00726605695055942,0.0100630663659815,-0.0269896670278831,0.0124575531267643,0.47027548905318
NMR metabolomics,X23428.Concentration of VLDL Particles,FAM171A2,Protein FAM171A2,40482,0.0114758639295281,0.015903399003267,-0.0196947981168752,0.0426465259759315,0.470556498576534
NMR metabolomics,X23428.Concentration of VLDL Particles,CDHR1,Cadherin-related family member 1,42311,0.00306396251475477,0.00425233526697028,-0.00527061460850698,0.0113985396380165,0.471207611927261
NMR metabolomics,X23428.Concentration of VLDL Particles,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",40116,-0.003103825048825,0.00431774075563976,-0.0115665969298789,0.00535894683222893,0.472246283630753
NMR metabolomics,X23428.Concentration of VLDL Particles,CLSTN1,Calsyntenin-1,42311,0.00379097163153922,0.00528106567986259,-0.00655991710099146,0.0141418603640699,0.472867394480346
NMR metabolomics,X23428.Concentration of VLDL Particles,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,40136,-0.00417560055831284,0.00582761625130813,-0.0155977284108768,0.00724652729425109,0.473685936674687
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,42357,-0.00346118438591894,0.0048623932840886,-0.0129914752227326,0.00606910645089472,0.476584327250623
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPS16,"28S ribosomal protein S16, mitochondrial",40199,0.0020162225102102,0.00283439035174588,-0.00353918257921172,0.00757162759963213,0.476887056202586
NMR metabolomics,X23428.Concentration of VLDL Particles,NPHS2,Podocin,40199,-0.00744435467813985,0.0104707855102261,-0.027967094278183,0.0130783849219033,0.477121426902245
NMR metabolomics,X23428.Concentration of VLDL Particles,ECSCR,Endothelial cell-specific chemotaxis regulator,40136,-0.00364838325816747,0.00514111471223273,-0.0137249680941436,0.00642820157780869,0.477937388283323
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNF174,Zinc finger protein 174,40199,0.00262648916105502,0.00373181550469323,-0.00468786922814371,0.00994084755025374,0.481565980917937
NMR metabolomics,X23428.Concentration of VLDL Particles,GAD2,Glutamate decarboxylase 2,40199,-0.00322500347950394,0.00459648274637619,-0.0122341096624013,0.00578410270339339,0.482928399215768
NMR metabolomics,X23428.Concentration of VLDL Particles,IL13,Interleukin-13,42370,-0.00329350897688853,0.0047184488131105,-0.0125416686505851,0.00595465069680804,0.485185309460838
NMR metabolomics,X23428.Concentration of VLDL Particles,EVI2B,Protein EVI2B,40080,-0.0028261330961678,0.00407913206046659,-0.0108212319346823,0.00516896574234671,0.488432864193441
NMR metabolomics,X23428.Concentration of VLDL Particles,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42737,0.00236105455757192,0.00344061076024004,-0.00438254253249857,0.0091046516476424,0.492579054389654
NMR metabolomics,X23428.Concentration of VLDL Particles,CD248,Endosialin,40527,0.0027790025647289,0.00405352348043747,-0.00516590345692853,0.0107239085863863,0.492993897251949
NMR metabolomics,X23428.Concentration of VLDL Particles,OSTN,Osteocrin,40182,-0.00284750219586743,0.00416349772216155,-0.0110079577313041,0.0053129533395692,0.494039676758547
NMR metabolomics,X23428.Concentration of VLDL Particles,TFRC,Transferrin receptor protein 1,42673,-0.00255517287901263,0.0037533079433281,-0.0099116564479357,0.00480131068991044,0.496023092761244
NMR metabolomics,X23428.Concentration of VLDL Particles,LYPD1,Ly6/PLAUR domain-containing protein 1,42311,-0.00409827746238509,0.00609518363886593,-0.0160448373945623,0.00784828246979212,0.501353875901757
NMR metabolomics,X23428.Concentration of VLDL Particles,CDC25A,M-phase inducer phosphatase 1,40080,-0.00260772267072573,0.0038839396673827,-0.0102202444187958,0.00500479907734436,0.501972517788964
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRE2,Adhesion G protein-coupled receptor E2,42676,0.00188300486418743,0.00280945257374469,-0.00362352218035216,0.00738953190872701,0.502716884934198
NMR metabolomics,X23428.Concentration of VLDL Particles,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,40302,-0.00421223278179584,0.00631222333951979,-0.0165841905272546,0.00815972496366296,0.504585672783407
NMR metabolomics,X23428.Concentration of VLDL Particles,TMED1,Transmembrane emp24 domain-containing protein 1,40302,0.00358825205856664,0.00538335285327359,-0.00696311953384959,0.0141396236509829,0.505076045060689
NMR metabolomics,X23428.Concentration of VLDL Particles,RAP1A,Ras-related protein Rap-1A,40199,0.00469143222850245,0.00707747945301869,-0.00918042749941418,0.0185632919564191,0.507429199804923
NMR metabolomics,X23428.Concentration of VLDL Particles,GKN1,Gastrokine-1,42017,0.00184125590759283,0.00279293562769336,-0.00363289792268616,0.00731540973787182,0.509744072361792
NMR metabolomics,X23428.Concentration of VLDL Particles,CDH1,Cadherin-1,42188,-0.00260178728618587,0.00394681958298668,-0.0103375536688398,0.00513397909646803,0.509771900647292
NMR metabolomics,X23428.Concentration of VLDL Particles,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42611,0.00281337151209767,0.00427232289289659,-0.00556038135797965,0.011187124382175,0.510221146838392
NMR metabolomics,X23428.Concentration of VLDL Particles,DNLZ,DNL-type zinc finger protein,40136,0.00595327926219635,0.00907305265793777,-0.0118299039473617,0.0237364624717544,0.511741713840474
NMR metabolomics,X23428.Concentration of VLDL Particles,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,40116,0.0016887896600026,0.00257875195745492,-0.00336556417660905,0.00674314349661425,0.51255466978944
NMR metabolomics,X23428.Concentration of VLDL Particles,EIF5A,Eukaryotic translation initiation factor 5A-1,42370,0.00193191967744611,0.00295692158445087,-0.0038636466280776,0.00772748598296982,0.513538804817657
NMR metabolomics,X23428.Concentration of VLDL Particles,GPR101,Probable G-protein coupled receptor 101,40136,-0.00393168571530017,0.00601950996629469,-0.0157299252492378,0.00786655381863742,0.513668722830948
NMR metabolomics,X23428.Concentration of VLDL Particles,PFDN6,Prefoldin subunit 6,40182,0.00420977867006085,0.0064475068101646,-0.00842733467786176,0.0168468920179835,0.513814263019748
NMR metabolomics,X23428.Concentration of VLDL Particles,AMY2A,Pancreatic alpha-amylase,42114,-0.00314864204226359,0.0048623632579564,-0.0126788740278581,0.00638158994333094,0.517285060997911
NMR metabolomics,X23428.Concentration of VLDL Particles,ARNT,Aryl hydrocarbon receptor nuclear translocator,42370,0.00234909442120901,0.00363926199696693,-0.00478385909284617,0.0094820479352642,0.518623216100467
NMR metabolomics,X23428.Concentration of VLDL Particles,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,40449,-0.00451912662805993,0.00701044062256934,-0.0182595902482958,0.00922133699217598,0.519181394471337
NMR metabolomics,X23428.Concentration of VLDL Particles,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42587,-0.00264330439963039,0.00411186818720134,-0.010702566046545,0.00541595724728425,0.520334029087157
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP5F1D,"ATP synthase subunit delta, mitochondrial",40116,0.00332990390827744,0.00518163319549968,-0.00682609715490193,0.0134859049714568,0.520473822594747
NMR metabolomics,X23428.Concentration of VLDL Particles,PALLD,Palladin,40199,0.00248370231361003,0.00388501944872637,-0.00513093580589365,0.0100983404331137,0.522639524499677
NMR metabolomics,X23428.Concentration of VLDL Particles,DCUN1D1,DCN1-like protein 1,40136,-0.00477165416872173,0.00746872209071996,-0.0194103494665329,0.00986704112908938,0.522911149541351
NMR metabolomics,X23428.Concentration of VLDL Particles,MERTK,Tyrosine-protein kinase Mer,42754,-0.00161615387162873,0.00253466485104321,-0.00658409697967343,0.00335178923641597,0.523731615943374
NMR metabolomics,X23428.Concentration of VLDL Particles,RICTOR,Rapamycin-insensitive companion of mTOR,40199,0.00309935693770082,0.00487990451742627,-0.00646525591645467,0.0126639697918563,0.525359084721086
NMR metabolomics,X23428.Concentration of VLDL Particles,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42711,-0.00296821405602547,0.00472443192050948,-0.0122281006202241,0.00629167250817312,0.529838359284215
NMR metabolomics,X23428.Concentration of VLDL Particles,TSPAN15,Tetraspanin-15,40116,0.0032611204352907,0.00519561420867485,-0.006922283413712,0.0134445242842934,0.530234617882254
NMR metabolomics,X23428.Concentration of VLDL Particles,TGOLN2,Trans-Golgi network integral membrane protein 2,40532,0.00169471137275385,0.00271048000496883,-0.00361782943698507,0.00700725218249276,0.531823508249844
NMR metabolomics,X23428.Concentration of VLDL Particles,CXADR,Coxsackievirus and adenovirus receptor,42594,0.00320056416396664,0.00514471861116296,-0.00688308431391276,0.0132842126418461,0.533882262844573
NMR metabolomics,X23428.Concentration of VLDL Particles,CHI3L1,Chitinase-3-like protein 1,42416,0.00507804000915739,0.00817235567388924,-0.0109397771116655,0.0210958571299803,0.534368257410992
NMR metabolomics,X23428.Concentration of VLDL Particles,CHEK2,Serine/threonine-protein kinase Chk2,42357,0.00204718330794199,0.00330269381904951,-0.00442609657739506,0.00852046319327904,0.535365572858953
NMR metabolomics,X23428.Concentration of VLDL Particles,ZCCHC8,Zinc finger CCHC domain-containing protein 8,40116,0.00369588894643299,0.00601408882396613,-0.00809172514854063,0.0154835030414066,0.538872360897616
NMR metabolomics,X23428.Concentration of VLDL Particles,EDNRB,Endothelin receptor type B,40199,0.00272681656260056,0.0044443433071071,-0.00598409631932935,0.0114377294445305,0.539526941372894
NMR metabolomics,X23428.Concentration of VLDL Particles,IL1A,Interleukin-1 alpha,42370,0.00353575443674767,0.00579330553088764,-0.0078191244037921,0.0148906332772874,0.541662182723291
NMR metabolomics,X23428.Concentration of VLDL Particles,CBX2,Chromobox protein homolog 2,40116,0.00243972299894669,0.00400183111995402,-0.00540386599616318,0.0102833119940566,0.542105262702594
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM2,Intercellular adhesion molecule 2,42794,-0.00195772908160494,0.0032173167026107,-0.00826366981872191,0.00434821165551204,0.542867744247156
NMR metabolomics,X23428.Concentration of VLDL Particles,ANK2,Ankyrin-2,40116,0.00446349059216152,0.00734063418938691,-0.00992415241903682,0.0188511336033599,0.543165332017992
NMR metabolomics,X23428.Concentration of VLDL Particles,ITGA11,Integrin alpha-11,42594,-0.00203766496253061,0.00336825045717635,-0.00863943585859625,0.00456410593353502,0.545214207921361
NMR metabolomics,X23428.Concentration of VLDL Particles,TJP3,Tight junction protein ZO-3,40136,-0.0025362888921192,0.00419335413508502,-0.0107552629968858,0.00568268521264744,0.54530093299575
NMR metabolomics,X23428.Concentration of VLDL Particles,PIGR,Polymeric immunoglobulin receptor,42464,0.00214453797551674,0.00355414586105904,-0.00482158791215898,0.00911066386319245,0.546259229702115
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42594,0.00519172697188554,0.00861402208946516,-0.0116917563234662,0.0220752102672373,0.54671416628198
NMR metabolomics,X23428.Concentration of VLDL Particles,PYDC1,Pyrin domain-containing protein 1,40223,-0.0025139325565668,0.0042641574867863,-0.0108716812306679,0.00584381611753434,0.555504692049581
NMR metabolomics,X23428.Concentration of VLDL Particles,NLGN1,Neuroligin-1,40182,0.00407502580376369,0.00695460702545644,-0.00955600396613093,0.0177060555736583,0.557923680538587
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42495,0.00263124780699507,0.00450121260440849,-0.00619112889764557,0.0114536245116357,0.558850690925585
NMR metabolomics,X23428.Concentration of VLDL Particles,IL33,Interleukin-33,42370,0.00222264303601344,0.00385124914300523,-0.00532580528427682,0.0097710913563037,0.563866477962645
NMR metabolomics,X23428.Concentration of VLDL Particles,VSIG2,V-set and immunoglobulin domain-containing protein 2,40451,0.00375590934146919,0.00657358065306807,-0.00912830873854422,0.0166401274214826,0.567764126974367
NMR metabolomics,X23428.Concentration of VLDL Particles,MORF4L1,Mortality factor 4-like protein 1,40302,0.00226033093791637,0.00397729964589811,-0.00553517636804391,0.0100558382438767,0.569837381629899
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF7,Fibroblast growth factor 7,40080,0.00448613644344811,0.00789926866662477,-0.0109964301431364,0.0199687030300327,0.570102397758979
NMR metabolomics,X23428.Concentration of VLDL Particles,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,40302,-0.00255969437136434,0.00452824688620151,-0.0114350582683193,0.00631566952559063,0.571899706771146
NMR metabolomics,X23428.Concentration of VLDL Particles,UPK3BL1,Uroplakin-3b-like protein 1,40281,-0.0030370804360022,0.00542605069967978,-0.0136721398073746,0.00759797893537017,0.575680320170571
NMR metabolomics,X23428.Concentration of VLDL Particles,SAG,S-arrestin,40136,-0.00292162904303102,0.00522229160100324,-0.0131573205809974,0.00731406249493533,0.57586374403516
NMR metabolomics,X23428.Concentration of VLDL Particles,KIRREL1,Kin of IRRE-like protein 1,40136,-0.00320565552627174,0.00573505664206077,-0.0144463665447108,0.00803505549216737,0.576201854879027
NMR metabolomics,X23428.Concentration of VLDL Particles,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,40136,0.00185180977547922,0.00331517382205632,-0.00464593091575117,0.00834955046670961,0.57645570827972
NMR metabolomics,X23428.Concentration of VLDL Particles,BHLHE40,Class E basic helix-loop-helix protein 40,40136,0.00389023375068683,0.00699331087812173,-0.00981665557043176,0.0175971230718054,0.578031343194495
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTNAP2,Contactin-associated protein-like 2,42594,-0.00230424949625967,0.00415479103243341,-0.0104476399198292,0.00583914092730981,0.579177151651295
NMR metabolomics,X23428.Concentration of VLDL Particles,RBFOX3,RNA binding protein fox-1 homolog 3,40482,-0.00220939836548048,0.0039929663511053,-0.0100356124136469,0.0056168156826859,0.580053513793328
NMR metabolomics,X23428.Concentration of VLDL Particles,TXK,Tyrosine-protein kinase TXK,40302,0.00410806965643672,0.00747312012587785,-0.0105392457902839,0.0187553851031573,0.582527439927278
NMR metabolomics,X23428.Concentration of VLDL Particles,PRC1,Protein regulator of cytokinesis 1,40451,0.00243327944742495,0.0044281765486379,-0.00624594658790533,0.0111125054827552,0.582673817540387
NMR metabolomics,X23428.Concentration of VLDL Particles,DUSP29,Dual specificity phosphatase 29,40182,0.00364814884127277,0.00670235689319501,-0.00948847066938944,0.016784768351935,0.586240344786904
NMR metabolomics,X23428.Concentration of VLDL Particles,REG4,Regenerating islet-derived protein 4,42638,-0.00282217952912318,0.00521693300667462,-0.0130473682222054,0.00740300916395907,0.588540489671608
NMR metabolomics,X23428.Concentration of VLDL Particles,COPE,Coatomer subunit epsilon,42311,0.00254576109297217,0.00471453818023126,-0.00669473374028111,0.0117862559262255,0.589219294930307
NMR metabolomics,X23428.Concentration of VLDL Particles,TPBGL,Trophoblast glycoprotein-like,40182,-0.00224330875670972,0.00418070472875082,-0.0104374900250613,0.00595087251164188,0.591564293487006
NMR metabolomics,X23428.Concentration of VLDL Particles,ALDH2,"Aldehyde dehydrogenase, mitochondrial",40451,-0.00282077064285604,0.00526837157272713,-0.0131467789254012,0.00750523763968913,0.592372778209644
NMR metabolomics,X23428.Concentration of VLDL Particles,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42638,0.00184572202307701,0.00345333730157244,-0.00492281908800497,0.008614263134159,0.59302186618798
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRV1,Adhesion G-protein coupled receptor V1,40136,-0.00377329072946389,0.00709630520972766,-0.0176820489405301,0.0101354674816023,0.594926503426778
NMR metabolomics,X23428.Concentration of VLDL Particles,ERCC1,DNA excision repair protein ERCC-1,40080,0.00180761225305525,0.00340424236440296,-0.00486470278117455,0.00847992728728505,0.595437844347968
NMR metabolomics,X23428.Concentration of VLDL Particles,ARG2,"Arginase-2, mitochondrial",40451,-0.00224337285975724,0.00424914580567104,-0.0105716986388725,0.006084952919358,0.597538511723643
NMR metabolomics,X23428.Concentration of VLDL Particles,ADAMTSL5,ADAMTS-like protein 5,40511,0.00207119725131369,0.00392882344959453,-0.00562929670989159,0.00977169121251897,0.598078911105639
NMR metabolomics,X23428.Concentration of VLDL Particles,CD200,OX-2 membrane glycoprotein,42594,0.00143386577146537,0.00272521919614318,-0.00390756385297526,0.006775295395906,0.598794816597302
NMR metabolomics,X23428.Concentration of VLDL Particles,LYPD8,Ly6/PLAUR domain-containing protein 8,42346,0.00264304010271175,0.00503092408760152,-0.00721757110898723,0.0125036513144107,0.599342664265701
NMR metabolomics,X23428.Concentration of VLDL Particles,NRCAM,Neuronal cell adhesion molecule,42636,0.00149898836354344,0.00288397541923385,-0.00415360345815492,0.00715158018524179,0.603236206113083
NMR metabolomics,X23428.Concentration of VLDL Particles,TEX33,Testis-expressed protein 33,40302,0.00197402128535535,0.0037999637342712,-0.0054739076338162,0.00942195020452689,0.6034334485747
NMR metabolomics,X23428.Concentration of VLDL Particles,WFDC12,WAP four-disulfide core domain protein 12,42698,-0.00331227896029494,0.00649707115303577,-0.0160465384202451,0.00942198049965517,0.610192143269085
NMR metabolomics,X23428.Concentration of VLDL Particles,NCAM1,Neural cell adhesion molecule 1,42689,0.00151456665291254,0.00299863129815386,-0.00436275069146902,0.00739188399729411,0.613506690276859
NMR metabolomics,X23428.Concentration of VLDL Particles,NCR1,Natural cytotoxicity triggering receptor 1,42566,0.00192795512610443,0.00384190225477174,-0.00560217329324817,0.00945808354545703,0.615800256289627
NMR metabolomics,X23428.Concentration of VLDL Particles,ADGRE5,Adhesion G protein-coupled receptor E5,42737,0.00154917739526226,0.00309015821076998,-0.0045075326978469,0.00760588748837141,0.616149689878537
NMR metabolomics,X23428.Concentration of VLDL Particles,RASA1,Ras GTPase-activating protein 1,42311,0.00161366035048059,0.00321888891197658,-0.00469536191699351,0.00792268261795468,0.616161567191355
NMR metabolomics,X23428.Concentration of VLDL Particles,DHODH,Dihydroorotate dehydrogenase,40116,0.0024303886581613,0.00484886883335583,-0.00707339425521612,0.0119341715715387,0.616220796818578
NMR metabolomics,X23428.Concentration of VLDL Particles,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,40116,-0.00337357679602955,0.00673896817200992,-0.016581954413169,0.00983480082110989,0.616657596998479
NMR metabolomics,X23428.Concentration of VLDL Particles,ENPEP,Glutamyl aminopeptidase,40116,0.00237452749918434,0.00475577469693288,-0.00694679090680411,0.0116958459051728,0.617582674738571
NMR metabolomics,X23428.Concentration of VLDL Particles,EPB41L5,Band 4.1-like protein 5,40182,0.00302554676708376,0.00609876090690154,-0.00892802461044327,0.0149791181446108,0.619839394594591
NMR metabolomics,X23428.Concentration of VLDL Particles,HTR1B,5-hydroxytryptamine receptor 1B,40136,-0.00212738981730164,0.00430966834421042,-0.010574339771954,0.00631956013735078,0.621576068148493
NMR metabolomics,X23428.Concentration of VLDL Particles,CRX,Cone-rod homeobox protein,42357,0.00518324613135341,0.0105556088130451,-0.015505747142215,0.0258722394049218,0.623405004425185
NMR metabolomics,X23428.Concentration of VLDL Particles,CYTH3,Cytohesin-3,40080,-0.00364954975414599,0.00744171379802053,-0.0182353087982662,0.0109362092899743,0.623848087448825
NMR metabolomics,X23428.Concentration of VLDL Particles,PILRB,Paired immunoglobulin-like type 2 receptor beta,42636,0.00283377463639935,0.00577846494273581,-0.00849201665136284,0.0141595659241615,0.623856992235964
NMR metabolomics,X23428.Concentration of VLDL Particles,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",40116,-0.00340252874270916,0.00696983346709111,-0.0170634023382077,0.0102583448527894,0.625432613052157
NMR metabolomics,X23428.Concentration of VLDL Particles,ADRA2A,Alpha-2A adrenergic receptor,40116,-0.00335692627875903,0.00693465706246973,-0.0169488541211997,0.0102350015636816,0.628339057567808
NMR metabolomics,X23428.Concentration of VLDL Particles,CAPN3,Calpain-3,40451,-0.00182009959686036,0.00380232251619173,-0.00927265172859615,0.00563245253487544,0.632174871680261
NMR metabolomics,X23428.Concentration of VLDL Particles,PAEP,Glycodelin,42495,0.00427882060729821,0.00895105744167105,-0.0132652519783771,0.0218228931929735,0.632640953338924
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPT,Microtubule-associated protein tau,42311,-0.00252665419556597,0.00529029499162588,-0.0128956323791527,0.00784232398802076,0.632941636521357
NMR metabolomics,X23428.Concentration of VLDL Particles,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,40451,0.003596277949445,0.00762070103098659,-0.0113402960712887,0.0185328519701787,0.637000839414192
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC6A,C-type lectin domain family 6 member A,42346,0.00218172549976849,0.00472128378774428,-0.00707199072421029,0.0114354417237473,0.644014176589429
NMR metabolomics,X23428.Concentration of VLDL Particles,DCDC2C,Doublecortin domain-containing protein 2C,40080,0.00291193174378692,0.00630933162604305,-0.00945435824325746,0.0152782217308313,0.644429225613573
NMR metabolomics,X23428.Concentration of VLDL Particles,PFDN4,Prefoldin subunit 4,40080,0.00239529651639298,0.00523173802879611,-0.0078589100200474,0.0126495030528334,0.647076866526892
NMR metabolomics,X23428.Concentration of VLDL Particles,PNLIPRP2,Pancreatic lipase-related protein 2,42618,0.0134220759887291,0.0293965801934107,-0.0441952211903559,0.0710393731678142,0.647975810397489
NMR metabolomics,X23428.Concentration of VLDL Particles,FOLR3,Folate receptor gamma,42629,0.00838176696326017,0.0183896446889721,-0.0276619366271251,0.0444254705536454,0.648550285963182
NMR metabolomics,X23428.Concentration of VLDL Particles,BSND,Barttin,40080,0.00154623738669131,0.00340139726631317,-0.00512050125528251,0.00821297602866512,0.649414097768586
NMR metabolomics,X23428.Concentration of VLDL Particles,LELP1,Late cornified envelope-like proline-rich protein 1,40136,0.00331262832625498,0.00730993135842624,-0.0110148371362604,0.0176400937887704,0.650436625698456
NMR metabolomics,X23428.Concentration of VLDL Particles,CD3G,T-cell surface glycoprotein CD3 gamma chain,40199,0.00408583326692798,0.00902836902515252,-0.013609770022371,0.0217814365562269,0.65087815131278
NMR metabolomics,X23428.Concentration of VLDL Particles,FZD10,Frizzled-10,40182,0.00271327827303269,0.0060390578583196,-0.00912327512927373,0.0145498316753391,0.653232530193339
NMR metabolomics,X23428.Concentration of VLDL Particles,NEB,Nebulin,40116,-0.00171339622939723,0.00382845159246014,-0.00921716135061911,0.00579036889182465,0.654492014530547
NMR metabolomics,X23428.Concentration of VLDL Particles,MYBPC2,"Myosin-binding protein C, fast-type",40223,-0.00375902538946843,0.0084488604073604,-0.0203187917878948,0.012800741008958,0.656389856703009
NMR metabolomics,X23428.Concentration of VLDL Particles,EPGN,Epigen,40451,0.00200984697533848,0.00452583603242514,-0.0068607916482148,0.0108804855988918,0.656991091802241
NMR metabolomics,X23428.Concentration of VLDL Particles,THY1,Thy-1 membrane glycoprotein,42711,-0.00132564852048622,0.0029885138973339,-0.00718313575926066,0.00453183871828823,0.657352514885557
NMR metabolomics,X23428.Concentration of VLDL Particles,IL10,Interleukin-10,42370,0.00373395539608906,0.00844029463344969,-0.0128090220854723,0.0202769328776505,0.65820969363472
NMR metabolomics,X23428.Concentration of VLDL Particles,TUBB3,Tubulin beta-3 chain,40136,-0.00123945423589739,0.00280347550659067,-0.00673426622881511,0.00425535775702033,0.658415847861655
NMR metabolomics,X23428.Concentration of VLDL Particles,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42676,0.00251594021657443,0.00570462791194243,-0.00866513049083274,0.0136970109239816,0.659194775980239
NMR metabolomics,X23428.Concentration of VLDL Particles,CD82,CD82 antigen,40302,-0.00178227323388908,0.00407993370633624,-0.0097789432983081,0.00621439683052994,0.662236769004137
NMR metabolomics,X23428.Concentration of VLDL Particles,PDIA2,Protein disulfide-isomerase A2,40080,0.00183146574419863,0.00419868608159111,-0.00639795897571993,0.0100608904641172,0.662700472334484
NMR metabolomics,X23428.Concentration of VLDL Particles,IFNL1,Interferon lambda-1,42311,-0.00198258052879971,0.00455012887556252,-0.0109008331249023,0.00693567206730283,0.663047322165202
NMR metabolomics,X23428.Concentration of VLDL Particles,FCRLB,Fc receptor-like B,42346,0.00280498933115527,0.00645061462272982,-0.00983821532939518,0.0154481939917057,0.66368524512427
NMR metabolomics,X23428.Concentration of VLDL Particles,TSLP,Thymic stromal lymphopoietin,42357,0.00263436183977438,0.00606121801002862,-0.00924562545988171,0.0145143491394305,0.663841175862361
NMR metabolomics,X23428.Concentration of VLDL Particles,PSAPL1,Proactivator polypeptide-like 1,40449,0.0021886985529584,0.00507998050178386,-0.00776806323053798,0.0121454603364548,0.666587273055298
NMR metabolomics,X23428.Concentration of VLDL Particles,TET2,Methylcytosine dioxygenase TET2,40286,0.00438574538006852,0.0101929720293808,-0.0155924797975178,0.0243639705576549,0.667006514490269
NMR metabolomics,X23428.Concentration of VLDL Particles,MYH4,Myosin-4,40116,-0.00194398329623461,0.00452102284513558,-0.0108051880727004,0.00691722148023114,0.66721321952727
NMR metabolomics,X23428.Concentration of VLDL Particles,GNPDA1,Glucosamine-6-phosphate isomerase 1,40223,0.00142664411189483,0.00333944956601706,-0.00511867703749862,0.00797196526128827,0.669235184170805
NMR metabolomics,X23428.Concentration of VLDL Particles,TMED4,Transmembrane emp24 domain-containing protein 4,40116,0.00242568694366187,0.00571336809043933,-0.00877251451359922,0.013623888400923,0.671163346183067
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNF830,Zinc finger protein 830,40451,-0.0032656826189949,0.00771176914674736,-0.0183807501466197,0.0118493849086299,0.671962388989473
NMR metabolomics,X23428.Concentration of VLDL Particles,SMC3,Structural maintenance of chromosomes protein 3,40080,0.00234086779116892,0.00553521934018644,-0.0085081621155965,0.0131898976979343,0.672373474409165
NMR metabolomics,X23428.Concentration of VLDL Particles,IL36A,Interleukin-36 alpha,40199,0.00239025289606848,0.00573867640540597,-0.00885755285852721,0.0136380586506642,0.677040284849149
NMR metabolomics,X23428.Concentration of VLDL Particles,CTAG1A_CTAG1B,Cancer/testis antigen 1,40287,-0.0020767509826499,0.00499853292358331,-0.0118738755128732,0.0077203735475734,0.677804369535003
NMR metabolomics,X23428.Concentration of VLDL Particles,RELB,Transcription factor RelB,40199,-0.00203609010403094,0.00495292738950446,-0.0117438277874597,0.00767164757939781,0.681015852038936
NMR metabolomics,X23428.Concentration of VLDL Particles,LRP1,Prolow-density lipoprotein receptor-related protein 1,42587,0.00107443586185099,0.00263635193152168,-0.0040928139239315,0.00624168564763347,0.683613201966626
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP8,Neutrophil collagenase,42681,-0.00292171577923422,0.00724069673674254,-0.0171134813832496,0.0112700498247812,0.686577217662437
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTF,Ciliary neurotrophic factor,40136,-0.00136595777296346,0.00342540476258384,-0.0080797511076278,0.00534783556170087,0.690068504428035
NMR metabolomics,X23428.Concentration of VLDL Particles,MYL6B,Myosin light chain 6B,40182,0.0035940282730278,0.00905264439387998,-0.014149154738977,0.0213372112850326,0.691364708139163
NMR metabolomics,X23428.Concentration of VLDL Particles,PRTN3,Myeloblastin,42276,-0.00192183454516508,0.00484346574592881,-0.0114150274071856,0.00757135831685539,0.691529441837166
NMR metabolomics,X23428.Concentration of VLDL Particles,CASQ2,Calsequestrin-2,40116,0.00194136513613691,0.00489596618411773,-0.00765472858473384,0.0115374588570076,0.691726698828175
NMR metabolomics,X23428.Concentration of VLDL Particles,CLMP,CXADR-like membrane protein,42721,0.000863739702143717,0.0021790543224897,-0.00340720676993609,0.00513468617422353,0.69182888882875
NMR metabolomics,X23428.Concentration of VLDL Particles,PADI2,Protein-arginine deiminase type-2,42370,0.002180308193144,0.00553447559461138,-0.00866726397229431,0.0130278803585823,0.693624125104666
NMR metabolomics,X23428.Concentration of VLDL Particles,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42674,-0.00136220724891587,0.00345987987061009,-0.00814357179531164,0.00541915729747989,0.693797555060025
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL28,"39S ribosomal protein L28, mitochondrial",40482,-0.00145173510579344,0.00369100489763283,-0.00868610470515379,0.00578263449356691,0.694092765347252
NMR metabolomics,X23428.Concentration of VLDL Particles,GAMT,Guanidinoacetate N-methyltransferase,40116,-0.0014858317738291,0.00377776501720515,-0.0088902512075512,0.005918587659893,0.694098402652491
NMR metabolomics,X23428.Concentration of VLDL Particles,AKAP12,A-kinase anchor protein 12,40283,-0.0008569919595699,0.00219467649208001,-0.00515855788404673,0.00344457396490693,0.69618419623556
NMR metabolomics,X23428.Concentration of VLDL Particles,RYR1,Ryanodine receptor 1,40116,-0.00133414706300475,0.00343878509776935,-0.00807416585463268,0.00540587172862317,0.698045449495614
NMR metabolomics,X23428.Concentration of VLDL Particles,UGDH,UDP-glucose 6-dehydrogenase,40116,0.00368597785735938,0.00953634521607202,-0.0150052587661418,0.0223772144808605,0.699119922450324
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMG4,Proteasome assembly chaperone 4,40199,0.00218782970492631,0.00567402784746412,-0.00893326487610337,0.013308924285956,0.699810233492097
NMR metabolomics,X23428.Concentration of VLDL Particles,IL2RB,Interleukin-2 receptor subunit beta,42370,0.00150238742894984,0.00390123539696811,-0.00614403394910766,0.00914880880700735,0.700165427554648
NMR metabolomics,X23428.Concentration of VLDL Particles,RBM25,RNA-binding protein 25,40080,-0.00182079233682462,0.00472933980997345,-0.0110902983643726,0.00744871369072335,0.700245483801158
NMR metabolomics,X23428.Concentration of VLDL Particles,HK2,Hexokinase-2,42357,0.00105356108599697,0.00274050527612974,-0.00431782925521732,0.00642495142721126,0.700658234079837
NMR metabolomics,X23428.Concentration of VLDL Particles,GAST,Gastrin,40483,0.00549536943591318,0.0144490080258042,-0.022824686294663,0.0338154251664894,0.703708743588971
NMR metabolomics,X23428.Concentration of VLDL Particles,NXPE4,NXPE family member 4,40116,0.00127791550799062,0.00336096971294326,-0.00530958512937817,0.00786541614535942,0.703787828696318
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF168,E3 ubiquitin-protein ligase RNF168,40199,0.00150442639226084,0.00399998988257517,-0.0063355537775865,0.00934440656210817,0.706844192116661
NMR metabolomics,X23428.Concentration of VLDL Particles,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,40527,0.00101459801639345,0.00270013078856694,-0.00427765832919775,0.00630685436198465,0.707103221984383
NMR metabolomics,X23428.Concentration of VLDL Particles,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,40136,0.0023880915214243,0.00635695345322081,-0.0100715372468885,0.0148477202897371,0.707172471133849
NMR metabolomics,X23428.Concentration of VLDL Particles,NCLN,Nicalin,42370,-0.00190952354233608,0.00515210373675223,-0.0120076468663704,0.00818859978169828,0.710919188539777
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF20,Fibroblast growth factor 20,40199,0.0016554379325359,0.00449863375826989,-0.00716188423367309,0.0104727600987449,0.712890138870054
NMR metabolomics,X23428.Concentration of VLDL Particles,EFNB2,Ephrin-B2,40182,0.00198971917682998,0.00543023542460533,-0.00865354225539646,0.0126329806090564,0.714062557018162
NMR metabolomics,X23428.Concentration of VLDL Particles,HIF1A,Hypoxia-inducible factor 1-alpha,40199,-0.00225644495469898,0.00619106615541104,-0.0143909346193046,0.00987804470990666,0.715515633649296
NMR metabolomics,X23428.Concentration of VLDL Particles,ERVV_1,,40116,0.00158148065479826,0.00435107171375764,-0.00694661990416672,0.0101095812137632,0.716261434286388
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,40283,-0.00155525442290688,0.00430958062947404,-0.010002032456676,0.00689152361086224,0.718193780555936
NMR metabolomics,X23428.Concentration of VLDL Particles,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",40199,0.0015269139142472,0.00423240247500415,-0.00676859493676093,0.00982242276525533,0.718280069019707
NMR metabolomics,X23428.Concentration of VLDL Particles,PKLR,Pyruvate kinase PKLR,42636,-0.00232724505759694,0.00646312240585656,-0.0149949649730758,0.0103404748578819,0.718792509890746
NMR metabolomics,X23428.Concentration of VLDL Particles,NPTN,Neuroplastin,42346,0.00281040717208745,0.00781053337479201,-0.0124982382425049,0.0181190525866798,0.718985507284012
NMR metabolomics,X23428.Concentration of VLDL Particles,PI16,Peptidase inhibitor 16,40532,-0.000893973743493673,0.00249859087584711,-0.00579121186015402,0.00400326437316667,0.720506262014258
NMR metabolomics,X23428.Concentration of VLDL Particles,SCN3A,Sodium channel protein type 3 subunit alpha,40182,-0.00131761517679039,0.00369304621342081,-0.00855598575509518,0.00592075540151439,0.72126130348786
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHA10,Ephrin type-A receptor 10,42311,-0.00237165390088913,0.00665597138858381,-0.0154173578225134,0.0106740500207351,0.721606869231119
NMR metabolomics,X23428.Concentration of VLDL Particles,HEPACAM2,HEPACAM family member 2,40483,-0.0014876148745211,0.00418821605826593,-0.00969651834872233,0.00672128859968012,0.722453459926715
NMR metabolomics,X23428.Concentration of VLDL Particles,IMPG1,Interphotoreceptor matrix proteoglycan 1,40136,0.0010648937116208,0.003007919778859,-0.00483062905494284,0.00696041647818444,0.723323253989429
NMR metabolomics,X23428.Concentration of VLDL Particles,MAGEA3,Melanoma-associated antigen 3,40302,-0.00305624325727404,0.0086472680468654,-0.0200048886291302,0.0138924021145821,0.723769397994124
NMR metabolomics,X23428.Concentration of VLDL Particles,IL20,Interleukin-20,42370,0.00172656733545241,0.00488635101189948,-0.00785068064787057,0.0113038153187754,0.723835521944132
NMR metabolomics,X23428.Concentration of VLDL Particles,TPSD1,Tryptase delta,40482,-0.00130832242330201,0.00381890523932726,-0.00879337669238345,0.00617673184577942,0.731912580495968
NMR metabolomics,X23428.Concentration of VLDL Particles,CLEC10A,C-type lectin domain family 10 member A,42495,-0.00123882557707549,0.00361838291153747,-0.00833085608368893,0.00585320492953795,0.732077909527101
NMR metabolomics,X23428.Concentration of VLDL Particles,TNNI3,"Troponin I, cardiac muscle",42357,0.00284844344543115,0.0083748047738695,-0.0135661739113531,0.0192630608022154,0.733771152311513
NMR metabolomics,X23428.Concentration of VLDL Particles,PTK7,Inactive tyrosine-protein kinase 7,42311,-0.00128107656727752,0.00379575507031934,-0.00872075650510343,0.00615860337054838,0.735743579642047
NMR metabolomics,X23428.Concentration of VLDL Particles,PLXDC2,Plexin domain-containing protein 2,40483,0.000906913327143655,0.00271368606663404,-0.00441191136345905,0.00622573801774636,0.73823500674257
NMR metabolomics,X23428.Concentration of VLDL Particles,HBZ,Hemoglobin subunit zeta,40511,0.00353124077435195,0.0105861862104927,-0.0172176841982137,0.0242801657469176,0.738709765969729
NMR metabolomics,X23428.Concentration of VLDL Particles,ARMCX2,Armadillo repeat-containing X-linked protein 2,40136,-0.00208040614538812,0.00623913092245794,-0.0143091027534057,0.0101482904626294,0.738804893498859
NMR metabolomics,X23428.Concentration of VLDL Particles,TMED10,Transmembrane emp24 domain-containing protein 10,40116,-0.00159267268123484,0.00480766385412927,-0.0110156938353282,0.00783034847285853,0.740440954971373
NMR metabolomics,X23428.Concentration of VLDL Particles,KLHL41,Kelch-like protein 41,40482,-0.00156533606434166,0.00476514093999426,-0.0109050123067304,0.00777434017804709,0.742541757997978
NMR metabolomics,X23428.Concentration of VLDL Particles,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",40199,0.000925132248569955,0.00283211072597099,-0.00462580477433318,0.00647606927147309,0.743932615835826
NMR metabolomics,X23428.Concentration of VLDL Particles,TP53BP1,TP53-binding protein 1,40199,-0.00282521172819549,0.0086532845876029,-0.0197856495198972,0.0141352260635062,0.744059788940947
NMR metabolomics,X23428.Concentration of VLDL Particles,KDM3A,Lysine-specific demethylase 3A,40199,-0.00283735834968411,0.00873550879043275,-0.0199589555789323,0.0142842388795641,0.74533297833973
NMR metabolomics,X23428.Concentration of VLDL Particles,CHL1,Neural cell adhesion molecule L1-like protein,42668,0.000980258192995031,0.00302363649550833,-0.0049460693382013,0.00690658572419136,0.74579284590792
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC34A3,Sodium-dependent phosphate transport protein 2C,40080,0.0016097920588879,0.00503668213385339,-0.00826210492346473,0.0114816890412405,0.749267404225649
NMR metabolomics,X23428.Concentration of VLDL Particles,IL3RA,Interleukin-3 receptor subunit alpha,42370,-0.00103588273536923,0.00325281392059975,-0.00741139801974474,0.00533963254900628,0.750143034515317
NMR metabolomics,X23428.Concentration of VLDL Particles,DDX1,ATP-dependent RNA helicase DDX1,40449,-0.00156371439797064,0.00497601508861598,-0.011316703971658,0.00818927517571669,0.753336741893664
NMR metabolomics,X23428.Concentration of VLDL Particles,PSCA,Prostate stem cell antigen,40449,0.00829008270204303,0.0264771196115213,-0.0436050717365387,0.0601852371406248,0.754207720273547
NMR metabolomics,X23428.Concentration of VLDL Particles,REST,RE1-silencing transcription factor,40080,0.00106942659836223,0.00341773617657705,-0.00562933630772879,0.00776818950445324,0.754358863974128
NMR metabolomics,X23428.Concentration of VLDL Particles,SHC1,SHC-transforming protein 1,40080,0.00366203845428776,0.0117701310841003,-0.0194074184705488,0.0267314953791244,0.755707909793733
NMR metabolomics,X23428.Concentration of VLDL Particles,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,40449,0.00534427840558918,0.0174247260587084,-0.0288081846694793,0.0394967414806577,0.75907238292949
NMR metabolomics,X23428.Concentration of VLDL Particles,SLAMF1,Signaling lymphocytic activation molecule,42370,-0.00183667841043207,0.0060188410797117,-0.013633606926667,0.00996025010580285,0.760253055211733
NMR metabolomics,X23428.Concentration of VLDL Particles,TAP1,Antigen peptide transporter 1,40302,0.00187184673816794,0.00613656557704035,-0.0101558217928312,0.013899515269167,0.760347760242814
NMR metabolomics,X23428.Concentration of VLDL Particles,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",40482,0.00122709597240258,0.0040609546958974,-0.00673237523155633,0.00918656717636148,0.762528547873604
NMR metabolomics,X23428.Concentration of VLDL Particles,OPTC,Opticin,42587,0.00138885675503242,0.00459740401534959,-0.00762205511505277,0.0103997686251176,0.762583673377334
NMR metabolomics,X23428.Concentration of VLDL Particles,VNN2,Vascular non-inflammatory molecule 2,42587,0.00136103579865793,0.00451661504838506,-0.00749152969617678,0.0102136012934926,0.763160085693444
NMR metabolomics,X23428.Concentration of VLDL Particles,MYOC,Myocilin,42611,0.00133442541520555,0.00443636076601988,-0.0073608416861934,0.0100296925166045,0.763577153207534
NMR metabolomics,X23428.Concentration of VLDL Particles,CGN,Cingulin,40182,0.00122813171112482,0.00410152336459756,-0.00681085408348639,0.00926711750573604,0.764615300187562
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTNAP4,Contactin-associated protein-like 4,40182,0.00306326010239881,0.0102392326476836,-0.017005635887061,0.0231321560918587,0.764816825435794
NMR metabolomics,X23428.Concentration of VLDL Particles,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,40116,-0.00112458968539352,0.00376215824934448,-0.00849841985410869,0.00624924048332166,0.765005690439549
NMR metabolomics,X23428.Concentration of VLDL Particles,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42594,-0.00447342281015949,0.0149767558454081,-0.0338278642671594,0.0248810186468405,0.765180424251493
NMR metabolomics,X23428.Concentration of VLDL Particles,TYMP,Thymidine phosphorylase,42563,0.00192313689623681,0.00644187398878748,-0.0107029361217866,0.0145492099142603,0.765298080058888
NMR metabolomics,X23428.Concentration of VLDL Particles,TOP1MT,"DNA topoisomerase I, mitochondrial",40080,-0.00145145583848798,0.00487777006195752,-0.0110118851599247,0.00810897348294877,0.766040526460463
NMR metabolomics,X23428.Concentration of VLDL Particles,ACHE,Acetylcholinesterase,40283,-0.000980774685213218,0.00331141930203128,-0.00747115651719453,0.00550960714676809,0.767098510178549
NMR metabolomics,X23428.Concentration of VLDL Particles,HTR1A,5-hydroxytryptamine receptor 1A,40136,0.00231050725489458,0.00781889918898577,-0.0130145351555175,0.0176355496653067,0.767615357122055
NMR metabolomics,X23428.Concentration of VLDL Particles,PRAME,Melanoma antigen preferentially expressed in tumors,40080,-0.000739032503026205,0.00251232845047648,-0.00566319626596011,0.0041851312599077,0.768639438447767
NMR metabolomics,X23428.Concentration of VLDL Particles,HDDC2,5'-deoxynucleotidase HDDC2,40449,0.00128131498780401,0.00436973059611243,-0.00728335698057636,0.00984598695618437,0.769355454005629
NMR metabolomics,X23428.Concentration of VLDL Particles,SUSD4,Sushi domain-containing protein 4,40451,0.00120019587905836,0.00417438822471266,-0.00698160504137845,0.00938199679949518,0.77372392530538
NMR metabolomics,X23428.Concentration of VLDL Particles,IL19,Interleukin-19,42261,-0.00206191243272095,0.00717616544430304,-0.0161271967035549,0.012003371838113,0.773865830183815
NMR metabolomics,X23428.Concentration of VLDL Particles,PCNA,Proliferating cell nuclear antigen,40080,0.00178838421691124,0.00623138362840496,-0.0104251276947625,0.014001896128585,0.774120594448342
NMR metabolomics,X23428.Concentration of VLDL Particles,VEGFD,Vascular endothelial growth factor D,42734,-0.0010250570139997,0.00358045829870781,-0.00804275527946701,0.0059926412514676,0.774658769406165
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMC3,26S proteasome regulatory subunit 6A,40080,0.000851314622833167,0.00305129318854417,-0.00512922002671341,0.00683184927237975,0.780249163049933
NMR metabolomics,X23428.Concentration of VLDL Particles,MSLNL,Mesothelin-like protein,40182,-0.00109166505365358,0.003917548897697,-0.0087700608931397,0.00658673078583253,0.78051083417488
NMR metabolomics,X23428.Concentration of VLDL Particles,GIPC2,PDZ domain-containing protein GIPC2,40483,-0.000853324299270054,0.00307724175386266,-0.00688471813684087,0.00517806953830076,0.781553549359493
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF2RB,Cytokine receptor common subunit beta,40199,-0.00117238039028093,0.00433766719998912,-0.0096742081022596,0.00732944732169773,0.786950681550442
NMR metabolomics,X23428.Concentration of VLDL Particles,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42611,-0.00310568804933007,0.0117793983676967,-0.0261933088500156,0.0199819327513554,0.792050426284948
NMR metabolomics,X23428.Concentration of VLDL Particles,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,40527,-0.00065882742059789,0.00251465667068174,-0.00558755449513409,0.00426989965393832,0.79333007508434
NMR metabolomics,X23428.Concentration of VLDL Particles,NGFR,Tumor necrosis factor receptor superfamily member 16,40511,-0.000770255996096008,0.00294432600790414,-0.00654113497158812,0.00500062297939611,0.793629285520543
NMR metabolomics,X23428.Concentration of VLDL Particles,CSH1,Chorionic somatomammotropin hormone 1,40532,-0.000732844049299322,0.00283706890111682,-0.00629349909548829,0.00482781099688964,0.79617214525045
NMR metabolomics,X23428.Concentration of VLDL Particles,PXDNL,Peroxidasin-like protein,40451,-0.00141824066417635,0.00554334686179103,-0.0122832005132868,0.00944671918493406,0.798074769742027
NMR metabolomics,X23428.Concentration of VLDL Particles,GJA8,Gap junction alpha-8 protein,40080,-0.00165612175097547,0.00650152163854632,-0.0143991041625263,0.0110868606605753,0.798937745180174
NMR metabolomics,X23428.Concentration of VLDL Particles,FHIP2A,FHF complex subunit HOOK interacting protein 2A,40116,0.00117122820527647,0.00474385305466849,-0.00812672378187377,0.0104691801924267,0.804995006375866
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP5PO,"ATP synthase subunit O, mitochondrial",42311,0.000991363747189583,0.00406626419172789,-0.00697851406859707,0.00896124156297624,0.807387907032417
NMR metabolomics,X23428.Concentration of VLDL Particles,IL12RB2,Interleukin-12 receptor subunit beta-2,40199,-0.00101262209097527,0.00415632912994525,-0.00915902718566796,0.00713378300371742,0.807519021065266
NMR metabolomics,X23428.Concentration of VLDL Particles,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42495,0.00148627237796476,0.00613622094686252,-0.0105407206778858,0.0135132654338153,0.808618870089823
NMR metabolomics,X23428.Concentration of VLDL Particles,HSP90B1,Endoplasmin,42247,-0.00159644107010984,0.00662885618437108,-0.0145889991914771,0.0113961170512575,0.809689065311609
NMR metabolomics,X23428.Concentration of VLDL Particles,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,40116,-0.00142558859559977,0.0059723089802408,-0.0131313141968717,0.0102801370056722,0.811342897398562
NMR metabolomics,X23428.Concentration of VLDL Particles,PCDH17,Protocadherin-17,42636,0.000879687440976147,0.0036956322303208,-0.00636375173045263,0.00812312661240492,0.811858075165423
NMR metabolomics,X23428.Concentration of VLDL Particles,SEMA4C,Semaphorin-4C,42587,0.000640148133443858,0.00276013209602798,-0.00476971077477098,0.00605000704165869,0.816598544601846
NMR metabolomics,X23428.Concentration of VLDL Particles,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,40302,0.00143707425081594,0.00626788444221482,-0.0108479792559251,0.013722127757557,0.818658778658807
NMR metabolomics,X23428.Concentration of VLDL Particles,FDX1,"Adrenodoxin, mitochondrial",40116,0.00138974037616847,0.0061749021625309,-0.0107130678623921,0.013492548614729,0.821934680073942
NMR metabolomics,X23428.Concentration of VLDL Particles,ALMS1,Alstrom syndrome protein 1,40302,-0.000969847704100537,0.00444186790425154,-0.00967590879643354,0.00773621338823247,0.827166421062986
NMR metabolomics,X23428.Concentration of VLDL Particles,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,40255,0.0010374410644034,0.00481619861317781,-0.00840230821742511,0.0104771903462319,0.829454280720756
NMR metabolomics,X23428.Concentration of VLDL Particles,CLNS1A,Methylosome subunit pICln,40182,0.000709014158591707,0.00331912882906819,-0.00579647834638195,0.00721450666356537,0.83085162769574
NMR metabolomics,X23428.Concentration of VLDL Particles,BRME1,Break repair meiotic recombinase recruitment factor 1,40136,0.000889671739112062,0.00417795981338522,-0.00729912949512296,0.00907847297334709,0.831374559860494
NMR metabolomics,X23428.Concentration of VLDL Particles,SSB,Lupus La protein,42311,-0.00122585186062669,0.00578810269942403,-0.0125705331514978,0.0101188294302444,0.832275564076234
NMR metabolomics,X23428.Concentration of VLDL Particles,HCG22,Protein PBMUCL2,40116,-0.00119714811264382,0.00568315141519282,-0.0123361248864217,0.0099418286611341,0.833165384727484
NMR metabolomics,X23428.Concentration of VLDL Particles,FBLN2,Fibulin-2,40527,0.000679458438638458,0.00324866730562469,-0.00568792948038593,0.00704684635766284,0.834334981347069
NMR metabolomics,X23428.Concentration of VLDL Particles,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,40302,0.000986086718777054,0.00471549148289363,-0.00825627658769446,0.0102284500252486,0.834361187829527
NMR metabolomics,X23428.Concentration of VLDL Particles,ESR1,Estrogen receptor,40199,-0.00113758581877324,0.00551343547061958,-0.0119439193411876,0.00966874770364114,0.836537150201859
NMR metabolomics,X23428.Concentration of VLDL Particles,TFF2,Trefoil factor 2,42654,-0.00118195983305955,0.00577160859648324,-0.0124943126821667,0.0101303930160476,0.837740365081287
NMR metabolomics,X23428.Concentration of VLDL Particles,FOS,Proto-oncogene c-Fos,40065,-0.000713888729255798,0.00356019271990948,-0.00769186646027837,0.00626408900176678,0.841077913823599
NMR metabolomics,X23428.Concentration of VLDL Particles,IL3,Interleukin-3,40080,0.00121287415430637,0.00615658819734416,-0.0108540387124882,0.0132797870211009,0.843827875284187
NMR metabolomics,X23428.Concentration of VLDL Particles,NRN1,Neuritin,40482,-0.000704018303072537,0.00361760487968523,-0.00779452386725558,0.00638648726111051,0.845702594692863
NMR metabolomics,X23428.Concentration of VLDL Particles,MAPRE3,Microtubule-associated protein RP/EB family member 3,40080,-0.00276695333007341,0.0142772993815137,-0.0307504601178403,0.0252165534576935,0.846335405857882
NMR metabolomics,X23428.Concentration of VLDL Particles,KHDC3L,KH domain-containing protein 3,40080,0.0013218189332057,0.00687672727805768,-0.0121565665317874,0.0148002043981988,0.84757637973648
NMR metabolomics,X23428.Concentration of VLDL Particles,UHRF2,E3 ubiquitin-protein ligase UHRF2,40116,-0.000694030334381779,0.00361467617848423,-0.00777879564421086,0.0063907349754473,0.847743064306262
NMR metabolomics,X23428.Concentration of VLDL Particles,PDCD1LG2,Programmed cell death 1 ligand 2,42587,0.000602614620432207,0.00316214070249001,-0.00559518115644821,0.00680041039731263,0.848864029798081
NMR metabolomics,X23428.Concentration of VLDL Particles,WNT9A,Protein Wnt-9a,42370,0.000553760860621618,0.00294964018671438,-0.00522753390533857,0.00633505562658181,0.851084582601413
NMR metabolomics,X23428.Concentration of VLDL Particles,COL4A4,Collagen alpha-4(IV) chain,40284,0.000992829921090696,0.00532975864750083,-0.00945349702801094,0.0114391568701923,0.85222823287502
NMR metabolomics,X23428.Concentration of VLDL Particles,TPRKB,EKC/KEOPS complex subunit TPRKB,40080,-0.00120096522536033,0.00657526100687774,-0.0140884767988407,0.01168654634812,0.855076790679243
NMR metabolomics,X23428.Concentration of VLDL Particles,BEX3,Protein BEX3,40080,-0.000863116374643373,0.00476319159698881,-0.0101989719047414,0.0084727391554547,0.856209674295862
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJA1,DnaJ homolog subfamily A member 1,40080,-0.000857223247762518,0.00474932094529696,-0.0101658923005446,0.00845144580501951,0.856768237724559
NMR metabolomics,X23428.Concentration of VLDL Particles,CNTN1,Contactin-1,42794,0.000494844602615967,0.00276141220476241,-0.00491752331871835,0.00590721252395029,0.857783465286595
NMR metabolomics,X23428.Concentration of VLDL Particles,ANKRA2,Ankyrin repeat family A protein 2,40080,0.00101450541090051,0.00571957816977517,-0.0101958678018588,0.0122248786236599,0.859217797703506
NMR metabolomics,X23428.Concentration of VLDL Particles,RUVBL1,RuvB-like 1,42346,0.00185715172151247,0.0104954398794353,-0.0187139104421807,0.0224282138852057,0.859551613428799
NMR metabolomics,X23428.Concentration of VLDL Particles,RNF4,E3 ubiquitin-protein ligase RNF4,40302,-0.00117762380919859,0.00667645478574438,-0.0142634751892576,0.0119082275708604,0.859995017635836
NMR metabolomics,X23428.Concentration of VLDL Particles,RETN,Resistin,42598,-0.000745305024489335,0.0043032434741289,-0.00917966223378197,0.0076890521848033,0.862499897413178
NMR metabolomics,X23428.Concentration of VLDL Particles,PTPRS,Receptor-type tyrosine-protein phosphatase S,42794,-0.000420799021234123,0.00246241958346151,-0.00524714140481868,0.00440554336235043,0.864314035088385
NMR metabolomics,X23428.Concentration of VLDL Particles,SPINT3,Kunitz-type protease inhibitor 3,40449,0.00231813575131538,0.0147824061679175,-0.0266553803378029,0.0312916518404336,0.875391718672829
NMR metabolomics,X23428.Concentration of VLDL Particles,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,40182,-0.000806976874253783,0.00515560332246163,-0.0109119593862786,0.00929800563777101,0.875622692251553
NMR metabolomics,X23428.Concentration of VLDL Particles,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",40136,-0.000886964565123111,0.00567660318198569,-0.0120131068018151,0.0102391776715688,0.875839498999118
NMR metabolomics,X23428.Concentration of VLDL Particles,SOD2,"Superoxide dismutase [Mn], mitochondrial",42611,0.000566627497120955,0.00374408714609979,-0.00677178330923463,0.00790503830347654,0.879710351113109
NMR metabolomics,X23428.Concentration of VLDL Particles,KLK1,Kallikrein-1,42505,0.00193111010545515,0.0128609933738731,-0.0232764369073362,0.0271386571182465,0.880646587856305
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFBR1,TGF-beta receptor type-1,40199,-0.000319808406429448,0.00215434289822468,-0.00454232048694982,0.00390270367409092,0.881991753476577
NMR metabolomics,X23428.Concentration of VLDL Particles,SLC1A4,Neutral amino acid transporter A,40182,-0.000760512256764816,0.00518642244243227,-0.0109259002439321,0.00940487573040244,0.883422633424456
NMR metabolomics,X23428.Concentration of VLDL Particles,LRP2BP,LRP2-binding protein,40182,-0.0012502398642397,0.00858857952101216,-0.0180838557254235,0.0155833759969441,0.884263490769265
NMR metabolomics,X23428.Concentration of VLDL Particles,TPT1,Translationally-controlled tumor protein,42370,0.000943895238928206,0.00649493339250793,-0.0117861742103873,0.0136739646882437,0.884454185177928
NMR metabolomics,X23428.Concentration of VLDL Particles,CD160,CD160 antigen,42754,0.000703297416232627,0.00486803454787916,-0.00883805029761053,0.0102446451300758,0.885129469627387
NMR metabolomics,X23428.Concentration of VLDL Particles,MRPL24,"39S ribosomal protein L24, mitochondrial",40116,0.000525591878282958,0.00389230733366419,-0.00710333049569886,0.00815451425226477,0.892587876844125
NMR metabolomics,X23428.Concentration of VLDL Particles,APOA4,Apolipoprotein A-IV,40539,-0.000439529207998815,0.00359235405780158,-0.0074805431612899,0.00660148474529228,0.902622968552029
NMR metabolomics,X23428.Concentration of VLDL Particles,MEGF11,Multiple epidermal growth factor-like domains protein 11,40116,0.00041018793815384,0.00335550366274774,-0.00616659924083173,0.00698697511713941,0.902708561211532
NMR metabolomics,X23428.Concentration of VLDL Particles,HBQ1,Hemoglobin subunit theta-1,42721,-0.000707297117510812,0.0059794325272064,-0.0124269848708353,0.0110123906358137,0.905840956236286
NMR metabolomics,X23428.Concentration of VLDL Particles,CNGB3,Cyclic nucleotide-gated cation channel beta-3,40136,-0.000606987369881485,0.00536707811967284,-0.0111264604844402,0.00991248574467727,0.909957657901498
NMR metabolomics,X23428.Concentration of VLDL Particles,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42746,-0.000450740461844643,0.00400700786874589,-0.00830447588458658,0.0074029949608973,0.910438118234399
NMR metabolomics,X23428.Concentration of VLDL Particles,FSHB,Follitropin subunit beta,40223,0.000589787397595253,0.0053942287962865,-0.0099829010431263,0.0111624758383168,0.912937395206841
NMR metabolomics,X23428.Concentration of VLDL Particles,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42618,-0.000798621279541007,0.00740570268274678,-0.0153137985377247,0.0137165559786427,0.914125262880942
NMR metabolomics,X23428.Concentration of VLDL Particles,DAND5,DAN domain family member 5,40199,-0.000561978045500638,0.00552538345115306,-0.0113917296097606,0.0102677735187594,0.918989968010387
NMR metabolomics,X23428.Concentration of VLDL Particles,GAD1,Glutamate decarboxylase 1,40080,0.000260612596155155,0.00260756630649338,-0.00485021736457186,0.00537144255688217,0.920390019019421
NMR metabolomics,X23428.Concentration of VLDL Particles,CREB3,Cyclic AMP-responsive element-binding protein 3,40080,0.000571151096025453,0.00574579152244271,-0.0106906002879623,0.0118329024800132,0.920819829835969
NMR metabolomics,X23428.Concentration of VLDL Particles,PSMA1,Proteasome subunit alpha type-1,42346,0.000455088077222117,0.00459097395789858,-0.0085432208802591,0.00945339703470333,0.921039187318068
NMR metabolomics,X23428.Concentration of VLDL Particles,TPPP2,Tubulin polymerization-promoting protein family member 2,40302,-0.000737942832362814,0.00808014137939071,-0.0165750199359686,0.015099134271243,0.927233648385075
NMR metabolomics,X23428.Concentration of VLDL Particles,DNAJA4,DnaJ homolog subfamily A member 4,40483,-0.000641138740577125,0.00702662551450419,-0.0144133247490053,0.0131310472678511,0.927300183186407
NMR metabolomics,X23428.Concentration of VLDL Particles,CRYBB2,Beta-crystallin B2,40483,-0.000705436344535222,0.00811871568406305,-0.0166181190852988,0.0152072463962284,0.930760377861979
NMR metabolomics,X23428.Concentration of VLDL Particles,VTCN1,V-set domain-containing T-cell activation inhibitor 1,42346,-0.000274839014029314,0.00316374400692599,-0.00647577726760425,0.00592609923954562,0.930775019619449
NMR metabolomics,X23428.Concentration of VLDL Particles,ATP2B4,Plasma membrane calcium-transporting ATPase 4,40116,0.000513889674636238,0.00611068661030337,-0.0114630560815584,0.0124908354308308,0.932980947037737
NMR metabolomics,X23428.Concentration of VLDL Particles,CA8,Carbonic anhydrase-related protein,40199,-0.0002398317184815,0.00285482951473467,-0.00583529756736145,0.00535563413039845,0.933050707836454
NMR metabolomics,X23428.Concentration of VLDL Particles,PPT1,Palmitoyl-protein thioesterase 1,40182,-0.000610960825717129,0.00766834746615995,-0.0156409218593906,0.0144190002079564,0.936498724994899
NMR metabolomics,X23428.Concentration of VLDL Particles,CPLX2,Complexin-2,40080,-0.000250202070972816,0.00316369876829771,-0.00645105165683632,0.00595064751489069,0.936966228213736
NMR metabolomics,X23428.Concentration of VLDL Particles,EPHA2,Ephrin type-A receptor 2,42125,0.000261785330315595,0.00334437227178342,-0.00629318432237991,0.0068167549830111,0.937609422804269
NMR metabolomics,X23428.Concentration of VLDL Particles,ATRAID,All-trans retinoic acid-induced differentiation factor,40449,0.000224789608717072,0.00295452953958096,-0.0055660882888616,0.00601566750629575,0.939354380157344
NMR metabolomics,X23428.Concentration of VLDL Particles,CINP,Cyclin-dependent kinase 2-interacting protein,40302,0.000315147550989356,0.00437163328365052,-0.00825325368496567,0.00888354878694438,0.942532218000021
NMR metabolomics,X23428.Concentration of VLDL Particles,MMP15,Matrix metalloproteinase-15,40511,0.000348541976150854,0.00486206202101896,-0.00918109958504631,0.00987818353734802,0.942853032193682
NMR metabolomics,X23428.Concentration of VLDL Particles,CTHRC1,Collagen triple helix repeat-containing protein 1,40527,0.000202246663950296,0.00292443284161987,-0.00552964170562465,0.00593413503352524,0.944865417925209
NMR metabolomics,X23428.Concentration of VLDL Particles,IZUMO1,Izumo sperm-egg fusion protein 1,40080,0.000303288546887974,0.00475209598327236,-0.00901081958032586,0.00961739667410181,0.949113085893339
NMR metabolomics,X23428.Concentration of VLDL Particles,HMMR,Hyaluronan mediated motility receptor,40059,-0.000312768948975649,0.004951190532189,-0.0100171023920661,0.0093915644941148,0.949631934879551
NMR metabolomics,X23428.Concentration of VLDL Particles,EVPL,Envoplakin,40302,0.000205307156434775,0.00350570225002015,-0.00666586925360472,0.00707648356647427,0.953300618248646
NMR metabolomics,X23428.Concentration of VLDL Particles,CDAN1,Codanin-1,40483,0.000131580178588221,0.00224898319494622,-0.00427642688350636,0.0045395872406828,0.953346205316339
NMR metabolomics,X23428.Concentration of VLDL Particles,SCIN,Adseverin,40136,0.000418679216664523,0.00726769921898224,-0.0138260112525407,0.0146633696858697,0.954061753724585
NMR metabolomics,X23428.Concentration of VLDL Particles,ZNF75D,Zinc finger protein 75D,40302,0.000331996260850978,0.00611070070956399,-0.0116449771298945,0.0123089696515964,0.956672978772365
NMR metabolomics,X23428.Concentration of VLDL Particles,FGF6,Fibroblast growth factor 6,40199,-0.000216289865398637,0.00413427962761722,-0.00831947793552838,0.00788689820473111,0.958277682169516
NMR metabolomics,X23428.Concentration of VLDL Particles,CHIT1,Chitotriosidase-1,42699,-0.00078179648720106,0.0153032532606304,-0.0307761728780367,0.0292125799036345,0.959256992789737
NMR metabolomics,X23428.Concentration of VLDL Particles,TNN,Tenascin-N,40527,0.000218970375961945,0.00438351350788425,-0.00837271609949119,0.00881065685141508,0.960160590474395
NMR metabolomics,X23428.Concentration of VLDL Particles,NENF,Neudesin,40451,0.000517203683994486,0.0109456391925294,-0.0209362491333631,0.0219706565013521,0.962313197165835
NMR metabolomics,X23428.Concentration of VLDL Particles,HLA_A,,40482,0.000155430250315367,0.00329897189741831,-0.00631055466862452,0.00662141516925525,0.962422601665425
NMR metabolomics,X23428.Concentration of VLDL Particles,RANGAP1,Ran GTPase-activating protein 1,42346,0.000204247665000633,0.00479644107092696,-0.0091967768340162,0.00960527216401746,0.966034458221119
NMR metabolomics,X23428.Concentration of VLDL Particles,TAGLN3,Transgelin-3,40080,0.000257707661342276,0.00610717096818055,-0.0117123474362916,0.0122277627589761,0.966341988348724
NMR metabolomics,X23428.Concentration of VLDL Particles,OSM,Oncostatin-M,42534,-0.000290164018026915,0.0069428003389229,-0.0138980526823158,0.013317724646262,0.966663931636866
NMR metabolomics,X23428.Concentration of VLDL Particles,SMPD3,Sphingomyelin phosphodiesterase 3,40199,0.000216439920732809,0.00546470248652204,-0.0104943769528504,0.010927256794316,0.968407245411737
NMR metabolomics,X23428.Concentration of VLDL Particles,ATF4,Cyclic AMP-dependent transcription factor ATF-4,40080,-0.000136492839341319,0.00344624453945672,-0.0068911321366765,0.00661814645799386,0.968407767033135
NMR metabolomics,X23428.Concentration of VLDL Particles,H2AP,Huntingtin-interacting protein M,40080,-0.000200122921322047,0.00524766005935334,-0.0104855366376546,0.0100852907950105,0.969580227582121
NMR metabolomics,X23428.Concentration of VLDL Particles,BTNL10,Butyrophilin-like protein 10,40080,0.0001497183536703,0.00424908423628109,-0.00817848674944063,0.00847792345678123,0.971892648579414
NMR metabolomics,X23428.Concentration of VLDL Particles,MN1,Transcriptional activator MN1,40182,-0.000190593498049837,0.00590104760865077,-0.0117566468110054,0.0113754598149057,0.974234793142536
NMR metabolomics,X23428.Concentration of VLDL Particles,IL13RA2,Interleukin-13 receptor subunit alpha-2,40136,8.56874001295532e-05,0.00289239238096733,-0.00558340166656641,0.00575477646682552,0.976366591176911
NMR metabolomics,X23428.Concentration of VLDL Particles,KRT8,"Keratin, type II cytoskeletal 8",40136,-0.000237902248374481,0.00807681192378615,-0.0160684536189953,0.0155926491222464,0.976502269712751
NMR metabolomics,X23428.Concentration of VLDL Particles,CD164L2,CD164 sialomucin-like 2 protein,40182,0.000103736713455214,0.00362752699163285,-0.00700621619014517,0.00721368961705559,0.977186452853163
NMR metabolomics,X23428.Concentration of VLDL Particles,RLN1,Prorelaxin H1,40482,0.000122947801718824,0.00481495311095839,-0.00931436029575961,0.00956025589919726,0.979629018598127
NMR metabolomics,X23428.Concentration of VLDL Particles,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,40451,9.63887312221793e-05,0.00446517681434417,-0.0086553578248924,0.00884813528733676,0.982777972124999
NMR metabolomics,X23428.Concentration of VLDL Particles,ICAM3,Intercellular adhesion molecule 3,42794,5.26218317325905e-05,0.00266910075881192,-0.00517881565553876,0.00528405931900394,0.984270861544058
NMR metabolomics,X23428.Concentration of VLDL Particles,OSMR,Oncostatin-M-specific receptor subunit beta,42705,-3.3818930148169e-05,0.00200430854618689,-0.00396226368067448,0.00389462582037814,0.986538089359009
NMR metabolomics,X23428.Concentration of VLDL Particles,IL22,Interleukin-22,40451,0.000111772496874924,0.0069617396958195,-0.0135332373069313,0.0137567823006811,0.987190595827347
NMR metabolomics,X23428.Concentration of VLDL Particles,TGFBR3,Transforming growth factor beta receptor type 3,42794,-2.59464441146503e-05,0.00314454688980426,-0.006189258348131,0.0061373654599017,0.99341665034223
NMR metabolomics,X23428.Concentration of VLDL Particles,PHLDB2,Pleckstrin homology-like domain family B member 2,40080,-2.13357432510393e-05,0.00959215263449522,-0.0188219549068617,0.0187792834203596,0.99822531440024
